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Dear Participants,
On behalf of the local Organizing Committee of the
University Medical Centre Nijmegen, it is my pleasure to
welcome you to the sixth European Meeting on Mitochon-
drial Pathology (Euromit 6).
In the year 2004, the University Children’s Hospital, to
which the Nijmegen Centre for Mitochondrial Disorders, the
principle organisers of this meeting, belongs, celebrates its
fiftieth anniversary with lots of different activities, the Euro-
mit 6 meeting being one of the most important scientific ones.
The number of participants of the Euromit meetings is
steadily growing. This year we will have around 400
participants from all over the world! The success of the
Euromit meetings can be explained not only by the high
scientific level covering the whole spectrum from basic
science to clinical research but is also due to the increased
importance mitochondrial energy metabolism has in a broad
range of different disease areas.doi:10.1016/j.bbabio.2004.05.001In this abstract book, you will find all the contributions of
the participants of Euromit 6. The programme with invited
speakers, free communications and a timetable is included.
Also, as a result of this conference, a special BBA issue—
sponsored by Elsevier—will be published shortly after the
meeting. This special issue will contain articles from the
invited speakers.
The conference will take place in the ‘‘Studiecentrum der
Medische Wetenschappen’’ of the University Medical Centre
Nijmegen. Lectures will be held in the ‘‘Lammers Zaal’’ on
the first floor. A slide-preview room, a computer room with
access to e-mail and the Internet, and a room for small
meetings (approximately 25 people maximum) are available
at the ‘‘Studiecentrum’’.
I wish you a most exciting and enjoyable meeting, as
well as a great time in Nijmegen.Prof. Dr. Jan A.M. Smeitink
Chairman Nijmegen Centre for Mitochondrial Disorders
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I-1
Mitochondrial medicine
S. DiMauro
Columbia University, 4-420 College of Physicians and
Surgeons, 630 West 168th Street, 10032 New York, NY, USA
sd12@columbia.edu
The concept of mitochondrial disease was introduced in
1962, when Luft and coworkers described a woman with
severe hypermetabolism not due to ‘‘loose coupling’’ of
oxidative phosphorylation in muscle mitochondria. During
the decade that followed, the attention of clinical scientists
was largely directed to muscle morphology: ‘‘megaconial’’
and ‘‘pleoconial’’ myopathies were described by Shy and
Gonatas, and the ‘‘ragged-red fibers’’ (RRF) were intro-
duced by W. King Engel.
In the 1970s, biochemical studies began identifying
specific metabolic defects, leading to a classification of
the mitochondrial diseases into five major groups: (i) defects
of substrate transport; (ii) defects of substrate utilization;
(iii) defects of the Krebs cycle; (iv) defects of the electron-
transport chain; and (v) defects of oxidation/phosphoryla-
tion coupling. However, the term mitochondrial diseases has
been restricted to defects of the respiratory chain. This
conventional wisdom is supported by the biochemical
complexity of the respiratory chain and by its dual genetic
control, explaining the extraordinary clinical and genetic
heterogeneity of mitochondrial diseases.
The ‘‘molecular age’’ started in 1988, when mitochon-
drial DNA (mtDNA) deletions were associated to myopathy
by the late Anita Harding and her coworkers in London, and
a point mutation in the mtDNA ND4 gene was associated to
Leber’s hereditary optic neuropathy (LHON) by Doug
Wallace’s group in Atlanta.
I-2
Clinical presentation and disease course of
mitochondrial disease in children
A. Munnich
Department of Genetics and INSERM U-393 Hoˆpital
Necker Enfants Malades, 75743 Paris, France
munnich@necker.fr
Owing to the ubiquitous nature of oxidative phosphory-
lation, a defect of the mitochondrial respiratory chain should
be considered in any unexplained association of symptoms,
with a progressive course and involving seemingly unrelat-
ed organs or tissue. The disease may begin at virtually any
age, even antenatally. Reviewing a large series of provenrespiratory chain deficiency, we investigated the antenatal
manifestations of oxidative phosphorylation disorders in our
series. A total of 300 cases of proven respiratory enzyme
deficiency were retrospectively reviewed for fetal develop-
ment based on course and duration of pregnancy, antenatal
ultrasonography and birth weight, length and head circum-
ference. Particular attention was given to fetal movements,
oligo/hydramnios, fetal cardiac rhythms and heart ultra-
sounds (US) and US/echodoppler signs of brain, facial,
trunk, limb and organ anomalies. Retrospective analyses
detected low birth weight (below the 3rd centile for gesta-
tional age) in 23% of cases (68/300, P= 0.000001). Failure to
thrive was either isolated (48/300, 16%) or associated with
otherwise unexplained anomalies (20/300, 7%, P= 0.0001).
Antenatal anomalies were usually multiple and involved
several organs sharing no common function or embryolog-
ical origin. The following anomalies were observed: poly-
hydramnios (6/20), oligoamnios (2/20), arthrogryposis
(1/20), decreased fetal movements (1/20), ventricular septal
defects (2/20), hypertrophic cardiomyopathy (4/20), cardiac
rhythm anomalies (4/20), hydronephrosis (3/20), VACTERL
association (2/20) or a complex gastro-intestinal malforma-
tion (1/20). Central nervous system anomalies included
cerebellar agenesis, porencephalic cysts and enlarged ven-
tricles. These anomalies remained unexplained during preg-
nancy and only ascribed to the disease postnatally. They
were not related to the type or severity of enzyme deficiency.
While a number of metabolic diseases undergo a symp-
tom-free period, it appears that respiratory chain deficiency
may have an early antenatal expression, probably related to
the hitherto unknown time course of disease gene expres-
sion in the embryofetal period.
I-3
Clinical presentation and disease course of
mitochondrial disease in adults
D. Turnbull*, A. Schaefer
School of Neurosciences and Psychiatry, Department of
Neurology, Royal Victoria Infirmary, University of New-
castle, The Medical School, Framlington Place, NE2 4HH
Newcastle upon Tyne, United Kingdom
d.m.turnbull@ncl.ac.uk
The clinical features of mitochondrial disease in adults are
extremely variable. Some patients present with symptoms
and signs which are well recognised in mitochondrial disease
such as chronic progressive external ophthalmoplegia or
diabetes and deafness. However, many patients do not present
with phenotypes that are readily recognised as mitochondrial
disease and making a clinical diagnosis remains a consider-
able challenge. The involvement of different systems or the
presence of a maternally family history may be an important
clue to the diagnosis in some patients. Many adult patients
with mitochondrial disease have defects of the mitochondrial
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degree of heteroplasmy observed in different patients.
Our group has been collecting follow-up data from our
patients with mitochondrial disease for several years and for
some patients the disease has a benign clinical course.
However, for others close follow-up is essential to monitor
the development of treatable clinical problems such as
diabetes and cardiac conduction defects. Collecting infor-
mation on the natural history of specific mitochondrial
diseases is important to develop guidelines for management
for individual patients.
O-1
Surprising phenotypes of mtDNA maintenance protein
defects
A. Suomalainen-Wartiovaara*, P. Luoma, A. Melberg, K.
Nikali, H. Pihko, T. Lo¨nnqvist, G. van Goethem, A. Paetau,
B. Udd
Programme of Neurosciences, r. c522B, Helsinki University,
Biomedicum-Helsinki, Haartmaninkatu 8, P.O. Box 63,
00290 Helsinki, Finland
anu.wartiovaara@helsinki.fi
Mutations of mitochondrial replication helicase Twinkle
and mitochondrial DNA polymerase gamma (POLG) have
recently been shown to underlie inherited progressive ex-
ternal ophthalmoplegia (PEO) and result in accumulation of
multiple mtDNA deletions in the patients’ tissues. Typical
findings are COX-negative fibres in muscle biopsy sample
and multiple mtDNA mutations in Southern blot.
We have characterized in detail the clinical and molecular
genetic features of our family material with a variety of
neurological disturbances, for mutations in Twinkle and
POLG. We focused on such families, who had some symp-
toms described in PEO-families, such as Parkinsonism, poly-
neuropathy and ataxia. All these families did not have PEO.
We describe here two completely new neurodegenera-
tive phenotypes with POLG or Twinkle mutations, not
previously associated with mtDNA maintenance proteins.
These patients do not have PEO. These patients have
been completely missed in routine DNA and morpholog-
ical diagnostic procedures, since they do not show
morphological changes in the muscle suggestive of mito-
chondrial myopathy, nor do they have mtDNA deletions
detectable by Southern blot analysis. We have identified
a founder mutation in Finland for an adult-onset reces-
sive neurodegenerative disease, the prevalence of which
exceeds Friedreich’s ataxia in Finland. We also describe
an infantile neurodegenerative disorder associated with
recessive mutations of Twinkle. This is the first report of
recessive Twinkle mutations. Thirdly, we also report
highly significant (P < 10 6) co-segregation of Parkin-
sonism in our PEO families with dominant POLG
mutations.Our results show that mtDNA maintenance protein
defects can cause CNS-restricted neurodegenerative pheno-
types of infantile and adult onset.
I-4
The epidemiology of mitochondrial disorders
P. Chinnery*, A. Schaefer, D. Turnbull and the Newcastle
Mitochondrial Group
Mitochondrial Research Group, University of Newcastle
upon Tyne, NE2 4HH Newcastle upon Tyne, United Kingdom
P.F.Chinnery@newcastle.ac.uk
Until recently mitochondrial disorders were thought to be
extremely rare, only affecting one or two per million of the
population, but recent epidemiological studies in Europe and
Australia have shown that, as a group, mitochondrial diseases
are amongst the most common inherited disorders, affecting
at least 1 in 10,000 of the general population. The story is,
however, far from complete. With the increasing awareness
of mitochondrial disease amongst non-specialist physicians,
greater availability of biochemical andmolecular tests, and an
ever expanding phenotype, the true prevalence of mitochon-
drial disease is likely to be much greater than the published
figures. Over the last 5 years, we have continued to identify
new cases within a relatively small, well-defined area. De-
tailed family studies have revealed an increasing number of
oligosymptomatic cases in families with mtDNA and nuclear
genetic disorders. A number of additional questions also
remain unresolved. Does the incidence vary in different
ethnic groups, and what are the genetic and environmental
factors that influence the penetrance of different mtDNA
mutations? These issues have important implications for our
understanding of the pathogenesis of mitochondrial disease,
and the provision of health care to patients and their families.
I-5
Magnetic resonance in mitochondrial disorders
M. van der Knaap*, J. Valk
Neurology, Vrije Universiteit Medisch Centrum, P.O. Box
7057, 1007 MB Amsterdam, The Netherlands
ms.vanderknaap@vumc.nl
In mitochondrial disorders, magnetic resonance imaging
(MRI) and spectroscopy (MRS) are important mainly in two
aspects: diagnosis and monitoring.
MRI of the brain may facilitate a diagnosis in patients
who present with an encephalopathy. Different patterns of
abnormalities can be recognized:
a pattern of energy failure, consisting of cortical pseudo-
infarcts, basal ganglia lesions and brain stem lesions, in the
acute phase often with contrast enhancement.
EUROMIT 68a pattern of chronic neurodegeneration with global
cerebral and/or cerebellar atrophy.
a pattern of focal or diffuse white matter abnormalities,
often with cystic degeneration and areas of contrast
enhancement.
malformations are rare and may include agenesis of the
corpus callosum and cortical dysplasia.
The first pattern is typically seen in MELAS, Leigh
syndrome and NARP. The second pattern is seen in
MERFF. The third pattern may be seen in complex I
deficiency, succinate dehydrogenase deficiency, cyto-
chrome c oxidase deficiency and MNGIE. The fourth
pattern is seen in severe variants of pyruvate dehydroge-
nase complex deficiency. Patients often display a combi-
nation of abnormalities from different patterns on their
MRIs. Cerebral white matter abnormalities in combination
with lesions in the basal ganglia and brain stem are
relatively frequent and, for example, typical for Kearns–
Sayre syndrome. Many patients with significant cerebral
white matter abnormalities on the basis of a mitochondrial
disorder have basal ganglia lesions. The latter feature
facilitates the diagnosis.
Characteristic for mitochondrial disorders is that abnor-
malities may come and go and be entirely or partially
reversible. This makes MRI useful in the monitoring of
abnormalities over time and under treatment.
Proton MRS reveals variable elevations of lactate in
mitochondrial disorders, although lactate is not elevated in
all patients. Some found a good correlation between brain and
CSF levels of lactate, but discrepancies have been described
repeatedly. There is a regional variability in elevations of
cerebral lactate, lactate elevations being most pronounced in
regions where MRI shows fresh structural abnormalities.
Lactate decreases again when the lesion turns into inactive
scar tissue. In pyruvate dehydrogenase complex deficiency,
elevated cerebral pyruvate may be demonstrable in addition
to the elevated lactate. In patients with succinate dehydroge-
nase deficiency, elevated succinate can easily be detected. In
addition, spectroscopic changes are present related to tissue
damage, including a decrease in N-acetylaspartate, glutamate
and creatine, related to neuronal dysfunction and loss. The
spectroscopic features can be used to monitor the course of
disease, in particular to evaluate effects of treatment.
O-2
Clinical spectrum, morbidity, and mortality in 113
patients with mitochondrial disease
F. Scaglia*, J. Towbin, W. Craigen, J. Belmont, E. Smith, S.
Fernbach, J. Hunter, G. Vladutiu, L.-J. Wong, H. Vogel
Molecular and Human Genetics, Baylor College of Medi-
cine, One Baylor Plaza, 77030 Houston, TX, USA
fscaglia@bcm.tmc.eduMitochondrial disorders are clinical entities associated
with abnormalities of oxidative phosphorylation. Since
their natural history remains largely unknown, the aim of
this study was to investigate the clinical history of
pediatric mitochondrial disorders based on different pre-
senting features. By using the modified Walker criteria,
113 patients with definite mitochondrial disease were
identified. Respiratory chain (RC) defects were found
in 71% of the patients who underwent a muscle biopsy.
Complex I (32%), and combined complex I, III, and IV
deficiencies (26%) were the most common causes of RC
defects, followed by complex III (19%), complex IV
(16%), and complex II deficiencies (7%). MtDNA ab-
normalities were found in 11% of the patients. Forty-two
percent of the children studied exhibited cardiomyopathy,
however, the majority (58%) had predominant neuromus-
cular manifestations. No correlation between the type of
RC defect and the clinical presentation was noted. The
mean age of diagnosis was 33 months in the cardiac
group and 44 months in the non-cardiac group (P <
0.005). Patients with cardiomyopathy had an 18% sur-
vival rate at 16 years of age compared to patients with
neuromuscular features, who had a 90% survival at
the same age (P < 0.0001). This study supports the
concept that in patients with RC defects, cardiomyopathy
is more common than previously believed, and that
patients with cardiomyopathy follow a more severe
clinical course, regardless of the associated RC defect.
MtDNA mutations were found in a minority of patients,
underlining the fact that most of the mitochondrial
disorders of childhood follow a Mendelian pattern of
inheritance.
O-3
Brain MRI and proton MR spectroscopy (MRS) in the
diagnostic evaluation of children with respiratory chain
(RC) defects
A. Dinopoulos*, K. Cecil, B. Wong, M. Schapiro, T.
DeGrauw, J. Egelhoff
Neurology, Cincinnati Children Hospital Medical Center,
333 Burnet Avenue, 45229-3039 Cincinnati, OH, USA
argidino@yahoo.com
Objective: To compare the morphological and regional
metabolite changes with MRI and MRS in patients with RC
defects.
Method/Results: We retrospectively evaluated MRI and
MRS studies in 47 children (mean age of presentation 1.7
years) with RC deficiency. Patients were divided in three
groups (22 ‘‘definite’’, 14 ‘‘probable’’, 11 ‘‘possible’’)
according to Modified Adult Criteria for the diagnosis of
RC defect (lactate peak on MRS was not used as criterion).
Imaging abnormalities were compared in three groups using
x2 statistics.
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imaging 3.5 years). All patients with ‘‘pure’’ myopathy had
normal initial and follow-up studies. Abnormalities in
patients with encephalomyopathy were in ‘‘definite’’/‘‘prob-
able’’/‘‘possible’’, respectively:
Deep-gray matter: 42%/7.7%/0% {2 = 8.1 df = 2
P= 0.02}
Delay of myelination: 32%/46%/37%
Leukoencephalopathy: 26%(subcortical involvement)/
31%/25%
Cerebral atrophy: 37%/23%/12%
Cerebellar atrophy: 47%/38%/0%
Lactate peak: 79%/36%/0% {2 = 13.2 df = 2 P= 0.01}
Low NAA/Cr: 64%/27%/25%
Conclusion: The most prominent structural abnormality,
mainly in patients with definite RC defect, is the deep gray-
matter involvement and represents a useful diagnostic marker
for the disease. Delay of myelination, leukoencephalopathy
and cerebral atrophy are observed across all groups and are
nonspecific. Subcortical WM involvement is the main leu-
koencephalopathy pattern on the ‘‘definite’’ group. Cerebel-
lar atrophy is more frequent than cerebral atrophy. The
presence of lactate peak on MRS, in the absence of hypoxia,
ischemia or infection, is an independent metabolic marker
and can be used to enhance the diagnostic certainty in RC
defects. A low NAA/Cr was observed in all groups and it is a
nonspecific marker.
I-6
Biochemical and molecular diagnostics: how do we
decide what gene(s) to investigate?
D. Thorburn
Mitochondrial Research, Murdoch Children’s Research In-
stitute, Royal Children’s Hospital, Flemington Rd Parkville,
VIC 3052 Melbourne, Australia
thorburd@cryptic.rch.unimelb.edu.au
Clinical phenotype, family history, muscle histochemis-
try and respiratory chain enzymology all provide useful
clues for guiding studies to identify the causative gene in
patients with mitochondrial disorders. However, in most
cases these indicators have low predictive value. For exam-
ple, complex I deficiency can be caused by mutations in at
least eight nuclear-encoded subunit genes, six mtDNA-
encoded subunit genes, and a substantial number of uniden-
tified genes. Clearly, we need other methods to help guide
molecular investigations, and two such approaches will be
discussed. Blue Native PAGE immunoblotting is being used
in an increasing number of labs as a supplementary method
to enzyme diagnosis, and it appears that mutations in
specific genes usually give consistent BN-PAGE results.
In complex I deficiency, for example, mutations in somesubunits such as ND6 and ND1 give gross diminution in the
amount of fully assembled complex, while mutations in
ND3 have relatively little effect on the BN-PAGE profile.
Mutations in some nuclear-encoded subunits such as
NDUFS4 result in loss of fully assembled complex I with
accumulation of a large assembly intermediate of f 700
kDa. DNA microarrays are also an attractive way to attempt
to predict the causative gene. Results with Affymetrix
cDNA chips or custom-made cDNA ‘‘mitochips’’ have been
promising but are expensive and prone to difficulty with
interindividual variation. An alternative approach is to use
cheaper Compugen oligo-arrays representing 19,000 genes,
which recently allowed us to identify gross underexpression
in two patient cell lines of a subunit gene not previously
shown to cause complex I deficiency.
I-7
Molecular diagnostics: new developments
A. Ro¨tig
Hoˆpital Necker-Enfants Malades, INSERM U393, 149 Rue
de Se`vres, 75015 Paris, France
roetig@necker.fr
The mitochondrial respiratory chain (RC) results from
the expression of both mitochondrial and nuclear genes.
The number of disease-causing mutations in nuclear
genes is steadily growing and mtDNA deletions and
mutations account for no more than 15–20% of patients.
Unfortunately, for only very few patients have the
disease causing mutations been identified. Thus, eluci-
dating the genetic bases of RC is both essential for
genetic diagnosis of patients and for fundamental knowl-
edge of these disorders. The molecular diagnostics of
mitochondrial disorders come under both genetic diag-
nostic and research. Indeed, identification of a new gene
in a specific patient allows to perform genetic diagnosis
in other families and identification of mutations in
already known disease-causing genes allows to constitute
a cohort of patients for further functional studies. Thus,
elucidating the genetic bases of RC deficiency is an
essential task that needs the use of several appropriate
strategies. Fine phenotypage of patients and candidate
gene screening is a first step for the constitution of well-
characterized cohorts of patients. Genetic mapping has to
be used in large families. This approach is greatly
enhanced in the case of consanguineous families. The
consanguinity of the parents should also lead to test
genetic markers surrounding the gene loci rather than to
directly sequence several candidate genes. However, the
main problem is encountered in the cases of sporadic
cases for which no genetic approaches can be developed.
In these cases, functional complementation by human
chromosomes or cDNA is the only presently available
strategy.
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Consensual protocols for the spectrophotometric assays
of respiratory chain activities
A. Lombes
Institut de Myologie, CHU Pitie´-Salpeˆtrie`re, Human Mito-
chondrial Disease French Network, INSERM 582, AP/HP,
47, bd de l’hoˆpital, 75651 Paris, France
a.lombes@myologie.chups.jussieu.fr
Mitochondrial disorders have very diverse clinical presen-
tations. Genetic investigations are most often conducted after
a first diagnosis based on metabolic alterations, morpholog-
ical anomalies, and/or defects of themitochondrial respiratory
chain. For efficient screening, this body of arguments has to
be searched for by comparable protocols. In France, the
hospitals involved in the diagnosis of mitochondrial diseases
use quite different protocols. We have evaluated the conse-
quences of the diverse protocols by analysis of an identical
sample. The results demonstrate the need to obtain consensual
protocols in the prospect of multicentric recruitment of
patients with similar defect. These protocols were chosen by
discussion and then experimentally validated on beef heart
mitochondria and on postnuclear supernatants from mouse
and human muscle. The goal was to have reliable assays with
(1) really maximum velocities (to better distinguish mild
defects), (2) linear reaction with time (to avoid miscalcula-
tions), and (3) reaction rate proportional to the amount of
tissue (to avoid false positive and false negative). This work
demonstrates the difficulties of the respiratory chain assays.
The complete set of experimental validations will be acces-
sible on thewebsite HCForum. In general, themore active the
activity, the more difficult to reach the proposed goal. Several
unexpected behaviourwere observed (particularly in complex
I and complex III analyses). In order to set up a quality control,
we have started to immortalize skin fibroblasts from patients
expressing diverse defects of the respiratory chain. We have
also started experimental validation of the consensual proto-
cols on normal cultured skin fibroblasts.
O-5
Automated analysis of respiratory chain complex (RCC)
enzyme activities in cultured skin fibroblasts
S. Hahn*, S. Hartman, J. Huey, M. Magera, D. Matern, P.
Rinaldo, S. Pitkanen, N. MacKay, J. Cameron, B. Robinson
Lab Med and Pathology, Mayo Clinic, 200 First St. SW,
Hilton 330, 55902 Rochester, MN, USA
hahn.sihoun@mayo.edu
We have developed an automated spectrophotometric
assay in cultured skin fibroblasts to determine the following
RCC activities: rotenone-sensitive NADH CoQ reductase(Complex I), rotenone-sensitive NADH-cytochrome c reduc-
tase (I + III), succinate cytochrome c reductase (II + III), and
cytochrome c oxidase (IV). Citrate synthase (CS) is also
measured as indicator of cellular integrity and mitochondrial
proliferation, and for result normalization purposes. Skin
fibroblasts are cultured in uridine-supplemented media, har-
vested, and diluted to 1 mg/ml protein. All five RCC compo-
nents are analyzed simultaneously on a Hitachi 912 automatic
analyzer. Enzyme activities are reported as nmol substrate/
min/mg protein and mU/mg protein. Reference ranges were
derived from the analysis of normal cell lines purchased from
commercial sources. Intra-assay precision (N = 10) for each of
the five RC profile assays yielded coefficients of variance
ranging from 0% to 9%, with a mean of 3%. Seven disease
controls including complex I, II + III, and IV deficiencies
were blindly tested for validation. Concordant results were
obtained in all but one case. One discrepant result was
obtained from a cell line diagnosed elsewhere to have
complex I deficiency. Our analysis showed normal activity
(66% ofmean control value) withmild CS elevation (141%of
mean control value). If confirmed by additional studies, this
discrepancy could be explained by a spontaneous recovery of
activity over period time in cultured condition, a previously
described event in RCC disorders. Advantages of this auto-
mated method are fast analytical time (less than 1 h), reduced
sample size, and improved analytical precision.
I-8
New genes in mitochondrial disorders
M. Zeviani
Division of Molecular Neurogenetics, Instituto Nazionale
Neurologico, Via Temolo 4, 20126 Milan, Italy
zeviani@tin.it
The identification of nuclear disease genes is a ‘‘hot
issue’’ in mitochondrial medicine. We still ignore the
genetic cause in more than 80% of infantile, and in
approximately 50% of adult-onset, mitochondrial disorders.
High-throughput, automated analysis of mtDNA has be-
come available in several specialized centers worldwide,
and helps exclude a primary involvement of the mitochon-
drial genome in these cases. The discovery of new disease
genes is hampered by the remarkable clinical and genetic
heterogeneity of mitochondrial syndromes and the scarcity
of informative families. On the other hand, the development
of new bioinformatics algorithms and the completion of the
human genome project are new tools that, together with
traditional strategies, can help progress in this area. An
example is the recent discovery of the gene responsible for
Ethylmalonic Encephalopathy (EE), a devastating infantile
metabolic disorder affecting brain, gastrointestinal tract and
peripheral vessels. Using an integration of physical and
functional genomic data sets, we identified ETHE1 as a
new gene, responsible for EE. The corresponding protein
EUROMIT 6 11product is targeted to mitochondria and internalized into the
matrix after energy-dependent cleavage of a short leader
peptide. The severe consequences of its malfunctioning
indicate an important role of the ETHE1 gene product in
mitochondrial homeostasis and energy metabolism. Similar
strategies led us to identify new disease loci for different
biochemical defects of the respiratory chain. Finally, the
characterization of the clinical spectrum associated with
mutations in individual genes is important for the establish-
ment of diagnostic guidelines in mitochondrial disorders.
I-9
How to find genes for recessive oxidative phosphorylation
disorders, and what to do once you have found them
E. Shoubridge
McGill University, Montreal Neurological Institute, H3A
2B4 Montreal, Canada
eric@ericpc.mni.mcgill.ca
Most autosomal recessive oxidative phosphorylation dis-
orders show up in the pediatric population, and they are
nearly always fatal in the first years of life. In addition, there is
a great deal of genetic heterogeneity associated with similar
biochemical deficiencies, so gene discovery by conventional
linkage analysis is usually not feasible. Primary skin fibro-
blast or myoblast cultures from these patients often exhibit a
biochemical phenotype, and it is therefore possible to con-
template identifying the underlying genetic defects by func-
tional complementation techniques such as transduction with
retroviral expression libraries, microcell-mediated chromo-
some transfer, or overexpression of candidate genes using
retroviral vectors. I will discuss our efforts along these lines in
patients with isolated Complex I and Complex IV defects and
in patients with multiple respiratory chain enzyme deficien-
cies. I will also show how studies in cell lines and tissues from
patients who have mutations in assembly factors or structural
subunits have contributed to our understanding of the assem-
bly of the respiratory chain complexes.
O-6
Truncated product of the bifunctional DLST gene
involved in the assembly of the mitochondrial respiratory
complexes and associated with Alzheimer’s disease
S. Ohta
Department of Biochemistry and Cell Biology, Institute of
Development and Aging Sciences, Nippon Medical School,
1-396 Kosugi-cho, Nakahara-ku, 211-8533 Kawasaki, Japan
ohta@nms.ac.jp
Dihydrolipoamide succinyltransferase (DLST) is a sub-
unit-enzyme of the alpha ketoglutarate dehydrogenase com-
plex involved in the Krebs cycle. We previously reported agenetic association between polymorphisms of the DLST
gene and Alzheimer’s disease (AD) [Lancet 350 (1977)
1367]. While studying how the DLST genotype contributes
to the pathogenesis of AD, we detected a novel mRNA that is
transcribed starting from intron 7 and its translational product
(designated MIRTD). MIRTD localized to the intermem-
brane space of mitochondria. To investigate the function of
MIRTD, we established human neuroblastoma cell lines
expressing a kind of ribozyme that specifically digests the
MIRTD mRNA. The expression of the ribozyme specifically
eliminated the MIRTD protein and the resultant MIRTD-
deficient cells exhibited a marked decrease in the amounts of
subunits of the complexes I and IV, resulting in a decline of
the respiratory activity. A pulse-label experiment revealed
that the loss of the subunits is a posttranslational event. Thus,
the DLST gene bifunctionally contributes to mitochondrial
energy metabolism: the full-length DLST protein is involved
in the Krebs cycle in the matrix while the truncated version,
MIRTD, contributes to the assembly of the respiratory com-
plexes in the intermembrane space. In addition, MIRTD
expression was decreased depending upon the AD-associated
polymorphism of the DLST gene. Moreover, the MIRTD-
mRNAwas not detected in the brains isolated from half of AD
patients. Several laboratories have reported the association
between AD and defects of complex IV. Therefore, decrease
of MIRTD may contribute to AD by affecting the biogenesis
of the mitochondrial respiratory chain.
O-7
Pyruvate dehydrogenase E1 beta subunit deficiency
G. Brown*, R. Brown, R. Head, I. Boubriak, J. Leonard,
N. Thomas
Genetics Unit, Department of Biochemistry, University of
Oxford, South Parks Road, OX1 3QU Oxford, United
Kingdom
garry.brown@bioch.ox.ac.uk
Pyruvate dehydrogenase deficiency is clinically highly
heterogeneous, with presentations including neonatal lactic
acidosis, Leigh syndrome and chronic neurodegeneration.
The pyruvate dehydrogenase complex is composed of
multiple copies of five main subunits, the E1 alpha and
E1 beta subunits of the E1 (pyruvate dehydrogenase)
component, E2 (dihydrolipoamidetransacetylase), E3 (dihy-
drolipoamide dehydrogenase) and the E3 binding protein.
The clinical heterogeneity does not simply reflect underly-
ing genetic variability as the great majority of cases are due
to mutations in the X-linked gene for the E1 alpha subunit.
A small number of patients have mutations in the E3 and E3
binding protein genes, but no mutations have previously
been defined in the genes for either the E1 beta or E2
subunits. We describe two unrelated patients with pyruvate
dehydrogenase deficiency due to mutations in the gene for
the E1 beta subunit. Both patients presented with lactic
EUROMIT 612acidosis and muscle hypotonia in infancy and had marked
reduction in enzyme activity and immunoreactive E1 beta
protein. In each case there was a missense mutation (Y132C
and P344S), which is predicted to reduce the stability of the
tetrameric, alpha2-beta2, E1 enzyme. Activity of the pyru-
vate dehydrogenase complex was restored in cultured
fibroblasts from both patients by transfection and expres-
sion of the normal E1 beta coding sequence.
I-10
Structural proteomics of mitochondria
J. Walker
Wellcome Trust, MRC Building, Medical Research Council
Dunn Human Nutrition Unit, Hills Road, CB2 2XY Cam-
bridge, United Kingdom
walker@mrc-dunn.cam.ac.uk
Almost all of the major components of mitochondrial
inner membranes were identified before the proteomic age.
Reanalysis of these membranes by mass spectrometric meth-
ods has confirmed the presence of its protein components, but
the identification of some important proteins required careful
detailed analysis. Other components that were known to be
present, including hydrophobic proteins, small proteins and
highly charged proteins, for example, were missed. It is likely
that many less abundant mitochondrial membrane proteins
were alsomissed and that they remain to be discovered.Many
of the proteins that were detected contain posttranslational
modifications that have been defined by detailed analysis,
and some of these modifications are transient. Other proteins
are known to be present, but their biological functions are
unknown. Thus, the definition of the mitochondrial mem-
brane proteome is far from complete.
The determination of the structural proteome of the
respiratory chain is well advanced. High-resolution structures
have been solved for complexes II, III and IV, and the
structural analysis of ATP synthase is at an advanced stage.
The structural analysis of complex I and of the transport
proteins that support respiration is just beginning.
The lecture will review the achievements and the prob-
lems that remain to be solved in establishing the structural
proteome of mitochondrial membranes.
I-11
Replication of mitochondrial DNA
I. Holt*, T. Yasukawa, A. Reyes, M. Yang, M. Bowmaker
MRC Dunn Human Nutrition Unit, Hills Road, CB 2XY,
Cambridge, United Kingdom
ih@mrc-dunn.cam.ac.uk
Mitochondrial DNA (mtDNA) of humans and other
mammals was long believed to replicate via a strand-asynchronous mechanism, which entailed continuous syn-
thesis of both strands of DNA from physically and
temporally distinct sites. Replication by such a mecha-
nism would inevitably give rise to molecules with exten-
sive single-stranded regions. We have demonstrated that
the majority of replicating molecules are double-stranded
in carefully prepared mtDNA samples, and that single-
stranded regions arise as artefacts due to RNase degra-
dation. This is because mtDNA replication frequently
involves wholesale ribonucleotide incorporation on one
strand.
In parallel studies, we have found that replication ini-
tiates not from a discrete unidirectional origin, as was
previously supposed, but bidirectionally from multiple sites
dispersed across a broad zone. Unlike the E. coli chromo-
some, the mtDNA terminus is not opposite the origin
(initiation zone), hence one replication fork arrests much
earlier than the other, thereafter giving the illusion of
unidirectional replication. Replication of mtDNA generally
terminates in the major non-coding region.
I will describe new data which suggest the centre of the
initiation zone maps to the ND 6 gene and that initiation can
occur either side of the displacement loop.
I-12
Mammalian mitochondrial transcription and DNA
replication: in vitro reconstitution and molecular
characterization
C. Gustafsson*, M. Falkenberg
Department of Medical Nutrition, Karolinska Institute,
Novum, KUS-Huddinge, SE-141 86, Stockholm, Sweden
claes.gustafsson@mednut.ki.se
Mammalian mtDNA only contains two major pro-
moters, the light- and heavy-strand promoters (LSP and
HSP), which produce near-genomic length transcripts that
after RNA processing release individual mRNAs, tRNAs
and rRNAs. We have previously identified two transcrip-
tion factors, transcription factors B1 (TFB1M) and B2
(TFB2M), and demonstrated that they can each support
promoter-specific mtDNA transcription in a pure recom-
binant in vitro system containing mitochondrial RNA
polymerase (POLRMT) and mitochondrial transcription
factor A (TFAM). Our current studies demonstrate that
RNA polymerse specifically recognizes sequence ele-
ments localized between nt  1 and  14 relative to
the transcription start site, much similar to what has
previously been described for the homologous RNA
polymerase encoded by bacteriophage T7.
Transcription from LSP is not only necessary for gene
expression but also for production of RNA primers
required for initiation of mtDNA replication origin of
leading-strand replication (OH). We will here describe our
current studies of replication primer formation and attempt
EUROMIT 6 13to reconstitute OH-dependent initiation of mtDNA repli-
cation in vitro.
O-8
The majority of TFAM molecules are required for
maintenance of mitochondrial DNA and a minority for
transcription: TFAM-titration model
D. Kang
Clinical Chemistry and Laboratory Medicine, Kyushu Uni-
versity, 3-1-1 Maidashi Higashi-ku, 812-8582 Fukuoka,
Japan
kang@cclm.med.kyushu-u.ac.jp
Mitochondrial transcription factor A (TFAM), a tran-
scription factor for mitochondrial DNA (mtDNA), is a
member of the high mobility group proteins and also
possesses properties of nonspecific DNA-binding. Be-
cause replication of mtDNA is proposed to be coupled
with transcription, TFAM is thought to be essential for
replication of mtDNA. To clarify a role of TFAM in the
maintenance of mtDNA, we varied the amount of TFAM
in HeLa cells using a Tet-off gene expression system
and RNA interference. The amount of mtDNA changed
in direct proportion to that of TFAM, showing the
amount of mtDNA is precisely determined by the
amount of TFAM. TFAM lacking the C-terminal 25
amino acids (C-tail), which does not activate transcrip-
tion, was as effective as full-length TFAM, suggesting
that the transcription activity of TFAM does not mainly
contribute to the determination of the amount of
mtDNA. When we knocked down endogenous TFAM
to about 15% by RNA interference while maintaining the
amount of mtDNA by expressing the C-tail-deleted
TFAM, the mitochondrial transcription rate was main-
tained at a control level, suggesting that TFAM is in
excess for transcription but is dose-limiting for the
determination of the amount of mtDNA. Based on the
findings that (1) the recombinant TFAM as well as
endogenous TFAM are mostly bound to mtDNA, (2)
TFAM is abundant enough to cover the entire region of
mtDNA, and (3) TFAM is dose-limiting for the amount
of mtDNA, we propose a model that TFAM titrates the
mass of mtDNA directly.
O-9
Organization and dynamics of human mitochondrial
DNA
M. Rojo*, F. Malka, F. Legros, P. Frachon, A. Lombe`s
Institut de Myologie-CHU Pitie´-Salpeˆtrie`re, INSERM U582,
47, Bd de l’hopital, 75651, Paris Cedex 13, France
m.rojo@myologie.chups.jussieu.frHeteroplasmic mutations of mitochondrial DNA
(mtDNA) are an important source of human diseases.
The mechanisms governing transmission, segregation and
complementation of heteroplasmic mtDNA-mutations are
unknown but depend on the nature and dynamics of the
mitochondrial compartment as well as on the intrami-
tochondrial organization and mobility of mtDNA. We
show that mtDNA of human primary and immortal cells
is organized in several hundreds of nucleoids that
contain a mean of two to eight mtDNA molecules
each. Nucleoids are enriched in mitochondrial transcrip-
tion factor A and distribute throughout the entire mito-
chondrial compartment. Using cell fusion experiments,
we demonstrate that nucleoids and respiratory complexes
are mobile and diffuse efficiently into mitochondria
previously devoid of mtDNA. In contrast, nucleoid
mobility was lower within mitochondria of mtDNA-
containing cells, as differently labeled mtDNA molecules
remained spatially segregated in a significant fraction
(37%) of the polykaryons. These results show that
fusion-mediated exchange and intramitochondrial mobil-
ity of endogenous mitochondrial components are not
rate-limiting for intermitochondrial complementation but
can contribute to the segregation of mtDNA molecules,
and thus of mtDNA mutations, during cell growth and
division.
I-13
The chaperone/Tom70 mitochondrial targeting pathway
J. Young
Cellular Biochemistry, Max Planck Institute for Bio-
chemistry, Am Klopferspitz 18a, D-82152 Martinsried,
Germany
young@biochem.mpg.de
Most mitochondrial proteins are synthesized on ribo-
somes in the cytosol, and imported into the organelle
after translation. In mammals, many proteins of the inner
membrane metabolite carrier protein family are bound by
the cytosolic chaperones Hsc70 and Hsp90 during their
targeting. Docking of the chaperones onto the Tom70
import receptor is important for the transfer of the carrier
preproteins to the translocation machinery of the mito-
chondrial outer membrane. Disruption of the interaction
between the chaperones and Tom70 interferes with the
import of Tom70-dependent preproteins. Also, inhibition
of either Hsc70 or Hsp90 activity diminishes the import
efficiency of these preproteins. In the cytosol, these
preproteins are maintained in high-molecular-weight
chaperone complexes similar to those active in the
folding of cytosolic polypeptides. All of the components
required for mitochondrial targeting are contained in the
chaperone complexes. Thus, the Hsc70 and Hsp90 chap-
erone system responsible for polypeptide folding also
EUROMIT 614participates in the distinct but related process of protein
targeting.
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Regulation of mitochondrial activity by proteolysis
T. Langer
Institut fu¨r Genetik, Universita¨t zu Ko¨ln, Zu¨lpicherstrasse
47, 50674 Ko¨ln, Germany
Thomas.Langer@uni-koeln.de
The biogenesis and homeostasis of mitochondria is
controlled by conserved and ubiquitous ATP-dependent
proteases residing within the organelle. The identification
of a disease-causing mutation in paraplegin has recently
linked a dysfunction in the mitochondrial quality control
system to axonal degeneration in hereditary spastic paraple-
gia (HSP). Paraplegin represents a subunit of a highly
conserved ATP-dependent AAA protease in the inner mem-
brane of mitochondria. Two AAA proteases built up of
homologous subunits and exposing catalytic sites to oppo-
site membrane surfaces are apparently ubiquitously present
in mitochondria of eukaryotic cells. The m-AAA protease is
active on the matrix side and is composed of Yta10 and
Yta12 subunits in S. cerevisiae and of Afg3L2 and para-
plegin subunits in human mitochondria. Complementation
studies in yeast revealed functional conservation of mito-
chondrial AAA proteases. m-AAA proteases are crucial for
mitochondrial activity in yeast and human cells. Yeast cells
lacking the m-AAA protease exhibit deficiencies in the
expression of mitochondrially encoded polypeptides and
the posttranslational assembly of respiratory chain com-
plexes. Similarly, HSP fibroblasts show deficiencies in
complex I activity and resistance towards reactive oxygen
species. Ongoing studies to characterise the cellular function
of the conserved proteolytic system within mitochondria
will be discussed.
O-10
Chaperone-like activities of a new cytosolic factor AIP
and import receptors Tom20 and Tom22 facilitate
mitochondrial protein import
M. Mori*, M. Yano, K. Terada
Molecular Genetics, Kumamoto University School of Med-
icine, 1-1-1, Honjo, 860-8556, Kumamoto, Japan
masa@gpo.kumamoto-u.ac.jp
Most mitochondrial proteins are synthesized in the
cytosol with N-terminal presequences, maintained in a
loosely folded import-competent conformation by cytosolic
chaperones, and are imported into mitochondria via trans-
locator complexes containing preprotein receptors Tom20
and Tom22. We identified arylhydrocarbon receptor inter-acting protein (AIP), a cytosolic factor which interacts with
both Tom20 and preproteins [J. Cell Biol. 163 (2003) 45].
In vitro import assay showed that AIP prevents pre-orni-
thine transcarbamylase (pOTC) from loss of import-com-
petency. In cultured cells, overexpression of AIP enhanced
pOTC import, and its depletion by RNA interference
impaired the import. In vitro binding assay revealed that
AIP as well as Tom20 preferentially bind to mitochondrial
preproteins. Formation of a ternary complex of Tom20,
AIP and preprotein was also observed. These results
indicate that AIP functions as a cytosolic factor that
mediates preprotein import into mitochondria. Furthermore,
aggregation suppression assay using citrate synthase
showed that both AIP and Tom20 have chaperone-like
activities to prevent this protein from aggregating [J. Biol.
Chem., in press]. Tom20 binds to guanidinium chloride-
unfolded substrate proteins regardless of the absence of
presequence. Overexpression of Tom20 suppressed the
cytosolic degradation of pOTC. Tom22 also showed a
similar aggregation suppression activity, whereas Tom70
did not. Together, these results suggest that AIP, Tom20
and Tom22 have chaperone-like function to prevent their
substrate preproteins from degradation in the cytosol and
on the mitochondrial surface, and facilitate their import into
the organelle.
O-11
Biogenesis of the mitochondrial inner membrane
C. Koehler
Chemistry and Biochemistry, UCLA, 10337 Caribou Lane,
P.O. Box 951569, 90077, Los Angeles, CA, USA
koehler@chem.ucla.edu
The mitochondrion has two pathways for the import of
proteins coded in the nucleus. The general import pathway
is utilized by precursors with an amino-terminal targeting
presequence. Precursors are first translocated across the
Translocase of the Outer Membrane (TOM) and then
through the Translocase of the Inner Membrane(TIM23).
From our work, we identified a second import pathway for
the import and insertion of inner membrane proteins such as
those in the mitochondrial carrier family and the import
components. This import pathway is referred to the TIM22
pathway. Components include a family of small Tim
proteins in the mitochondrial intermembrane space, Tim8p,
Tim9p, Tim10p, Tim12p, and Tim13p, and the inner
membrane proteins, Tim22p, Tim18p, and Tim54p. Protein
import is an essential function for yeast and most of these
genes are required for viability. Mutations in the human
homolog of Tim8p, DDP1 (Deafness/Dystonia protein),
cause the X-link Mohr–Tranebjaerg syndrome (MTS).
Symptoms include blindness, deafness, dystonia, and men-
tal deterioration. We have shown that the Tim8p–Tim13p
complex fails to assemble in fibroblasts derived from
EUROMIT 6 15patients. From biochemical studies in yeast, we have shown
that DDP1 mediates the import of Tim23p. A decreased
abundance of these translocators may be the underlying
cause of MTS.
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Mouse models of isolated cytochrome oxidase deficiency
C. Moraes*, F. Diaz
Department of Neurology and Cell Biology and Anatomy,
University of Miami, 1095 NW 14th Terrace, 33136 Miami,
FL, USA
cmoraes@med.miami.edu
We have developed mouse models of cytochrome c
oxidase deficiency by the conditional deletion of the COX
10 gene, which is necessary for the formation of heme A in
mitochondria.
Deletion of COX 10 in the CNS by the synapsin-Cre led
to death on days P9–P12, in a model resembling Leigh
syndrome. Immunohistochemical studies showed the pres-
ence of cortical neurons with reduced COX I and increased
SDH(Fp). COX enzyme activity in KO brain homogenates
was decreased by 20%.
Deletion of COX 10 in the CNS by the CamKIIa-Cre led
to a neurological phenotype starting at age P105–P120.
These mice exhibited altered behavior with excited/maniac
phases interspersed with inactive/unresponsive phases. The
phenotype worsened in the course of 4–5 weeks leading to
death. Brain homogenates from mice at P120 showed a
drastic reduction in COX I, but normal levels of subunits
belonging to other OXPHOS complexes, suggesting that
neurons with no or low COX were still present in knockout
mice brains. COX enzyme activity in KO brain homoge-
nates was decreased by 70–90%.
Deletion of COX 10 by the myosin light chain-Cre led to
a myopathy with patchy distribution of COX negative and
positive segments. This pattern is due to the incomplete
deletion of both COX 10 alleles in some nuclear domains.
The myopathy had onset at P90, leading to death at P120–
180. COX activity in P30 mouse muscle mitochondria was
20% of controls. Muscle mitochondria of P120 animals had
less than 5% of the normal COX activity.
I-16
Molecular genetics of complex I-deficient Chinese
hamster cell lines
I. Scheffler*, N. Yadava, P. Potluri, P. Mahapatra
Division of Biological Sciences, Section of Molecular Biol-
ogy, University of California, San Diego, La Jolla, CA
92093-0322, USA
ischeffler@ucsd.eduOur laboratory has described a series of Chinese hamster
cell mutants with very severe complex I deficiencies.
Defects in three X-linked genes had been proposed, and
two of these genes have now been identified. The third may
be defective in an assembly factor or an as yet unidentified
subunit. One group of mutants is defective in the NDUFA1
gene encoding the MWFE subunit. Various mutant alleles
have been characterized, including a null mutant. We have
recently described an inducible system in which MWFE
synthesis is under the control of an inducible promoter. Such
a system promises to be useful to study the assembly of
complex I. Studies on the import and orientation of this
integral membrane protein will be described: it has an
atypical mitochondrial targeting sequence that is not pro-
cessed after import. A second group of mutants has been
characterized with chain-terminating codons in the gene for
the ESSS subunit. This subunit is also absolutely required
for complex I assembly and activity.
Our null mutants can be complemented with cDNA
constructs encoding wild-type or modified MWFE or ESSS
subunits epitope-tagged with either HIS or HA. Such
epitope-tagged proteins can be expressed in a wild-type
background and compete with the endogenous subunit for
assembly. The epitope-tagged subunits are useful in cross-
linking studies to determine protein–protein interactions in
the integral membrane subcomplex, and even in the various
mutants in which complex I assembly is incomplete.
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Alternative topogenesis of Mgm1 is essential for the
integrity of mitochondrial structure
M. Herlan*, C. Bornho¨vd, K. Hell, F. Vogel, W. Neupert,
A. Reichert
Physiological Chemistry, Ludwig-Maximilians-Universita¨t
Mu¨nchen, Butenandtstrasse 5, 81377 Mu¨nchen, Germany
mark.herlan@bio.med.uni-muenchen.de
Mitochondrial morphology and inheritance of mito-
chondrial DNA (mtDNA) in yeast depend on the dyna-
min-like GTPase Mgm1. Mgm1 is present in two
isoforms in the intermembrane space of mitochondria.
The large isoform (l-Mgm1) is anchored to the inner
membrane with an N-terminal hydrophobic segment
which is absent in the short isoform (s-Mgm1). s-Mgm1
is generated by proteolytic cleavage of l-Mgm1 by the
inner membrane rhomboid-type protease Pcp1. Both the
deletion of MGM1 and of PCP1 result in fragmentation
of mitochondria and loss of mtDNA. We show that the
deletion phenotype of PCP1 is a direct consequence of the
absence of s-Mgm1 and that both isoforms of Mgm1 are
required for its function. Near its N-terminus Mgm1 con-
tains two conserved hydrophobic segments. The more C-
terminal one is cleaved by Pcp1. However, changing the
hydrophobicity of the N-terminal one influences the ratio of
EUROMIT 616both Mgm1 isoforms. Furthermore, the generation of s-
Mgm1 and mitochondrial morphology depend on the ATP
level in the matrix. Based on these data, we present a model
of alternative topogenesis, which ensures the balanced for-
mation of both Mgm1 isoforms. This model suggests how on
a molecular level the ATP concentration in the matrix may
influence mitochondrial morphology.
O-13
COX assembly: Mss51p and Cox14p jointly regulate
Cox1p expression in the yeast S. cerevisiae
A. Barrientos*, A. Tzagoloff, A. Zambrano
Neurology, University of Miami, 1600 10th Ave, 33136 FL,
USA
abarrientos@med.miami.edu
Mutations in SURF1, the human homolog of yeast SHY1
are responsible for Leigh syndrome, a neuropathy associated
with cytochrome oxidase (COX) deficiency. Previous stud-
ies of the yeast model of this diseaseshowed that mutant
forms of Mss51p, a translational activator of Cox1 mRNA,
partially rescue the COX deficiency of shy1 mutants by
restoring normal synthesis of the mitochondrially encoded
Cox1p subunit of COX.
Here we present evidence showing that the synthesis
of Cox1p, measured in vivo, is reduced in most COX
mutants but is restored to that of wild type by the same
mutation that suppresses shy1 mutants. An important
exception is a null mutation in COX14, which by itself
or in combination with other COX mutations does not
affect Cox1p synthesis. Cox14p and Mss51p are shown
to interact with Cox1p and with each other. We propose
that the Cox14p-dependent interaction of Mss51p with
Cox1p, to form a transient Cox14p–Cox1p–Mss51p
complex, functions to down-regulate Cox1p synthesis.
The release of Mss51p from the complex occurs at a
downstream step of the assembly pathway, probably
catalyzed by Shy1p.
I-17
Respiratory chain defects: what do we know for sure
about their consequences in vivo?
P. Rustin
INSERM U393, Handicaps Ge´ne´tiques de l’Enfant, Hoˆpital
Necker-Enfants Malades, 75015 Paris, France
rustin@necker.fr
Respiratory chain deficiency can be the source of a
multitude of cellular malfunctions which relative inci-
dence on observed cellular phenotypes and clinical fea-
tures remains to be established in most cases. This
basically reflects the chief importance of mitochondrialactivities in any living cell and the high degree of
integration of both metabolic and signalling pathways
where mitochondria play often a key role. In practice,
the ignorance of the actual consequences of respiratory
chain defects certainly often hampers our ability to
possibly counteract their presumably deleterious, but yet
poorly defined effects. Indeed, at least from a theoretical
point of view, the consequences of any respiratory chain
defect constitute a quasi-endless list, which can be some-
what subcategorized according to their presumed mecha-
nism. However, much less has been experimentally
established in vivo. The scarcity of available material at
least in human, the various severity and nature of the
defects, the tissue to tissue differences, and the high
number of interacting factors make it difficult to reach
unequivocal conclusions. The aim of the presentation will
be to review the few established consequences of respi-
ratory chain defects, in situ and in vivo, and to examine
their potential link with recognized clinical features asso-
ciated with respiratory chain deficiencies.
I-18
Dying mitochondria in agonizing cells
G. Kroemer
CNRS-UMR8125, Institut Gustave Roussy, Pavillon de
Recherche 1, 39 Rue Camille Desmoulins, 94805 Villejuif,
France
kroemer@igr.fr
In biochemical terms, apoptosis relies on mitochondrial
membrane permeabilization (MMP) and/or caspase acti-
vation of caspases. Apoptosis-inducing factor (AIF) is a
flavoprotein with NADH oxidase activity normally
contained in the mitochondrial intermembrane. Upon
apoptosis induction, AIF translocates from mitochondria
to the cytosol and to the nucleus. We have performed an
extensive search for AIF-binding proteins, by screening
for AIF partners that may enhance or inhibit its apopto-
genic function. Cyclophilin A (CypA) was determined to
interact with apoptosis inducing factor (AIF) by mass
spectroscopy, co-immunoprecipitation, pull-down assays,
and molecular modeling. Recombinant AIF and CypA
proteins synergized in vitro in the degradation of plasmid
DNA, as well as in the capacity to induce DNA loss in
purified nuclei. AIF mutants lacking the CypA-binding
domain were inefficient apoptosis sensitizers. Moreover,
AIF failed to sensitize CypA knockout cells to apoptosis
induction, and this defect in the AIF response was
reversed by reintroduction of the CypA gene into
CypA-deficient cells. Thus, AIF and CypA collaborate
in apoptotic chromatinolysis. The principal AIF-inhibitory
protein turned out to be Hsp70, an established apoptosis
inhibitor. The Hsp70-binding domain of AIF does no
overlap with its CypA binding domain. Hsp70 inhibits
EUROMIT 6 17AIF by preventing its mitochondrio-nuclear translocation.
Inhibition of the interaction between Hsp70 and AIF by
an AIF-derived decoy of Hsp70 (AAD70) facilitates the
nuclear translocation of endogenous AIF in Hsp70
expressing cells and sensitizes a number of cancer cell
lines to cell death induction.
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Mutation-specific mitochondrial remodeling in complex
I-deficient patient fibroblasts
W. Koopman*, H.-J. Visch, T. Welting, G. Pruijn, L. van
den Heuvel, J. Smeitink, P. Willems
Microscopical Imaging Center NCMLS, University of
Nijmegen, P.O. Box 9101, 6500 HB Nijmegen, The
Netherlands
w.koopman@ncmls.kun.nl
In this study we investigated cellular consequences of
mutations in nuclear-encoded subunits of complex I (CI)
of the respiratory chain. For this purpose we correlated
mitochondrial shape and number, the expression profile
of key mitochondrial proteins in human fibroblast cell
lines derived from 4 healthy subjects and 13 patients
with an isolated CI deficiency. Computer-assisted analy-
sis of mitochondrial morphology revealed distinct muta-
tion-dependent aberrations in mitochondrial morphology.
These aberrations were independent of cell cycle phase
and were abolished during complementation assays. Two
distinct classes of mutations were distinguished, one in
which mitochondrial number and degree of branching
were proportional to CI activity (class I) and another
where these two parameters were negatively or uncorrelated
with CI activity (class II). For both classes, total expression of
the CI-39 kDa subunit correlated linearly with CI activity and
the amount of CI-39 in fully assembled CI. These findings
indicate the presence of a general adaptive mechanism, which
combines mitochondrial biogenesis with increased expres-
sion of CI and, consequently, CI activity.We conclude that the
effectiveness of this mechanism in counterbalancing CI defi-
ciency depends on the nature of the mutation.
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Miro, a novel GTPase with Ca2 +-binding EF-hand
motifs, may integrate cell-signaling pathways with
mitochondrial dynamics
K. Okamoto*, R. Frederick, J. McCaffery, J. Shaw
Department of Biology, University of Utah, 257 South 1400
East, 84112 Salt Lake City, UT, USA
kokamoto@biology.utah.edu
Although mitochondria are known to be dynamic
organelles, changing size, shape and distribution in re-sponse to cellular signals, a protein that senses such signals
and modulates mitochondrial dynamics has not been iden-
tified. A genomic search for human Rho-type GTPases
revealed Miro (for mitochondrial Rho), an evolutionarily
conserved protein family with a unique domain structure:
two tandem Ca2 +-binding EF-hand motifs flanked by two
GTPase domains. Studies in mammalian cells raised the
possibility that Miro may be involved in mitochondrial
homeostasis and apoptosis.
To understand the role of Miro in mitochondrial
dynamics and Ca2 +-sensing, we initiated studies on
Ymr1p (yeast Miro) in S. cerevisiae. We found that
deletion of the YMR1 gene altered wild-type mitochon-
drial tubular networks. Mitochondria in cells lacking
Ymr1p form collapsed tubules, grape-like clusters and
distorted spheres. These morphological changes are not
due to defects in mitochondrial fission or fusion, as
neither process is abolished in the ymr1 null mutant. In
addition, inner mitochondrial membrane cristae formation
occurs in abnormally shaped organelles. Microscopic and
biochemical fractionation studies localized Ymr1p in the
outer mitochondrial membrane as a tail-anchored protein
with its N terminus exposed to the cytoplasm. Moreover,
mutational analysis indicated that both of the GTPase
domains and the EF-hand motifs are important for
Ymr1p function. These observations suggest that Ymr1p
is a mitochondrial transmembrane GTPase required for
mitochondrial morphology maintenance. Studies are un-
derway to determine whether and how Miro integrates
intracellular Ca2 +-signaling events with mitochondrial
dynamics.
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Mitochondrial disease in flies
H. Jacobs*,1,2, S. Manjiry1, D. Moreno1, E. Kemppainen1,2,
K. O’Dell2
1Institute of Medical Technology, University of Tampere,
FIN 33014, Tampere, Finland
2Institute of Biomedical and Life Sciences, University of
Glasgow, Scotland
howard.t.jacobs@uta.fi
The Drosophila mutant tko, affecting the mitochondrial
protein synthetic apparatus, exhibits respiratory chain defi-
ciency and a phenotype resembling various features of
mitochondrial disease in humans (paralytic seizures, deaf-
ness, developmental retardation). We are using this mutant
to analyse the cellular and genomic targets of mitochondrial
dysfunction, and to identify ways in which the phenotype
can be alleviated.
Transgenic expression of wild-type tko in different
patterns in the mutant background reveals critical times
and cell-types for production of components of the mito-
EUROMIT 618chondrial disease-like phenotype. Mitochondrial bioenergy
deficit during the period of maximal growth, as well as in
different parts of the nervous system, appears to be most
deleterious.
Inbreeding of tko mutant lines results in a systematic
improvement in all phenotypic parameters tested. We report
the first results of genetic mapping and transcriptomic
analysis, which gives clues as to the genes and pathways
that can modify mitochondrial disease-like phenotypes in a
model metazoan.
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A switch in metabolism precedes increased
mitochondrial biogenesis in respiratory chain-deficient
mouse hearts
A. Hansson*, N. Hance, E. Dufour, A. Rantanen, K.
Hultenby, D. Clayton, R. Wibom, N.-G. Larsson
Medical nutrition, Karolinska Institutet, Novum, KUS-Hud-
dinge, SE-141 86 Stockholm, Sweden
anna.hansson@mednut.ki.se
We investigated temporal changes occurring during de-
velopment and progression of respiratory chain dysfunction
in mice with tissue-specific knockout of mitochondrial
transcription factor A (Tfam) in the heart.
Mitochondrial DNA levels were reduced to f 25% in
knockout mouse hearts at 2 weeks of age. The heart size of
knockout mice increased progressively starting at 3 weeks
of age until death occurred at f 10–12 weeks of age.
Knockout mice developed a severe decline in respiratory
chain enzyme activities in the heart and a simultaneous
reduction of mitochondrial ATP production rate starting
f 2 weeks of age. Mitochondrial mass was normal until a
late stage of disease when an increase of f 25% was
observed.
Studying gene expression with microarrays, we found a
coordinate down-regulation of genes encoding fatty acid
oxidation enzymes in knockout hearts, whereas several
genes encoding glycolytic enzymes were up-regulated.
During the fetal stages the mammalian heart mainly relies
on glucose as an energy substrate. Immediately after birth
the expression of genes that are involved in fatty acid
oxidation is induced and the adult heart predominantly uses
fatty acids as a source for energy production. Our findings
are consistent with reactivation of the fetal gene expression
pattern, a common phenomenon during different forms of
cardiomyopathy. In the Tfam knockout mice this switch
occurred at an early stage of disease before the increase of
mitochondrial mass. It is unlikely that this response is
beneficial for optimal function of the heart and may instead
be a contributing factor to the progression of mitochondrial
cardiomyopathy.O-17
Modelling mitochondrial complex I disorders in the
nematode Caenorhabditis elegans
L. Grad*, B. Lemire
Biochemistry, University of Alberta, 4-74 Medical Sciences
Building, T6G 2H7 Edmonton, Alberta, Canada
lgrad@ualberta.ca
Mitochondrial dysfunction, with an estimated incidence
of 1 in 10,000 live births, is among the most common
genetically determined conditions. Missense mutations in
the human NDUFV1 gene, which encodes the 51-kDa
active site subunit of the NADH-ubiquinone oxidoreductase
or complex I, can lead to severe neurological disorders.
Owing to the rare and often sporadic nature of mitochon-
drial disorders, the mechanisms of pathogenesis of most
mutations remain poorly understood. We have generated
transgenic strains of Caenorhabditis elegans that express
disease-causing mutations in the nuo-1 gene, the C. elegans
homologue of NDUFV1. The transgenic strains demonstrate
hallmark features of complex I dysfunction such as lactic
acidosis and decreased NADH-dependent mitochondrial
respiration. Furthermore, mutant strains are hypersensitive
to exogenous oxidative stress. The lactic acidosis induced
by the NDUFV1 mutations could be partially corrected with
the vitamins riboflavin and thiamine, or with sodium
dichloroacetate, an activator of the pyruvate dehydrogenase
complex, resulting in significant increases in animal fitness.
Surprisingly, cytochrome c oxidase activity and protein
levels were reduced, establishing a connection between
complexes I and IV. Our results indicate that complex I
mutations exert their pathogenic effects in multiple ways: by
impeding the metabolism of NADH, by increasing the
production of reactive oxygen species, and by interfering
with the function or assembly of other mitochondrial respi-
ratory chain components.
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Gene expression profiles define mitochondrial pathology
in yeast mutants and human disease
H. Smeets*, L. Eijssen, R. Mineri, R. van Eijsden, P.
Lindsey, C. van den Burg, R. Peeters, I. De Coo, H. Scholte,
E. Rubio, M. Zeviani, R. Vlietinck, V. Tiranti
Genetics and Cell Biology, University of Maastricht, Uni-
versiteitssingel 50, 6200 MD Maastricht, The Netherlands
bert.smeets@molcelb.unimaas.nl
Gene expression profiling and data analysis were
performed in yeast and human mutants of the mitochon-
drial system. Mathematical techniques were derived from
EUROMIT 6 19basic statistics, clustering, discriminant analysis and prin-
cipal component analysis (PCA). Background knowledge
was incorporated for the yeast data by downloading web-
site ontology annotations automatically. We used the set
from Hughes et al. [Cell 102 (2000) 109; or http://
www.rii.com] containing whole genome expression pro-
files of 300 gene knockout experiments in yeast. PCA
reduced the dimension of the data set significantly with-
out losing much of the information and reduced noise as
well. By subsequent discriminant analysis, we could
distinguish mitochondrial gene knockouts from non-mito-
chondrial gene knockouts (cytoskeleton, cell membrane,
cell wall, cytoplasm, lysosome/vacuole/peroxisome). As a
next step, we applied the same approach on Affymetrix
GeneCHIP data (U133A) of a group of 18 fibroblast cell
lines of patients with Leigh disease, caused by a Surf1-
mutation and 11 controls. The Surf1-patients could be
reliably distinguished from the controls by the expression
changes of only three genes. It is not clear at this point if
these classifiers are generally applicable and reflect Surf1-
specific pathology or are a common characteristic of
mitochondrial pathology. Gene expression studies in ad-
ditional Surf1-patients and patients with mtDNA caused
Leigh and MELAS syndrome and with secondary mito-
chondrial pathology are currently being performed to
solve this question. As differences in gene expression in
fibroblasts were not very explicit, we are also testing
muscle biopsy specimens to identify pathogenic genetic
pathways in mitochondrial disease.
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Immunological and proteomics approaches to
characterisation of mitochondrial diseases
R. Capaldi*, J. Murray, R. Aggeler, L. Byrne, M. Marusich
Institute of Molecular Biology, University of Oregon, 97403
OR, USA
rcapaldi@oregon.uoregon.edu
Diagnosis of genetic mitochondrial diseases remains
difficult. Similarly, analysis of the role of OXPHOS in late
onset conditions such as Parkinsons disease, Alzheimers
disease and NIDDM is limited by a lack of straightforward
approaches for isolating the respiratory chain complexes and
ATP synthase for detailed study of amounts, specific activ-
ities and posttranslational modifications.
We have now obtained monoclonal antibodies, which
can isolate each of the five OXPHOS complexes in active
form and fully assembled. We show how these mAbs can be
used to quantitate the levels of the different complexes in as
little as 10 mg of mitochondria and how posttranslational
modifications including oxidative damage and phosphory-
lation can be determined by mass spectrometry on equally
low amounts of patient material.O-19
Integrative analysis of the mitochondrial proteome
H. Prokisch*, C. Andreoli, C. Scharfe, L. Steinmetz,
T. Meitinger
Institute of Human Genetics, TU-Munich, Trogerstrasse 32,
81675 Munich, Germany
prokisch@gsf.de
A broad range of genome-wide studies involving mito-
chondrial proteins have been accumulated recently. These
include expression profiling, deletion phenotype screening,
large-scale localisation studies, protein–protein interactions
and proteomic studies by mass spectrometry to name but a
few. While their information content is often complementa-
ry, sensitivity and specificity of different methods to detect
mitochondrial proteins vary greatly. The integration of these
systematic studies allows the prediction of candidates with
high accuracy and provides a way of benchmarking indi-
vidual high throughput (HT) experiments.
In a first step, we integrated 22 data sets from HT
approaches with relevance for mitochondria in the online
database MitoP2. For the evaluation of sensitivity and
specificity of the various experiments, we generated a
reference set of mitochondrial proteins based on direct
evidence in single gene studies. The comparison of
different approaches to characterize the mitochondrial
proteome reveals strengths and weaknesses of the
approaches. Using the collected data, we developed a
new strategy for the prediction of organellar proteins. A
Support Vector Machine was trained with two data sets
covering the reference set (n = 477) and a set of non-
mitochondrial proteins (n = 300). The Leave-One-Out es-
timation of the SVM prediction revealed a precision of
90%. Altogether SVM predicts 200 new candidates. Each
new candidate was identified in several HT approaches,
indicating saturation of the mitochondrial parts list. Most
proteins were identified by HT localisation experiments,
followed by proteomics and deletion phenotype screens.
By providing new mitochondrial candidate proteins, the
MitoP2 database will help to improve the genetic anal-
ysis of human mitochondriopathies.
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Mitochondria and cancer
L. Aaltonen
Department of Medical Genetics, Biomedicum Helsinki,
University of Helsinki, Finnish Academy of Sciences, P.O.
Box 63 (Haartmaninkatu 8), Fin-00014 Helsinki, Finland
lauri.aaltonen@helsinki.fi
EUROMIT 620The key role of mitochondria in cancer is well estab-
lished; e.g. their involvement in apoptotic mechanisms is
of great importance. Recently, a new link between mito-
chondria and cancer has been introduced. We have shown
that heterozygous dominantly inherited inactivating muta-
tions in fumarate hydratase (FH) gene predispose to uterine
and cutaneous leiomyomatosis, leiomyosarcoma, and renal
cell cancer (hereditary leiomyomatosis and renal cell
cancer, HLRCC). Succinate dehydrogenase (SDH) defects
have previously been shown to predispose to paraganglio-
mas, and tricarboxylic acid cycle (TCAC) defects are a
known cause for recessive neurodegenerative disorders.
We have now found common ground for the FH and
SDH phenotypes by identifying SDHB as a new renal cell
cancer predisposition gene. These studies have revitalized
the field of TCAC research in view of cancer.
However, it is unknown how FH and SDH defects cause
tumor predisposition. Furthermore, the presence of an un-
known genetic modifier appears to be necessary—at least in
the case of FH defects—to promote progression from benign
tumors to cancer. Possible tumorigenic mechanisms involved
include hypoxia response, induction of oxidative stress, and
DNA damage. Previously unknown functions not connected
to energy metabolism may also exist and should be searched
for.
Our further work is focused on characterization of the
clinical tumor phenotype in FH mutation families, identifi-
cation of the modifier gene required for the malignant
phenotype, and functional studies on mutant and wild-type
fumarase in tumor cell lines.
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Succinate dehydrogenase and mitochondrial signalling
in HIF1a stabilization
M. Selak*, E. Gottlieb
Beatson Institute for Cancer Research, Garscube Estate,
Switchback Road, G61 1BD, Glasgow, United Kingdom
m.selak@beatson.gla.ac.uk
Hypoxia-inducible factor (HIF) is a heterodimeric tran-
scription factor consisting of HIFa and HIFb subunits, which
mediates adaptive responses to changes in tissue oxygena-
tion. The oxygen-regulated subunit HIFa is stabilized in cells
exposed to hypoxia. HIFa is negatively regulated at the level
of protein turnover by proline hydroxylation, which mediates
von Hippel–Lindau protein binding, ubiquinylation and
proteasome degradation. Proline hydroxylation is catalyzed
by prolyl-4-hydroxylases (PHD), oxygen and Fe2 +-requiring
dioxygenases which decarboxylate 2-oxoglutaric acid to
produce succinate. We hypothesized that inhibition of suc-
cinate dehydrogenase (SDH) using RNAi’s targeted to SDH
subunits B and D would lead to an accumulation of succinatein the cytosol which would then inhibit PHD and stabilize
HIFa. Western blots using an anti-HIF1a antibody showed
that HIF1a is stabilized by transient transfection with SDH
RNAi in HEK293 and H1299 cells under normoxic
conditions. SDH activity measured as TTFA-sensitive
succinate-DCIP oxidoreductase is decreased in RNAi-
transfected HEK293 cells. GC-MS analysis demonstrated
that succinate concentrations are significantly elevated in
cell extracts prepared from RNAi-treated cells. Moreover,
HIF1a levels are increased in cells treated with dimethyl-
succinate, which directly elevates succinate levels. These
results demonstrate that inhibition of SDH elevates cellular
succinate levels and stabilizes HIF1a, indicating that
mitochondria can generate signals, which may enhance
tumour progression by favoring adaptations to growth
under hypoxic conditions.
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Reconstructing proto-mitochondrial metabolism
M. Huynen*, T. Gabaldon
Nijmegen Center for Molecular Life Sciences, Center for
Molecular and Biomolecular Informatics, University Med-
ical Centre Nijmegen, Toernooiveld 1, 6525 ED Nijmegen,
The Netherlands
m.huynen@cmbi.kun.nl
Mitochondria are ATP-producing eukaryotic organelles
derived from the endosymbiosis of an alpha-proteobacte-
rium. Using large-scale phylogenetic analyses to detect
eukaryotic proteins that are phylogenetically closely related
to alpha-proteobacterial proteins, we have reconstructed the
proteome of the ancestral mitochondrion, the proto-mito-
chondrion. Based on the 630 proteins in this proteome, we
subsequently derive its metabolism, which is geared towards
energy conversion with the oxidation of fatty acids and
glycerol as the main catabolic pathways. Comparing the
reconstructed proto-mitochondrial proteome with current
human and yeast mitochondrial proteomes reveals that the
transition from endosymbiont to modern organelle was
accompanied by major changes not only in the distribution
of functional groups but also in their composition. The
metabolism got more biased towards energy conversion
and protein synthesis by diminishing functional classes such
as amino acid and nucleotide metabolism, and losing others
like carbohydrate metabolism and transport or cell envelope
biogenesis. Some of these pathways have, however, not
been lost from the cell, and have instead moved to other
locations within it. This retargeting process has affected
more than two thirds of the proto-mitochondrial derived
proteins encoded in yeast and human genomes.
1. Gabaldon, T. and Huynen, M.A. (2003) Science, 301,
609.
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Yarrowia lipolytica, a model organism to study
mitochondrial complex I by yeast genetics
U. Brandt*, A. Garofano, L. Grgic, V. Zickermann, S.
Dro¨se, S. Kerscher
Institu¨t fu¨r Biochemie I, Universita¨t Frankfurt, Fachbereich
Medizin, ZBC, Theodor-Stern-Kai 7 Haus 25B, D-60590
Frankfurt am Main, Germany
Brandt@zbc.kgu.de
We have established the obligate aerobic yeast Yarrowia
lipolytica as a powerful new model for the structural and
functional analysis of mitochondrial complex I. All rele-
vant yeast genetic tools have been developed in recent
years for this nonconventional yeast and the genome has
been sequenced. Complex I is an essential enzyme in Y.
lipolytica. Nevertheless, complex I deletion strains could
be generated by attaching the targeting sequence of com-
plex I subunit to an external ‘‘alternative’’ NADH-dehy-
drogenase (NDH2) present in this yeast. Thereby, we could
complement complex I deficiency by redirecting NDH2 to
the matrix side. Deletion strains for several complex I
subunits have been constructed that can be complemented
by shuttle plasmids carrying the deleted gene. This allows
for efficient site-directed mutagenesis of individual sub-
units of Y. lipolytica complex I and was used to reconstruct
and characterize several pathogenic mutations in the PSST,
TYKY and 24-kDa subunits of complex I that cause severe
neuromuscular disorders in man. Yellow fluorescent protein
was attached to the carboxy-terminus of the 30-kDa subunit
and allows in vivo localization of complex I within the Y.
lipolytica mitochondria.
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Creation of mtDNA mutator mice
A. Trifunovic*,1,2, N.-G. Larsson1,2, A. Wredenberg1,2, M.
Falkenberg1, J. Spelbrink3, A. Rovio3, C. Bruder4, M.
Bohlooly-Y4, S. Gidlo¨f1,2, A. Oldfors5, R. Wibom6, J.
To¨rnell4, H. Jacobs3
1Departments of Medical Nutrition, Karolinska Institutet,
Novum, Karolinska University Hospital, S-141 86 Stock-
holm, Sweden
2Biosciences, Karolinska Institutet, Novum, Karolinska Uni-
versity Hospital, S-141 86 Stockholm, Sweden
3Institute of Medical Technology and Tampere University
Hospital, FIN-33014 University of Tampere, Finland
4Astra Zeneca R&D, SE-431 83 Mo¨lndal, Sweden
5Department of Pathology, Sahlgrenska University Hospi-
tal, Go¨teborg, Sweden
6Department of Laboratory Medicine, Karolinska Institutet,
Karolinska University Hospital, S-141 86 Stockholm, SwedenIt has been extensively documented that the normal
ageing process in humans, monkeys and rodents is
associated with accumulation of low levels of point
mutations and deletions of mtDNA. The role of somatic
mtDNA mutations in ageing has been questioned because
the overall level of any of these mtDNA mutations in a
tissue is usually considerably lower than the threshold
level required to cause respiratory chain dysfunction.
However, somatic mtDNA mutations associated with
ageing are not evenly distributed but can accumulate
clonally in certain cells where they cause a respiratory
chain deficiency. This leads to a mosaic pattern with
scattered respiratory chain-deficient cells in different tis-
sues of aged individuals. The mitochondrial theory of
ageing is supported by a wealth of correlative data as
described above, but has remained highly controversial in
the absence of supporting experimental data. We have
now addressed this question by generating mtDNA-muta-
tor mice by gene targeting of the gene for catalytic
subunit of mitochondrial DNA polymerase. We will
describe phenotypes in these mice and also present state-
gies for using these mice to generate mouse lines with
specific mtDNA mutations.
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Mitochondria-mediated nuclear mutator phenotype in
Saccharomyces cerevisiae
K. Singh*, A. Rasmussen1,2, A. Chatterjee1,
L. Rasmussen2
Department of Cancer Genetics, Roswell Park Cancer
Institute, Elm and Carlton Streets, 14263 Buffalo, NY, USA
1Sidney Kimmel Cancer Center, Johns Hopkins School of
Medicine, Bunting-Blaustein Cancer Research Building,
1650 Orleans Street, Baltimore, MD 21231, USA
2Department of Life Sciences and Chemistry, Roskilde
University, 4000 Roskilde, Denmark
Keshav.singh@roswellpark.org
Using Saccharomyces cerevisiae as a model organism, we
analyzed the consequences of disrupting mitochondrial
function on mutagenesis of the nuclear genome. We mea-
sured the frequency of canavanine resistant colonies as a
measure of nuclear mutator phenotype. Our data suggest that
mitochondrial dysfunction leads to nuclear mutator pheno-
type (i) when oxidative phosphorylation is blocked in wild-
type yeast at mitochondrial complex III by antimycin A and
(ii) in mutant strains lacking the entire mitochondrial genome
(rho0) or those with deleted mitochondrial DNA (rho ).
The nuclear mutation frequencies obtained for antimycin A-
treated cells as well as for rho and rho0 cells were f 2–3-
fold higher compared to untreated control and wild-type
cells, respectively. Blockage of oxidative phosphorylation by
antimycin A treatment led to increased intracellular levels of
ROS. In contrast, inactivation of mitochondrial activity
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ROS. We also demonstrate that in rho0 cells the REV1,
REV3 or REV7 gene products, all implicated in error-prone
translesion DNA synthesis (TLS), mediate mutagenesis in
the nuclear genome. However, TLS was not involved in
nuclear DNA mutagenesis caused by inhibition of mitochon-
drial function by antimycin A. Together, our data suggest
that mitochondrial dysfunction is mutagenic and multiple
pathways are involved in this nuclear mutator phenotype.
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Treatment strategies for disorders of the mitochondrial
genome
B. Lightowlers
Neurobiology and Psychiatry, Medical School, University
of Newcastle upon Tyne, School of Neurology, Framling-
ton Place, NE2-4HH Newcastle upon Tyne, United
Kingdom
r.n.lightowlers@ncl.ac.uk
Patients suffering from defects of the mitochondrial
genome can present with a bewildering spectrum of clinical
disorders. These chronic progressive diseases commonly
affect post mitotic tissue and for the vast majority of patients
there is no effective cure or treatment. In this overview, I
will present several important and exciting bodies of work
that have been reported by groups working in this demand-
ing and frustrating area of research.
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Use it or lose it?—Exercise training implications of
mtDNA disorders
T. Taivassalo
Institute for Exercise and Environmental Medicine, Dallas,
TX, USA
tanjataivassalo@texashealth.org
To train or not to train, this is the question for patients
with heteroplasmic mitochondrial DNA (mtDNA) disor-
ders. Endurance exercise training induces adaptive prolif-
eration of mitochondria in healthy muscle, increasing
capacity for exercise and oxidative phosphorylation. Lim-
ited physical activity has the converse effect, with a
down-regulation of mitochondria resulting in decreased
exercise tolerance. In patients with mtDNA defects, we
have consistently demonstrated benefits of endurance
training that improve oxidative capacity. In a recent study,
physiological and biochemical improvements were attrib-
uted to training-induced increases in mitochondrial numb-
ers that in most patients resulted in increased levels of
rate-limiting enzymes, suggesting increases in absolutelevels of wild-type (wt) mtDNA. However, the concom-
itant finding of an increase in mutant to wt mtDNA ratio
raised concern for advisability of endurance training.
Furthermore, effects of longer-term training and cycles
of physical inactivity (normally associated with a down-
regulation of mitochondrial volume) following training
(particularly in the setting of a new mutation load) on
mutant and wt mitochondrial genomes are unknown. To
determine whether training increases in mutant mtDNA
levels may be offset by increases in absolute wt mtDNA
levels and ultimately to determine advisability of endur-
ance training as therapy, we have combined efforts with
our collaborators in Newcastle. Preliminary results of this
current study assessing the effects of training and de-
training on physiology, biochemistry and single-fiber
molecular genetics in heteroplasmic patients will be
presented. Currently, we are unable to clearly advise our
patients to ‘‘use it or lose it’’—underscoring the impor-
tance of these exercise training studies.
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Aerobic training improves oxidative capacity in patients
with mitochondrial myopathy
J. Vissing*, D. Olsen, T. Jeppesen, F. Wibrand, M. Schwartz
Neurology, Rigshospitalet, Blegdamsvej 9, DK-2100 Copen-
hagen, Denmark
vissing@rh.dk
Mitochondrial myopathies (MM) are characterized by
exercise intolerance. We investigated the efficacy and safety
of low-intensity dynamic exercise training in MM.
Seven patients with molecularly well-defined defects of
mtDNA and seven healthy, age- and gender-matched sub-
jects were studied. All subjects cycled for 30 min on a
stationary bike, five times a week for 12 weeks, at an
intensity corresponding to 65% of their maximal oxygen
uptake. Maximal oxygen uptake, workload, heart rate,
plasma lactate levels, and in patients, muscle mutation load
were measured before and after training.
Aerobic training increased maximal oxygen uptake by
14F 3%, workload by 28F 12% and the concentration of
citrate synthase by 81F11% and the activity of citrate
synthase-corrected complex I activity by 101F16% in
muscle of MM patients, while the initial mutation load in
muscle of 70F 7% was unaffected by training. Responses
to aerobic training in the healthy control subjects closely
paralleled those found in the MM patients. Training did not
affect creatine kinase levels in MM patients, except tempo-
rarily in one.
This study shows that chronic aerobic training improves
oxidative capacity in patients with MM. Since training did
not induce an increase in plasma creatine kinase levels and
muscle mutation load, aerobic exercise training seems to be
a safe and effective method to improve endurance in MM.
EUROMIT 6 23Ongoing studies in patients with low mutation loads in
muscle, in whom mutation load will also be studied after
deconditioning following training, will more conclusively
establish the safety and efficacy of training as a treatment in
MM.
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Ketogenic treatment reduces the proportion of mutated
mitochondrial DNAs
E. Schon*, S. Santra, R. Gilkerson, M. Davidson
Neurology, Columbia University, 630 West 168th street,
P&S 4-431, 10032 New York, NY, USA
eas3@columbia.edu
Large-scale partial deletions of mitochondrial DNA
(mtDNA) cause sporadic Kearns–Sayre syndrome (KSS),a fatal multisystem disorder, in which the majority of
mtDNAs in affected tissues is deleted. Since most
mtDNA-related diseases, including KSS, are recessive, only
a few wild-type mtDNAs (wt-mtDNAs) can compensate for
the deleterious effects of many deleted mtDNAs. We have
developed a pharmacological approach to treat KSS in vitro,
in which we grow cells in medium containing ketone bodies
replacing glucose as the carbon source. Cells containing
100% deleted mtDNA died after 5 days of treatment,
whereas those containing 100% wt-mtDNA survived. Fur-
thermore, in a cloned heteroplasmic cell line, the proportion
of wt-mtDNA increased from 7% initially tof 23% after 5
days in ketogenic medium, and there was a dramatic
improvement in mitochondrial protein synthesis in these
cells, implying that they had crossed the threshold for
respiratory chain function. We also provide strong evidence
that treatment with ketone bodies caused this ‘‘heteroplas-
mic shifting’’ not only among cells (i.e. intercellular selec-
tion) but also within cells (i.e. intracellular selection).
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Addition of tenofovir to a didanosine-based highly
active antiretroviral therapy increases mitochondrial
toxicity
G. Garrabou*,1, S. Lo´pez1, E. Negredo2, J. Puig2, L. Ruiz2,
E. Sanjurjo1, J. Casademont1, F. Cardellach1, B. Clotet2,
O`. Miro´1
1Mitochondrial Research Laboratory, Muscle Research
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170, 08036 Barcelona, Spain
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Trias i Pujol University Hospital (Badalona), Universitat
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Objectives: Tenofovir disoproxil fumarate (TDF) is a
nucleotide analogue that has been reported to be free
of adverse effects on mitochondria. We evaluate the
effects of the introduction of TDF on a highly active
antiretroviral therapy (HAART) schedule containing dida-
nosine (ddI) on mitochondrial mass, mitochondrial DNA
(mtDNA) content and cytochrome c oxidase (COX)
activity.
Methods: Fifty HIV-infected patients receiving a ddI-
based HAART schedule were recruited, and changed to ddI
plus TDF (300 mg/day) and nevirapine (400 mg/day)
(n = 25, cases) or maintained with the same HAART
scheme (n = 25, controls). All patients were symptom-free
with undetectable viral load along the study. Peripheral
blood mononuclear cells (PBMCs) were obtained at 0
(baseline), 6 and 12 months. The quantity of mitochondria
was assessed by the spectrophotometric measurement of
the citrate synthase activity, the content of mtDNA by
quantitative real-time PCR, and the activity of COX by
spectrophotometry.
Results: Cases and controls maintained unchanged
all mitochondrial parameters at 6 months with respect
to baseline. Conversely, at 12 months we found that
mtDNA content was reduced in both, cases and
controls, while mitochondrial mass and COX activity
were found to be significantly decreased only in
cases.
Conclusions: A decrease in mitochondrial mass,
mtDNA content and COX activity is detected after 12
months of the addition of TDF to HAART schedules
containing ddI. This diffuse deterioration of mitochondrial
parameters could be due to TDF itself, the increase of ddI
concentrations caused by TDF, or both. The relevance of
these biochemical findings in clinical practice remains to
be determined.P-2
Thymidine phosphorylase administration through
platelets infusion transiently reduces nucleoside
accumulation in MNGIE
R. Marti*, M. Lara, I. Illa, P. Madoz, L. Massuet, A.
Andreu, M. Hirano
CIBBIM, Hospital General Vall Hebron, Pg Vall Hebron
119-129, 08035 Barcelona, Spain
rmarti@vhebron.net
Mitochondrial neurogastrointestinal encephalomyopathy
(MNGIE) is an autosomal recessive disease caused by
mutations in the gene encoding the enzyme thymidine
phosphorylase (TP). Lack of function of TP in MNGIE
patients produces the toxic accumulation of thymidine
(dThd) and deoxyuridine (dUrd), which affect mitochondri-
al functions. Thus, we predict that reduction of circulating
levels of these nucleosides could be therapeutic. In healthy
subjects, platelets contain abundant functional TP; therefore,
administration of platelets to MNGIE patients is predicted to
lower dThd and dUrd accumulation in blood, and possibly
prevents mitochondrial dysfunction. In order to test the
biochemical and clinical effects of platelets infusion on
MNGIE, we treated a 23-year-old MNGIE woman with
three infusions of 5 1011 platelets from a healthy donor
every 3–4 days (period of treatment, 8 days). Infusion of
platelets transiently provided circulating TP to the patient
(30% to 40% of control values, 24 h after each infusion
followed by a gradual decline of TP activity). Consistent
reductions of dThd and dUrd plasma levels (to 50–70% of
baseline values) were observed during TP restoration and,
concomitantly, nucleoside urine excretion virtually disap-
peared. No clinical changes were detected by physical
examination before and after the treatment period. Although
clearly insufficient as a treatment, the partial reductions of
dThd and dUrd after platelet infusion to MNGIE patients
provide valuable data in support of an enzyme therapy-
based strategy. Our results indicate that TP restoration in
MNGIE patients can ameliorate biochemical imbalances
that cause the disease.
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Deoxyguanosine kinase (DGUOK) mutations in multiple
mitochondrial respiratory chain deficiencies
A. Slama*, I. Giurgea, D. Debrey, D. Bridoux, P. de Lonlay,
P. Levy, D. Chretien, M. Brivet, A. LeGrand, P. Rustin, A.
Munnich, A. Ro¨tig
Laboratoire de Biochimie1, AP-HP Hoˆpital Biceˆtre,78, rue
du Gl Leclerc, 94270 Le Kremlin-Biceˆtre, France
abdel.slama@bct.ap-hop-paris.fr
EUROMIT 6 25Deoxyguanosine kinase (DGUOK) is a mitochondrial
protein involved in the supply of deoxyribonucleotides
in mitochondria and therefore in the maintenance of
the mitochondrial DNA. DGUOK mutations are associ-
ated with mitochondrial DNA depletion and result in
multiple deficiencies of the respiratory chain. Complex
II, encoded only by nuclear genes, is normal in those
patients. Children with DGUOK mutations usually pres-
ent a hepatocerebral disease. In order to estimate the
prevalence of DGUOK mutations in multiple respiratory
chain deficiencies (complex I + IV or complex I + III +
IV), we have studied the DGUOK gene in a series of
32 patients with various clinical presentations and vari-
ous tissue expression of the RC deficiency. We identified
previously unreported DGUOK mutations in six patients.
Three patients, born to consanguineous parents, were
homozygous for a missense mutation (M1T and L250S
in two sibs), one patient presented a homozygous 4-bp
insertion (TGAT 796–799) and three patients were
compound heterozygous (E165V/L226R and Q211G/
L266R in two sibs). All these patients presented hypo-
tonia and liver failure. Interestingly, some patients with
hepatocerebral disease and multiple respiratory chain
deficiency did not present DGUOK mutations.
These findings allowed us to propose prenatal diag-
nosis in two families. One pregnancy was interrupted
but the second allowed the birth of a healthy child. In
one family a neonatal diagnosis for the second sib
permitted a prophylactic treatment with ursodeoxycholic
acid. This child is actually 19 months old, has a normal
neurological development and is on liver transplantation
list.
In conclusion, a high prevalence of DGUOK mutations
(22%) was observed in patients with multiple respiratory
chain deficiencies. Moreover, patients with DGUOK muta-
tions presented a homogeneous hepatocerebral phenotype as
previously reported.
P-4
Exploring the use of the bacterial conjugation system to
deliver DNA to mitochondria
A. de Groof*, Y. Lim, R. Gilkerson, M. Bhattacharjee, D.
Figurski, E. Schon
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For reasons unknown, organellar DNA transfection
methods that work in lower eukaryotes have failed to work
in mammalian cells. The inability to transfect mitochondria
with exogenous DNA is a great stumbling block to progress
in making cell culture or mouse models of mitochondrial
disease, and in understanding of mammalian mitochondrial
genetics in general.We are exploring the possibility of using components of
the bacterial conjugation system as tools to deliver DNA to
mitochondria. Specifically, we want to achieve the follow-
ing goals:
(a) to show that DNA can be delivered to isolated
mitochondria via the protein importation pathway in
vitro using components of the bacterial conjugation
machinery.
(b) to show that DNA can be delivered to mitochondria in
vivo using the bacterial conjugation system.
In a later phase, we hope to be able to select for
introduced mitochondrial genomes in mitochondria in
living cells using metabolic and/or antibiotic selection
strategies.
Some major hurdles in transfection of mitochondria in a
genetically stable and heritable manner will be discussed.
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MtDNA in myopathies: absence of a preferential
haplotypic background for deletions and a search
for inversions
A. Goios*, L. Pereira, C. Nogueira, C. Pereira, L. Vilarinho,
A. Amorim
Population Genetics, IPATIMUP, R. Dr. Roberto Frias s/n,
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Pathogenic defects in mtDNA can be divided into point
mutations or large-scale rearrangements. Single or multiple
macrodeletions are found in patients with different myopa-
thies, with symptoms including ocular and hearing problems,
weakness, ataxia, and cardiac and endocrine disorders. These
rearrangements have been associated with the presence of
directly repeated sequences in its breakpoints, although the
factors of its occurrence just in some of the regions and in
some individuals have not yet been identified. Various studies
have reported or denied connections between the phenotypic
expression of mtDNA mutations and certain haplogroup(s).
Namely, a relationship between haplogroups U/K and the
clinical features of patients with single mtDNA common
deletion was described. We analyzed patients (n = 31) with
single or multiple mtDNA deletions, and typed them for the
HVRI and HVRII. We found no significant association
between any of the most frequent haplogroups and the
presence of the common deletion or with the development
of other macrodeletions. Additionally, in 16 mtDNA dele-
tions detected, 13 were not formerly reported, 7 of which
present direct repeats of 2–12 bp on its breakpoints. We are
now analyzing samples of patients with myopathies that do
not exhibit mtDNA deletions or the substitutions at the
positions 3243, 3271, 8344, 8356, 8993 and 9176. We are
typing them for the only pathogenic mtDNA inversion
EUROMIT 626reported yet by a screening method of co-amplification using
specific primers for the normal and the inverted sequences (in
the region 3901–3908 bp). In 20 individuals already typed,
the inversion was not detected.
P-6
Novel mutations in thymidine kinase-2 associated with
fatal mitochondrial myopathy and mtDNA depletion
A. Oldfors*, A.-R. Moslemi, M. Tulinius, N. Darin, E.
Holme
Pathology, Laboratory medicine, Sahlgrenska Hospital, 413
45 Go¨teborg, Sweden
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Mitochondrial DNA (mtDNA) depletion syndromes
(MDS) are autosomal recessive disorders of infancy or
childhood characterized by decreased mitochondrial DNA
(mtDNA) copy number and respiratory chain dysfunction
in affected tissues. The myopathic form of MDS has been
reported to be associated with mutations in the thymidine
kinase-2 (TK2) gene while the hepatocerebral forms have
mutations in the deoxyguanosine kinase (DGUOK) gene.
In this study we have analyzed three patients with MDS for
mutations in the TK2 and DGUOK genes. One patient was
compound heterozygous for two novel mutations in TK2:
T33M in exon 3 and R152W in exon 8. The parents were
heterozygous for the respective mutations showing that the
mutations were allelic. The patient and one older sister died
at 2 years of age due to rapidly progressive myopathy with
respiratory failure. The diagnosis of mitochondrial myopa-
thy with respiratory chain deficiency and hyperlactatemia
was made at the age of 1 year. The muscle biopsy showed
marked deficiency of cytochrome c oxidase in addition to
muscle fibers with accumulation of ultrastructurally abnor-
mal mitochondria. There was a severe reduction of mtDNA
copy number (less than 10% of normal) in muscle tissue.
Immunostaining showed severe reduction of mtDNA in
cytochrome c oxidase-deficient muscle fibers with accumu-
lation of mitochondria. Our findings extend the list of TK2
mutations associated with myopathic form of MDS.
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Expression of ATPAF1 and ATPAF2 genes encoding
F1-ATPase assembly proteins in mammalian tissues
A. Pickova*, Z. Krejcik, J. Paul, V. Petruzzella, V. Paces
and J. Houstek
Department of Bioenergetics, Inst. of Physiology, Academy
of Sciences of the Czech Republic, Videnska 1083, 14220
Prague 4, Czech Republic
pickovaa@biomed.cas.czATPAF1 and ATPAF2 genes code for specific assem-
bly factors essential for biosynthesis of the catalytic F1
part of the mammalian ATPase. Nevertheless, their role in
the control of ATPase biogenesis remains unclear. In one
case of mitochondrial disease, the ATPase deficiency was
ascribed to the ATPAF2 mutation. On the contrary, we
were unable to find mutations in ATPAF2 or F1-subunit
genes in several other nuclear defects of ATPase assem-
bly. We examined levels of ATPAF1 and ATPAF2 tran-
scripts in relation to the mRNA levels for F1-alpha and
F1-beta, the interaction subunits, in mouse heart, kidney,
brown fat, liver, muscle and brain by QT-RT-PCR. While
ATPAF1 behaves as a uniformly transcribed housekeeping
gene, ATPAF2 is highly regulated and its expression
differs up to 30-fold in mammalian tissues, being the
most active in ATPase-poor thermogenic brown fat. Al-
though ATPAF2 mRNA levels are two orders of magni-
tude less abundant than F1-alpha and F1-beta mRNAs,
the tissue-specific expression profile of ATPAF2 corre-
sponds to that of F1-alpha and F1-beta genes. This is in
accordance with the presence of several transcriptional
elements, found to be active in various mitochondria-
related nuclear genes, in ATPAF2 promoter region. Anal-
ysis of human fibroblasts showed about 10 times lower
levels of ATPAF1 and ATPAF2 mRNAs compared to the
transcripts of F1-subunits, and comparable levels of these
transcripts in controls and patients with ATPase deficien-
cy. Our results indicate that these ATPase defects are not
caused by down-regulation of ATPAF1 and ATPAF2
genes.
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A. Meulemans*,1, S. Seneca1, W. Lissens1, J. Smet2, R. Van
Coster2, I. Liebaers1, L. De Meirleir1
1Medical Genetics, AZ-VUB, Laarbeeklaan 101, 1090 Brus-
sel, Belgium
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Many patients are suspected to have a mitochondrial
disease, based on their clinical symptoms or after bio-
chemical investigations, although very often no genetic
defect can be found. We selected a group of 20 patients
with clinical and biochemical evidence of a decreased
complex I activity, one of the most common enzyme
defects of the OXPHOS disorders. The nucleotide se-
quence of mitochondrially encoded tRNA and MTATP6/
8 genes had not revealed pathogenic mutations in these
patients. The Denaturating Gradient Gel Electroforesis
(DGGE) system was used to search for mutations in the
seven mitochondrial-encoded subunits of complex I. In this
group of 20 patients, a total of 96 nucleotide changes were
EUROMIT 6 27detected. Most of them were benign polymorphisms.
Eleven sequence variations have never been described
before, but since they did not fulfill any of the criteria
for pathogenicity, we considered them as rather rare poly-
morphisms. Six of the 96 identified nucleotide variations
were previously reported as pathogenic mutations, al-
though a lot of controversy still exists about their patho-
genic nature, especially because they are also found in
some healthy controls. In six patients, up to eight or more
polymorphisms were found. It has been suggested that it is
the cumulative effect of these polymorphisms that causes
disease. However, as we suspect that the 96 identified
nucleotides changes are polymorphisms which cannot
cause disease on their own, this study indirectly confirms
the important role of the nuclear-encoded genes in causing
complex I deficiencies.
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MELAS and L-arginine therapy
Y. Koga*, Y. Akita, J. Nishioka, N. Povalko, T. Matsuishi
Pediatrics, Kurume University, 67 Asahi-machi, 830-0011
Kurume, Japan
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Background: Based on a hypothesis that the stroke-like
episode in the syndrome of mitochondrial myopathy, en-
cephalopathy, lactic acidosis, and stroke-like episodes
(MELAS) is caused by impaired vasodilation in an intrace-
rebral arterial segment, we evaluated effects of administer-
ing L-arginine, a nitric oxide precursor.
Methods: We assessed clinical status and biochemical
parameters in venous blood during interictal and acute
phases in 24 MELAS patients, and also in control subjects.
In 34 stroke-like episodes, patients were infused with either
0.5 g/kg of L-arginine or a placebo. In some acute episodes,
treatment effect on cerebral blood flow was studied; in some
interictal patients, oral L-arginine prophylaxis was studied.
Results: Concentrations of L-arginine (46.6 + 12.7 Amol/
l), citrulline (23.2 + 10.2 Amol/l), and nitric oxide metab-
olites (NOx; 24.0 + 9.8 Amol/l) during the acute phase of
MELAS were significantly lower than in control subjects
(108.1 + 27.6, 34.6 + 8.8, and 45.4 + 30.5 Amol/l, respec-
tively), but asymmetrical dimethylarginine (ADMA) was
not significantly decreased during this phase (0.45 + 0.10
Amol/l). At 30 min after L-arginine infusion, all symptoms
suggesting stroke were significantly improved, in associ-
ation with significantly increased L-arginine, citrulline,
NOx, and cGMP. Increased tracer uptake showed im-
provement in blood flow in the freshly infracted region.
Lactate and its ratio to pyruvate were restored to interictal-
phase values 24 h after L-arginine infusion. With oral
administration of L-arginine in the interictal phase, fre-
quency and severity of stroke-like episodes decreased
significantly.Conclusions: L-arginine therapy showed promise in treat-
ing stroke-like episodes in MELAS.
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Long-surviving Leigh syndrome patients with COX
deficiency and SURF1 mutations
A. van Riesen*, H. Antonicka, E. Kra¨mer, A. Ohlenbusch,
E. Shoubridge, E. Wilichowski
DNA-Labor, 1D3 642, Neuropa¨diatrie, Universitiy Child-
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Most study groups agree on early onset and death before
adolescence to be major features of LS patients with COX
deficiency and SURF1 mutations. We found two patients
who survived their 10th birthday.
Patient 1 developed nearly normal in her first year. She
then got retarded in psychomotor skills. A muscle biopsy
revealed a COX deficiency. We sequenced the SURF1
exons and found compound heterozygosity for 574–
575insCTGC and 74G >A, which leads to a frameshift
and a nonsense codon, respectively. No Surf1 protein was
detectable on Western blots. At age 18 she is mentally well
preserved, though the disease clearly progresses.
Patient 2 developed symptoms in his second year. His
psychomotor skills were well preserved for a long time, and
he was able to attend for 1 year at a regular elementary
school. He was diagnosed in his 7th year with elevated
lactate levels in CSF and decreased COX activity in muscle.
Molecular investigations in this patient detected a new
mutation in SURF1 (269T>C) causing an exchange of
leucine to proline. In Western blot studies we were able to
detect a decreased amount of Surf1 protein. The boy is 13
years old now.
Almost all SURF1 mutations described so far resulted in
complete loss of the protein and are associated with poor
clinical prognosis. The long survival of two patients de-
scribed here indicates that small amounts of Surf1 protein
are protective against severe illness and that additional
factors might compensate the devastating effects of com-
plete protein loss.
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Fungal strains with complex I mutations implicated in
mitochondrial disease
A. Videira*, M. Duarte, A. Ushakova
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EUROMIT 628The primary function of mitochondria is to convert
energy via oxidative phosphorylation, a process mediated
by the mitochondrial respiratory chain. Mutations in mito-
chondrial proteins encoded by both mitochondrial and
nuclear DNA are implicated in a wide range of mitochon-
drial diseases. Complex I deficiency is a major contributor
to these disorders and mutations in nuclear-coded subunits
of the enzyme have been specifically identified in severe
pathological cases. We developed Neurospora crassa
strains harbouring mutations in the TYKY, PSST and 51-
kDa homologous subunits, equivalent to those found in
human diseases. These subunits are involved in the cata-
lytic activity of complex I and the point mutations target
amino acid residues that are fully conserved between fungi
and humans.
The point mutations P88L and R111H were separately
introduced in the TYKY homologue, the V135M mutation
was created in the PSST homologue and the A353V and
T435M mutations were separately generated in the 51-kDa
protein. All alterations were performed in cDNAs, which
were then expressed in the corresponding null-mutant under
the control of a heterologous promoter. P88L, R111H and
V135M strains contain a fully assembled complex I in
contrast to the respective null-mutants, where formation of
the peripheral arm of the enzyme is prevented. Isolated
complex I from these strains displays spectroscopic and
enzymatic properties similar to those observed in the wild-
type enzyme. Characterization of the A353V and T435M
mutants in terms of enzyme structure and function is
underway and will be presented.
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Introduction: Leber’s Hereditary Optic Neuropathy
(LHON) is a mitochondrial and multisystemic disease
manifested by acute or subacute loss of central vision.
Neurophysiological findings (electromyoneurography and
multimodal evoked potentials) confirm asymptomatic in-
volvement of the other organ systems. The aim of the studyis to examine functionality of the auditory pathway using
BAEP.
Materials and methods: Research included seven patients
with clinically and genetically confirmed diagnosis of
LHON, aged between 11 and 48 (average age 22.3 years),
five males (71.4%) and two females (28.6%), and 13
asymptomatic family members from six families, aged
between 12 and 53 (average age 30.1 years), four males
(30.8%) and nine females (69.2%). All of examined subjects
have BAEP done on the apparatus Medelec Sapphire
Premiere.
Results: Three ‘‘primary’’ LHON mutations of the mito-
chondrial genome have been found on seven patients from
seven families—three of them have 11778, three have 3460
and one has 14484. All of those seven have pathological
BAEP with interpeak latency (IPL) prolongation between
the first and the fifth wave (IPL I–V) and IPL I–III,
unilaterally or bilaterally, while only one patient has IPL
III–V prolongation on both sides. Examination of the
family members showed IPL I–V prolongation in nine of
them, among which five have IPL I–III prolongation,
unilaterally or bilaterally, and only one unilateral IPL I–
III prolongation. BAEP finding was normal on three family
members. All examined subjects are previously tested and
had normal audiometry.
Conclusion: Prolongation in I–III IPL suggests slowed
conduction along eighth cranial nerve. Asymmetrically
increased IPL III–V on the level of the brainstem is
hard to explain. IPL I–V prolongation suggests conduc-
tion defect along the intraaxial acoustic pathways. Path-
ological BAEP indicates multisystemic character of the
LHON.
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Screening for somatic mtDNA alterations in neoplasias
by denaturing high-performance liquid chromatography
B. Kofler*, D. Meierhofer, S. Ebner, J. Mayr, K. Fink1, N.
Schmeller1, N. Jones, W. Sperl
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To elucidate the relationship between tumorigenesis
and mtDNA alterations in various types of cancer, a rapid
screening method for somatic mtDNA variations was
established. Denaturing HPLC analysis was employed
because it has been shown to have a high sensitivity
and specificity for detection of mtDNA alterations. This is
especially important in tumor tissues with low tumor cell
content where somatic mtDNA mutations specific for the
tumor cells might not be detected by conventional meth-
ods like sequencing. The entire mtDNA of tumor tissue
EUROMIT 6 29and the corresponding normal tissue from adult renal cell
carcinoma (RCC) and childhood acute lymphoblastic
leukaemia was amplified in 300–550-bp overlapping
fragments. The DNA mixtures were denatured and rean-
nealed, and the homo- and heteroduplices were evaluated
by temperature-modulated heteroduplex analysis by
DHPLC.
In RCC tissues (n = 11), we found two homo- and one
heteroplasmic somatic mtDNA mutation. Independently of
the presence of somatic mtDNA alterations, in all RCCs
investigated, a dramatic decrease in the mtDNA content was
detected. In leukemia samples (n = 6), we found two hetero-
plasmic somatic mutations. One patient showed more than
10 heteroplasmic mtDNA variations shortly after comple-
tion of chemotherapy. Further investigations revealed that
the variations were not induced by chemotherapy but might
be due to the transfusion of platelets.
Our screening method proofed to be able to detect
somatic mtDNA mutations in a percentage which has
already been reported for other tumors. In cases of alloge-
neic platelet infusion, care has to be taken with interpreta-
tion of mtDNA sequence variations in blood samples of
leukemic patients.
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Autosomal recessive mitochondrial ataxic syndrome due
to mitochondrial polymerase gamma mutations
L. Bindoff*, S, Winterthun, G. Ferrari, L. He, R. Taylor, M.
Zeviani, D. Turnbull, B. Engelsen, G. Moen
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We describe three families and one sporadic case with a
syndrome that includes a progressive ataxia, epilepsy, my-
oclonus, tremor, peripheral neuropathy, headache and oph-
thalmoplegia. In most cases, headache and/or epilepsy is the
first symptom and ophthalmoplegia is a late feature. The
ataxia is due to a combination of central and peripheral
disease and the commonest form of epilepsy was focal and
involving the occipital lobes. MRI shows changes in the
central cerebellum, olivary nuclei, occipital cortex and
thalami. Mitochondrial dysfunction is suggested by the
finding of cytochrome c oxidase (COX)-deficient fibres in
muscle, although in one case these were rare and in another
completely absent. Multiple mitochondrial DNA deletions
could be demonstrated in all affected individuals. Deletions
could be detected using standard methods of analysis in two
families, but in two cases, including the one with no COX-
deficient fibres, real-time PCR analysis was required to
confirm the presence of this abnormality. Genetic studies
reveal mutations in the mitochondrial DNA-dependent
DNA polymerase gamma (POLG) gene. These findings
confirm the importance of POLG in the causation ofrecessive neurological disease, show that mutations in this
gene cause a much wider phenotype than recognised previ-
ously, and demonstrate how the phenotype may evolve with
time. The study also highlights the importance of using
sensitive methods for detecting the presence of multiple
mtDNA deletions.
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Mitochondrial therapies for HIV lipoatrophy
M. Gerschenson*, D. Libutti, D. Tran, B. Shiramizu, L.
Day, M. Marcelo, C. Shikuma
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The goal of this study is to identify interventions to
reverse or delay the progression of lipoatrophy occurring
in HIV-infected individuals following treatment with
antiretroviral therapy. The combination of mitochondrial
co-factors, co-enzyme Q10 and acetyl-L-carnitine, together
with Niaspan and Pioglitazone are being evaluated in a
24-week pilot investigation of HIV lipoatrophic patients
with two study arms. There is a treatment group (n = 10)
and a control group (n = 10) that will undergo the same
assessments. Patients are being monitored for changes in
fat content by whole-body dual energy X-ray absorpti-
ometry (DEXA) and abdominal eight-slice CT scan.
Serial fasting lipids, glucose, insulin, and lactate levels
will also be performed. To date, three male patients on
the treatment arm and one male and one female patient
on the control arm have completed the study. The DEXA
analyses of arms, legs, trunks, and muscle peripheral fat
did not change in either group. More interestingly, lactic
acid levels decreased by 24% over the 24 weeks in the
treatment arm (from an average of 2.1 to 1.6 mmol/l),
whereas in the control arm, lactic acid levels increased
by 36% (from an average of 0.9 to 1.4 mmol/l). In
conclusion, the preliminary clinical metabolic data sug-
gest that this intervention may be affecting mitochondrial
metabolism.
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Drosophila VDAC: a model system to study
mitochondrial function
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EUROMIT 630Voltage-dependent anion channels (VDACs) are a family
of small pore-forming proteins of the mitochondrial outer
membrane found in all eukaryotes. VDACs play an impor-
tant role in the regulated flux of metabolites between the
cytosolic and mitochondrial compartments and three distinct
mammalian isoforms have been identified. The specific
physiologic and potential pathophysiologic roles of the
various isoforms are not understood, but animal and cell
culture experiments suggest that the various isoforms func-
tion in apoptosis, learning and reproduction. Recent annota-
tion of the Drosophila melanogaster genome has revealed
three putative VDAC isoforms (CG17137, CG17139,
CG17140) closely linked to the previously reported Dro-
sophila VDAC (porin). Molecular characterizations reveal a
complex sex-specific expression pattern for these genes.
When expressed in yeast deficient for VDAC, porin and
CG17137 rescue a conditional-lethal phenotype. Electro-
physiological characterization of these proteins in reconsti-
tuted systems demonstrates a differential ability to
permeabilize lipid bilayers and liposomes. Analysis of flies
homozygous for hypomorphic P element alleles of porin
reveals abnormal phenotypes including partial lethality,
neuromuscular dysfunction and male infertility phenotypes
reminiscent of mouse VDAC mutants. Transgenic expres-
sion of porin in the homozygous, hypomorphic background
rescues the partial lethality and neuromuscular phenotypes.
Tissue-specific overexpression of CG17139 and CG17140
leads to developmental defects, while a truncating deletion
of CG17140 results in recessive lethality. These studies
demonstrate that Drosophila VDAC homologs have
retained important aspects of VDAC structure and function,
warranting further studies to utilize this genetic model
system in delineating fundamental conserved roles of
VDACs and mitochondria in eukaryotic cell function.
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Mitochondrial gene expression and transcription in
Alzheimer’s disease patients
B. Rodriguez-Santiago*, V. Nunes
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We present an analysis of the steady-state levels of
mitochondrial RNA and an estimation of the transcription
rates in cerebellum, hippocampus, frontal cortex and
lymphocytes from AD patients and controls. The expres-
sion of the genes ND4, 12S, Cyt b, COX II and ND6
(encoded by the mtDNA) in AD patients and controls has
been measured by performing reverse transcription fol-
lowed by real-time PCR quantification method based on
Lightcycler technology using SYBR Green I dye. Gene
expression was also analysed by performing classic dot
blot experiments to compare the two techniques. Estima-
tion of the transcription rate was calculated by combiningthe mtDNA data and RNA data obtained for the gene
expression studies. Our real-time PCR experiments of
gene expression revealed results equivalent to those
obtained with dot blot experiments. Real-time PCR could
be the technique of choice to replace classic laborious,
time- and sample-consuming experiments such as North-
ern, dot or slot blots for analysing gene expression. The
relationship between mtDNA content, steady-state RNA
levels and transcription rates in these AD samples is also
discussed.
P-18
Generation and characterization of a new loxable
knockout model of the Surf1 gene
C. Dell’Agnello*, F. Invernizzi, C. Tiveron, A. Iellem, A.
Agostino, G. Fagiolari, A. Prelle, M. Zeviani
Division of Molecular Neurogenetics, National Neurologi-
cal Institute, Via Temolo 4, 20126 Milano, Italy
carlotta49@hotmail.com
Leigh encephalopathy associated with COX deficiency
is one of the most common disorders of the mitochondrial
respiratory chain in infancy. In most cases it is due to
loss of function mutations of Surf1, a COX assembler.
We have developed a first constitutive knockout (KO)
mouse model for Surf1 by replacing the central region of
the gene with a Neo cassette (Neo allele). The Surf1 null
Neo/Neo mice were characterized by the following fea-
tures: (1) high post-implantation embryonic lethality, af-
fecting approximately 90% of the  / individuals; (2)
significant deficit in muscle strength and motor perfor-
mance; (3) a partial, isolated defect of COX activity in
skeletal muscle and liver, and, to a lesser extent, heart
and brain; (4) absence of overt neurological symptoms.
To test whether the high embryolethality in Neo/Neo
individuals was due to a role of Surf1 in early embryo-
genesis, we created a second murine model characterized
by a minimal structural perturbation of the recombinant
alleles. This was achieved by introducing a Neo cassette
flanked by two lox-P sites (neolox-P allele) within exon 7
of the Surf1 gene. The neolox-P/ + heterozygous animals
were normal but never gave birth to homozygous neolox-
P/neolox-P individuals. By contrast, after elimination of
the Neo cassette by using the cre recombinase, the
percentage of homozygous lox-P/lox-P KO animals was
restored to the expected 25%. The animals showed high
level of lactic acid in the blood and a generalized COX
defect. The rotation-rod test was normal and there was
no spontaneous neurodegeneration. These results demon-
strate that (i) the absence of Surf-1 does not compromise
per se embryonic vitality, and (ii) unknown compensa-
tory mechanisms prevent the Surf1 null lox-P/lox-P mice
from developing the severe phenotype observed in
humans.
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Differential display analysis of thyroid oncocytoma:
searching for mitochondrial proliferation mechanism
C. Jacques*, O. Baris, D. Mirebeau, F. Savagner, Y.
Malthiery, P. Reynier
INSERM E0018, CHU Angers, 4 rue Larrey, 49033 Angers,
France
caroline.jacques@med.univ-angers.fr
In order to find new proteins involved in the mitochon-
drial biogenesis and/or in oncocytoma tumorigenesis, we
performed a differential display analysis on two thyroid
oncocytic adenomas, tumours characterised by the presence
of a large number of mitochondria, versus paired control
thyroid tissue. The 360 overexpressed and 100 underex-
pressed fragments in the tumour were spotted on Nylon
membranes macro-arrays with additional mitochondrial
genes. The hybridisation of four other paired oncocytoma/
normal thyroid couples on the macroarrays confirmed the
differential expression for 49 overexpressed and 12 under-
expressed fragments. Among the overexpressed genes, genes
coding for mitochondrial components are well represented
with 12 mtDNA-encoded genes and two nuclear-encoded
genes, UCP2 and ANT2, of which up-regulation had
already been described in oncocytoma. The Cathepsin B
gene is involved in the processing of the thyroglobulin
and has been shown to be up-regulated in human thyroid
tumours. The remaining known genes are involved in
various metabolisms (transcription modulation, translation,
ubiquitination, etc.). Among the underexpressed genes,
the Pendrin, which codes for an apical transporter of
chloride/iodide ions, is known to be modulated in ex-
pression and location in a context of thyroid tumour. In
silico, five unidentified genes show, in their promoter,
potential regulatory sequence for transcription factors
known to be involved in the mitochondrial biogenesis;
for three of them, the potential corresponding protein
shows a putative N-terminal mitochondrial targeting sig-
nal. Further analysis to investigate the involvement of
these genes in mitochondrial biogenesis and/or thyroid
tumorigenesis is ongoing.
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Investigation of mitochondrial function in the
pilocarpine model of epilepsy
C. Tengan*, I. Nasseh, D. Amado, E. Cavalheiro, M.
Naffah-Mazzacoratti
Neurology, Universidade Federal de Sao Paulo, R. Pedro
de Toledo, 781, 7o. andar, 04039-032 Sao Paulo, Brasil
chtengan@neuro.epm.brThe presence of epileptic seizures as one of the manifes-
tations of several mitochondrial disorders may suggest the
involvement of mitochondrial dysfunction in epileptogene-
sis. Considering the important role of mitochondria on
neuronal cell death and generation of reactive oxygen species
(ROS), the findings of apoptosis and increased production of
ROS in experimental induced epilepsy support this hypoth-
esis. However, studies investigating mitochondrial involve-
ment in epilepsy showed variable results: deficiency in
complex I or IV (in patients), deficiency in complex I and
IV (in pilocarpine model), increased expression in subunit I
of cytochrome c oxidase (COX) and complex I (in genetic
model) and normal COX activity (in kindling model).
We investigated the possible role of mitochondrial dys-
function in epileptogenesis using the pilocarpine model of
temporal lobe epilepsy. We studied mtDNA abnormalities
(by PCR and Southern blotting), COX expression and
activity (by Western blotting and immunohistochemistry)
in rats in the chronic phase of the model, when spontaneous
and recurrent seizures begin to occur.
A 4.8-kb mtDNA deletion was detected by PCR but with
a frequency similar to the age-matched control group. No
other rearrangements or quantitative alterations of mtDNA
were detected. Abnormalities of mitochondrial protein
(COX I, COX IV, SDH) expression were not detected in
hippocampus by Western blotting or immunohistochemistry.
COX activity (by histochemistry) did not show abnormal-
ities in different regions of hippocampus in experimental
animals. In conclusion, our results could not demonstrate a
mitochondrial involvement in epileptogenesis. (Supported
by FAPESP).
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Renal oncocytomas as a model to study the regulation of
mitochondrial proliferation
S. Zanssen*, B. Gunawan, L. Fuzesi, D. Warburton,
E. Schon
Neurology, Columbia University, 630 West 168th Street,
10032 New York, NY, USA
sz2106@columbia.edu
Mitochondrial defects have been associated with severe
neurodegenerative disorders and with human cancers. A
variety of encephalomyopathies have been linked to alter-
ations of mtDNA. The predominantly neurological symp-
toms are not produced by the mutations per se, but by an
unregulated proliferation of pathologic mitochondria. We
are using oncocytomas, which are mostly benign epithelial
tumors whose predominant feature is a massive accumula-
tion of mitochondria in the cytoplasm, as a way to search for
unknown genes that play a role in regulation of mitochon-
drial proliferation.
We studied three oncocytomas with 11q13 rearrange-
ments. Fluorescent in situ hybridization (FISH) using BAC
EUROMIT 632clones in the region showed that the 11q13 breakpoints in all
three tumors are near the CCND1 (BCL1) gene. None of the
breakpoints disrupts any known gene other than CCND1, but
gene prediction programs suggest several human genes in the
breakpoint region. The rearrangement in one tumor consisted
of a segmental duplication that included 11q13, presenting
several mitochondrially targeted genes immediately distal to
CCND1 as interesting candidate genes.
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Role of the ND4L and the ND9 subunits in the
activity and assembly of complex I in Chlamydomonas
reinhardtii
C. Remacle*, P. Cardol, R. Matagne, M. Radoux,
P. Minet
Life Sciences, University of Lie`ge, Bvd du rectorat, 27 B22,
B-4000, Lie`ge, Belgium
c.remacle@ulg.ac.be
Seven to nine subunits (ND1–7, 9, 4L) are usually
encoded in the mitochondrial genomes of eukaryotic cells.
In Chlamydomonas reinhardtii, only five subunits (ND1,
ND2, ND4, ND5 and ND6) are mitochondrial-encoded.
Genomic analysis has allowed us to identify the Nd3,
Nd4L, Nd7 and Nd9 genes in the nuclear genome of this
alga. In this study, the Nd4L and Nd9 genes have been
inactivated by RNA interference. For that purpose, con-
structions bearing a fragment of the targeted genes in the
sense direction followed by the corresponding cDNAs in the
antisense direction have been put under the NIT/ARS
promoter of Chlamydomonas reinhardtii. Transformant cells
with an intact copy of the chimeric construction have been
identified after cotransformation. Activity and assembly of
complex I have been analysed in the transformed cells.
Northern blots have been performed in order to detect cells
showing a reduced or a null expression of the Nd4L or Nd9
genes. Our results showed that in cells where the expression
of Nd4L or Nd9 has been suppressed, activity and assembly
of whole complex I are abolished.
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Modifiers of phenotype in a Drosophila model of
mitochondrial disease
D. Moreno Fernandez-Ayala*, E. Kemppainen, J. Toivonen,
K. O’Dell, H. Jacobs
Molecular Biology, IMT-University of Tampere, Biokatu, 6,
FIN-33014 Tampere, Finland
daniel.moreno@uta.fi
Mutations in the maternally inherited mitochondrial ge-
nome (mtDNA) or in nuclear genes involved in either
mitochondrial metabolism or mtDNA maintenance manifestwith a wide range of clinical phenotypes, commonly affecting
‘high energy’ tissues (heart, skeletal muscle, the CNS and
sensorineural epithelia).
Our work is focused on exploiting a Drosophilamutant in
the nuclear gene technical knockout (tko), encoding mitor-
ibosomal protein S12, which is involved in fidelity of protein
synthesis. One mutation, tko25t, giving the substitution
L85H in a conserved amino acid of the protein, confers a
phenotype with some resemblances to human mitochondrial
diseases, such as developmental delay, paralytic seizures,
hyporeactivity and defective auditory function.
Continuous selection during inbreeding of tko25t mutant
flies in an initially mixed genetic background produced
different sub-lines showing various degrees of recovery
towards the wild-type phenotype. These should represent
useful paradigms for identifying genes and pathways that
can or do modify phenotype in human mitochondrial
disease. We present a preliminary transcriptomic analysis
of these lines, identifying modifier genes responsible for the
restoration the phenotype in these lines.
P-24
Relationship between mutational load and increased
lactate production in olfactory epithelial cells with the
MELAS a3243g mutation
S. Campbell, A. Mackay-Sim, C. Sue*
Neurogenetics, Department of Neurology, Royal North
Shore Hospital St Leonard’s, NSW 2065 Sydney, Australia
csue@med.usyd.edu.au
Background: MELAS syndrome is associated with the
MELAS A3243G mutation. In its most severe form, affect-
ed patients suffer stroke-like episodes; focal neurological
deficits associated with lactic acidosis and a clinical pro-
drome of headache, nausea or vomiting. Lactic acidosis
often heralds the onset of a stroke-like episode.
Aim: To determine the relationship between lactic acido-
sis and mutational load in neural cell lines containing the
MELAS A3243G mutation.
Methods: Olfactory epithelial biopsies were obtained
from a patient with MELAS A3243G and 7 control subjects.
Cultured cells were stained for glial markers that indicated a
neural origin. Lactic acid production was measured after
cultured cells that had been deprived of glucose for 1 h. To
reduce mutational load, cells were cultured in galactose-
supplemented (glucose-free) media for 2–6 days. Mutation-
al load was determined using PCR/RFLP analysis.
Results: Cells cultured from olfactory epithelial biopsies
were shown to express GFAP, indicating that they were
neural in origin. Cells with the MELAS A3243G mutation
produced an increased amount of lactate (3Amol/h/mg
protein) when compared to cells derived from control
subjects (1.8Amol/h/mg protein). Mutational load of
MELAS A3243G containing cells decreased from 56% to
EUROMI4% after culturing in galactose-supplemented (glucose-free)
media for 2 days. Lactic acid accumulation returned to
normal control values when the mutational load decreased.
Conclusions: Cells harbouring the pathogenic MELAS
A3243G mutation produce more lactate than cells derived
from control subjects. A decrease in mutational load signif-
icantly reduced the lactate production of these cells. High
mutational loads are responsible for the increased lactate
production in neural cells containing the MELAS A3243G
mutation.
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An anti-apoptotic viral protein that recruits Bax to
mitochondria
D. Poncet*, N. Larochette, A.-L. Pauleau, P. Boya, A.-A.
Jil, P.-F. Cartron, F. Vallette, C. Shnebelen, L. Bartle, A.
Skaletskaya, D. Boutolleau, J.-C. Martinou, V. Goldmacher,
G. Kroemer, N. Zamzami
Ge´ne´tique oncologique PR1, Institut Gustave Roussy, 39 rue
Camille Desmoulins, 94805 Villejuis, France
poncet@igr.fr
The viral mitochondria-localized inhibitor of apoptosis
(vMIA), encoded by the UL37 gene of human cytomegalo-
virus, inhibits apoptosis-associated mitochondrial membrane
permeabilization (MMP) by a mechanism different from that
of Bcl-2. Here we show that vMIA induces several changes
in Bax that resemble those found in apoptotic cells, yet take
place in unstimulated, non-apoptotic vMIA-expressing cells.
These changes include the constitutive localization of Bax at
mitochondria where it associates tightly with the mitochon-
drial membrane, forming high molecular weight aggregates
that contain vMIA. vMIA recruits Bax to mitochondria, but
delays relocation of caspase-8-activated truncated Bid-GFP
(t-Bid-GFP) to mitochondria. The ability of vMIA and its
deletion mutants to associate with Bax and to induce
relocation of Bax to mitochondria correlate with their anti-
apoptotic activity and with their ability to suppress MMP.
Taken together, our data indicate that vMIA blocks apoptosis
via its interaction with Bax. vMIA neutralizes Bax by
recruiting it to mitochondria and ‘‘freezing’’ its pro-apoptotic
activity, yet undescribed viral strategy of subverting an
intrinsic pathway of apoptotic signaling.
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CDNA-based screening and analysis of the OPA1 gene in
patients with autosomal dominant optic atrophy
S. Schimpf*, S. Schaich, B. Wissinger
Universita¨ts-Augenklinik Abt. II, Molekulargenetisches La-
bor, Auf der Morgenstelle 15, 72076 Tu¨bingen, Germany
Simone.Schimpf@gmx.deAutosomal dominant optic atrophy (adOA) is the most
common form of inherited optic neuropathy. The predom-
inant locus was linked to chromosome 3q28–q29 and the
disease-causing gene OPA1, which encodes a dynamin-
related GTPase targeted into mitochondria, was identified.
Up to now, 89 different OPA1 mutations in 159 unrelated
families have been identified.
Because of the complex structure of the OPA1 gene
within 30 coding exons, the commonly used mutation
detection technique, exon by exon sequencing, is laborious
and expensive. Moreover, putative splice site mutations
cannot be functionally characterised and mutations in the
unspecified promoter region or larger deletions may not be
detected. To overcome these problems, we establish a
cDNA-based screening analysis using RNA isolated from
blood leukocytes or cell lines. RNA samples were reverse
transcribed, the entire coding region of the OPA1 gene
was amplified as four overlapping cDNA fragments and
screened by direct sequencing. Using this method we have
identified 34 different OPA1 mutations including 6 frame-
shift, 10 missense, 3 nonsense and 15 splicing mutations.
Twelve of these splicing mutations lead to skipping of the
flanking exon and three of them to an activation of a
cryptic splice site. We noticed that some mutations that
lead to a premature stop codon are underrepresented at the
cDNA level, which most likely results from nonsense
mediated mRNA decay. Allele-specific cDNA quantifica-
tion applying pyrosequencing was used to confirm and
quantify the reduced levels of the mutant transcripts.
These results provide additional evidence that haploinsuf-
ficiency may represent a mechanism for the development
of adOA.
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Expression analysis of the dynamin related OPA1
protein in the human brain
S. Bette*, H. Schlaszus, B. Wissinger, R. Meyermann,
M. Mittelbronn
Universita¨ts-Augenklinik Abt. II, Molekulargenetisches La-
bor, Auf der Morgenstelle 15, 72076 Tuebingen, Germany
sbette@gmx.de
Autosomal dominant optic atrophy (adOA) is the most
prevalent hereditary optic neuropathy. The majority of
cases of adOA is associated with mutations in the OPA1
gene. This OPA1 gene encodes a 1015-amino-acid poly-
peptide (approximately 110 kDa) with similarities to GTP-
binding proteins of the dynamin protein family. The OPA1
protein is imported into mitochondria where it is attached
to the inner membrane facing the intermembrane space.
OPA1 may represent the human ortholog of the S. cerevi-
siae MgmI and the S. pombe MspI proteins, which are
important for mitochondrial inheritance and maintenance in
T 6 33
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expressed in all tissues examined, with the highest tran-
script levels in the retina and in the brain. Here we
addressed the cell type specific expression of the OPA1
protein in human brain sections using immunohistochem-
ical techniques and Western blot analysis.
We studied OPA1 expression in normal brains obtained
at autopsy from patients with no reported neurological
symptoms or diseases. We analysed paraffin sections and
tissue homogenates of the cerebellum and different areas of
the cerebrum using a polyclonal antibody raised against a
carboxy-terminal peptide of OPA1.
We found OPA1 expression in somata and dendrites of
neurons of the layers II–VI of the motor cortex and frontal
lobe. In the cerebellar cortex OPA1 expression was detected
in the Purkinje cell layer, in the granule cell layer and in the
molecular layer. Double labelling experiments showed that
OPA1 is also expressed in GFAP-positive astrocytes, which
was confirmed by Western blot analysis.
P-28
Two families with milder course of Leigh syndrome
associated with SURF1 gene mutations
D. Piekutowska-Abramczuk*, E. Popowska, M. Pronicki, E.
Karczmarewicz, J. Sykut-Cegielska, T. Kmiec, E. Ciara, D.
Jurkiewicz, M. Borucka-Mankiewicz, P. Kowalski, M. Kra-
jewska-Walasek, E. Pronicka
Department of Medical Genetics, The Children’s Memorial
Health Institute, Al.Dzieci Polskich 20, 04-730 Warsaw,
Poland
dorota.abr@wp.pl
COX-deficient Leigh syndrome (LSCOX ), inherited as
an autosomal recessive trait, is one of the most common
encephalomyelopathies of infancy or childhood. Clinical
presentation includes muscle hypotonia, developmental de-
lay, psychomotor retardation, respiratory abnormalities and
brainstem or basal ganglia dysfunction. The elevated lactate
level in cerebrospinal fluid and serum is observed. The
pathological hallmarks of LS are bilateral, symmetric necro-
tizing lesions in the basal ganglia, thalamus, brainstem and
spinal cord. It was established that mutations in the SURF1
gene are responsible for the most cases of Leigh syndrome
associated with severe COX deficiency. The SURF1 gene,
located on chromosome 9q34, is engaged in assembly of
cytochrome c oxidase complex. Most patients carry frame-
shift or nonsense mutations predicting loss of function of the
SURF1 protein.Missensemutations are uncommon, as only a
few have been described in typical COX-deficient Leigh
patients.
We present two families (seven children) with mild
clinical course of the disease. One of two novel missense
mutations, M235T or Y274C, in combination with recurrent
frameshift 845delCT was identified in each patient. Enzy-matic and histopathological study of muscle biopsy speci-
mens revealed decreased COX activity and normal/increased
citric synthase values. Progression of the disease is relatively
slow. Three of the patients survived 18, 17 and 12 years with
undisturbed mental development. They demonstrate only
light respiratory involvement. Our patients belong to a small
group of a few reported cases with the phenotype of late
Leigh syndrome associated with SURF1 mutations.
The study was supported by EC QLG1-CT-2002-90358
and KBN Project-6PO5E05420.
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Mitochondrial disease: new prevalence figures with
major resource implications
A. Schaefer*, E. Blakely, C. Hayes, R. McFarland, P.
Chinnery, R. Taylor, D. Turnbull
Department of Neurology, The University of Newcastle,
Framlington Place, NE2 4HH, Newcastle upon Tyne,
United Kingdom
andrew.schaefer@ncl.ac.uk
The true prevalence of mitochondrial disease within
Europe is uncertain. Increased clinical awareness and
advances in molecular genetic techniques have led to
increasing numbers of diagnoses in most specialist centres,
yet mitochondrial disease is still considered to be a rare
condition, attracting little in the way of specific resource
allocation. Marked clinical heterogeneity, diverse referral
patterns, and asymptomatic carriage of mitochondrial
DNA mutations undermine attempts to accurately measure
its prevalence.
The Newcastle Mitochondrial Centre acts as a tertiary
referral centre for mitochondrial disease in the North East of
England. Within genetically characterised pedigrees, we
identified clinically affected adults below retirement age,
living within the North East at the midpoint of 2001. Pedigree
analysis was then performed to identify relatives directly at
risk of developing mitochondrial disease. The minimum
point prevalence of clinically affected adults in the North
East of England was 10/100,000. The prevalence of those
affected or at risk was 28.6/100,000. This equivocates to
nearly 17,000 individuals within the UK and over 230,000
individuals throughout Europe. These figures are far in
excess of previous estimates and do not include large paedi-
atric cohorts.
The diagnostic processes, family tracing, and associated
genetic counselling involved in confirming these figures
merely represent our basic clinical obligation in a progres-
sive and disabling genetic disease. At present there are few
guidelines for the genetic and clinical diagnosis, or the
management of these important disorders. Our study high-
lights the pressing need for such guidelines, especially in
view of the complex genetics in many patients.
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Mitochondrial DNA variation and Parkinson disease
A. Pyle*, W. Tiangyou, S. Keers, C. Lambert, D. Burn, T.
Foltynie, R. Barker, P. Chinnery
Neurology, University of Newcastle, Medical School, NE2
4HH Newcastle upon Tyne, United Kingdom
angela.pyle@ncl.ac.uk
Mitochondrial dysfunction has been implicated in the
pathogenesis of Parkinson disease (PD). Complex I
defects have been documented in the substantia nigra
and platelets of patients with PD. Cybrid studies have
implicated mitochondrial DNA (mtDNA) but the under-
lying gene defects have yet to be identified. In a recent
North American study, mtDNA haplogroup J and hap-
logroup K were associated with a decreased risk of PD
when compared to mtDNA haplogroup H. Here we report
our study of mtDNA haplogroups in two large indepen-
dent European cohorts of 515 patients with PD and 292
controls subjects.
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Mitochondrial toxicity: mtDNA depletion in peripheral
blood mononuclear cells from HIV-infected individuals
is enhanced after co-infection with HBV/HCV
A. de Ronde*, C. de Mendoza, M. de Baar, F. Blanco, T.
Garcia-Benayas, K. Smolders, P. Ferna´ndez-Casas, J. Gon-
za´lez-Lahoz, V. Soriano
Human Retrovirology, Academic Medical Center, Meiberg-
dreef 15, P.O. Box 22660, 1105 AZ, Amsterdam, The
Netherlands
ronde@amc.uva.nl
Mitochondrial damage seems to be responsible for
many of the long-term toxicities associated with treatment
of HIV infection with nucleoside reverse transcriptase
inhibitors. However, its incidence, and the precise role of
different compounds and of HIV infection itself have not
been elucidated yet.
To evaluate possible factors associated with mitochon-
drial damage in HIV infection, mitochondrial DNA
(mtDNA) was measured in PBMCs from a total of 69
individuals. A duplex real-time NASBA assay was used
and experiments were run in duplicate. The mtDNA copy
number per cell was estimated based on the parallel mea-
surement of nuclear DNA in one-tube reaction for each
individual. Serum lactate, lipids, hepatitis B and C status
and current antiretroviral therapy were recorded.
The median mtDNA value for the 11 HIV-negative per-
sons was 773 copies/cell (IQR: 587–921), whereas it was
352 copies/cell (IQR: 257–529) among 58 HIV-positive
patients (P < 0.001). Among HIV-pos individuals, 48 onantiretrovirals tended to show median mtDNA values higher
than 10 subjects who were drug-naive (353 versus 294
copies/cell; P= 0.320). Overall, lower mtDNA levels were
associated with higher lactate levels. In HIV-pos patients,
lactate and mtDNAwere significantly correlated (P= 0.025).
Finally, co-infection with HCVand/or HBVwas significantly
associated with lower mtDNA values (P= 0.016). We con-
clude that HIV infection reduces mtDNA in PBMCs. Anti-
retroviral therapy tends to alleviate this depletion. There is a
correlation between lactate levels and mtDNA. Interestingly,
chronic infection with hepatitis viruses could result in further
loss of mtDNA in HIV-positive patients.
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The pathophysiological mechanism of thymidine kinase
2 deficiency in mtDNA depletion
A. Saada*, E. Ben-Shalom, R. Zyslin, C. Miller,
O. Elpeleg
Metabolic Disease Unit, Shaare Zedek Medical Center, Beyt
vegan, P.O. Box 3235, 91031 Jerusalem, Israel
saada@szmc.org.il
The thymidine kinase 2 (TK2) is a key enzyme in the
mitochondrial nucleotide salvage pathway, providing the
mitochondria with deoxyribonucleotides essential for mi-
tochondrial DNA (mtDNA) synthesis.
Mutated TK2 is associated with mtDNA depletion and
respiratory chain dysfunction, manifesting as severe skeletal
myopathy in infancy.
Although the diagnosis of TK2 deficiency has been
facilitated by the finding of several new mutations, the
pathophysiological mechanisms of this defect remain to be
elucidated. The reasons for normal fetal development, the
sparing of non-affected tissues and the events leading to
decreased mtDNA synthesis are still obscure.
We speculate that normal fetal development is main-
tained by the activity of cytosolic nucleoside kinases. Our
findings indicate that residual TK2 activity is responsible
for the lack of involvement of certain tissues. Similarly,
we show that imbalanced mitochondrial dNTP pools with
markedly decreased thymidine triphosphate content are
the major aberrations in fibroblasts of TK2-deficient
patients.
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Stimulation of oxidative phosphorylation complex
biogenesis by the von Hippel Lindau factor
C. Godinot*, E. Hervouet, J. Demont, H. Simonnet
Center of Molecular and Cellular Genetics-UMR 5534
CNRS, University Claude Bernard of Lyon 1, 43 bvd du
11 novembre, 69622 Villeurbanne, France
godinot@univ-lyon1.fr
EUROMIT 636According to the Warburg’s hypothesis, mitochondrial
function is impaired in several types of cancer. In agreement
with this hypothesis, we had previously shown that, in renal
carcinomas, low oxidative phosphorylation correlates with
tumor aggressiveness. The mechanisms underlying this
impairment are not understood. In the most aggressive renal
cancers, the clear cell renal carcinomas (CCRCs), the tumor
suppressor gene VHL (von Hippel Lindau factor) is invali-
dated. Hence, the transfection of the VHL gene in cells
depleted of VHL suppresses their ability to form tumors
when they are injected into nude mice. However, several
genetic alterations are observed in addition to the VHL
inactivation. In order to know whether VHL invalidation
was responsible for the mitochondrial impairment, we have
compared mitochondrial functions in 786-0 or RCC10 cells
originally deficient in VHL to those of the same cells
transfected with ectopic VHL. We show that the presence
of pVHL increased mitochondrial contents of respiratory
chain complexes and restored their functions. The presence
of VHL permitted the cells to rely on their mitochondrial
ATP production when growing in the absence of glucose. In
addition, we show that the VHL-dependent activation of the
OXPHOS complex biogenesis was not associated to signif-
icant changes in transcript amounts of nuclear factors:
mitochondrial transcription factor A, Tfam, or other redox-
responsive nuclear transcription factors such as NRF-1 or
NRF-2. Therefore, another VHL-dependent regulatory
mechanism of OXPHOS biogenesis is postulated.
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Analysis of the subunit composition of mitochondrial
respiratory complexes from different species
C. Lemaire*, A. Guillot, L. Negroni, C. Sellem, M. Zivy, A.
Sainsard-Chanet, G. Dujardin
CGM-Ferme du Moulon, CNRS-INRA, Av de la Terrasse,
91198 Gif sur Yvette, France
lemaire@cgm.cnrs-gif.fr
We have used Blue Native Polyacrylamide Gel Electro-
phoresis (BN PAGE) to separate the mitochondrial respira-
tory complexes from different species.
The presence and composition of the five respiratory
complexes were analyzed by combining three different
methods:
– histochemical staining methods to detect the enzymatic
activities of complexes I, II, IV and V directly in blue
native gels [Electrophoresis 18 (1997) 2059–2064]
– immunodetection of subunits with specific antibodies
– mass spectrophotometry to determine the subunit com-
position of the complexes.
In the latter method, the BN PAGE band was isolated
and fragmented by enzymes or chemical reagents.The peptides generated were then analyzed by LC-
MS/MS.
These methods were used to determine the effect of
various mutations on the assembly of the respiratory com-
plexes, in particular for different oxa1 mutations in Saccha-
romyces cerevisiae and Podospora anserina.
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Direct repeats in mtDNA constrain life span in mammals
D. Samuels
Virginia Bioinformatics Institute, Virginia Tech., Bioinfor-
matics Facility 1, 24061 Blacksburg, VA, USA
dcsamuels@vbi.vt.edu
Deletions are often found in the mtDNA of elderly
organisms. These deletions are often, though not always,
flanked by direct repeats. From an analysis of the
mtDNA sequences of 61 mammalian species we find
that there is a constraint relationship between the number
of the longer repeats (>11 bp) and life expectancy for
each species. We also show that for most species the
number of repeats in the mtDNA sequences is greater
than the number in the corresponding randomly shuffled
sequence, with the largest increases occurring among the
short lived species. We will discuss other related factors,
such as repeat location within the genome, repeat length
and base composition.
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Leigh’s Syndrome in siblings carrying the Focal
Bilateral Striatal Necrosis 9176T>C mutation
G. Gray*, T. Hutchin, A. Chakrapani, J. Wright
Clinical Chemistry, Childrens Hospital, Steelhouse Lane,
B4 6NH Birmingham, United Kingdom
george.gray@bch.nhs.uk
A male infant of Greek and British ancestry presented at
9 months of age with a sudden loss of developmental
milestones. An MRI scan revealed bilateral altered signals
in the caudate nuclei, putamina and globus pallidus consis-
tent with Leigh’s syndrome. Since this episode he has made
slow motor progress and at 30 months has central hypoto-
nia, mild dystonia of his arms but no speech or swallowing
difficulties. He walks with an ataxic gait and is intellectually
normal. His younger sister had normal development until 7
months after which she regressed over a 3-month period.
She subsequently regained the ability to smile and interact
but at 15 months had an acute presentation with hypotonia,
encephalopathy and tachypnoeia. She was found to have a
plasma lactate of 5.3 mmol/l and a renal tubular acidosis and
was treated with oral bicarbonate; all developmental mile-
stones were lost. Since then she has made slow and steady
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hypotonia, a well-developed pincer grasp, limb ataxia,
drooling and some intellectual impairment but no dystonia.
Overall she is more severely affected than her brother.
Blood mitochondrial DNA analysis by a PCR/RFLP method
and by sequencing revealed apparent homoplasmy for the
Focal Bilateral Striatal Necrosis (FBSN) 9176T>C mutation
in both siblings and a level of approximately 50% in the
asymptomatic mother. This mutation affects subunit 6 of the
ATP synthetase complex and has been reported to date in
nine families with Leigh-like syndromes showing varying
severity including severe, slowly progressive and non-pro-
gressive phenotypes.
P-37
Two regions with multiple heteroplasmic length variants
in the mitochondrial DNA of a family with diabetes and
hearing disturbances
G. Janssen*, A. Neu, L. ’t Hart, C. Marchien, T. van de
Sande, J. Antonie Maassen
Molecular Cell Biology, LUMC, Wassenaarseweg 72, 2333
AL Leiden, The Netherlands
g.m.c.janssen@lumc.nl
We have identified two locations (nt568 and nt8281)
with multiple heteroplasmic length variants in the mito-
chondrial DNA of a family originating from Asia Minor.
The nt8281 length variants stably inherit in a maternal way
with no major changes in the length distribution in leuco-
cytes of the offspring. In contrast, during culture of the
fibroblasts derived from the proband, the length of the
homopolymeric cytidine tracts is increased with on average
two additional insertions. Furthermore, the heterogeneity in
the polycytidine tract starting at position 568 is also
extended by on average one cytidine upon culture of these
fibroblasts.
Therefore, a mechanism seems active that drives these
fibroblasts towards the enrichment of longer cytidine
tracts. Functional analysis revealed that aberrations in the
intergenic COII-tRNALys and the 568 regions are insuffi-
cient to induce a detectable decrease in mitochondrial
respiration.
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Functions and dysfunctions of the human dynamin OPA1
G. Lenaers*, A. Olichon, C. Delettre, C. Hamel,
P. Belenguer
LBCMCP, CNRS UMR 5088, Universite´ Paul Sabatier, Bat
4R3-B1, 31062 Toulouse, France
glen@cict.frThe OPA1 mitochondrial dynamin, localised to the
IMS associated to the cristae membrane, is involved in
an inherited neurological retinopathy. Extinction of
OPA1 expression in Hela cells induces major mitochon-
drial modifications including fission of the network,
loss of the DeltaPsi, cristae destructuration and ulti-
mately apoptosis, suggesting a pleiotropic function of
OPA1.
We will present data concerning the singular functions
of the different OPA1 variants and the effects of
expressing pathological OPA1 alleles on the structure
and dynamics of mitochondria and on the apoptotic
process.
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Lethal MELAS syndrome in a teenager with mtDNA
tRNA 3271 mutation
H. Pihko
Pediatric Neurology, University of Helsinki, P.O. Box 280,
00029 HUS, Helsinki, Finland
helena.pihko@heslinki.fi
MELAS typically presents as stroke-like episodes lead-
ing to focal neurological deficits, seizures, headache and
cognitive deterioration. An A-to-G transition at mt
(t)RNA 3243 is present in 80% of the patients. Another
tRNA mutation, T3271C, is found in about 10% of
MELAS patients, mostly of oriental origin. According to
Tarnopolsky et al. (1998), the two phenotypes are similar,
but the age of onset is later in T3271C mutation. Our
patient was the first of three children, with healthy
parents and two sisters. Her early growth and develop-
ment were normal. She was investigated at the age of 6
because of weight loss and poor growth. Exercise intol-
erance, WPW syndrome and cystic changes in the thyroid
gland led to the search of a mitochondrial disease. Her
muscle showed RRFs and complex I deficiency. No
mtDNA arrangements were discovered. At the age of
14 strenuous exercise led to severe lactic acidosis, kidney
failure, and pericardial and pleural effusion. Frequent
partial seizures without loss of consciousness began at
17 years, and she died within 2 months after rapid
increase in seizure frequency. Previously normal MRI
showed now stroke-like lesions. Neuropathological
changes were compatible with MELAS. The T3271C
mutation was discovered post mortem. The proportion
of T3271C mutant was over 90% of total mtDNA in her
fibroblasts, and the amount of mutant mtDNA was 78–
96% in other tissues. The amount of mutant mtDNA in
blood leucocytes of mother and two younger sisters was
5%, 27% and 4%, respectively. The sister with 27%
mutant mtDNA had developed diabetes at the age of
18. Hospital for children and adolescents 1, Department
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Research Center 4, University of Helsinki.
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Respiratory chain enzyme deficiency expressed during
muscle development
J.-W. Taanman*, M. Orth, S. Williams, I. Oluwole, S.
Rahman, P. Clayton, J. Leonard
Clinical Neurosciences, RFUCMS, Rowland Hill Street,
NW3 2PF London, United Kingdom
j.taanman@rfc.ucl.ac.uk
We studied myoblast cell cultures from four unrelated,
paediatric patients with marked mitochondrial respiratory
chain enzyme deficiencies in skeletal muscle, but with
no apparent mitochondrial DNA abnormalities. Despite
the obvious enzyme defects in muscle tissue, biochemical
assays revealed that respiratory chain enzyme activities
were normal or only mildly affected in the myoblast
cultures. Immunoblot analysis of native gels and cyto-
chemical staining of the myoblast cultures corroborated
the results of the biochemical assays. Myotubes were, on
the other hand, clearly affected in all four patient
cultures. In both patient and control myotubes, steady-
state levels of respiratory chain enzyme subunits and
activity of cytochrome c oxidase were higher than in
myoblasts. In contrast to control myotubes, however,
patient myotubes contained swollen and unevenly dis-
tributed mitochondria and cytochrome c oxidase staining
was irregular. The life span of patient myotubes was
dramatically shorter than of control myotubes. Our
results suggest that the respiratory chain enzyme defects
seen in skeletal muscle biopsies from these patients may
be due to, or enhanced by, a failure of normal mito-
chondrial biogenesis during muscle development.
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Identification of a novel mutation in the catalytic subunit
1 of the pyruvate dehydrogenase phosphatase (PDP1)
gene in two brothers
J. Cameron*, M. Maj, V. Levandovskiy, N. MacKay, R.
Baumgartner, B. Robinson
Department Metabolism, Robinson Lab rm 9125Elm, Hos-
pital for Sick Children, 555 University Ave., M5g1x8 Tor-
onto, Ontario, Canada
jessie_cameron@hotmail.comPyruvate dehydrogenase deficiency (PDH; OMIM
312170) is a clinically heterogeneous disorder causedby mutations in the E1alpha, E3 and protein X compo-
nents. PDH activity is regulated by phosphorylation: it is
inactivated by PDH kinase and activated by PDH phos-
phatase, PDP. Patients have been reported in the literature
that have a reduction in PDH phosphatase activity, but no
mutation has ever been identified.
We have identified two brothers with hypotonia,
feeding difficulties and delayed psychomotor develop-
ment with elevated lactate levels. Both patients dem-
onstrated deficient native PDH activity in skin
fibroblasts and lymphoblasts. However, activation of
the PDH complex using dichloroacetate showed almost
normal PDH activity, suggesting there was a possible
problem with the efficient regulation of the enzyme
complex.
PDP is a dimeric enzyme that consists of a catalytic
and regulatory subunit; the catalytic subunit has two
isoforms which show differing dependencies to Ca2 +
and Mg2 +. After sequencing the cDNA of all three
genes, we identified a three-base-pair deletion in the
PDP1 gene in both brothers, which was confirmed in
genomic DNA. We have isolated purified human PDP1
and PDP2 proteins and showed them to be active in
vitro. We are currently identifying methods by which
we can restore PDH activity in the patients, both in
intact cells (transfection) and in lysates (enzyme
replacement).
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Assigning pathogenicity to mitochondrial tRNA
mutations: when ‘‘definitely maybe’’ is not good
enough
J. Elson*, R. McFarland, R. Taylor, N. Howell, D. Turnbull
Department of Neurology, Newcastle University, 61
West Road, NE4 9PX Newcastle upon Tyne, United
Kingdom
j.l.elson@ncl.ac.uk
Mitochondrial tRNA (mt-tRNA) mutations have a wide
spectrum of effect, some are tolerated others result in
disease. Not all the factors that influence the pathogenic-
ity of mt-tRNA mutations are quantified, thus predicting
phenotypic effects from sequence variation in mt-tRNA
genes is extremely difficult. Reliably distinguishing path-
ogenic mutations from neutral variations would be a
major advance in the understanding of these molecules.
We reviewed the literature for each mt-tRNA mutation
listed as pathogenic on the MITOMAP database and we
scored each according to the extent and quality of the
evidence for pathogenicity.
The following conclusions could be made: (a) f 73%
of pathogenic mutations occur in the stems of mt-tRNA;
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the acceptor/anti-codon stems; (c) disruption of Watson–
Crick base pairing is an almost universal feature of
pathogenic mutations occurring in the stem structures;
(d) disruption of C–G base pairing is a significantly
more common feature of pathogenic mutations than
neutral variants; and (e) when pathogenic mutations
occur in loop structures, they tend to occur in loops
that are unusual in their size and/or influence the tertiary
folding/function of the mt-tRNA.
What we have discovered will give guidance for current
sequencing studies. In the long term we hope to be able to
build a diagnostic tool using an artificial neural network to
be available on the web that will be able to integrate
information from clinical observations, biochemistry, histo-
chemistiy and evolutionary/structural information to pro-
duce a probability that a presented change is involved in
pathogenicity.
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Functional alteration of cytochrome c oxidase by
SURF1 mutations in Leigh syndrome at normoxia and
hypoxia
J. Houstek*, P. Pecina, M. Capkova, E. Gnaiger, A. Dubot,
A. Vojtiskova, H. Hansikova, H. Houstkova, J. Zeman, C.
Godinot, E. Pronicka
Department of Bioenergetics, Institute of Physiology, Acad-
emy of Sciences of the Czech Republic, Videnska 1083, 142
20 Prague, Czech Republic
houstek@biomed.cas.cz
We performed a complex functional characterization
of fibroblasts harboring different SURF1 mutations
from patients presenting with severe and generalized
COX defect. WB analysis revealed 85% decrease of
the normal-size COX complexes and significant accu-
mulation of incomplete COX assemblies of 90–120
kDa. Spectrophotometric assay of COX activity
showed a 70–90% decrease in lauryl maltoside-solu-
bilised fibroblasts. In contrast, oxygen consumption in
patient cells revealed only a 13–31% decrease of
COX activity that was highly sensitive to lauryl
maltoside. ADP-stimulated respiration was 50% de-
creased and cytofluorometry showed a significant
decrease of mitochondrial membrane potential in state
4, and a 2.4-fold higher sensitivity of mitochondrial
potential to uncoupler. These data indicate that the
absence of the Surf1 protein leads to the formation
of incomplete, detergent-sensitive COX assemblies,
which in situ maintain rather high electron-transport
activity, while their H+-pumping is impaired. As the
cells with SURF1 mutations showed hardly detectablechanges of respiratory rates at normoxic conditions,
we analyzed their respiratory response to low oxygen.
The oxygen kinetics was quantified by p50 (the pO2
at half-maximal respiration rate) in intact coupled
cells and in digitonin-permeabilized uncoupled cells.
In both cases, the p50 in patients was elevated,
indicating two- to threefold decreased affinity of
COX to oxygen. This would mean that the depressed
oxygen affinity may in vivo lead to limitations of
respiration because tissue pO2 is physiologically rather
depressed. Even more pronounced effect can be
expected during respiratory tract infections when the
oxygen supply to tissues is limited and Leigh syn-
drome patients significantly worsen.
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The use of muscle needle biopsy specimens in mitochon-
drial enzyme diagnostics
K. Schoonderwoerd*,1, F. Sadeghi Niaraki1, W. Sluiter2, E.
de Wit2, R. de Coo3
1Clinical Genetics, ErasmusMC, Dr Molewaterplein 50,
3015 GE, Rotterdam, The Netherlands
2Biochemistry, ErasmusMC, Dr Molewaterplein 50, 3000
DR, Rotterdam, The Netherlands
3Neurology, ErasmusMC, Dr Molewaterplein 60, 3015 GJ,
Rotterdam, The Netherlands
g.schoonderwoerd@erasmusmc.nl
Despite the possible use of human skin fibroblasts
for diagnostic studies, muscle is the tissue of choice to
study oxidative phosphorylation. A drawback is that a
rather a large biopsy is needed of at least 150–200-mg
wet weight being rather unattractive for the patient. To
investigate if mitochondrial enzyme diagnostics is pos-
sible in smaller samples obtained by needle biopsy, we
have scaled down our spectrophotometric methods for
the biochemical analysis of the oxidative phosphoryla-
tion in tissue homogenates. We have determined the
activities of complexes I, II, III, IV and V in about 60
needle biopsies (weighing about 10–20 mg). The mean
activity of all complexes, expressed on the amount of
citrate synthetase, was not different from the values
obtained earlier in a group of large muscle biopsy
specimens. Besides the adjustment of our spectropho-
tometric methods, we also adjusted our polarographic
method in order to study the oxygen consumption and
ATP synthesis in small, fresh muscle biopsies. In an
initial study we were able to detect the oxygen
consumption in a fresh needle biopsy of only about
40 mg. We conclude that it is not longer necessary to
obtain large surgical biopsies for reliable mitochondrial
enzyme diagnostics.
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Human heart mitochondrial proteome elucidated by 2D
electrophoresis and MALDI-TOF analysis
M. Farhoud*,1,2, J. Wessels1, P. Steenbakkers3, L. Nijt-
mans1, B. van Engelen2, R. Wevers2, J. Smeitink1, L. van
den Heuvel1
1Nijmegen Center for Mitochondrial Disorders, Department
of Pediatrics, University Medical Center, Nijmegen, P.O.
Box 9101, 6500 HB Nijmegen, The Netherlands
2Neuromuscular Centre, Institute of Neurology, University
Medical Centre, Nijmegen, The Netherlands
3Department of Microbiology, Faculty of Science, Univer-
sity of Nijmegen, Nijmegen, The Netherlands
m.farhoud@cukz.umcn.nl
Proteins represent the primary functional output of the
cell and therefore might be expected to provide the most
relevant information in biomedical research. This is partic-
ularly true when interpretation of their expression takes into
account their dynamics in a specific biological context. For
this purpose, two-dimensional gel electrophoresis-based
proteomics (2D-proteomics) has been implemented thor-
oughly in recent years to address different topics in biomed-
ical research. Also recently, Blue-Native gel electrophoresis
has been applied in proteomics as a separation method due to
its greater ability (compared to conventional 2D gel electro-
phoresis) to separate hydrophobic membrane proteins. Using
both techniques, and in combination with MALDI-TOF as
identification method, we have recently started to analyse the
mitochondrial proteome of control human heart. At present,
we have been able to identify 348 different proteins, 100 of
which have already been annotated as mitochondrial. As this
effort continues we are confident that much more proteins
are still to be identified and, therefore, more information will
be presented during the meeting. Eventually we will estab-
lish a reference map for human heart mitochondrial proteins
for future comparative proteomics.
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Missense mutation in mitochondrial glutamate
transporter in autosomal recessive neonatal myoclonic
epilepsy
L. Colleaux*, F. Molinari, M. Rio, A. Raas-Rothschild, P.
Rustin, A. Munnich
Hopital Necker-Enfants Malades, INSERM U393, 149 rue
de Sevres, 75743 Paris, France
colleaux@necker.fr
Early myoclonic encephalopathies (EME) are early-onset
epileptic encephalopathies with frequent seizures in the
neonatal and early infancy period. These disorders are
characterized by a typical EEG pattern, namely suppres-sion-burst, in which higher-voltage bursts of slow waves
mixed with multifocal spikes alternate with isoelectric
suppression phase. Affected children also present severe
neurological anomalies with fatal outcome. The causes of
EME are various including metabolic diseases and brain
malformations. However, despite recent advances in the
elucidation of the molecular bases, the cause of these
disorders remains largely unknown.
Here we report the identification of a novel gene in-
volved in autosomal recessive EME. Homozygosity map-
ping in an inbred Israelian family with four affected children
localized the disease-causing gene on chromosome 11p15.5.
This interval encompasses the SLC25A22 gene (also known
as GC1) encoding one of the two mitochondrial glutamate
transporter. We identified a missense mutation (Pro 206
Leu) which co-segregates with the disease and alters a
highly conserved amino acid. Functional analysis shows
that cultured skin fibroblasts harboring the mutation were
strongly defective in the oxidation of glutamate, supporting
the notion of an impaired glutamate transport across the
inner mitochondrial membrane as a cause of EME.
Our data suggest that a defect in glutamate mitochondrial
transport may interfere with normal neuronal function, pro-
viding new insight into the understanding of the physiopath-
ological bases of idiopathic neonatal myoclonic epilepsy.
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The incidence of a minor arc mitochondrial DNA
deletion in human skin cancer and its novel use
as a highly sensitive marker for sunlight exposure
M. Birch-Machin*, K. Krishnan, A. Harbottle
Dermatology, Newcastle University, Medical School, NE2
4HH Newcastle-upon-Tyne, United Kingdom
m.a.birch-machin@ncl.ac.uk
The incidence of non-melanoma skin cancer (NMSC) is
increasing worldwide with more than 1 million annual cases
in the USA. Our group has pioneered the use of mtDNA as a
biomarker of the UVR exposure in human skin, which is the
major determinant of NMSC.
We show for the first time in human skin that a rarely
reported mtDNA deletion in the minor arc can be used to
distinguish between constant (face and hands) and intermit-
tent (trunk and legs) sun-exposed skin. This is important as
NMSC is formed on constant exposed skin. PCR investiga-
tion of 104 skin samples from different sites of sun exposure
identified the deletion in 31/42 constant sun-exposed sam-
ples which contrasts markedly (P < 0.0001 Fisher’s exact
test) with the intermittent samples (i.e. 8/42). The deletion
was absent in 20 sun-protected samples. Having developed
a real-time Taqman PCR assay, a higher level of the deletion
occurs in constant (n = 30) than in intermittent (n = 18) sun-
exposed samples (P= 0.016 two-tailed t test). Seventy-three
percent of tumour samples (n = 30) also harboured the
EUROMIT 6 41deletion, and mutational analysis using DHPLC (Mitoscreen
kit, Transgenomics) identified a somatic heteroplasmic T–C
mutation at np7705.
The deletion was induced in cultured human skin cells
through repetitive sublethal doses of solar UVR thereby
confirming that the deletion in human skin is directly related
to UVR exposure.
This novel deletion is the most sensitive mtDNA marker
of sun exposure in human skin and occurs in a high
proportion of NMSCs. Applications include its use as a
highly sensitive UVR biomarker for early detection of
NMSC development.
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A homoplasmic ND5 mutation associated with MELAS:
mitochondria as ATP consumers?
M. McKenzie*, D. Liolitsa, S. Sisodiya, N. Wood, M.
Duchen, M. Hanna
Physiology, University College London, Gower St., WC1E
6BT London, United Kingdom
m.mckenzie@ucl.ac.uk
Homoplasmic mtDNA variants found in patients present-
ing with multisystem mitochondrial disease are usually dis-
missed as nonpathogenic polymorphisms. We report here the
first homoplasmic mtDNA point mutation with variable
penetrance causing a multisystem neurological disease in-
cluding MELAS. A severely affected proband and her
asymptomatic mother both harboured a homoplasmic ND5
gene mutation (13565C>T) resulting in a serine to phenylal-
anine amino acid change (S410F). Transmitochondrial cybrid
studies confirmed the pathogenicity of the mutation. Com-
plex I-linked respiration in the mutant cybrid was reduced
(37% of control) and lactate generation over 48 h in the
mutant cybrid was increased (24% above control).
Mitochondrial membrane potential (Dwm) in the S410F
mutant cybrid was 28% less than in control cybrids and was
further reduced by blocking the adenine nucleotide trans-
locator (ANT) with 10 AM bongkrekic acid, suggesting that
Dwm in the S410F mutant is partially maintained by reversal
of the ANT (as in U0, mtDNA-less, cells). Blocking the
mitochondrial ATPase with 2.5 Ag/ml oligomycin caused
hyperpolarisation of Dwm and decreased NADH oxidation in
control cells whereas Dwm and NADH oxidation remained
unchanged in the S410F mutant.
Mitochondrial calcium uptake was impaired in the S410F
mutant cybrid. Thus, analysis of the S410F mutation has
revealed multiple mechanisms that may contribute to its
pathogenicity. Impaired mitochondrial Ca2 + uptake may
impair the ability of mitochondria to up-regulate ATP pro-
duction with increased demand. Defects in respiratory chain
function causing a loss of potential may result in the mutant
mitochondria functioning as ATP ‘consumers’ rather than
‘producers’.P-49
MIDAS, a nuclear gene product involved in the
biogenesis of mitochondria in response to their
dysfunction
N. Kamimura*, S. Asoh, K. Munakata, Y. Goto, S. Ohta
Department of Biochem. Cell Biol., Inst. Dev. Aging Sci,
NMS, Kosugi-cho, Nakahara-ku, 211-8533 Kawasaki, Japan
nanakash@nms.ac.jp
Mitochondrial mass is altered in response to external
stimuli and mitochondrial DNA (mtDNA) damage. The
biogenesis of mitochondria requires the metabolism of mito-
chondrial phospholipids and the expression of a large number
of genes. Several transctiptional activators and coactivators
have been shown to be involved in mitochondrial biogenesis
in response to external stimuli. However, the mechanism of
mitochondrial biogenesis in response to mtDNA damage is
not understood. To investigate this mechanism, we screened
the factors whose expression was enhanced in a cell line
lacking mtDNA and identified a factor, MIDAS (mitochon-
drial DNA absence-sensitive factor). The expression of
MIDAS was examined in muscle fibers of patients with
mitochondrial diseases, CPEO (chronic progressive external
ophthalmopelia; a large deletion in mtDNA) and MELAS
(mitochondrial myopathy, encephalopathy, lactic acidosis
and stroke-like episodes; a point mutation in mtDNA).
MIDAS was more expressed only in muscle fibers in
which mitochondria were dysfunctional and accumulated,
suggesting that the expression of MIDAS was enhanced
in response to mtDNA damage. A majority of MIDAS
localized in mitochondria with a small fraction in the
Golgi apparatus in HeLa cells. To examine the function of
MIDAS, we constructed HeLa cells constitutively express-
ing MIDAS. The increase of the total mass of mitochon-
dria in MIDAS transfectants was revealed by three
independent methods: (1) three-dimensional imaging
analysis of mitochondria, (2) flow cytometry using Mito-
Tracker Green and (3) assay of cardiolipin, a mitochon-
dria-specific lipid. These data indicated that MIDAS is
involved in the regulation of mitochondrial lipids in
response to mitochondrial dysfunction.
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Proteomic and genomic analysis of Chlamydomonas
reinhardtii complex I: conserved components in
eukaryotes
P. Cardol*, F. Vanrobaeys, B. Devreese, J. VanBeeumen, R.
Matagne, C. Remacle
Life sciences, University of Liege, Bvd du rectorat, 27, B22,
B-4000 Lie`ge, Belgium
pierre.cardol@ulg.ac.be
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tase (complex I) is the most intricate membrane-bound
enzyme of the mitochondrial respiratory chain. A compre-
hensive analysis of the bovine enzyme revealed that it is
composed of 45 subunits. In this work, we have first attemp-
ted to characterize the subunit content of the complex I from
the unicellular green alga Chlamydomonas reinhardtii. Anal-
ysis by Blue-native polyacrylamide gel electrophoresis
coupled to tandem mass spectrometry (MS) has allowed
the identification of 30 proteins in the Chlamydomonas
enzyme. Comparison of the known complex I compo-
nents from higher plants, mammals, worms and fungi
with the MS data set and the translated sequences from
the algal genomes revealed that the complex I in
Chlamydomonas might be composed of 42 proteins for
a total molecular mass of about 1000 kDa.
By compiling recent data, it appeared that a set of 27
proteins are widely conserved in eukaryotic complex I. We
describe here five new subunit families (ESSS, PFFD, B12,
B14.7, B16.6), extending to 32 the number of widely con-
served complex I components. In parallel, a variable number
of subunits seems to be specific to each eukaryotic kingdom
(animals, fungi or plants). However, since the degree of
conservation of most of these proteins within their class is
rather low, it is hard to know without additional information
whether some of these proteins represent less conserved
homologues, structural counterparts or are real lineage-spe-
cific components that would have been acquired or lost
during the evolution in specific groups.
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Functional complementation, homozygosity mapping
and transcriptome analysis reveal a novel cause for
respiratory chain complex I deficiency
R. Salemi*, D. Kirby, C. Sugiana, E. Oldaker, A. Ohtake,
M. Ryan, Y. Yuen, D. Thorburn
Mitochondrial Research, Murdoch Childrens Research In-
stitute, Flemington Road Parkville, 3052, Melbourne, Vic-
toria, Australia
ren.salemi@mcri.edu.au
Complex I deficiency accounts for f 30% of respiratory
chain disorders. To date, mutations have been identified in
eight nuclear genes and six mitochondrial DNA genes
encoding the most conserved complex I subunits. There
appear to be a substantial number of unidentified genes
causing complex I deficiency, some of which are likely to
be involved in complex I assembly. We are attempting to find
novel causes of complex I deficiency, initially by using
complementation analysis to identify multiple patients with
defects in the same gene. Of eight patients with an unknown
autosomal recessive cause, two cell lines failed to comple-
ment and showed a similar profile of abnormal complex I
assembly intermediates. These cell lines were studied by anintegrated approach using homozygosity mapping, chromo-
some transfers and expression analysis of 18,000 genes in
patient cell lines with oligonucleotide microarrays. This
implicated a complex I subunit gene not previously associ-
ated with complex I deficiency, which was grossly underex-
pressed in the two patient cell lines. Both patients had
homozygous mutations in this gene, one causing a splicing
abnormality and the other a large deletion. This integrated
approach offers promise for identifying other unknown
causes of respiratory chain disorders.
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A homoplasmic mtDNA mutation promotes rapid decay
of deacylated mt-tRNAVal
R. McFarland*, D. Pye, M. Glanville, Z. Chrzanowska-
Lightowlers, D. Turnbull, R. Lightowlers
Neurology, Neurobiology and Psychiatry, University of
Newcastle upon Tyne, Framlington Place, NE2 4HH New-
castle upon Tyne, United Kingdom
robert.mcfarland@ncl.ac.uk
Homoplasmic mitochondrial tRNA (mt-tRNA) muta-
tions are recognised as the cause of a variety of organ
specific and multi-system diseases. Families harbouring
such mt-tRNA mutations often demonstrate considerable
clinical variability. The basis of this phenotypic disparity
is poorly understood, but is thought to involve factors
related to both the mutation and the nuclear background.
We have investigated the molecular aetiology of the
homoplasmic 1624C>T mt-tRNAVal mutation in cell lines
and muscle from both mildly and severely affected indi-
viduals. Steady-state levels of mt-tRNAVal are decreased
in myoblast and fibroblast cell lines from individuals
harbouring the 1624C>T mutation when compared with
controls. However, the steady-state levels of mt-tRNAVal
in cultured cells are significantly greater than those found
in muscle, where a profound biochemical defect has
previously been identified. We have also demonstrated
reductions in the steady-state level of mt-tRNAVal in
143B and A549 transmitochondrial cybrid cells, compara-
ble to those seen in patient myoblasts. Thus, irrespective
of the nuclear background or cell type, steady-state levels
of mutated mt-tRNAVal remain low, confirming the
1624C>T mutation as the primary aetiological factor. We
have shown in myoblast cultures that reduction in the steady-
state level of mt-tRNAVal is due to rapid degradation of the
mutated mt-tRNAVal and, furthermore, that the deacylated
form of mutated mt-tRNAVal is more readily degraded than
the aminoacylated species. Therefore, unlike many other mt-
tRNAmutations, the 1624C>Tmutation exerts its pathogenic
effect by decreasing the stability of the deacylated species,
and thereby limits the availability of mutated mt-tRNA for
aminoacylation.
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Mitochondrial DNA mutations in human colonic crypt
stem cells
R. Taylor*, L. He, L. Greaves, G. Taylor, M. Barron,
D. Turnbull
Mitochondrial Research Group, School of Neurology, Neu-
robiology and Psychiatry, University of Newcastle upon
Tyne, The Medical School, NE2 4HH, Newcastle-upon-
Tyne, United Kingdom
r.w.taylor@ncl.ac.uk
Firmly established as important causes of neurological
disease, the true impact of mitochondrial DNA (mtDNA)
mutation in human pathology remains undetermined. In
addition to the well-documented, pathogenic mtDNA muta-
tions that are associated with classical ‘‘mitochondrial’’
phenotypes, somatic mtDNA mutations accumulate to high
levels in individual cells during the course of normal ageing
and though a causal link has not been established, they have
been widely demonstrated in a variety of human tumours.
Until recently, however, there were no data to support the
accumulation of mtDNA mutations in stem cell populations.
To address this question, we have performed extensive
histochemical analysis and mtDNA sequencing of human
colonic epithelium, a tissue in which the progeny of a
limited number of stem cells can be easily identified within
colonic crypts. In this actively dividing tissue, we find
extensive respiratory chain deficiency, which has led us to
make the following observations:
[1] there is widespread cytochrome c oxidase (COX)
deficiency affecting whole and partial crypts
[2] we find a high incidence of mtDNA mutation, with
approximately 50% of all cells studied (both COX-
deficient and COX-positive) harbouring somatic
mtDNA mutation
[3] there is an increase in the incidence of mtDNA
mutation, and the associated biochemical phenotype,
with age and
[4] these mtDNA mutations are present in colonic crypt
stem cells prior to malignant transformation.
We believe our observations in human colonic crypt stem
cells are relevant to other human stem cell populations.
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Regulation of nuclear-encoded mitochondrial genes in
myogenesis
S. Goffart*, R. Wiesner
Vegetative Physiology, University of Cologne, Robert-Koch-
Straße 39, 50931 Cologne, Germany
steffi.goffart@uni-koeln.deMitochondrial biogenesis requires expression of
around 1000 genes localized on both the mitochondrial
DNA and the nuclear genome. The pathways which lead
to coordinated expression of the nuclear-encoded genes
and to synchronization with the mitochondrial genome
are yet unclear.
To find factors involved in gene regulation, we
analyzed myogenesis of skeletal muscle cells in vitro.
During differentiation of myoblasts to myotubes, mito-
chondrial mass and activity are strongly increased. The
basic regulatory mechanisms triggering mitochondrial
biogenesis were studied by analysing expression of three
nuclear-encoded mitochondrial genes: expression of
CytC, TFAM and COXIV is up-regulated by factors of
4–6, as studied by Western, Northern and luciferase
reporter assays.
Promoter studies revealed the dependence of cytC
induction on a CRE site at pos.  109 of the promoter
sequence. Protein–DNA interaction analysis and changes
in phosphorylation pattern of CREB proteins during
differentiation gave evidence that cytC gene expression
is regulated by the CREB pathway, while the role of
CREB for TFAM and COXIV expression needs to be
analyzed in more detail.
To further investigate common regulatory features of the
analyzed promoters, the function of an unknown consensus
sequence present in all three promoter was also analyzed,
and proteins binding to this site were identified.
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Correlation of mitochondrial copy number with
cytochrome c oxidase histochemistry
S. Durham*, S. Keers, P. Chinnery
Mitochondrial Research Group, University of Newcastle
upon Tyne Medical School, Framlington Place, NE2 4HH
Newcastle upon Tyne, United Kingdom
steve.durham@ncl.ac.uk
Heteroplasmic mitochondrial DNA (mtDNA) muta-
tions only cause a biochemical defect when the percent-
age level of mutated mtDNA exceeds a critical threshold
level, but it is not clear what exactly causes the loss of
respiratory function for different mtDNA mutations. Is
there an increase in mutated mtDNA having a dominant
negative effect? Is there a decrease in the number of
wild-type molecules? What is the relationship of mtDNA
proliferation to this process? To address these questions
we have developed a quantitative real time PCR assay,
which allows the accurate determination of mitochondrial
copy number down to 20 molecules. Using this assay,
we have measured both the total mitochondrial copy
number and the number of wild-type molecules in single
muscle fibres from patients with known mtDNA muta-
tions. Here we describe the variation in copy number
EUROMIT 644that we have seen in these patients and how it correlates
with cytochrome oxidase activity.
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A proteomic approach to mtDNA depletion
S. Adams*, P. Field, V. Freeman, C. Brock, N. Zitzmann,
J. Poulton
Obstetrics and Gynaecology, University of Oxford, John
Radcliffe Hospital, OX3 9DU Oxford, United Kingdom
sadams@gwmail.jr2.ox.ac.uk
Depletion of mitochondrial DNA is a disorder of
mtDNA maintenance, replication and/or repair. It is
characterised by a reduction in copy number of DNA
molecules in affected tissues, and additional mtDNA
mutations may contribute to the phenotype. This is a
tissue-specific condition in which many of the affected
patients present with a generalised disease involving at
least the brain, muscle and/or liver, and the remaining
patients with single organ disease of which 2/3 involve
the muscle and 1/3 the liver. The autosomal nature of
depletion suggests involvement of a nuclear factor, and
complementation analysis has implicated thymidine ki-
nase in myopathic disease and deoxyguanosine kinase in
hepatocerebral disease. To further our understanding of
this disease, we have performed 2D-PAGE of seven
depletion patients and compared this to a control fibro-
blast line. Computer and mass spectrometric analysis of
these data has revealed common changes occurring in
these patients that may aid our understanding and
diagnosis of this disease.
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The significance of organic acid accumulation in
paragangliomas
J.-J. Brie`re*,1, J. Favier, D. Rabier2, P. Rustin1, A.-P.
Gimenez3
1INSERM U-393, Hoˆpital Necker-Enfants Malades, 149 rue
de Sevres, 75015 Paris, France
2De´partement de Biochimie, Hoˆpital Necker-Enfants
Malades
3De´partement de Ge´ne´tique Mole´culaire, Hoˆpital Europe´en
Georges Pompidou, Paris, France
briere@necker.nl
Abstracts:
Following the genetic delineation of the origin of a
number of paragangliomas and pheochromocytomas, it has
been shown that those due to mutations in the SDH A,B or
C gene resulted in the total absence of succinate dehydro-
genase activity in the tumors. Although the possibility that
other types of respiratory chain deficiency lead to tumorformation as well, it is striking that blockade of this
particular complex, and the metabolically related enzyme
fumarase, specifically causes either paraganglioma and/or
pheochromocytomas, or uterine and skin leiomyomatomsis
and papillary renal cancer, respectively. In the course of
our biochemical studies on paragangliomas and our
attempts to account for the variable consequences of
complex II and fumarase loss of activity (encephalopathies
or tumor formation), we found significant amount of
organic acids, especially succinate, in tumoral tissues.
Interestingly enough, although much higher in the tumors
from patients with mutant SDH, significant levels of
succinate (largely superior to the Km of the SDH for
succinate) were also observed in tumors with normal
succinate dehydrogenase activity. The mechanism leading
to this organic acid accumulation might well be related to
the Pasteur effect (known to take place in the tumor
tissues) and hypoxia, but succinate accumulation might
constitute a determining step in tumor formation either by
modulating the ability to control superoxide formation by
the respiratory chain or by interfering in the signalling
cascade for cell proliferation.
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Actin brain aggregation in identical twins with dystonia
and deafness: dysregulation of actin dynamics as a
consequence of a bioenergetic defect
V. Procaccio*, M. Gearing, S. Ono, J. Juncos, D. Wallace,
B. Wainer
Center for Molecular and Mitochondrial Medicine and
Genetics, University of California Irvine, 2034 Hewitt Hall,
92697 Irvine, CA, USA
vproca@uci.edu
Actin is a major cytoskeletal protein in neurons, and the
dynamics of its assembly is involved in many aspects of cell
motility and membrane turnover, representing a major ATP-
consuming process in cells. Actin is co-transported with
actin-binding proteins, including ADF and cofilin essential
for rapid turnover of actin filaments in vivo, regulated
through a phosphorylation process. Recently cofilin has been
shown to be translocated into mitochondria, crucial for the
initiation of apoptosis.
We have reported extensive actin aggregation in the
brains of identical twins with progressive dopa-unrespon-
sive generalized dystonia and deafness associated with
multiple developmental abnormalities. Immunohistochemi-
cal studies revealed that rod-like inclusions in neocortex
and basal ganglia were strongly immunoreactive with anti-
bodies to ADF/cofilin proteins. Two-dimensional electro-
phoresis of brain extracts demonstrated increased
phosphorylation of cofilin. DNA microarray studies of
mitochondrial gene expression using our Mitochip and
real-time quantitative PCR in brain tissues showed in-
EUROMIT 6 45creased gene expression of several genes including actin,
cofilin, genes involved in apoptosis and mitochondrial ROS
scavenging enzymes in response to increase mitochondrial
ROS production. Furthermore, expression of genes in-
volved in mitochondrial ATP production was down-regu-
lated in brain cortex. Sequencing of the entire mtDNA did
not show any abnormalities linking these cases to a nuclear
defect. Because actin reorganization requires ATP con-
sumption, a defect in mitochondrial bioenergetics may
perturb cellular ATP levels and alter the phosphorylation
state of cofilin. Rod formation in response to mitochondrial
stress is may be a common mechanism in mitochondrial
pathophysiology to protect neurons and conserve ATP by
slowing actin filaments dynamics.
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Detection of respiratory chain complex I activity in
blood lymphocytes
W. Sluiter*,1, E. de Wit1, L. Spruijt2, K. Schoonderwoerd3,
H. Smeets2, R. de Coo4
1Department of Biochemistry, Erasmus MC, Dr. Molenwa-
terplein 50, 1738, 3000 DR, The Netherlands
2Department of Clinical Genetics, Academic Hospital
Maastricht
3Department of Clinical Genetics, Erasmus MC Rotterdam
4Department of Neurology, Erasmus MC Sophia, Rotterdam
w.sluiter@erasmusmc.nl
The identification of a defect in oxidative phosphorylation
in a muscle biopsy is one of the complementary pillars to
diagnose mitochondrial encephalomyopathy (MM) in
patients. All respiratory chain complexes can be confidently
measured in muscle homogenates, but obtaining a muscle
biopsy is invasive and puts a heavy burden on a patient. A
skin biopsy is a less demanding alternative and is often used
additionally for the diagnosis of MM. A drawback is that a
defect in the mitochondrial DNA may disappear during
culture of the fibroblasts leading to false-negative results,
and that complex I activity cannot bemeasured reliably due to
the presence of very high rotenone-insensitive NADH-qui-
none oxidoreductase activity in those cells. An obvious
alternative is blood lymphocytes. These cells are not often
used to measure complex I activity spectrophotometrically,
because the issue of the limited access of substrates to the
respiratory chain complex hindering its detection is thus far
unresolved, despite some recent publications suggesting the
contrary.
We have developed a method to improve substrate access
to complex I to enable detection of its activity in blood
lymphocytes of normal donors. An initial study in affected
members of a Dutch family suffering fromLeber’s Hereditary
Optic Neuropathy (3460/ND1 mutation) indicates that a
biochemical phenotype can be detected in their blood lym-
phocytes using the new method.P-60
Human mitochondria possess a translation-dependent
deadenylation decay pathway
Z. Chrzanowska-Lightowlers*, R. Temperley,
R. Lightowlers
Neurology, The Medical School, University of Newcastle
upon Tyne, Framlington Place, NE2 4HH Newcastle upon
Tyne, United Kingdom
Z.Chrzanowska-Lightowlers@ncl.ac.uk
Human mtDNA is transcribed from both strands, pro-
ducing polycistronic RNA units. These units are rapidly
processed into discrete RNA species and immediately
matured to produce mt-mRNAs and mt-rRNAs that are
polyadenylated, or mt-tRNA species that carry a 3V CCA
trinucleotide. The mechanisms underlying these processes
are poorly characterised and the role of polyadenylation in
mammalian mitochondria is unclear.
A micro-deletion (??) has been identified in a patient
presenting with mtDNA disease. Loss of the two final
nucleotides of mtDNA-encoded MTATP6 removes the ter-
mination codon proximal to the processing site, generating
an in-frame fusion with MTCO3. Accurate processing at
this site still occurs, however, there is a marked decrease in
the steady state level of the bi-cistronic mRNA encoding
ATPase 8 and 6 (?? RNA14). We report how an mtDNA
mutation that results in the loss of a termination codon
causes instability of a mitochondrial mRNA by translation-
dependent deadenylation. Based on the recent identification
of a nonstop mediated decay pathway in the cytosol, a
model is proposed to explain this phenomenon.
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Targeting a peroxidase mimetic to mitochondria
A. Filipovska
MRC Dunn Human Nutrition Unit, Hills Road, CB2 2XY
Cambridge, United Kingdom
af@mrc-dunn.cam.ac.uk
Reactive oxygen species (ROS) are implicated in a range
of progressive neurodegenerative diseases such as Alzheim-
er’s disease, Parkinson’s disease and Friedreich’s ataxia.
Mitochondria are the major source of ROS production and
these ROS are detoxified by several antioxidant enzymes in
mitochondria including glutathione peroxidase and phos-
pholipid hydroperoxide glutathione peroxidase. Ebselen, a
glutathione peroxidase mimic, can ameliorate oxidative
stress that is a major cause of mitochondrial dysfunction.
However, its effect is limited since it is not concentrated in
mitochondria. We have developed mitoperoxidase, a mito-
chondria targeted derivative of Ebselen that effectively
catalyses the reduction of hydroperoxides using thiols such
EUROMIT 646as glutathione and thioredoxin as electron donors. Substrates
detoxified by mitoperoxidase include hydrogen peroxide,
tert-butylhydroperoxide and mitochondrial membrane-
bound phospholipids peroxides.
Mitoperoxidase is selectively accumulated into isolated
mitochondria as a result of the mitochondrial membrane
potential. It prevented lipid peroxidation in mitochondria
and mitochondrial membranes, measured by the oxidation
of cis-parinaric acid. Mitoperoxidase protected mitochon-
drial function in the presence of ferrous iron and hydrogen
peroxide and reduced membrane-bound hydroperoxides
following lipoxidase treatment. Hydroperoxides were not
reduced in mitochondria depleted of glutathione during the
membrane permeability transition or in mitochondria treated
with the oxidant diamide confirming that mitoperoxidase
can use glutathione as its thiol reductant. Mitoperoxidase
was taken up by mitochondria within RBL2H3 cells where
it delayed the onset of apoptosis induced by either 2-
deoxyglucose or hydrogen peroxide. In summary, mitoper-
oxidase is an effective mitochondrially targeted glutathione
peroxidase mimetic that protects against lipid peroxidation
and has therapeutic potential in diseases involving mito-
chondrial oxidative damage.
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Novel mitochondrial tRNATrp mutation associated with
encephalomyopathy: identification using polyacrylamide
gel electrophoresis coupled with matrix-assisted laser
desorption/ionisation mass spectrometry
A. Schaller*, M. Keller, S. Gallati
Inselspital, Division of Human Genetics, Freiburgstrasse,
3010 Bern, Switzerland
andre.schaller@dkf2.unibe.ch
More than 70 different point mutations in human mito-
chondrial tRNA genes are correlated with severe disorder,
including fatal cardiopathies, encephalopathies, myopa-
thies, and others. So far, investigation of the molecular
impact(s) of mutations has focused on the affected tRNA
itself by seeking structural and/or functional perturbations
capable of interfering with synthesis of the 13 mitochon-
drion-encoded subunits of respiratory chain complexes.
Here we report a fast and simple method for the structural
analysis of newly identified tRNA mutations. In analogy to
two-dimensional analysis, the mobility shift in native
polyacrylamide gel electrophoresis (PAGE) due to a nucle-
otide substitution of a single-stranded transfer ribonucleic
acid (tRNA) fragment serves as the first dimension for
tRNA mutation analysis. Matrix-assisted laser desorption/
ionisation mass spectrometry (MALDI-MS), as the second
dimension, allows precise determination of the mass of the
tRNA fragments resolved by native PAGE. Off-line com-
bination of native PAGE with MALDI-MS is demonstrated
for high-resolution analysis of mitochondrial tRNAs and itsmutants. Using this method, we characterised a novel
mitochondrial tRNATrp (T553C) mutation with late-onset
encephalomyopathiy.
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Biochemical andmolecular investigations in patients with
mitochondrial DNA depletion and dGK gene mutations
B. Mousson de Camaret*, A. Texier, S. Besson, M. Chas-
sagne, S. Padet, M. Raphat, G. Mandon, M.-T. Zabot, P.
Clerc-Renaud, G. Stepien, J.-W. Taanman
Laboratoire de Biochimie, Hoˆpital Debrousse, 29 rue Soeur
Bouvier, 69322 Lyon, France
mousson@univ-lyon1.fr
Mitochondrial DNA depletion syndrome, inherited as an
autosomal recessive trait, is a rare quantitative disorder
characterized by a variable tissue-specific reduction in
mtDNA copy number. The age of onset is usually in
infancy and patients die generally before 1 year of age.
Mutations in the TK2 and dGK nuclear genes, encoding for
two proteins involved in mitochondrial dNTP metabolism
and mtDNA replication, have been described for a small
subset of patients with a myopathic or hepatocerebral form,
respectively.
We investigate three patients presenting with different
clinical forms of mtDNA depletion, quantified by real-
time quantitative PCR. Three types of mutations in
homozygous or heterozygous state were identified in the
dGK gene: (1) one insertion (g.31355_31358 insGATT),
for one of the two patients with an isolated hepatic form,
(2) two original splice mutations (g.204 + 1 G>A and
g.23884 G>A) for the patient with the typical hepatocere-
bral form, (3) two new missense mutations (N46S and
L266R) for the third patient presenting with an unexpect-
ed reversion of an isolated hepatic form. The functional
consequence of these mutations was documented in mi-
tochondrial preparations from fibroblats by optimized
dGK activity measurement.
Identification of mutations in the dGK gene and assess-
ment of dGK activity in fibroblasts open new perspectives
to correlate genotypes with phenotypes and allow accurate
prenatal diagnosis in families with mtDNA depletion.
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The role of the immune system in tissue-specific mtDNA
segregation
B. Battersby*, E. Shoubridge
Human Genetics, Montreal Neurological Institute, 3801
University St., Room 676, H3A 2B4 Montreal, Quebec,
Canada
brendan.battersby@elf.mcgill.ca
EUROMIT 6 47In human mitochondrial encephalomyopathies due to
mtDNA mutations, there are distinct tissue-specific seg-
regation patterns associated with different mtDNA muta-
tions. The factors that control the segregation of mtDNA
sequence variants remain poorly understood. We have
studied the process of mtDNA segregation in heteroplas-
mic mice segregating two mtDNA genotypes, NZB and
BALB. Tissue-specific and age-dependent selection of
different mtDNA genotypes was observed in the liver,
kidney, and spleen. In mice, mitochondrially encoded
peptides can be presented as minor H antigens. We are
testing whether antigen presentation of different mito-
chondrially encoded peptides is responsible for directional
segregation of mitochondrial DNA genotypes. To address
this question, we have generated heteroplasmic mice
missing different components of the immune system,
from peptide processing to peptide recognition. We have
also characterized mtDNA segregation in different cell
lineages of the spleen to test whether selection for BALB
mtDNA is restricted or widespread. Different cell pop-
ulations were sorted by cell surface markers and geno-
typed for their respective heteroplasmy level. Selection
for the BALB mtDNA genotype was widespread occur-
ring in the following cell types: B-cells, T-cells, macro-
phages, and granulocytes. Identifying the mechanisms
responsible for tissue-specific mtDNA segregation in mice
will be essential to our understanding of human mito-
chondrial diseases.
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Alternative splicing and nonsense-mediated mRNA
decay in genetic disorder of complex I
V. Petruzzella*, D. Panelli, A. Torraco, A. Iuso, S. Scacco,
S. Papa
Department of Medical Biochemistry and Medical Biology,
University of Bari, Piazza G. Cesare 1, 70124 Bari, Italy
v.petruzzella@biochem.uniba.it
Human mitochondrial complex I (CxI) consists of at least
46 subunits whose function is mostly unknown. The 18-kDa
subunit, encoded by the nuclear NDUFS4 gene, is phos-
phorylated in response to cAMP promoting complex I
activity. In some severe forms of encephalomyopathies,
mutations affecting the expression of the 18-kDa subunit
prevent the assembly of a normal functional complex and
produce the appearance of defective subcomplexes. Inves-
tigations on the pathogenic mechanisms of three different
homozygous NDUFS4 mutations have revealed that each
mutation, although in the same gene, may act by a different
mechanism. The presence of a nonsense mutation, in one
patient, elicited a mechanism of mRNA degradation known
as Nonsense Mediated Decay (NMD), whereas in the other
two patients the steady-state amount of the transcript was
normal. Our results are consistent with the occurrence of amulti-step quality control system at posttranscriptional and/
or at posttranslational level to avoid the presence in the cell
of abnormal polypeptides resulting from mutations in the
NDUFS4 gene. NMD can be also involved in regulating the
expression of natural proteins and eliminating transcripts
that are generated in error by alternative splicing. Transla-
tion of such transcripts might, in fact, generate aberrant and
potential harmful proteins. Many alternative splicing events
are very rare and occur only in specific tissue at a specific
time of development and/or under certain physiological
conditions. We are investigating on the occurrence and role
of alternative transcripts of NDUFS4 gene and on the
isoforms of the NDUFS4 protein.
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Differences in assembly or stability of mitochondrial
OXPHOS complexes in inherited complex I deficiency
C. Ugalde*, R. Janssen, L. van den Heuvel, J. Smeitink,
L. Nijtmans
Nijmegen Centre for Mitochondrial Disorders, University
Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijme-
gen, The Netherlands
c.ugalde@cukz.umcn.nl
Mutations in NADH:ubiquinone oxidoreductase (com-
plex I) nuclear structural genes are the most common cause
of isolated complex I enzyme deficiencies. The cell biolog-
ical consequences of such mutations remain poorly under-
stood. We have used blue native electrophoresis to study how
different nuclear mutations affect the integrity of mitochon-
drial OXPHOS complexes in fibroblasts from complex I-
deficient patients. Our results show an important decrease in
the levels of intact complex I in patients harboring mutations
in nuclear-encoded complex I subunits, indicating that com-
plex I assembly and/or stability is compromised. Different
patterns of low molecular weight subcomplexes are present
in these patients, suggesting that the formation of the
peripheral arm is affected. Mutations in complex I genes
can also affect the stability of other mitochondrial com-
plexes, with a specific decrease of fully assembled complex
III in patients with mutations in NDUFS2 and NDUFS4.
These results suggest a physical interaction between both
complexes that could be mediated through these subunits.
We have extended the analysis to patients with an isolated
complex I deficiency in which no mutations in structural
subunits have been found. In this group, we can discriminate
between complex I assembly and catalytic defects attending
to the fact whether there is a correlation between assembly/
activity levels or not. This will help us to point more
selectively to candidate genes for pathogenic mutations that
could lead to an isolated complex I defect.
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Evaluation of assays for OXPHOS complexes in
mitochondria from fibroblasts and muscle homogenates:
pitfalls and limitations
D. Hahn*, J.-M. Nuoffer
Institut fu¨r klinische Chemie, Inselspital, Freiburgstrasse,
3012 Bern, Switzerland
dagmar.hahn@insel.ch
Biochemical approaches are necessary for the diagnosis
of defects of the oxidative phosphorylation system
(OXPHOS). Neither general diagnostic guidelines nor uni-
form methods are available; therefore, each lab has to
establish their own methods and reference values.
We evaluated and established methods to assay OXPHOS
activities. Maximal activity for CI-III required sonication of
isolated mitochondria, in contrast to CIV that is susceptible to
inactivation by mechanical disruption. In muscle homoge-
nates, sonication led to progressive loss of enzymatic activ-
ities. Further disruption techniques were necessary to obtain
optimal results: CI, hypotonic shock in H2O; CII, three cycles
of freezing in solid N2; CIII and CIV, N-dodecylmaltoside
present in the reaction buffer.
The activities of muscle homogenates as well as of mito-
chondria from fibroblasts were stable during several months.
The intra-/interassay variabilities for muscle homogenates
(%) are: CI, 2.4/10; CII, 6/12; CIII, 19.5/23; CIV, 16/20.
The higher values of CIII and CIV are rather due to
methological problems than to activity loss: the inhibitory
effect of antimycin A varies due to different cytochrom C
batches. CIV activity is very sensitive against homogenisa-
tion. Another problem is the fast initial burst of activity of
CIV, followed by a much slower reaction rate. Enzyme
assays were linear with respect to protein over a range of 5–
12 Ag mitochondrial protein for CI and CII, 5–20 Ag for
CIII and 1.5–12 Ag for CIV. For muscle homogenates 10–
90 Ag protein for CI, CII, CIII and 5–12 Ag for CIV have to
be used to be in the linear range.
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Detection and measurement of the mitochondrial
A3243G and A8344G mutations in samples from
patients and maternal relatives: observed intertissue
repartition profiles and potential use of quantitative
values, ratios or indexes
D. Sternberg*, C. Jardel, P. Laforeˆt, V. Jan, P. Blondy, B.
Eymard, A. Lombe`s
Batiment de la Pharmacie 1er etage, Labo Biochimie B
Groupe Hospitalier Pitie´ Salpetriere, 47 Boulevard de
l Hoˆpital, 75013 Paris, France
damien.sternberg@psl.ap-hop-paris.frAim, material and methods: The proportion of mutated
mitochondrial DNA species in different noninvasive biolog-
ical samples (blood, urinary, buccal or hair cells) from
patients with heteroplasmic mitochondrial DNA mutations
or their maternal relatives is an easily available parameter.
Forty-three independent occurrences of the A3243G and five
independent occurrences of the A8344G have been diag-
nosed in our laboratory. We collected multiple samples from
as many mutation carriers as possible. Two quantification
methods were assessed by using a heteroplasmic standard-
ized reference material for the A3243G mutation. We mea-
sured mutation loads in all samples, calculated intertissue
ratios, and searched to what extent observed quantitative
differences among interindividual result patterns may be
relevant to explain qualitative differences in the natural
history of disease among carriers, and may be of practical
use in medical practice.
Results: Intertissular distribution patterns are quite
different for the A3243G and the A8344G mutations,
although there are individual exceptions. The average
proportion of the A3243G mutation in urinary cells is
twice that in blood, which is relevant for diagnosis
practice. There is a clear correlation of global mutation
load and the presence of symptoms but a predictive index
is not easily defined. The threshold for symptoms seems
lower and less defined for the A3243G mutation than for
the A8344G.
Conclusion: The measurement of mutation load of
A3243G or A8344G is easy to perform in either biopsy-
obtained or noninvasive samples. Further analyses includ-
ing new cases will help making it more useful in clinical
practice.
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Elevated production of reactive oxygen species in
fibroblasts from patients with deficiencies in ATP
synthase
T. Mracek*, A. Vojtiskova, M. Wieckowski, R. Rizzuto,
J. Houstek
Bioenergetics, Inst. of Physiology AS CR, Videnska 1083,
142 20 Prague 4, Czech Republic
mracek@biomed.cas.cz
Genetic defects in enzymes of oxidative phosphoryla-
tion (OXPHOS) cause a broad spectrum of mitochondrial
encephalomyopaties. Apart from diminished ATP produc-
tion per se, elevated levels of ROS generated by defective
OXPHOS complexes are implicated in pathogenic mech-
anism of mitochondrial diseases. This view is supported
by measurements of ROS production by mitochondria of
patients with complex I defects and also by the data from
mice with knock-out in MnSOD gene. In our work we
used fibroblasts from patients with deficiencies in ATP
synthase to study consequences of OXPHOS mutations on
EUROMIT 6 49an in vivo ROS production, levels of cellular glutathione
and mitochondrial membrane potential. We established
methods for measurement of ROS production (with car-
boxy-H2DCFDA) and changes in mitochondrial mem-
brane potential (with TMRM) on confocal microscope
(Leica TCS SP 2) and flow cytometer (BD FASCScan)
with the possibility to relate both signals to mitochondrial
mass, determined by mitochondria selective probes Mito-
Tracker DeepRed or MitoTracker Green. We also used
fluorescence plate-reader (Wallac Victor2) for determina-
tion of ROS production on intact or digitonin-permeabi-
lized cells and for determination of glutathione levels
(with monochlorobimane). We found that ATPase-deficient
cells produce significantly higher amounts of ROS than
controls while levels of main cellular ROS scavenger
glutathione are only mildly decreased. High mitochondrial
membrane potential caused by defective discharge of
proton gradient by ATP synthase seems to be important
for increased ROS production in patient cells as uncoupler
(FCCP) reduced both mitochondrial membrane potential
and ROS production.
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Evolving phenotype in pyruvate dehydrogenase complex
deficiency
E. Morava*, R. Rodenburg, L. van den Heuvel, J. Smeitink
Nijmegen Centre for Mitochondrial Disorders, University
Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijme-
gen, The Netherlands
e.morava@cukz.umcn.nl
Pyruvate dehydrogenase complex (PDHc) is an intra-
mitochondrial multienzyme complex essential for the
aerobic oxidation of glucose. The disorder is genetically
heterogeneous, however, the majority of patients with a
PDHc defect have abnormalities in the major catalytic and
regulatory subunit, E1 alpha, which is encoded on the X
chromosome. The clinical spectrum of PDHc deficiency is
heterogeneous, particularly in heterozygous females, and
therefore the diagnosis may be difficult. The phenotypic
presentation generally includes lactic acidemia, muscle
hypotonia, central nervous system involvement, develop-
mental delay, seizures and characteristic dysmorphic fea-
tures. Patients may have other congenital malformations
including corpus callosum hypoplasia or ventricular septal
defect. We report on four patients with a PDHc defect,
one of whom carries a previously undescribed mutation in
the gene coding for the E1 alpha subunit of the enzyme
complex. The patients, two girls and two boys, demon-
strated the following unique clinical symptoms consecu-
tively: congenital epilepsy, congenital cataract, colobomas
with vermis aplasia, and one with a complex cyanotic
heart malformation.P-71
In vivo mitochondrial complementation preventing
individuals from respiration deficiency by pathogenic
mutant mtDNA
S. Akitsugu*, K. Nakada, H. Shitara, Y. Hiromichi, J.-I.
Hayashi
Institute of Biological Sciences, University of Tsukuba,
1-1-1 Tennodai, 305-8572 Tsukuba, Japan
asato@rinshoken.or.jp
Mammalian mitochondria are dynamic organelles, re-
peating fusion and fission. It has been difficult, however, to
show the occurrence of extensive complementation between
the fused mitochondria in mammalian species, because
sequence of mtDNA throughout an individual tends to be
uniform owing to its strictly maternal inheritance. We
previously showed the existence of extensive in vivo
mitochondrial complementation in Mito-Mice, mice carry-
ing pathogenic mutant mtDNA with large deletion. We
observed the uniform distribution of either COX-positive
or COX-negative mitochondria in any single cells of the
Mito-Mice. However, this evidence was not unambiguous,
since our experiments did not distinguish endogenous and
exogenous wild-type mtDNAs. This study resolves this
point with newly created Mito-Mice carrying endogenous
wild-type mtDNA of Mus spretus and exogenous patho-
genic deleted mtDNA from different mouse subspecies, M.
musculus domesticus. The results provide unambiguous
evidence for in vivo complementation between endogenous
and exogenous mitochondria. The mitochondrial comple-
mentation could correspond to a very unique and effective
defense system of the highly oxidative organelles for
preventing individuals from expressing mitochondrial dys-
function caused by mtDNA lesions, which have been
continuously created by oxidative stresses.
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Leber’s Hereditary Optic Neuropathy mutations alter
DNA replication and Complex I transcripts
G. Cortopassi*, A. Wong, H.-C. Tsai
VM: Molecular Biosciences, University of California, 1311
Haring Hall, 95616 Davis, USA
gacortopassi@ucdavis.edu
We carried out an oligonucleotide microarray experi-
ments in neural NT2 cybrids to better understand the
neural-specific consequences of the LHON mutations,
which we had previously observed to produce increased
mitochondrial ROS and a defect in cellular proliferation.
Several things were clear from the microarray analysis.
First, LHON mutations caused inhibition of many more
genes than were activated. Second, the biochemical path-
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main mechanisms were suggested by the analysis of NT2
cybrids. First, there was only overexpression of one
nuclear-encoded subunit of complex I observed, the
NDUFS4 transcript, which holds an iron–sulfur cluster
(ISC). The observation is consistent with the hypothesis
that the LHON mutations cause a structural change which
increases ROS production and damages the ISC bound by
NDUFS4 specifically; this hypothesis is consistent with
our previous data that demonstrated a LHON-specific
increase on mitochondrial superoxide and peroxide pro-
duction which was inhibitable by rotenone. We also
observed the LHON-dependent inhibition of multiple
genes involved in DNA replication and cell cycling. These
results were consistent with our earlier observation that
LHON neural cybrids were deficient in cellular prolifera-
tion and differentiation. Thus, microarray analysis suggests
two biochemical bases for LHON-dependent pathobio-
chemistry and pathophysiology.
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A novel heteroplasmic G14739A mutation in the
mitochondrial tRNAGlu in a myopathic patient
J. Mayr*, H. Fo¨rster, A. Kamper, W. Muss, M. Huemer,
W. Sperl
Department of Paediatrics, Paracelsus Private Medical
University Salzburg, Mu¨llner Hauptstr. 48, A-5020 Salz-
burg, Austria
h.mayr@lks.at
Case: At the age of 7 years the girl was introduced to our
gastroenterologist due to inappetance and weakness. Slight-
ly increased GOT, LDH and CK levels and a discrete
muscular atrophy were detected. Bicycle-ergometry showed
pathological increase of lactate (from 2.4 up to 8.0 mmol/l)
already after short exercise load which exhausted the
patient. In EMG a clear myopathic pattern was seen.
Therefore, muscle biopsy was performed.
Results: Functional biochemical investigation of native
mitochondria investigated by respirometry and substrate
oxidation showed normal values relative to the amount of
tissue and protein, respectively; relative to citrate synthase, all
values were approximately 40% reduced. A shifted pattern
was found in oxidative phosphorylation enzymes with high
citrate synthase and complex II. Histochemically numerous
ragged-red and cytochrome c oxidase negative fibres were
found. Electron microscopy revealed irregular mega-mito-
chondria with tubular structures and focally subsarcolemmal
glycogen accumulations. Genetic screening of the tRNAs and
rRNAs of the mitochondrial genome with denaturing HPLC
showed an abnormal result in the region of the tRNAGlu
where a heteroplasmic exchange of G14739A was found in
sequence analysis. The mutation was present at circa 90% in
muscle.Discussion: This girl presents with a relatively mild defect
in themitochondrial energymetabolism and unspecific symp-
toms. Ergometry, EMG, morphology, biochemistry and final-
ly the presence of a heteroplasmicmutation in amitochondrial
tRNA clearly defined the presence of a mitochondrial myop-
athy. In the tRNAGlu, previously, only one other mutation
(T14709C) was reported, which was associated either with
mitochondrial myopathy, deafness or diabetes.
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Investigating mitochondrial DNA heteroplasmy in the
female germline
T. Wai
Human Genetics, Montreal Neurological Institute, 3801
University St., H3A 2B4 Montreal, Quebec, Canada
timothy.wai@mail.mcgill.ca
Mitochondrial DNA heteroplasmy frequencies are
known to exhibit wide variation during the matrilineal
inheritance of mitochondria. It has been shown that the
enormous intergenerational variance of mtDNA hetero-
plasmy can be accounted for by a rapid and random
expansion from a small, restricted pool of mtDNA in the
female germline. Although endpoint observations of con-
siderable heteroplasmy variances have been documented,
the factors that are involved in this process have not yet
been investigated.
We hypothesize that mitochondrial DNA copy number
and respiratory chain function are important factors during
this critical genetic bottleneck. Using the Cre-lox recombi-
nation system in our previously established heteroplasmic
mouse model, we test this hypothesis by knocking out
floxed m-TFAM in a lineage-specific manner using trans-
genic mice that express Cre-recombinase from a TNAP or
ZP3 promoters. Tissue nonspecific alkaline phosphatase
(TNAP) expression is confined to the primordial germ cells
(PGC) and Zona Pellucida 3 (ZP3) is expressed in the
growing oocyte. The excision efficiency of m-TFAM by
the Cre-recombinase is monitored using a double reporter
transgene, Z/AP. Using an Oct4-GFP transgene, whose
expression is largely restricted to PGCs, FACS sorting of
PGCs allows for the analysis of heteroplasmy frequency in
the female germline throughout its development.
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The effect of ‘‘atypical’’ antipsychotics on the OXPHOS
system in peripheral blood mononuclear cells
J. Casademont*, S. Lo´pez, M. Pico´n, G. Garrabou, A.
Infante, O. Miro´, F. Cardellach
Internal Medicine, Hospital Clı´nic-IDIBAPS-Universitat de
Barcelona, Villarroel 170, 08036 Barcelona, Spain
jordi@medicina.ub.es
EUROMIT 6 51Background: A limitation in the use of classical neuro-
leptic drugs is the eventual appearance of extrapyramidal
symptoms. Many experimental studies in rats have related
these symptoms with a defect in OXPHOS, specially with
Complex I. One of the advantages of the more recently
introduced ‘‘atypical’’ neuroleptics is a lesser incidence of
movement disorders.
Objective: To study the OXPHOS system in peripheral
blood mononuclear cells (PBMCs) of psychotic patients
without signs or symptoms of extrapyramidal dysfunction
either in nontreated (naı¨ve) or treated with risperidone
or clozapine, two frequently used atypical neuroleptic
agents.
Materials and methods: PBMCs from naı¨ve schizophren-
ic patients (n = 15) as well as from patients under chronic
treatment with risperidone (n = 17) or clozapine (n = 16)
were collected. Eight naı¨ve patients were reanalysed 6
months after initiating treatment with risperidone. Respira-
tory activity was polarographically determined in intact cells
and after membrane permeabilization followed by the addi-
tion of pyruvate-malate, glutamate-malate or succinate as
substrates. Absolute enzyme activities (complexes I through
V of the OXPHOS system) were spectrophotometrically
quantified.
Results: Forty-eight patients were analysed. Specific
activity of Complex I (80–90% rotenone-NADH:ubiqui-
none oxidoreductase sensible activity) was reliably mea-
sured. We did not find differences between naı¨ve,
risperidone or clozapine-treated patients. However, when
naı¨ve patients were reanalysed after 6 months of treatment, a
decrease in oxidation of pyruvate-malate and glutamate-
malate could be demonstrated.
Conclusions: The importance of a decrease in complex I
substrate oxidation in a nontarget tissue for neuroleptics
remains to be established.
Supported by Marato´ de TV3 01/1710.
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Point-mutations in tRNASer(UCN) lead to
conformational changes: evidence for altered tertiary
structure and additional posttranslational modification
J.-C. von Kleist-Retzow*, M. Mo¨llers, E. Cengic, M. Helm,
M. Jaksch, K. Weber, R. Wiesner
Department of Pediatrics, University of Cologne, Josef-
Stelzmann-Str., 50924 Cologne, Germany
juergen-christoph.vonkleist@medizin.uni-koeln.de
MtDNA point mutations are underlying a tremendous
number of different clinical phenotypes. Beyond segrega-
tion, heteroplasmy and threshold, a variety of different
pathomechanisms are caused by these mutations and it is
tempting to speculate that these also contribute to the
clinical variability. However, still not enough is knownwhy the change of a single base pair is ultimately either
classifiable as a simple polymorphism or is leading to often
serious disease. We have studied the consequences of two
pathogenic point mutations (T7512C and G7497A) in the
tRNA Ser (UCN) gene using osteosarcoma cell cybrids
incorporating both mutations at almost homoplasmic levels,
and have obtained evidence for conformational changes
caused by either mutation. If run under non-denaturating
conditions, we detected on Northern blots an altered elec-
trophoretic mobility of both tRNAs. Furthermore, we intro-
duced both mutations into synthetic tRNA molecules
produced by in vitro transcription. With the in vitro tran-
scribed molecules we found that the G7497A mutation
alone was sufficient to cause an altered electrophoretic
mobility, while T7512C was not. However, in both cases
the mobility of the synthetic molecules was still different
compared to the endogenous molecules. We conclude that
the G7497A mutation per se is leading to a conformational
change, while within the cell either mutation causes addi-
tional posttranslational modifications.
P-77
Normal mitochondrial creatine kinase in human creatine
depletion (GA)
K. Peltola*, M. Tarnopolsky, H. Kalimo, O. Simell, O.
Heinonen
Department of Physiology, University of Turku, Kiinamyl-
lynkatu 10, 20520 Turku, Finland
katja.peltola@utu.fi
Mitochondrial creatine kinase (mtCK) is located in the
mitochondrial intermembrane space and phosphorylates
creatine (Cr) to phosphocreatine (PCr). Recent reports have
addressed the role of mtCK in the functional coupling of
mitochondrial oxidation and phosphorylation.
In myopathies featuring modestly decreased Cr content,
sarcomeric mtCK is reportedly decreased (muscle dystro-
phy) or increased (mitochondrial myopathies). Furthermore,
an accumulation of intramitochondrial mtCK inclusions is
seen in some mitochondrial myopathies. However, the
regulation of mtCK with regard to cellular Cr content is
not well understood.
Gyrate atrophy (GA) is a rare inborn error of metabolism
featuring Cr depletion in muscle and brain due to inhibition
of Cr synthesis in the kidney. Thus, GA constitutes a model
for Cr human depletion.
We investigated mtCK adaptation to human muscle
creatine depletion.
Muscle biopsy samples of four male GA patients (age
19–49 years) with biochemically verified 50% depletion of
Cr, PCr and ATP were analysed by Western blot with
antibodies against human sarcomeric mtCK. Samples from
EUROMIT 652healthy age- and physical activity-matched men served as
controls.
Despite a marked decrease in Cr and PCr concentrations,
sarcomeric mtCK content was similar in GA patients and
controls.
Thus, in conclusion, our data indicate that modest
decreases in cellular Cr, PCr and ATP concentrations per
se do not affect mtCK protein content in human skeletal
muscle.
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Carnitine palmitoyltransferase II deficiency:
biochemical and mutation analysis in patients detected
by tandem mass spectrometric acylcarnitine profiling
K. Gempel*, A. Rettinger, I. Bieger, M. Bauer, K. Gerbitz
Inst. Clinical Chemistry, Academic Hospital Schwabing,
Ko¨lner Platz 1, 80804 Muenchen, Germany
klaus.gempel@lrz.uni-muenchen.de
Mitochondrial carnitine palmitoyltransferase II (CPT
II) deficiency is the most common inherited disorder of
lipid metabolism in adults. Patients suffer from recurrent
myoglobinuria, muscular weakness and myalgia, triggered
by exertional exercise, cold, infection, and/or prolonged
fasting. We have previously shown that tandem mass
spectrometric serum acylcarnitine profiling is a sensitive,
rapid and noninvasive tool for detection of CPT II
deficiency (Gempel et al., 2002). Seven newly diagnosed
patients were further characterized by measurement of
CPT II activity in leukocytes and/or muscle biopsy and
by mutation analysis of the CPT2 gene. The most
sensitive (C16 +C18:1/C2) acylcarnitine ratio was clearly
elevated in all patients (range: 0.119–0.263; reference
range: 0.011–0.048). CPT II activity in leukocytes as
measured in the backward direction and inhibition of
CPT I by 5% Triton X-100 ranged from 0.01 to 0.46
nmol/min/mg protein (reference range: 1.0–2.5). A com-
bined PCR-RFLP and gene sequencing approach revealed
six different pathogenic mutations which have been
previously described in association with the muscular
phenotype of CPT II deficiency. Two patients were
homozygous for the common S113L mutation, while
three patients had an S113L mutation in combination
with E487K (two brothers) or 1238_1239delAG/F448L.
The second most prevalent mutation P50H was found in
one patient together with the R124X mutation. The
seventh patient was homozygous for the R161W muta-
tion. In conclusion, we show that CPT II deficiency can
be safely and rapidly diagnosed from a small blood
sample by a combined tandem mass spectrometric, bio-
chemical and genetic approach.P-79
Utility of real time qPCR in molecular diagnosis of
mitochondrial DNA disorders
L.-J. Wong*, R.-K. Bai
Inst. Mol and Hum Genet, Georgetown University, 3800
Reservoir Rd., 541477, 20007, Washington DC, USA
wonglj@georgetown.edu
Molecular diagnosis of mitochondrial DNA (mtDNA)
disorder is usually focused on point mutations and large
deletions. PCR/RFLP or PCR/ASO (allele specific oligonu-
cleotide) dot blot analysis for point mutations and Southern
blot analysis for large deletions are the common methods
used. These procedures require multiple steps including
PCR, restriction enzyme digestion, and hybridization. To
measure mutant heteroplasmy, radioactive labeling and
quantitative analysis of the signal intensities are necessary.
We developed real time quantitative PCR (RT qPCR)
method to detect and quantify the mutation in one step.
For point mutations, allele-specific primers for either the
wild-type or the mutant target sequences are designed
(ARMS RT qPCR) for PCR, and the copy number of target
sequence was measured. For deletions, primers that amplify
the region that is always not deleted and the region that is
present in >95% of the deletion molecules so far identified
are used. Inclusion of a nuclear reference gene allows the
measurement of copy number ratio of mtDNA to nuclear
DNA. Using this method, a point mutation present at as low
as 0.1% was detected in a single-step reaction. In addition,
multiple deletions with mtDNA depletion can be simulta-
neously detected and quantified by RT qPCR. Furthermore,
we were able to identify a patient who had about 92%
deletion mutant mtDNA in muscle but her mtDNA was
amplified ninefold that resulted in mild Kearns–Sayre
syndrome. Our data demonstrate that RT qPCR provides
an effective one-step, qualitative and quantitative analysis
for molecular diagnosis of mitochondrial DNA disorders.
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Complex I assembly in human cells
L. Nijtmans*, C. Ugalde, R. Vogel, R. Huijbens, B. van den
Heuvel, J. Smeitink
Nijmegen Centre for Mitochondrial Disorders, University
Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijme-
gen, The Netherlands
l.nijtmans@cukz.umcn.nl
The 46-subunit-containing complex I (CI) is the largest
complex of the oxidative phosphorylation (OXPHOS)
system. The assembly of this complex is still poorly
understood and insight in the assembly will provide
information about the nature of the CI deficiencies and
EUROMIT 6 53might reveal the possible disease mechanisms. Therefore,
we studied the assembly of complex I in human cells. We
used cells devoid of mitochondrial DNA to test whether
subcomplexes could be formed. In such a system, no fully
assembled complex I can be formed because the essential
ND subunits are lacking. We found, however, that still
subcomplexes could be formed. To further address the
nature of the subcomplexes, we blocked complex I assem-
bly by inhibiting mitochondrial protein translation with the
drug doxycycline. After releasing this block, CI resumes
and assembly intermediates can be observed. By analysis
of the distinct subcomplexes we propose that assembly of
complex I occurs in distinct steps and is a semi-sequential
process (subcomplexes are formed which are joined to-
gether to form a fully assembled complex). The membrane
part of the complex is separately formed in distinct steps
of which the 39-kDa subunit forms a subcomplex to which
ND1, ND6 and the 15-kDa subunit are subsequently
added. To this subcomplex another subcomplex containing
the B17 subunit is assembled. A hydrophilic subcomplex
is formed by the 30-kDa subunit to which subsequently
several subunits are added. At a late stage this subcomplex
is joined to the membrane arm and the holo-complex I is
formed.
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Reduced efficiency of 3Vend cleavage and CCA addition
with mutant human mitochondrial tRNAs could
contribute to pathogenesis
L. Levinger*,1, M. Mo¨rl2, C. Florentz3
1Natural Sciences/Biology, York College/CUNY, 94-20 Guy
R. Brewer Blvd., 11451 Jamaica, NY, USA
2Max-Planck-Institute for Evolutionary Anthropology, Leip-
zig, Germany
3UPR 9002 du CNRS, IBMC, Strasbourg, France
louie@york.cuny.edu
Over 150 mutations in the mitochondrial genome are
associated with human mitochondrial disease. Two thirds
of them fall in tRNA genes, which constitute only one-
tenth of the mitochondrial genome. Twenty-two tRNAs,
one for each of 18 amino acids and two for Ser and Leu,
punctuate the 13 mRNAs and 2 rRNAs in long polycis-
tronic transcripts with practically no spacers, requiring
precise endonucleolytic excision at both ends. Further-
more, CCA is not transcriptionally encoded, and must thus
be added post 3V end cleavage. Using unmodified tran-
scripts, we have investigated reaction efficiency and kinet-
ics of mitochondrial pre-tRNA 3V end cleavage and CCA
addition to test whether deficient tRNA 3V end maturation
correlates with mitochondrial pathology. The A7445G
substitution in tRNASer[UCN], associated with non-syn-
dromic deafness and suggestively located one nucleotide
on the 3V side of the 3V end cleavage site, cannot beprocessed by 3V-tRNase. Of the nine tested pathogenesis-
associated tRNAIle mutations, four reduce 3V-tRNase
cleavage efficiency ~10-fold, all due to reduced Vmax.
One of them (A4309G) causes a pronounced local change
in secondary structure. Three pathogenesis-associated
mutations in tRNALeu[UUR] reduce 3V-tRNase cleavage
efficiency, also through reduced Vmax. Strongest (f 3-fold)
reductions were observed with mutations A3302G and
C3303T on the 3V side of the acceptor stem. The
C3303T substitution reduced efficiency of CCA addition
>5-fold, but due to increased KM rather than reduced Vmax.
If the intramitochondrial concentration of tRNA processing
enzymes is limiting, the observed reductions in reaction
efficiencies, although modest, could contribute cumulative-
ly to mitochondrial pathology.
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Mitochondria and the eye: ageing and disease
M. Barron*, P. Griffiths, D. Turnbull
Neurology, Newcastle University, Framlington Place, NE2
4HH Newcastle upon Tyne, United Kingdom
m.j.barron@ncl.ac.uk
One of the most common organs affected in mitochondrial
disease is the eye. The clinical features include ptosis,
external ophthalmoplegia, optic atrophy, pigmentary retinop-
athy and cataract. These symptoms are often severely dis-
abling with loss of vision being a major concern.
The reasons for the involvement of particular ocular
tissues in mitochondrial disease are not known and until
now morphological studies have been hampered by a limited
supply of tissue to investigate. In particular, fresh frozen
tissue for the investigation of the histochemical andmolecular
genetic defects in different ocular regions has been limited.
We have had the opportunity to collect ocular tissue and
in some cases whole eyes from patients and control subjects
(donor eyes for corneal transplants). We have shown:
1. In patients with CPEO, the incidence of COX-deficient
extraocular muscle fibres is greater than that in skeletal
muscle.
2. Normal ageing results in an exponential rise in the
incidence of COX-deficient photoreceptors and ciliary
epithelial cells.
3. In two patients with mtDNA disease (3243 A>G,
14709 T>C mutations), we have looked at all eye
tissues. The most marked changes in the patient with
3243 A>G mutation was loss of ganglion cells,
compatible with optic atrophy, whereas in the patient
with 14709 T>C mutation the ocular changes
involved the ciliary epithelium and retinal pigmented
epithelium.
The tissues of the eye are heavily dependant on
oxidative phosphorylation for their energy supply and the
EUROMIT 654affected tissues reflect this both in ageing and in mtDNA
disease.
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Complex I-caused dysfunction in mitochondria of
human tumors and rat rhabdomyosarcoma
T. Kuhnt*,1, T. Pelz1, Q. Xying1, V. Spohn1, G. Ha¨nsgen1,
M. Bloching, A. Becker1, F. Zywietz2, J. Dunst1, S. Sierz1,
F. Gellerich1
1Department of Radiotherapy, Martin-Luther-University
Halle-Wittenberg (Muskellabor der Neurologischen Klinik
fu¨r Strahlentherapie der Martin-Luther-Universita¨t Halle
Wittenberg), Dryanderstrasse 04, 06097 Halle/Saale,
Germany
2Institut fu¨r Biophysik und Radiobiologie am Universita¨ts-
klinikum Hamburg-Eppendorf, Germany
thomas.kuhnt@medizin.uni-halle.de
Mitochondria seem to play an important role in energy
metabolism of tumor cells. The aim of this work was to
characterize mitochondrial function in human tumors [squa-
mous cell carcinoma (SCC), parotis Warthin’s tumor
(PWT)] as well as in an experimental rat rhabdomyosarco-
ma (RS) in comparison to tonsil mucous membranes (MM)
or muscle(M).
For that purpose we adapted the skinned fiber tech-
nique, previously used for investigation of muscle mito-
chondria only, to tumors and mucous membranes. Scaling
the pyruvate-dependent respiration on the succinate res-
piration measured in the same sample (SRPR), we
obtained a parameter that is independent from the amount
of mitochondria. SRPR was found to be 120F 18% in
normal human muscle and 132F 12% in healthy tonsil
mucous membranes but was reduced in tumors (SCC,
64F 15%; PWT, 21F13%; RS, 54F 23%). These de-
creased CI-dependent respiratory rates were at least in
part caused by decreased activities of CI and CI + III.
Moreover, in RS the rotenone inhibition of pyruvate-
dependent respiration was significantly reduced as it
was deduced from the higher level of rotenone-insensitive
respiration scaled to succinate-dependent respiration (RS,
35F 11%; rat skeletal muscle, 20F 13%). This was
paralleled by an increased level of rotenone insensitive
NADH oxidation in relation to the total activity (RS,
15F 8%; rat muscle, 80F 7%). In addition, the leak
respiration was clearly higher in RS compared to rat
muscle.
Data demonstrate a complex I-caused functional impair-
ment of mitochondria in three different types of tumors
(SCC, PWT, RS). These special metabolic properties of
tumor mitochondria could be used for selective therapeutic
concepts.P-84
Significant increase in mtDNA copies per cell in
PBMC from patients after 2 months on simvastatin
therapy
M. de Baar*, J.-A. Kuivenhoven, K. Smolders, M. Buite-
laar, A. Klerkx
Mitochondrial Toxicity, Primagen, Meibergdreef 59, 1105
BA Amsterdam, The Netherlands
M.P.deBaar@primagen.com
Frequently reported adverse effects of statins, com-
pounds for the treatment of hypercholesterolemia, are mus-
cle pain/weakening (f 10%) with usually elevated creatine
kinase levels and in some cases liver failure or rhabdomyol-
ysis. Studies have shown that statin treatment also affects
the morphology of mitochondria and results in the presence
of red-ragged fibers. We investigated whether statin treat-
ment resulted in changes in mtDNA in PBMC, using a real-
time NASBA assay quantifying mtDNA and nuclear DNA
in a one-tube format. A group of seven individuals with
elevated cholesterol levels were treated for 2 months with
40-mg simvastatin daily, whereas a group of six individuals
with elevated triglyceride levels were treated with 100-mg
ciprofibrate daily. A sample was taken at day 0 and after 2
months and analyzed for mtDNA content in a blinded way.
There was no significant change observed in mtDNA over
time in the control group on ciprofibrate (P= 0.292), while
the group on simvastatin showed a significant increase from
361 to 429 mean copies mtDNA per cell (P= 0.032). Statins
inhibit HMG-CoA reductase, eventually resulting in the
reduction of cholesterol, as well as a reduction of inter-
mediates in the cholesterol biosynthesis pathway like iso-
pentyl pyrophosphate, which also acts as precursor for
coenzyme Q10 (Co-Q10). Co-Q10 plays an important role
in the electron transport of the oxidative phosphorylation in
mitochondria and depletion might lead to disorders in the
energy metabolism. We hypothesize that depletion of Co-
Q10 results in increased levels of mtDNA possibly to
facilitate an increase of mRNA encoding for proteins, such
as the COX family of proteins, involved in the oxidative
phosphorylation.
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Altered nucleoside metabolism in MNGIE generates
atypical multiple deletions of mitochondrial DNA
M. Hirano*, R. Marti, Y. Nishigaki
Neurology, Columbia University, 630 West 168th St., P and
S 4-443, 10032 New York, NY, USA
mh29@columbia.edu
Mitochondrial neurogastrointestinal encephalomyopathy
(MNGIE) is an autosomal recessive disorder. In MNGIE,
EUROMIT 6 55skeletal muscle typically shows histochemical and biochem-
ical abnormalities of mitochondrial respiratory chain en-
zymes while tissues and cultured cells have revealed
depletion, multiple deletions, and site-specific point muta-
tions of mitochondrial DNA (mtDNA). MNGIE is caused by
mutations in the gene encoding thymidine phosphorylase
(TPase) and, as a consequence, TPase activity is drastically
reduced in patients. TPase is a cytosolic enzyme required to
maintain nucleoside homeostasis. Due to the loss of TPase
function, MNGIE patients have markedly elevated plasma
levels of thymidine and deoxyuridine. We have hypothesized
increased levels of intracellular thymidine and deoxyuridine
cause imbalances of mitochondrial nucleotide pools that, in
turn, lead to the mtDNA abnormalities. DNA from autopsy
tissues from three MNGIE patients and biopsied skeletal
muscles from six were studied. We detected significant
depletion of mtDNA in liver. We identified five major forms
of mtDNA deletions (including the ‘‘common’’ deletion) in
skeletal muscle of MNGIE patients. The nicotinamide ade-
nine dinucleotide dehydrogenase (ND) 5 gene is a hot-spot
for these rearrangements. Direct repeats (DRs) and imper-
fectly homologous sequences appear to mediate the forma-
tion of mtDNA deletions. A novel aspect of the mtDNA
deletions in MNGIE is the presence of microdeletions at the
imperfectly homologous breakpoints. The positions of the
breakpoints within the imperfectly homologous sequences
suggest that branch migration occurs and imply that intra-
molecular homologous recombination in nonreplicating mol-
ecules is more likely than slipped mispairing or illegitimate
elongation during replication.
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Lack of gastrointestinal symptoms in a 60-year-old
patient with MNGIE
M. Martin*, A. Bla´zquez, R. Martı´, J. Bautista, M. Lara, Y.
Campos, O. Belda, A. Andreu, J. Arenas
Centro de Investigacio´n, Hospital Universitario 12 de
Octubre, Avda. de Cordoba s/n, 28041 Madrid, Spain
mamcasanueva@yahoo.es
MNGIE is an autosomal recessive disorder due to muta-
tions in the thymidine phosphorylase (TP) gene character-
ized by gastrointestinal dysmotility, ptosis, PEO, peripheral
neuropathy, and leukoencephalopathy.
Case report: A 60-year-old female had bilateral ptosis
since childhood and since the age of 2 years she had
tremor. She was 145-cm high and 41 kg in weight at age
60. Neurological examination showed bilateral ptosis with
severe bilateral external ophthalmoplegia, and generalized
areflexia tremor. Cardiologic examination revealed a mild
thickening in the septum heart muscle. She never com-
plained from gastrointestinal symptoms. A radionuclide
gastric emptying functional test showed mild gastroparesis.
Venous lactate was elevated. Brain MRI revealed diffusehyperintense signal affecting cerebral hemispheres, mid-
brain and pons.
Results: Muscle biopsy showed RRF-COX-negative re-
sult. Muscle respiratory chain complexes were decreased.
Southern blot analysis failed to reveal macroscopic alter-
ations of mtDNA. Biochemical analysis showed negligible
TP activity in buffy coat and high plasma levels of thymi-
dine and deoxyuridine. We identified four heterozygous
nucleotide changes in the TP gene: c.228G>A (M76I),
c.847C>G (H283D), c.1311G>A (W437X) and the A465T
polymorphism. Molecular analysis in the proband’s daugh-
ter and sister demonstrated that the patient is a compound
heterozygote.
Conclusions: All reported MNGIE patients reported
so far showed gastrointestinal symptoms at some point
in their lives. The patient reported here has only
subclinical GI involvement at age 60, even though the
onset of her symptoms was in the childhood. Therefore,
biochemical diagnosis should always be performed to
unequivocally exclude this disorder in patients with
features suggestive of MNGIE, even in those lacking
gastrointestinal symptoms.
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Sequential dHPLC analysis of a clonally expanded
mitochondrial tRNALeu(UUR) mutation (G3242A) in a
patient with myelodysplastic syndrome (preleukemia)
during successful treatment with thalidomide
N. Gattermann
Ha¨matologie/Onkologie, Heinrich-Heine-Universita¨t,
Moorenstr. 5, D-40225 Du¨sseldorf, Germany
gattermann@med.uni-duesseldorf.de
In bone marrow cells of patients with myelodysplastic
syndrome (MDS), mitochondria often show ultrastructural
abnormalities, including pathological iron accumulation in
the mitochondria of erythroblasts. This suggests that mito-
chondrial dysfunction contributes to the pathophysiology of
MDS. We are finding clonally expanded somatic mutations
of mtDNA in the hematopoietic system of patients with
MDS, using heteroduplex analysis with denaturing HPLC
(Transgenomic WAVEk system).
In a patient with refractory anemia with excess blasts
(RAEB), heteroduplex analysis indicated that 40–50% of
mtDNA molecules in the bone marrow (BM) carried a
novel G3242A mutation in the mitochondrial transfer
RNA Leu(UUR). Surprisingly, the mutation was not
detectable by heteroduplex analysis in the peripheral
blood (PB). However, the rare circulating CD34+ pro-
genitor cells, selected by immunomagnetic beads, har-
bored the mutation with a proportion of approximately
50%. In hematopoietic colony assays, CD34+ cells from
BM and PB yielded only colonies with wild-type
mtDNA. These results indicate that the G3242A mito-
EUROMIT 656chondrial tRNA mutation in CD34+ cells was associated
with a maturation defect that contributed to ineffective
hematopoiesis.
The patient was treated with thalidomide which, through
ill-defined mechanism of action, achieved marked hemato-
logical improvement, with cessation of transfusion require-
ment. In parallel, the proportion of mutant mtDNA in the
bone marrow decreased from 50% in October, 2002, to
about 5% in November, 2003. While the diminished het-
eroduplex peak on dHPLC analysis correlated with hema-
tological improvement, heteroduplex analysis, with an in
vitro detection limit of 3% mutant mtDNA in the present
case, is not sensitive enough for minimal residual disease
detection.
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The functional analysis of an atp12 mutation in yeast
S. Seneca*, W. Lissens, R. Van Coster, J. Smet, V. Alder-
weireldt, S. Ackerman, I. Liebaers, L. De Meirleir
Medical Genetics, AZ-VUB, Laarbeeklaan 101, 1090
Brussels, Belgium
lgensas@az.vub.ac.be
Complex V (ATP synthase) of the respiratory chain
couples the proton gradient, generated by the respiratory
chain, to ATP synthesis. The ATP12 gene product is one of
the proteins required for assembly of part (F1 component) of
the ATP synthase.
Here, we report on the functional effect of a W94R
mutation, present in the ATP12 assembly gene of a patient
with an ATP synthase decreased activity. Multicopy plasmid
constructs containing the human and yeast wild-type ATP12
gene, as well as the human mutation W94R and the yeast
counterpart W103R, were prepared. These constructs were
introduced in a Saccharomyces cerevisiae W303 host strain
deprived of this ATP12 function (W303DATP12), and as
such respiratory-deficient. ATP synthase activity of purified
individual yeast transformants was assayed by growth studies
on a non-fermentable carbon source (ethanol-glycerol) and
by Blue Native Polyacrylamide Gel Electrophoresis stained
for ATP synthase catalytic activity. WT plasmid constructs
rescue the respiratory defect of a yatp12 mutant strain.
Growth on a non-fermentable carbon source such as
ethanol-glycerol was strongly impaired for the human
W94R mutant as compared to controls. However, the
growth of the yeast W103R mutant strain was normal on
ethanol-glycerol. Blue Native Polyacrylamide Gel Electro-
phoresis studies are in progress.
Our yeast complementation studies showed clearly that
the human W94R mutant does not confer the respiratory
competence to a W303DATP12 yeast strain and is most
probably the cause of the complex V dysfunction in our
patient.P-89
The roles of SCO1 and SCO2 in mitochondrial copper
delivery to cytochrome c oxidase
S. Leary*, E. Shoubridge
Molecular Neurogenetics, Montreal Neurological Institute,
Rm 676, Montreal Neurological Institute, H3A 2B4 Mon-
treal, QC, Canada
sleary@po-box.mcgill.ca
Although it is clear that both SCO1 and SCO2 play a
critical role in cytochrome c oxidase (COX) assembly in
humans, their molecular functions remain unknown. Mo-
lecular genetic analyses of SCO1 and SCO2 patient cell
lines and tissues were therefore undertaken in order to
further characterize their relative roles in mitochondrial
copper delivery to COX. Mutations in either SCO1 or
SCO2 had modest effects on the protein levels of other
factors known to participate in the mitochondrial copper
delivery pathway. With the exception of COX17, none of
these factors, when overexpressed, were able to rescue the
observed COX deficiency in either patient background.
Parallel experiments involving SCO1 and SCO2 suggest
that each fulfills a unique yet inter-dependent function in
the delivery of copper to COX during holoenzyme as-
sembly. Complimentary analyses in SCO2 patient tissues
further suggest a potential mechanism that explains the
relative roles of SCO1 and SCO2 in the biogenesis of the
CuA site contained within COX II. This model may also
provide some insight into the tissue-specific nature of the
observed clinical phenotypes.
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The glucose uptake stimulators YM-126414 and YM-
138552 are potent uncouplers of the mitochondrial
respiration
S. Droese*, G. Tschank, A. Lindenschmidt, U. Brandt
Institut fu¨r Biochemie I, Unviversita¨t Frankfurt, Fach-
bereich Medizin, ZBC, Theodor-Stern-Kai 7, 60590 Frank-
furt am Main, Germany
droese@zbc.kgu.de
The substances YM-138552 (5-chloro-N(2-chloro-4-
nitrophenyl)-2-hyroxy-3-methylbenz-amide) and YM-
126414 (1,3,3-trimethyl-2-(2-phenylaminovinyl)-3H-indo-
lium) show a stimulation of glucose uptake in myoblast
cell cultures. These results, as well as the observed effect
of the compounds on glucose transporter isotype 4
(GLUT4) redistribution, made them interesting candidates
for the development of new drugs against type 2
diabetes. We have investigated the effect of these two
compounds on the ‘state 4’ respiration of tightly coupled
EUROMIT 6 57rat liver mitochondria. Both compounds uncoupled mito-
chondrial respiration. YM-138552 was as effective (U50:
0.03F0.011 AM) as the well-known uncoupler FCCP
(U50: 0.039F 0.014 AM) whereas YM-126414 (U50:
24.3F4.2 AM) was nearly as effective as 2,4-dinitophe-
nol (U50: 4.95F 1.33 AM). We conclude that the ob-
served stimulation of glucose uptake observed in
myoblast cell cultures resulted primarily from the uncou-
pling activity of the compounds and that the observed
redistribution of GLUT4 was a secondary effect, caused
by the low energetic state of the cells.
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Genotype–phenotype correlations in a German adPEO
family carrying three mutations in POLG
T. Klopstock*, M. Jaksch, R. Horvath
Neurology, University of Munich, Marchioninistr. 15, 81377
Munich, Germany
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Objectives: Mutations in the adenine nucleotide trans-
locator (ANT1) and in the twinkle gene cause autosomal
dominant progressive external ophthalmoplegia (adPEO),
while mutations of DNA polymerase g (POLG) cause both
dominant and recessive forms of PEO. Here we report the
clinical and genetic findings in a German family with
adPEO and mutations in POLG.
Methods: A detailed clinical, histological and genetic
testing was performed in the index patient and in other
family members.
Results: The index patient presented with ptosis, PEO
and exercise intolerance since age 45. She had ragged-red
fibers on muscle histology and Southern blot showed
multiple mtDNA deletions. There were no mutations in
ANT1 and twinkle, but sequencing of POLG revealed three
previously described heterozygous missense mutations
(T251I, L304R and P587L). The 45-year-old daughter of
the index patient was clinically unaffected and carried only
the L304R mutation. A 47-year-old nephew was clinically
unaffected and had no mutations at all.
Discussion: The P587L mutation has previously been
described as the sole mutation in two PEO siblings and
in conjunction with the T251I mutation. The exact
pathogenic role of these mutations, which are described
on the same allele in European families with recessive
trait, is not completely understood. L304R has been
described as a recessive mutation, and seems to be
nonpathogenic in our family, unless the daughter of the
index family will develop PEO in the future. We will
gain more information on the pathogenic role of these
mutations after investigating all members of this adPEO
family.P-92
Somatic and germline mutation in GRIM-19, a dual
function gene involved in mitochondrial metabolism
and cell death, is linked to mitochondrion-rich (Hu¨rthle
cell) tumours of the thyroid
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Oxyphil or Hu¨rthle cell tumours of the thyroid are
characterized by their consistent excessive number of mito-
chondria. A recently discovered gene, GRIM-19, has been
found to fulfil two roles within the cell: as a member of the
interferon-beta- and retinoic acid-induced pathway of cell
death, and as part of the mitochondrial Complex I assembly.
In addition, a gene predisposing to thyroid tumours with cell
oxyphilia (TCO) has been mapped to chromosome 19p13.2
in one family. A cluster of genes involved in mitochondrial
metabolism occurs in this region; one of these is GRIM-19.
We have searched for GRIM-19 mutations in a series of 52
thyroid tumours. Somatic missense mutations in GRIM-19
were detected in three of 20 sporadic Hu¨rthle cell carcino-
mas. A germline mutation was detected in a Hu¨rthle cell
papillary carcinoma arising in a multinodular goitre com-
posed of Hu¨rthle cells. No mutations were detected in any of
the 20 non-Hu¨rthle cell carcinomas tested, nor in any of 96
blood donor samples. In one of the Hu¨rthle cell papillary
carcinomas positive for GRIM-19 mutation, we have also
detected a ret/PTC-1 rearrangement. No GRIM-19 muta-
tions were detected in any of the six cases of known familial
Hu¨rthle cell tumour tested, so that our results do not support
the identification of GRIM-19 as the TCO gene. We propose
that mutations in GRIM-19 can be involved in the genesis of
sporadic or familial Hu¨rthle cell tumours of the thyroid
through the dual function of GRIM-19 in mitochondrial
metabolism and cell death.
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Mutation in a nuclear gene involved in mitochondrial
protein translation in a patient with early fatal
hepato-encephalopathy
M. Coenen*, C. Ugalde, F. Sasarman, H. Antonicka, R.
Rossi, A. Heister, F. Trijbels, B. van den Heuvel, E. Shou-
bridge, J. Smeitink
Nijmegen Centre for Mithochondrial Disorders, University
Medical Centre Nijmegen, P.O. Box 9101, 6500 HB Nijme-
gen, The Netherlands
m.coenen@cukz.umcn.nl
Mitochondrial translation defects are the most common
cause of deficiencies in the enzyme complexes of the
oxidative phosphorylation (OXPHOS). Although all
known mutations of the mitochondrial translation appara-
tus are encoded by nuclear genes, all known molecular
defects associated with impaired mitochondrial translation
are due to mutations in mitochondrial DNA. We investi-
gated two siblings with a progressive hepato-encephalop-
athy, reduced levels of all OXPHOS complexes containing
mtDNA-encoded subunits, and a severe defect in mito-
chondrial translation. Blue Native PAGE analysis of
fibroblasts from the index case showed reduced amounts
of fully assembled complexes I, III, IV and V, while levels
of complex II were normal. With transmitochondrial
cybrids it was proved that the assembly defect was of
nuclear origin. Using microcell-mediated chromosome
transfer, we mapped the defective gene to a region on
chromosome 3. With a panel of microsatellite markers, we
could narrow down the region to 20cM. A database search
for candidate genes in this region identified two genes
predicted to code for proteins that are part of the mito-
chondrial translation machinery. A cDNA sequence anal-
ysis revealed a homozygous missense mutation in an
evolutionarily conserved residue in one of these genes.
The mitochondrial translation defect was complemented
with the wild-type human gene proving that the mutation
was indeed the cause of the disease. These results define a
new class of gene defects underlying OXPHOS disorders.
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Increased free radical production and oxidative
damage in transmitochondrial cybrids harbouring
the T14487C mutation in mitochondrial DNA
E. Garcia-Arumi*, R. Gonzalo, A. Solano, C. Vives, J.
Montoya, A. Andreu
CIBBIM, Hospital General Vall Hebron, Pg Vall Hebron
119-129, 08035 Barcelona, Spain
elengarcia@vhebron.netThere is an increasing evidence suggesting that free
radical (FR) damage plays a key role in the pathogenesis
of cell damage mediated by mtDNA mutations. However,
very few systematic studies in controlled experimental
models have been performed to assess this hypothesis.
We report biochemical data on a cell model of the
T14487C mutation in the ND6 gene of mtDNA. Here
we show that transmitochondrial cells harbouring homo-
plasmic levels of the mutation showed an increase in
hydrogen peroxide production (0.73 vs. 0.45 nmol H2O2/
min). Moreover, we also observed an increase of oxida-
tive damage on lipid and protein compounds, as assessed
by the measurement of malondialdehyde (0.38 vs. 0.20
nmol MDA/mg prot) and protein carbonyl content (two-
fold increase).
These results point out to the possibility that muta-
tions in complex I subunits lead to a significative
increase in FR production and a subsequent increase in
peroxidative damage on cell lipids and proteins. If free
radicals are involved directly or indirectly in the modu-
lation of the clinical phenotype in mitochondrial patients
is a question that remains to be clarified. This clarifica-
tion is important as may result in the development and
clinical use of therapeutic strategies addressed to deliver
antioxidant agents into dysfunctional mitochondria.
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Accumulation of homoplasmic mtDNA point
mutations in erythroblasts isolated from the bone
marrow of patients with refractory anemia with
ring sideroblasts
E. Babusiakova
Center for Integrated Genomics, Institute of Inherited
Metabolic Disorders, Ke Karlovu 2, 2 Prague, Czech
Republic
emko007@yahoo.com
Refractory anemia with ring sideroblasts (RARS) is a
hematopoietic stem cell disorder of unknown origin,
characterized by excessive iron accumulation in erythro-
blast’s mitochondria. It was hypothesised that mitochon-
drial iron overload may result from acquired
mitochondrial DNA (mtDNA) mutations and subsequent
impairment of the respiratory chain complexes function.
In our study, we analysed mtDNA sequence of three
RARS patients who were selected on the basis of high
sideroblasts content in their bone marrow. To analyse the
mtDNA sequence of iron storing mitochondria sensitive-
ly, we developed new protocols for selective erythro-
blasts isolation, mtDNA PCR amplification and mtDNA
sequencing. Using this approach, we found altogether 84
mtDNA single-nucleotide substitutions. These included
71 already published polymorphisms, five silent muta-
tions in MTATP8, MTND1, MTND2, MTND5, MTCOII
EUROMIT 6 59genes and eight novel mutations (two mutations in RNA
coding genes MTRNR2 and MTTM and six missense
mutations in genes MTATP6, MTATP8, MTND2,
MTCYB and MTCOI). With the exception of the muta-
tion G15084T in MTCYB, which was heteroplasmic, all
the other detected mutations were homoplasmic. Func-
tional analyses suggested that identified mutations
probably do not result in major perturbations of
mitochondrial functions and are tolerated (except for
heteroplasmic mutation G15084T). We propose a
mechanism in which single mtDNA mutation is
aquired first. When tolerated, it saturates to homo-
plasmy and causes minor perturbation of mitochondrial
metabolism, which increases mtDNA mutation rate and
accelerates generation of additional mutations. These
mutations, if tolerated, accumulate to homoplasmy
until a threshold level is exceeded and functional
impairment results in an ineffective hematopoiesis
and defective maturation of erythroblasts.
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POLG and Twinkle mutations causing progressive
external ophthalmoplegia and mitochondrial myopathy
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Background: The mendelian forms of progressive ex-
ternal ophthalmoplegia (PEO) are clinically and genetically
heterogeneous disorders characterized by accumulation of
deletions in mtDNA. They are associated with mutations in
three nuclear genes, adenine nucleotide translocator 1
(ANT 1), twinkle helicase (C10ORF2), and the catalytic
subunit of polymerase gamma (POLG1), all of them
encoding factors involved in mtDNA stability.
Objective and methods: (i) To investigate the frequency
and genotype–phenotype correlations of mutations in
patients with PEO or mitochondrial myopathy (MM)
associated with multiple deletions in mtDNA. Coding
regions and exon/intron boundaries of ANT1 and POLG,
and mutational hot spot region of C10ORF2 were se-
quenced. (ii) The study includes 19 patients.
Results: (i) We have identified five novel mutations in
POLG1 gene and a novel mutation in Twinkle. (ii) We havepartially characterized phenotypically and genetically a
series of patients:
Patient 9: PEO. Compound heterozygote for a P587L and
the novel missense mutation R853W in POLG1.
Patient 12: PEO. Compound heterozygote for the allele
T251I-P587L and the novel mutation M603L in POLG1.
Patient 14: PEO and generalized myopathy. Heterozy-
gous for the novel mutation D1184N in POLG1.
Patient 22: Left gastrocnemius atrophy. Heterozygous for
the novel mutation R1146C in POLG1.
Patient 20: adPEO. No deletions in mtDNA. Heterozy-
gous for a novel missense mutation, R357P in Twinkle.
These mutations affect conserved residues and are not
detected in 200 healthy control alleles.
Conclusions: We have identified mutations in our patients
with a proportion and clinical and genetic heterogeneous
manifestations similar to previously reported series.
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Mitochondrial toxicity due to antiviral therapy:
decreased mtDNA levels in blood cells of HIV-infected
individuals can further decrease or recover depending
on the used antiviral drugs
E. de Rooij*, M. Casula, I. Dobbelaer, E. Timmermans, K.
Smolders, M. Buitelaar, M. Westrop, B. van Gemen, A. de
Ronde, M. de Baar
Mitochondrial Toxicity, Primagen, Meibergdreef 59, 1105
BA, Amsterdam, The Netherlands
E.deRooy@primagen.com
Mitochondrial dysfunction as a result of depletion of
mitochondrial DNA (mtDNA) is one of the determinants of
the adverse effects caused by nucleoside analogue (NRTI)
treatment in HIV infection. Using a real-time NASBA assay
quantifying both mtDNA and nuclear DNA in one tube, we
have investigated the effects of some antiviral drugs on the
mtDNA content both in vitro and in vivo. In HepG2 cells, we
observed an increase in mtDNA copies per cell at low
concentrations of d4T ( < 30 mM) and at all tested concen-
trations of 3TC and AZT. At higher concentrations of d4T
(>30 mM) and all tested concentrations of ddC, a decrease in
mtDNA could be observed. Depletion of mtDNA in PBMC
due to HIV infection itself was aggravated by therapies
containing ddC, and/or ddI, possibly leading to severe
adverse effects. In contrast, more recent antiviral therapies,
also those containing d4T, resulted in an increase of mtDNA,
which is probably due to recovery from HIV infection
combined with less toxicity of the antiviral drug combina-
tions itself. Low mitochondrial toxicity may lead to an
increase of mtDNA to compensate limited mitochondrial
function loss similar to what has been observed in the in
vitro experiments. We conclude that the (combination of)
EUROMIT 660drugs used together with individual determinants are influ-
encing the course of mtDNA during therapy and the devel-
opment of adverse effects. The consequences of these
observations for the prediction of the development of adverse
effects, and as such on therapy management, are being
investigated in clinical studies.
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Transient infantile hepatic failure, profound mental
retardation and white matter abnormalities due to
mtDNA deletions
E. Leshinsky-Silver*, A. Levine, M. Perach, E. Hershko-
vitz, A. Nissenkorn, C. Vinkler, A. Saada, D. Lev, T.
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MtDNA deletions are associated with a number of
distinct clinical phenotypes. These include Kearns–Sayre
syndrome, Pearson marrow-pancreas syndrome, chronic
progressive external ophthalmoplegia and Mitochondrial
neuro-gastrointestinal encephalopathy (MNGIE). Gastroin-
testinal involvement is prominent in Pearson and MNGIE,
while white matter changes are especially prominent in
MNGIE and KSS. Here we describe a 15-month-old boy
who succumbed following multisystem involvement
which included: failure to thrive, transient liver and
pancreatic insufficiency, lack of any psychomotor devel-
opment, severe brain atrophy with white matter destruc-
tion. Elevated blood lactate and a lactate peak in the basal
ganglia (on MRS) were found. Thymidine phosphorylase
activity was normal. Muscle, fibroblast and liver respira-
tory chain enzyme activities were within the normal
range. The T8993G mtDNA mutation was excluded.
Southern blot analysis revealed multiple deletions. These
deletions were restricted to the liver.
To the best of our knowledge, this infantile devastating
clinical presentation with a combination of gastrointestinal
and white matter involvement has not been previously
described in association with mtDNA deletions, and thus
represents a further expansion of the spectrum of mito-
chondrial DNA deletion syndromes.
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Mitochondrial and nuclear genome responses in cells
with arrested transcription and translation
E. Bartnik*, J. Piechota, R. Szczesny, A. Chlebowski
Department of Genetics, University of Warsaw, Pawinskiego
5a, 02-106 Warsaw, Poland
ebartnik@ibb.waw.plMany mutations found in the mitochondrial and
nuclear genome cause impairment of mitochondrial trans-
lation or replication/translation systems (e.g. mutations in
mt-tRNA genes, depletions). The conditions existing in
cells with such mutations can be simulated by treatment
with exogenous compounds. Thamphenicol and ethidium
bromide are commonly used inhibitors of mitochondrial
translation and transcription, respectively. We present
changes in steady-state levels of mitochondrial transcripts
and of mitochondrial proteins encoded by nuclear genes
in cells treated with thamphenicol and ethidium bromide.
Alterations in activity of the glycolytic pathway and
respiratory chain content are also presented.
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Characterisation of undifferentiated and differentiated
RD-cybrids, harbouring 3243 MELAS mutation
F. Bragantini, P. Sabatelli, K. Morten, A. Russell, V.
Petronilli, B. Leger, L. Valente, J. Poulton, P. Magalhaes,
L. Vergani*
Department of Neurological Sciences, University of Padova,
C/O VIMM Via Orus 2, 35129 Padova, Italy
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Human cell lines harbouring MELAS 99% A3243G
mutant mtDNA in rhabdomyosarcoma background
(MELAS RD-cybrids) have established and induced to
differentiate after TPA treatment (aneural); further differen-
tiation has been also obtained by innervation of myotubes,
using transverse sections of embryonic spinal cord with
dorsal root ganglia attached (neural).
Mitochondrial shape and distribution in MELAS and WT
RD-cybrids were studied in undifferentiated, aneural and
neural cybrids.
In contrast to undifferentiated cybrids, neural MELAS
RD-cybrids displayed altered mitochondrial morphology,
compared to control RD-cybrids. Neural WT myotubes
had threadlike mitochondria distributed throughout the
myotubes, whereas mitochondria of MELAS myotubes
clustered around the nucleus. Mitochondrial distribution,
expressed as pixel area, was significantly reduced in
MELAS RD-cybrids compared to controls. Perinuclear
clustering of mitochondria was confirmed by TEM anal-
ysis. At high magnification MELAS mitochondria were
larger, swollen compared to WT, with abnormal tubular
cristae. The mitochondrial matrix contained dense grains
and crystals; a difference of undifferentiated MELAS
mitochondria that were similar to control. Treatment with
antioxidant N-acetyl-cysteine (0.5 mM) (NAC) restored
the threadlike shape and normal distribution on mitochon-
dria in differentiated MELAS RD-cybrids. Also ultra-
EUROMIT 6 61structural analysis revealed a decrease of dense grains
and normal cristae in mitochondria of MELAS differen-
tiated cells after NAC treatment. Aneural MELAS RD-
cybrids were similar to neural myotubes. In conclusion,
differentiated, but not undifferentiated, MELAS RD-
cybrids show mitochondria perturbation that is ameliorat-
ed by treatment with antioxidant NAC.
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Frataxin interacts with proteins involved in iron–sulfur
cluster biogenesis and repair in human cells
E. Napoli*, G. Tan, V. Seveso, F. Taroni, G. Cortopassi
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Microarray analysis in human cells have supported a
role for frataxin in iron–sulfur biogenesis and repair
(Tan et al., 2003). To identify frataxin’s interactors, we
have carried out analyses by co-immunoprecipitation,
mass spectrometry, and blue native gel electrophoresis.
We observed that anti-frataxin antibody co-immunopre-
cipiated the human ISC-U homolog, consistent with our
observation that ISC-U levels are decreased in cells of
patients with Friedreich’s ataxia. In addition, we observe
co-immunoprecipitation of frataxin with rhodanese,
which repairs mitochondrial ISCs, and strong correlation
of frataxin with rhodanese expression. Mass spectrome-
try of other mitochondrial proteins immunoprecipitated
by anti-frataxin antibody included dnaK, which interacts
with ISC proteins during their biogenesis. However, we
observed no interaction of frataxin with ISC-S, the
sulfur donor in ISC biogenesis, by co-immunoprecipita-
tion, and little alteration of ISC-S levels in human cells.
Furthermore, we did not observe any co-migration of
frataxin and HSC20, the mammalian homolog of the
bacterial HSC20. Thus, although frataxin interacts with
multiple proteins thought to be essential for mitochon-
drial ISC biogenesis and repair (ISC-U, rhodanese,
dnaK), consistent with a function of frataxin as an
ISC protein co-chaperone, it does not appear to interact
with ISC-S and HSC20 homologs. As the presumptive
consequence of this ISC defect, we observe decreased
activity of the ISC-dependent enzymes, increased mito-
chondrial free iron, increased level of mitochondrial
superoxide and peroxide, and increased activity of the
antioxidant enzyme glutathione peroxidase and increased
amount of GSSG in mutant cells; these data fit into a
unified model of FRDA pathophysiology which will be
presented.P-102
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Objective: Depletion of mitochondrial DNA (mtDNA)
has been considered a marker of mitochondrial toxicity
associated with antiretroviral therapy, although HIV infec-
tion itself could play a role in this effect. We determine the
mtDNA content in peripheral blood mononuclear cells
(PBMC) in naive HIV-infected patients and its potential
consequences in mitochondrial respiratory chain (MRC)
function.
Design: A prospective, cross-sectional study with cases
and healthy controls.
Methods: We measured: (1) the quantity of mtDNA by
real-time PCR; (2) the enzyme activities of complexes II,
III and IV of the MRC, citrate synthase (CS) and glycerol-
3-phosphate dehydrogenase (G3PD) by spectrophotome-
try; and (3) membrane lipid peroxidation by fluorimetry,
in PBMC of 25 asymptomatic HIV-infected patients who
had never received antiviral therapy and of 25 healthy
controls.
Results: In the HIV-infected group we found a 32%
decrease of mtDNA (P= 0.002) and a decline in the enzyme
activities of complex II (41% decrease, P < 0.001), complex
III (38% decrease, P < 0.001) and complex IV (19% de-
crease, P= 0.001) compared to controls. Both mtDNA
depletion and decreased MRC enzyme activities remained
significant, even when assessed per organelle (mitochon-
dria). CS activity did not differ between the two groups.
G3PD activity was found to be decreased by 22%
(P < 0.001) in the HIV-infected group. Lipid peroxidation
of PBMC was increased in HIV-infected patients compared
to controls (P= 0.007).
Conclusions: HIV infection is associated with mtDNA
depletion and extensive MRC disturbances not only
limited to complexes encoded by mtDNA. Therefore,
other mechanisms different from mtDNA depletion, like
apoptosis, could be responsible for such mitochondrial
damage.
EUROMIT 662P-103
Molecular characterization of a mouse cell line with a
COX10 gene knockout
F. Diaz*, S. Garcia, C. Moraes
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33136 Miami, FL, USA
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Cytochrome c oxidase (COX) has been associated with
multiple neuromuscular and neurodegenerative diseases.
COX biosynthesis depends on a large number of integral
subunits as well as assembly factors. COX10, an assembly
factor, is a protoheme:heme O farnesyl transferase involved
in heme a synthesis. COX10 has been found to be mutated
in some patients with COX deficiency.
We established a fibroblast cell line by infecting a primary
cell culture from a mouse homozygous for the floxed COX10
gene (exon 6) with a retrovirus expressing E6/E7. To generate
a cell culture model for COX deficiency, this cell line was
transfected with a plasmid expressing Cre recombinase.
Clones obtained were analyzed for exon 6 deletion and for
COX activity. Total cytochrome analysis from mitochondrial
preparations reveals the absence of only cyt aa3 in the
knockout clones. KO cells had undetectable levels of COX
I by immunocytochemistry and Western blot. KO clones also
showed decreased complex I + III and II + III enzyme activ-
ities. Analysis of respiratory complexes by blue native gels
also suggests that the levels of fully assembled complex I and
complex III are moderately decreased in the KO cells. We
were unable to detect formation of fully assembled or sub-
complex assemblies of COX as described in patients with
COX10 mutations. We were unable to detect any oxidative
damage (protein oxidation, H2O2 and super oxide formation)
in COX-deficient cells.
This cell culture model of COX deficiency should be
instrumental in helping us understand the pathophysiology of
COX deficiencies as well as in developing treatments.
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Functional and diagnostic consequences of a novel
mitochondrial tRNA mutation co-segregating with a
D-loop polymorphism
G. Zsurka*, R. Schro¨der, C. Kornblum, J. Rudolph, R.
Wiesner, C. Elger, W. Kunz
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We report on the biochemical and genetic analysis of a
28-year-old female patient presenting with chronic pro-
gressive external ophthalmoplegia (CPEO). In a muscle
biopsy showing multiple ragged red fibers, we identified anovel heteroplasmic G12276A mutation, residing in the
mitochondrial tRNA Leu(CUN) gene, as well as a previ-
ously described heteroplasmic D-loop polymorphism
(A185G). Both mutations were also present in fibroblasts,
buccal mucosa and blood, although at much lower levels
than in skeletal muscle. Northern blot analysis demon-
strated a 50% reduction of Leu (CUN) tRNA in skeletal
muscle in comparison to controls, indicating the low
stability of mutated tRNA due to DHU-stem mispairing.
This is most likely the mechanism how the G12278A
mutation leads to general failure of mitochondrial trans-
lation. As a consequence, individual muscle fibers har-
bouring G12276A mutation loads higher than 80%
showed severe decrease in cytochrome c oxidase (COX)
activity. This decrease of COX activity was unexpectedly
also seen in fibers showing a high degree of A185G
heteroplasmy. Comparing the distribution of G12276A
and A185G mutations, we found that three allelic combi-
nations were present in skeletal muscle. Our single fiber
analysis demonstrated a co-segregation of the mutant
12276A allele with the wild-type 185G allele, which
readily explains the pseudo-correlation of the neutral
185G D-loop polymorphism with the pathological bio-
chemical phenotype. Beyond the identification of the
pathomechanism of a novel mutation in the mitochondrial
tRNA Leu(CUN) gene causing CPEO, our study high-
lights the importance of whole mtDNA genetic analysis in
assessing the pathogenic relevance of individual hetero-
plasmic mtDNA point mutations.
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Sensory ataxic neuropathy due to a novel C10Orf2
(Twinkle) gene mutation with germline mosaicism
G.Hudson*, A. Schaefer, R. Taylor, M. Deschauer, D.
Turnbull, P. Chinnery
Mitochondrial Research Group, University of Newcastle
upon Tyne, Framlington Place, NE2 4HH Newcastle upon
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Autosomal progressive external ophthalmoplegia (PEO)
typically presents with ptosis and weakness of the extra-
ocular muscles due to the accumulation of multiple mito-
chondrial DNA (mtDNA) deletions in skeletal muscle. Many
patients develop with limb weakness and some have multi-
systemic involvement including hearing loss and psychiatric
abnormalities. Mutations in three nuclear genes (POLG1,
C10Orf2 which codes for the protein Twinkle, and ANT1)
are found in f 70% of families with dominant PEO, and
f 1/3 of sporadic cases of PEO with multiple mtDNA
deletions. We sequenced ANT1, C10Orf2, and POLG1
cohort of 25 sporadic English and German patients with
PEO and multiple deletions and identified a novel C10Orf2
mutation in one family with germline mosaicism. One
EUROMIT 6 63sibling presented with the clinical triad of sensory ataxic
neuropathy, dysarthria and ophthalmoparesis (SANDO), a
phenotype previously associated with the POLG1 gene,
illustrating the phenotypic overlap in autosomal PEO.
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MtDNA complementation and recombination in human
cells harboring pathogenic mutations in polypeptide-
coding genes
G. Manfredi*, M. D’Aurelio, C. Gajewski, M. Lin, G.
Lenaz, C. Moraes
Neurology and Neuroscience, Weill Medical College of
Cornell University, 430 east 63rd street apt 3N, 10021
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Complementation between mitochondrial (mt) DNA
molecules may represent an important line of defense
against the potentially detrimental effect of pathogenic
mtDNA mutations. Functional complementation between
mtDNAs harboring different tRNA mutations or deletions
has been previously demonstrated in mammalian cells.
Therefore, in order to assess whether complementation can
occur between mtDNAs harboring mutations in protein-
coding genes, we have generated hybrids by fusion of two
human cybrid cell lines each containing homoplasmic levels
of a distinct mtDNA mutation in a protein-coding gene. One
mutation resulted in the loss of subunit 1 of cytochrome
oxidase (COX1), the other resulted in loss of cytochrome B.
Individually these mutations caused complete lack of mito-
chondrial oxidative phosphorylation. We showed that, in the
COX1–Cytochrome B hybrids, oxidative phosphorylation
was recovered suggesting that functional complementation
had indeed occurred. In addition, we found evidence that, in
the hybrids, the two species of mtDNA had undergone
genetic recombination resulting in novel mtDNA molecules.
Although intermolecular mtDNA recombination is known
to occur in yeast and plants, its existence in human mito-
chondria is still controversial. To our knowledge, this is the
first demonstration that mtDNA recombination among mu-
tant mtDNAs can occur in mammalian cells.
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MtDNA deletions and not point mutations cause
mitochondrial myopathy in PEO with POLG1 mutations
G. Kollberg*, M. Jansson, A˚. Pe´rez-Bercoff, C. Lindberg, E.
Holme, A.-R. Moslemi, A. Oldfors
Department of Pathology, Gothenburg University, Institu-
tion for laboratory medicin, Gula stra˚ket 8, 413 45 Go¨te-
borg, Sweden
gittan.kollberg@pathology.gu.seObjective: To investigate whether mtDNA point muta-
tions, directly or indirectly, are involved in the pathogenesis
of mitochondrial myopathy in progressive external ophthal-
moplegia (PEO) associated with POLG1 mutations. POLG1
encodes the catalytic alpha subunit of polymerase gamma
and is the only polymerase known to be involved in mtDNA
replication. It has two functionally different domains, one
polymerase domain and one exonuclease domain with
proofreading activity.
Methods: Muscle biopsy specimens from patients with
POLG1 mutations, affecting either the exonuclease or the
polymerase domain, were investigated. Single cytochrome
c oxidase (COX)-deficient muscle fibers were dissected
and screened for clonally expanded mtDNA point muta-
tions by a sensitive denaturing gradient gel electrophoresis
analysis, in which three different regions of mtDNA
including five different tRNA genes were investigated.
To screen for randomly distributed mtDNA point muta-
tions in muscle homogenate, two regions of mtDNA
including deletion breakpoints were investigated by
high-fidelity PCR, followed by cloning and sequencing.
Large-scale mtDNA deletions were investigated by long-
range PCR analysis.
Results: All patients but not controls harboured multiple
mtDNA deletions. No point mutations were identified in
single COX-deficient muscle fibers. Cloning and sequenc-
ing of muscle homogenate identified occasional point muta-
tions at very low frequency in some of the patients.
Conclusions: mtDNA point mutations appear not to be
directly or indirectly involved in the pathogenesis of mito-
chondrial disease in patients with different POLG1 muta-
tions. These findings suggest that it is the polymerase and
not the proofreading activity of POLG1 that is disturbed in
PEO and cause multiple mtDNA deletions.
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Dominant-negative effect of specific mouse genes in a
human nuclear and mitochondrial background
H. Antonicka*, F. Sasarman, I. Ogilvie, E. Shoubridge
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Numerous strategies for the identification of a genetic
defect in patients with autosomal recessive mitochondrial
disorders have been used, including linkage analysis, over-
expression of candidate cDNAs, and functional complemen-
tation by microcell-mediated chromosomal transfer. Each of
these strategies has its limitations. Linkage analysis cannot be
used when family size is small, which is the situation in the
majority of cases. Chromosome transfer is the most generally
appreciable method; however, deletion mapping is compli-
cated by the low rate of informative markers after transfer.
EUROMIT 664We reasoned that chromosomal transfer might be made
more efficient if mouse chromosomes were used instead of
human chromosomes, as all chromosomes transferred would
be informative. To test this, we first fused patient and
control cell lines with mouse rho0 cells. The defect in
patient cells was not complemented; in fact, the fusion of
a control human fibroblast line or a human osteosarcoma
line with mouse rho0 cells resulted in severely decreased
activities and protein levels of oxidative phosphorylation
enzymes. The transfer of individual mouse chromosomes
into patient cells partially rescued the biochemical defect in
several patients. Alongside the rescue, we observed in some
cells a strong dominant negative effect of certain mouse
chromosomes on mitochondrial translation, activity and
protein levels of complex I and/or complex IV.
These data suggest a dominant negative effect of
specific mouse genes when present in a human nuclear
and mitochondrial background. We are currently mapping
these genes. Identifying the genes may provide some
insight into the regulation of oxidative phosphorylation in
higher vertebrates.
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Clinical, biochemical and molecular analyses in 177
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We present clinical, biochemical and molecular analyses
in 177 children with cytochrome c oxidase (COX) defi-
ciency from 140 families from Poland, Czech and Slovak
Republic with 53 million inhabitants. Methods: Activities
of respiratory chain complexes (RC) were measured in
fibroblasts or muscle mitochondria spectrophotometrically.
Amount and composition of RC were studied by 2D-
PAGE. SURF1 and SCO2 genes and mtDNA mutations
were analysed by cyclic sequencing and PCR-RFLP.
Results: Clinical symptoms started before the age of 3
months in 39% of children and between 3 and 18 months
in 40%. The most frequent symptoms were failure to thrive
(67%), neuronal impairment (90%) and cardiomyopathy
(23%). Sixty-seven percent of children died in early
childhood. Increased level of B-lactate, CSF-lactate, B-
alanine and CSF-alanine was found in 85%, 81%, 65%
and 73% of investigated patients. Isolated COX deficiency
was found in 99 children, combined COX deficiency in 78
children. Mutations in SURF1 gene were present in 46
patients (841delCT mutation in 72% of investigatedalleles) and mutations in SCO2 gene in 8 children
(G1541A mutation in 80%). MtDNA mutations were
found in 18 children (mtDNA deletion or depletion 8,
A3243G 6, A8344G, A8348G, G8364A and del9205TA
once). Conclusion: COX deficiency represents a heteroge-
neous group of diseases except for children with Leigh
syndrome and SURF1 mutations. Mutations 841delCT in
SURF1 gene and G1541A in SCO2 gene are prevalent, at
least in our Slavonic population. Detailed characterisation
of COX at the protein and molecular level is necessary for
genetic counselling and prenatal diagnosis in affected
families.
Supported by GACR-303/03/0749, MSM11110003, EU-
QLG1-CT-2002-90358.
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Clinical similarities and differences of four children with
mitochondrial DNA deletions
H. Mierzewska*, M. Pronicki, M. Houshmand, K. Tonska,
E. Rowinska, J. Sykut-Cegielska, E. Karczmarewicz, E.
Bartnik, E. Holme, E. Pronicka
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h.mierzewska@czd.waw.pl
Single deletions of mitochondrial DNA (del mtDNA)
are associated with a large range of various clinical
features. Clusters of symptoms known as Kearns–Sayre
syndrome and chronic progressive ophthalmoplegia were
described in adults and Pearson marrow-pancreas syn-
drome in children. A set of nonspecific symptoms and
signs differs from patient to patient.
The aim of our study is to provide a description of
clinical course in four children with single mtDNA dele-
tions. Failure to thrive, stunded growth (without GH
deficiency) and fatigability began from infantile period to
the age of 2. During the following years multiorgan
involvement developed. Hypoparathyroidism, diabetes mel-
litus and suprarenal insufficiency appeared at the age of 7
and the disorders had nontypical, strange course. Heart
conductive abnormalities were present in three cases from
late childhood to adolescence. Pearson-like diarrhea epi-
sode was seen only once. Macrocytic anaemia was found in
two out of four cases. Kidney leakage of magnesium
(evoking hypoparathyroidism) and sodium (imitating hypo-
corticism) as well as urinary phosphate and potassium loss
were frequently observed. Serum and cerebrospinal fluid
lactate levels were elevated. Delay of the diagnosis was
from 2 to 14 years.
In our opinion, a major condition to improve detection of
children with mitochondrial disorders is to measure lactate
levels in all available biological specimens, routinely. Early
referral to a diagnostic metabolic (mitochondrial) centre is
EUROMIT 6 65also important. Atypical or ‘‘strange’’ course of progressive
chronic disorder, when associated with lactic acidaemia,
should especially alert not only haematologists but also
paediatric endocrinologists and nephrologists.
The study was supported by EC-QLG1-CT-2002-90358.
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Inhibition of mitochondrial Na+/Ca2 + exchange restores
stimulus-induced ATP production and Ca2 + handling in
human complex I deficiency
H.-J. Visch*, G. Rutter, W. Koopman, A. Varadi, K.
Mitchell, L. van den Heuvel, J. Smeitink, P. Willems
NCMLS, University of Nijmegen, P.O. Box 9101, 6500 HB
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Human mitochondrial complex I (NADH:ubiquinone
oxidoreductase) of the oxidative phosphorylation (OX-
PHOS) system is a multi-protein assembly comprising both
nuclear- and mitochondrially encoded subunits. Deficiency
of this complex is associated with numerous clinical
syndromes ranging from highly progressive, often early
lethal encephalopathies, of which Leigh disease is the most
frequent, to neurodegenerative disorders in adult life,
including Leber’s hereditary optic neuropathy and Parkin-
son disease. We show here that the cytosolic Ca2 + signal
in response to hormonal stimulation with bradykinin was
impaired in skin fibroblasts from children in the age of 0–
5 years with an isolated complex I deficiency caused by
mutations in nuclear-encoded structural subunits of the
complex. Inhibition of mitochondrial Na+/Ca2 + exchange
by the benzothiazepine CGP37157 completely restored the
aberrant cytosolic Ca2 + signal. This effect of the inhibitor
was paralleled by complete restoration of the bradykinin-
induced increases in mitochondrial Ca2 + concentration and
ensuing ATP production. Thus, impaired mitochondrial
Ca2 + accumulation during cytosolic Ca2 + mobilization is
a major consequence of human complex I deficiency, a
finding which may provide the basis for the development
of new therapeutic approaches to this disorder.
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Late-onset disease model for adPEO-Twinkle
H. Tyynismaa*, A. Paetau, P. Rustin, H. Spelbrink, A.
Suomalainen
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Autosomal dominant progressive external ophthalmo-
plegia (adPEO) is a mitochondrial disease of adult onset,characterized by ophthalmoplegia, ptosis and exercise
intolerance, as well as a myriad of additional family-
specific symptoms ranging from major depression, par-
kinsonism, and secondary amenorrhea, to peripheral
neuropathy. The muscle samples of the patients show
that 3–10% of muscle fibers are COX-negative ragged
red fibers and contain multiple deletions of mitochondrial
DNA (mtDNA). We and others have characterized three
PEO-genes, which all can be thought to affect mitochon-
drial DNA maintenance: Twinkle, a mitochondrial heli-
case, mtDNA polymerase gamma and adenine nucleotide
translocator 1.
To study Twinkle-PEO pathogenesis, we created nine
transgenic mouse lines, which overexpress wild-type
Twinkle or two different patient mutations under ubiqui-
tous beta-actin promoter. The mutant mice develop nor-
mally, with no detectable differences compared to the
wild-type overexpressor until 1 year of age, when they
manifest a late-onset mitochondrial myopathy. We de-
scribe detailed characterization of these novel mice, with
age-related accumulative dysfunction of the mitochondrial
respiratory chain.
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Investigation of the genetic basis of isolated Complex I
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This study aims to investigate the genetic basis of
isolated autosomal recessive Complex I deficiency in seven
patients with apparent defects in the assembly of the mature
enzyme. To determine the number of genetic complemen-
tation groups, the patient cell lines were fused to one
another in a pairwise fashion. In all cases except one
(siblings), the fusion of two patient cell lines resulted in
the rescue of the Complex I defect. This experiment showed
that there are six different disease-causing genes in this
group of patients.
Mutations in eight of the nuclear-encoded structural
subunits of the enzyme have previously been described in
patients with Complex I deficiency, (NDUFS1, NDUFS2,
NDUFS3, NDUFS4, NDUFS7, NDUFS8, NDUFV1, and
NDUFV2). Retroviral expression vectors, containing the
above Complex I structural subunits, are being transduced
into our patient cell lines to test whether overexpression of
these subunits will rescue the defects. To date, overexpres-
sion of NDUFS4 was found to rescue the defect in one
patient. A mutation in this gene was then confirmed by
sequencing.
EUROMIT 666Finally, in order to try to discover other genes involved in
Complex I deficiency, microcell-mediated chromosome
transfer was performed on one patient using a mouse donor
line. The defect in this patient was rescued by the presence
of mouse chromosomes, and genotyping studies are being
carried out to try to identify the chromosome involved.
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Ischemic stroke and MELAS syndrome in young adults
J. Schmiedel*, A. Kotzian, G. Gahn, H. Reichmann
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01307 Dresden, Germany
Janet.Schmiedel@t-online.de
Background and purpose: A rare cause of ischemic
stroke in young adults is the MELAS syndrome (mitochon-
drial myopathy, encephalopathy, lactic acidosis and stroke-
like episodes). Previous publications suggest that around
10% of patients with occipital infarction (age < 45 at
diagnosis) harbour the typical mitochondrial MELAS mu-
tation and around 2% of all premature strokes (age < 30 at
diagnosis) were diagnosed with mitochondrial disease. The
purpose of our study was to examine the frequency of the
typical A3243G mutation in young patients (age < 45 at
diagnosis) presenting with ischemic stroke and to find out
whether it may reasonable to screen the patients for this
mutation routinely.
Methods and results: Since December 2001, altogether
75 patients were referred to our hospital with acute cerebral
ischemia (12 patients with transitory ischemic attack, 63
patients with manifest stroke). They underwent a neurolog-
ical examination and standard diagnostic procedures, in-
cluding blood examination, Doppler and duplex sonogra-
phy, cardiological and neuroradiological examination.
Additionally mitochondrial DNA was analyzed for the
A3243G MELAS mutation. In one patient we could identify
this mutation, thereby the patient showed most of the
clinical characteristics with lactic acidosis, seizures, senso-
neurinal deafness, diabetes mellitus and short stature.
Conclusions: MELAS syndrome is a rare cause for
ischemic stroke in young adults. Within 75 patients we
identified one with the typical clinical characteristics and
the mitochondrial A3243G mutation. In patients without
the typical clinical symptoms of the disease, we could
not find the mitochondrial mutation.
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Quinone analogues regulate mitochondrial substrate
competitive oxidation
J.-J. Brie`re*, D. Schlemmer, D. Chretien, P. Rustin
Hopital Necker-Enfants Malades, INSERM U393, 149 rue
de Sevres, 75015 Paris, France
briere@necker.frQuinone derivatives are among the rare compounds
successfully used as therapeutic reagents to fight mito-
chondrial diseases. However, their beneficial effect
appears to depend on their side chain which presum-
ably governs their interaction with the respiratory chain.
The effect of four quinone derivatives was compara-
tively studied on NADH- and succinate-competitive
oxidation by a sub-mitochondrial fraction. Under our
experimental conditions, the less hydrophobic deriva-
tives (menadione, duroquinol) poorly affected electron
flow from either NADH or succinate to oxygen, yet
readily diverting electrons from isolated complex I.
This latter effect was abolished by succinate addition.
More hydrophobic derivatives (idebenone, decylubiqui-
none) stimulated oxygen uptake from succinate. But
while NADH oxidation was slightly inhibited by ide-
benone, it was somewhat increased by decylubiquinone.
As a result, idebenone strongly favoured succinate over
NADH oxidation. This study therefore suggests that
any therapeutic use of quinone analogues should take
into account their specific effect on each respiratory
chain dehydrogenase.
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Developing a mouse model of the mitochondrial NARP
syndrome using AAV-ribozymes for ATP6
J. Bongorno*, J. Guy, A. Lewin
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ida, 1600 Archer Road, P.O. Box 100266, 32610 Gaines-
ville, FL, USA
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Neuropathy Ataxia and Retinitis Pigmentosa (NARP)
is caused by point mutations in the mitochondrial gene
ATP6 and leads to various types of retinopathies as well
as dementia and skeletal muscle weakness. There are
currently no animal models of this disease, so we are
developing a mouse model using an AAV-vectored
ribozyme imported into the mitochondria to disrupt the
ATP6 mRNA. The ribozyme is tagged on the end of the
5S rRNA for targeting to the mitochondria.
In cultured mouse cells expressing our ribozyme, we
have shown a reduction in the target mRNA by
quantitative RT-PCR, a defect in ATP synthesis in
permeabilized cells, and a growth defect in galactose
media. We have also looked at other mitochondrial
genes and saw a reduction in COX3 and ND4. These
cells were also found to have increased resistance to
cyanide, an indication of reduced cytochrome oxidase.
We are currently trying to rescue this defect with a
nuclear-encoded version of mouse ATP6 targeted to the
mitochondria. If we can rescue the defect with a single
protein, it would suggest that the reduction of other
mitochondrial mRNA is a secondary effect. Mice have
EUROMIT 6 67also been injected sub-retinally with the AAV-vectored
ribozyme and are being monitored by electroretinogram
(ERG.)
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Following Chernobyl accident, a dramatic increase in
childhood thyroid cancers was observed. Little is known
about the effects of radiation over the mitochondrial
genome (mtDNA). The aim of this work was to evaluate
the effect of radiation on mtDNA and the role of mtDNA
alterations in radiation-induced thyroid tumours. We stud-
ied DNA from tumour tissue and adjacent thyroid paren-
chyma in eight follicular thyroid adenomas (FA) and 15
papillary thyroid carcinomas (PTC), from which DNA
from peripheral blood leukocytes was also available. We
analysed the d-loop region in all cases, and the 13 mtDNA
genes coding for proteins of the oxidative phosphorylation
system in five PTC. We detected d-loop instability in one
of eight FA and in nine of 15 PTC. MtDNA point
mutations were also detected in all the five PTC. In the
five PTC, mtDNA mutations identical to those detected in
the tumours were detected in the adjacent thyroid paren-
chyma but not in the respective blood samples. The
comparison of this series with a similar series of sporadic
(nonirradiated) thyroid tumours disclosed a much higher
number of mtDNA alterations in the former. Our results
support the conclusion that radiation causes mtDNA muta-
tions and show that it is necessary to compare both tumour
and non-tumoural findings in the thyroid with a relatively
non-exposed tissue such as the blood. A larger series and a
thorough study of irradiated thyroids without tumours are
necessary to evaluate whether or not mtDNA mutations are
involved in the causation of post-Chernobyl thyroid
tumours.P-118
Transport dysfunction in mitochondrial diseases:
mutational analysis and transcription factors of hTomm
and hTimm genes
J. Blesa*, J. Hernandez, M. Lacalle, J. Prieto, M. Cortina, J.
Montoya, J. Hernandez-Yago
Cell Organization, Fundacion Valenciana de Investigaciones
Biomedicas, Amadeo de Saboya, 4, 46010 Valencia, Spain
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To understand the molecular bases of mitochondrial
diseases that could be due to defects in the mitochondrial
transport machinery, we carry out a comprehensive analy-
sis of alterations in the subunits of the Translocase Outer
and Inner Mitochondrial Membrane, TOMM and TIMM,
complexes. The mutational analysis includes exons, splice
junctions and promoter regions of hTomm and hTimm
genes in 288 DNA samples from patients. We report the
finding of several novel heterozygous DNA alterations
including frameshift and missense mutations. In addition,
Nuclear Respiratory Factors (NRFs) are involved in gov-
erning nucleo-mitochondrial interactions promoting the
expression of genes encoding respiratory subunits and
key components of the mtDNA transcription and replica-
tion machinery. TOMM70 plays a major role as a receptor
of hydrophobic preproteins targeted to the mitochondria.
TOMM20 recognizes preproteins containing N-terminal as
well as internal targeting signals. Analyses of the promoter
regions of these human genes reveal the presence of
putative NRF-1 and NRF-2 binding sites. To characterize
the activity of the Tomm70 and Tomm20 promoter, we
designed constructs containing different promoter regions
that were cloned in the pGL3-basic vector and assayed for
functionality after transient transfections by using a lucif-
erase reporter assay system. Mobility shift assays and
super-shift experiments using antibodies against NRF-2a
were also performed. Our results provide evidence for the
role of NRFs as transcription factors which are involved in
the regulation of these genes. This supports the idea that
function of NRFs in nucleo-mitochondrial coordination
could be extended to major receptors of the mitochondrial
protein import machinery.
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Endurance training in patients with single, large-scale
mtDNA deletions: molecular genetic studies
J. Gardner*, T. Taivassalo, A. Schaefer, E. Blakely, C.
Hayes, M. Barron, R. Haller, D. Turnbull, R. Taylor
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EUROMIT 668Previous studies have demonstrated that aerobic training
can increase work and oxidative capacity in patients with
pathogenic mitochondrial DNA (mtDNA) mutations. Al-
though the mechanisms underlying physiological improve-
ment are not fully understood, they are attributed to
training-induced increases in mitochondrial copy number
which, in most patients, resulted in increased levels of rate-
limiting enzymes (i.e. those affected by the mutation).
While this finding suggests an increase in absolute levels
of wild-type mtDNA, increases in the relative proportion
of mutant genomes were detected. Despite biochemical and
physiological improvements supporting the application of
endurance training in the management of patients with
mtDNA disorders, the expansion of mutant mtDNA raises
potential problems and, at present, we are unable to give
clear advice to our patients.
To explore these issues, seven patients with well-charac-
terised, single mtDNA deletions were subjected to 14 weeks
of endurance training followed by 14 weeks of either
maintenance training at similar intensity or a deconditioning
phase; physiological evaluation and muscle biopsy were
performed at baseline, 14 and 28 weeks. For each of the
biopsies, we present the following data:
[1] Activities of respiratory chain complexes and the matrix
marker citrate synthase in muscle homogenates
[2] Mitochondrial histochemistry evaluating the percentage
of respiratory-deficient fibres
[3] Southern blot analysis investigating changes in mtDNA
heteroplasmy in muscle homogenates
[4] Real-time PCR analysis of cytochrome c oxidase
(COX)-deficient and COX-positive fibres to establish
whether changes in the level of mtDNA deletion or
mtDNA copy number within individual fibres play a
crucial role in determining enzyme activity.
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Leber’s Hereditary Optic Neuropathy mutations in
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K. Tonska*, E. Bartnik
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Leber’s Herereditary Optic Nauropathy (LHON) is
caused by various point mutations in mitochondrial DNA.
Most of them are located in complex I genes. Three
mutations (G11778A, G3460A, T14484C) are responsible
for about 90% of Leber’s cases. The G11778A mutation is
diagnosed in about 69% of cases in Caucasian population.
Besides these common mutations there are multiple rare
mutations causing the disease. There seems to be a ‘‘hot
spot’’ in the ND6 gene because there are already five
mutations designed to this locus.In multiple studies the correlation between mitochondrial
haplogroup J and G11778A, T14484C mutations was
observed.
LHON is molecularly diagnosed in Poland from 2000.
We show the results of the common mutation screening and
haplogroup analysis of Polish patients with LHON. No
correlation between G11778A and haplogroup J was ob-
served. There are some data suggesting the correlation
between T14484C and J haplogroup, but the sample is too
small to make any statements.
In all the patients negative for three commonmutations we
also looked for new mutations in ND6 gene by SSCP and
sequencing.
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Genotype–phenotype correlation in children with
mutations in SCO2 and a novel mutation 1518delA
K. Vesela*, H. Hansikova, M. Tesarova, P. Martasek, M.
Elleder, J. Houstek, J. Zeman
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Cytochrome c oxidase (COX) deficiency represents one
of the most common mitochondrial disorders in childhood.
Sco2 protein, encoded by nuclear SCO2 gene, presumably
affects provision of Cu+ to CuA site of MTCO2. We present
genotype–phenotype correlation in seven children with
isolated COX deficiency and mutations in SCO2 gene.
Results: Molecular analyses revealed five children homozy-
gous for missense mutation G1541A (E140K), two other
compound heterozygous for mutation G1541A and nonsense
mutation C1280T (Q53X) or novel frame-shift mutation
1518delA, which disrupts the reading frame of mRNA and
gives rise to a truncated protein. In homozygous patients, the
clinical symptoms including inspiratory stridor, hypotonia,
encephalopathy and progressive respiratory insufficiency
developed between the third and sixth month of life. The
onset of the disease started in both heterozygotes at birth.
Severe hypertrophic cardiomyopathy was observed in the
child with mutations C1280T/G1541A and fatal neonatal
encephalopathy with cardiomyopathy in the child with
mutations 1518delA/G1541A. In homozygous patients, the
maximum of histopathological changes was found in the
brain with neuronal degeneration and infrequent increase in
the amount of neuronal mitochondria. No neurogenic atro-
phy of skeletal muscles, axonal degeneration or myelin
breakdown in skin nerves was observed. No substantial
changes were found in the heart. On the contrary, prominent
hypertropic cardiomyopathy without significant changes in
other organs was found in the child with mutation C1280T.
Conclusion: The disease was fatal in all our children with
COX deficiency and SCO2 mutations, but the course of the
EUROMIT 6 69disease remarkably differed depending on the type of muta-
tions. Supported by GACR-303/03/D132.
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Regulation of cytochrome c release via mitochondrial
NO-cGMP pathway in rat cardiac myocytes
K. Seya*, K.-I. Furukawa, S. Motomura
Department of Pharmacology, Hirosaki University School
of Medicine, Zaihu-cho, 036-8562 Hirosaki, Japan
seya@cc.hirosaki-u.ac.jp
Although the existence of cardiac mitochondrial cGMP
has been reported (Kimura and Murad, 1974), its physio-
logical property has been unknown. Recently, we have
demonstrated an increase in cardiac mitochondrial cGMP
level induced by nitric oxide (NO) donors. Then, we
investigated to clarify whether the increase in mitochondrial
cGMP by NO induces cytochrome c release from mitochon-
dria. Mitochondria were prepared from left ventricular
myocytes of male Wistar rats (350–400 g) and were
incubated in high-K medium (150 mM) at 30 jC. SNAP,
an NO donor, accelerated cytochrome c release from mito-
chondria, which was significantly inhibited by ODQ, a
guanylyl cyclase inhibitor, and oxyhemoglobin, an NO
scavenger. A membrane-permeable cGMP analogue, 8-Br-
cGMP, also increased cytochrome c release. However,
SNAP and 8-Br-cGMP neither induced mitochondrial swell-
ing nor depolarized the mitochondrial membrane potential.
We further confirmed that NO donor induced apoptosis in
the cultured cardiomyocytes from adult rats, which was
significantly inhibited in the presence of ODQ. These results
suggest that mitochondrial NO-cGMP pathway in cardiac
myocytes causes cytochrome c release from mitochondria
independent of mitochondrial permeability transition pore,
resulting in induction of apoptosis. Further investigations
are necessary to clear the mechanism of cytochrome c
release via mitochondrial NO-cGMP pathway in detail.
P-123
A potential disease mechanism for mutant
SOD1-associated ALS
S. Bacman*, I. Kirkinezos, D. Hernandez, W. Bradley,
C. Moraes
Neurology, University of Miami, School of Medicine, 1095
NW 14th Terrace (R-301), 33136 Miami, FL, USA
sbacman@miamiproject.med.miami.edu
Transgenic mice overexpressing the human SOD1 gene
containing a Gly to Ala substitution at amino acid position 93
(G93A-SOD1) were used to examine the mitochondrial
involvement in the pathogenesis of ALS. We observed a
decrease in mitochondrial respiration in brain and spinal cordof the G93A-SOD1mice. This decrease was significant at the
last step of the respiratory chain (cytochrome c oxidase), and
it was not observed in transgenic wild-type-SOD1 and non-
transgenic mice. By adding exogenous cytochrome c to brain
mitoplasts, the defect was abolished. Western blot studies
showed that there was an increased cytochrome c dissociation
from the inner mitochondrial membrane. Dissociation of
cytochrome c from the inner membrane has been associated
with oxidative damage to mitochondrial lipids, a process that
can be reversed by SOD1/catalase treatment. Preliminary in
vitro assays showed that the G93A SOD1 had a lower
capacity than the wt SOD1 to revert the cytochrome c
dissociation from the inner mitochondrial membrane. Lipid
peroxidation studies showed that mitochondrial membranes
in G93A SOD1 mice were three to eight times higher than in
total homogenates when compared to control mice. We
propose a mechanism by which mutant SOD1 predisposes
neurons to cytochrome c release and apoptotic death by
increasing the dissociation of cytochrome c from the inner
mitochondrial membrane.
P-124
Mitochondrial DNA (mtDNA) levels vary in subcuta-
neous adipose tissue from HIV-infected patients
D. Libutti*, C. Shikuma, B. Shiramizu, D. Tran, C. O’Cal-
laghan, M. Gerschenson
Hawaii AIDS Clinical Research Program, University of
Hawaii, 3675 Kilauea Avenue, 96816 Honolulu, HI, USA
libutti@hawaii.edu
Recently several studies have shown decreases in mtDNA
levels in subcutaneous adipose thigh tissues from lipoatro-
phic HIV-infected patients taking nucleoside reverse tran-
scriptase inhibitors (NRTIs) [JAIDS 30 (2002) 271; JAIDS
29 (2002) 117; AIDS 15 (2001) 1801]. Subcutaneous adi-
pose tissue can be obtained from different sites and mtDNA
copies/cell have not been compared until this study. Periph-
eral adipose tissues were obtained from neck, abdomen, and
thigh of seven HIV-seropositive patients treated with NRTIs-
containing highly active antiretroviral therapy (HAART)
with lipoatrophy for >6 months, seven HIV-infected patients
treated with NRTIs-containing HAARTwith no lipoatrophy,
five HIV-infected patients naı¨ve to HAART, and five HIV-
seronegative participants. Total DNA was isolated and in-
tegrity examined by agarose gel electrophoresis. Intact DNA
was assayed for mtDNA copies/cell by real-time PCR using
primers for the mitochondrial NADH dehydrogenase 2 and
the nuclear Fas genes. MtDNA values were highest in
seronegative patients’ neck fat, 976 + 292, and abdomens,
790 + 292, and lowest in thighs, 435 + 63 ( P < 0.05).
MtDNA levels were decreased 40–70% in seropositive
patients taking NRTIs compared to seropositive naı¨ve and
seronegative participants. Depletion was most severe in the
neck and abdomen compared to thigh. These studies dem-
EUROMIT 670onstrate that mtDNA levels vary in different subcutaneous
adipose depots suggesting metabolic differences.
P-125
Development and optimization of human MitoChip
L. Piherova*, A. Cˇı´zˇkova´, M. Jerˇa´bkova´, R. Iva´nek, J. Paul,
J. Housˇteˇk, S. Kmoch
Center for Integrated Genomics, Institute of Inherited Met-
abolic Disorders, Ke Karlovu 2, 2 Prague, Czech Republic
lenka.piherova@lf1.cuni.cz
Analysis of gene expression profiles became a powerful
tool in the cloning of disease genes and provides functional
insight into normal physiology and disease pathogenesis.
We decided to develop MitoChip, an oligonucleotide
microarray, which will interrogate ultimately expression of
all H800 human genes involved in mitochondria biogene-
sis, maintenance, and metabolism.
To test all the aspects of MitoChip fabrication and anal-
ysis, we, in a first round, selected 200 mitochondrial genes
involved in energymetabolism, oxidative stress and fatty acid
oxidation. For each gene we designed a unique 40-bp-long 5V-
amino-modified oligonucleotide. We optimized methods for
oligonucleotide attachment on poly-L-lysine-coated glass
slides, methods of cDNA labeling and hybridization condi-
tions and, currently, we tested gene expression profiles in
various control cell cultures and human tissues.
We believe that MitoChip will become an important
analytical approach for various mitochondria related studies.
P-126
Severe defect of complex I-dependent ATP synthesis
shapes the mitochondria-driven path of apoptotic cell
death in Leber’s Hereditary Optic Neuropathy
V. Carelli*, A. Ghelli, A. Baracca, C. Zanna, G. Sgarbi, G.
Solaini, G. Lenaz, M. Rugolo, A. Martinuzzi
Department of Neurological Sciences, University of Bolo-
gna, Via Ugo Foscolo 7, 40123 Bologna, Italy
carelli@neuro.unibo.it
We recently reported [J. Biol. Chem. 278 (2003) 4145]
apoptotic death of Leber’s Hereditary Optic Neuropathy
(LHON) cybrids (11778, 3460, and 14484 mutations) in
galactose medium. To better define the apoptotic pathway,
we assayed ATP synthesis driven by complex I/II sub-
strates in permeabilized cells, as well as the cellular ATP
content. All evaluations were corrected for citrate syn-
thase activity. The ATP content was also assayed during a
time-course experiment, after galactose replacement, as
well as the activation of caspase 3 and the release of
Endonuclease G (EndoG). Complex I-dependent ATP
synthesis was severely affected with all three mutations.However, total ATP content of LHON cybrids was only
slightly reduced compared to controls. In galactose medi-
um, LHON cybrids suffered a profound ATP depletion
with time. Despite the significant release of cytochrome c
from mitochondria, caspase-3 was not activated. Mito-
chondrial EndoG levels decreased in LHON cybrids after
16–48 h of galactose incubation while cytosolic Endo G
concurrently increased. This was not observed in control
cells. Our results reveal that LHON mutations profoundly
impair complex I-dependent synthesis of ATP. However,
compensatory mechanisms maintain an almost normal
content of total cellular ATP. LHON cybrid apoptotic
death was caspase-independent, which may depend on
the rapid ATP depletion suffered during galactose incu-
bation. The parallel release of EndoG from mitochondria
into the cytosolic fraction was probably responsible for
nuclear DNA laddering and apoptotic death. Bioenergetic
failure may therefore be more relevant than previously
believed in shaping retinal ganglion cell death in LHON.
Supported by Telethon-Italy (grant #GGP02323 to V.C.).
P-127
Mutations in AAC2, equivalent to human
adPEO-associated ANT1 mutations, lead to defective
oxidative phosphorylation in Saccharomyces cerevisiae
and affect mitochondrial DNA stability
L. Palmieri*, F. Fontanesi, P. Scarcia, T. Lodi, C. Donnini,
A. Viola, A. Limongelli, V. Tiranti, M. Zeviani, I. Ferrero
Department of Pharmaco-Biology, University of Bari, Via E.
Orabona 4, 70125 Bari, Italy
lpalm@farmbiol.uniba.it
Autosomal dominant external progressive ophthalmo-
plegia (adPEO) is a mitochondrial disorder associated with
the presence of multiple deletions of mtDNA. Four
adPEO-associated missense mutations have been identified
in the ANT1 gene encoding the muscle-heart specific
isoform of the mitochondrial adenine nucleotide transloca-
tor. Since ANT1 is not expressed in cultured fibroblasts or
myoblasts, to investigate their consequences on cellular
physiology, we introduced adPEO-associated ANT1 muta-
tions at equivalent positions in AAC2, the yeast orthologue
of human ANT1. Their expression in aac2-defective hap-
loid strains of Saccharomyces cerevisiae resulted in a
marked growth defect on non-fermentable carbon sources,
and a concurrent reduction of the amount of mitochondrial
cytochromes, cytochrome c oxidase activity and cellular
respiration. Upon solubilization from mitochondrial mem-
branes and functional reconstitution into liposomes, the
AAC2 pathogenic mutants showed a marked ATP>ADP
preference compared to wild-type AAC2. Insertion of the
aac2 mutant alleles in combination with the endogenous
wild-type AAC2 gene caused a significant reduction in
cytochrome content and increased mtDNA instability. The
EUROMIT 6 71analysis of petite mutants in the heteroallelic strains
AAC2/aac2A128P and AAC2/aac2S303M showed that
all of them were rho , indicating that neither the synthe-
sis of mtDNA nor its segregation was inhibited. The
increase in the rate of petite colonies observed in our
mutant strains can account for the slow, progressive
accumulation of multiple deletions in human mtDNA
which is proposed to lead to adPEO. These results validate
the yeast S. cerevisiae as a suitable in vivo model to
further study the early biochemical and cellular consequen-
ces of adPEO-associated ANT1 mutations.
P-128
Tissue-specific cytochrome c oxidase assembly defects
due to mutation in SCO2
L. Stiburek*, K. Vesela, H. Hansikova, M. Tesarova, J.
Houstek, J. Zeman
Faculty of Medicine, Department of Pediatrics, Centre of
Integrated Genomics, Charles University, Ke Karlovu 2, 2-
12900 Prague, Czech Republic
lstib@lf1.cuni.cz
Sco2 protein involved in cytochrome c oxidase (COX)
assembly presumably affects provision of Cu+ to CuA site of
MTCO2. We studied the interactions and levels of COX
subunits in heart, skeletal muscle and liver from three patients
with COX deficiency and mutations in SCO2 (two G1541A
homozygotes and one C1280T/G1541A compound hetero-
zygote). Methods: Activity of COX was determined spectro-
photometricaly. Interactions and levels of COX subunits were
characterised by 1D-PAGE (native), 2D-PAGE (native/dena-
turing), SDS-PAGE and immunoblot analysis. Results: The
activity of COXwas markedly decreased in heart and skeletal
muscle but only a mild decrease was found in liver and
cultured fibroblasts. Tissue-specific COX assembly defects
were found with decreased levels of holo-enzyme complex
and increased levels of specific assembly intermediates. In the
liver, most of the relevant cross-reactive material was located
in holo-enzyme spots whereas in heart and skeletal muscle
were detected severely decreased levels of holo-enzyme and
markedly increased levels of assembly intermediates. Heart
and skeletal muscle contained three major faster migrating
assembly intermediates: the first one comprised only
MTCO1, the second MTCO1, COX4 and COX5A, and the
third contained at least MTCO1, COX4, COX5A and
MTCO2. The tissues from C1280T/G1541A heterozygote
showed apparently more severe assembly defects and lower
steady-state levels of COX subunits than tissues from
G1541A homozygotes. Conclusions: We demonstrate that
tissue-specific decrease in COX activity in patients with
SCO2 mutations is associated with similar extent of tissue-
specific COX assembly impairment, resulting in decreased
levels of holo-enzyme complex and increased levels of
assembly intermediates. Supported by GACR-303/03/H065.P-129
Intracellular ATP depletion and increase of oxidized
glutathione in cultured cystinotic fibroblasts
E. Levtchenko*, M. Wilmer, A. de Graaf-Hess, J. Koende-
rink, H. Blom, L. van den Heuvel, L. Monnens
Pediatrics, UMC St. Radboud, Geert Grooteplein 10, P.O.
Box 9101, 6500 HB Nijmegen, The Netherlands
e.levtchenko@cukz.umcn.nl
Background: Cystinosis is characterized by a defective
transport of amino acid cystine out of lysosomes due to
mutations of CTNS gene, encoding lysosomal cystine carrier.
Based on in vitro studies of proximal tubular cells loaded with
cystine dimethyl esters, ATP depletion is supposed to cause
renal Fanconi syndrome in cystinosis. Increased excretion of
5-oxoproline in patients not treated with cysteamine raises the
hypothesis of the alteration in gamma-glutamyl cycle.
The aim of the study was to investigate whether intra-
cellular ATP and glutathione content were depleted in
cultured fibroblasts of patients with cystinosis.
Methods: Intracellular cystine, total and oxidized gluta-
thione and ATP content as well as activity of Na-K ATPase
and of mitochondrial respiratory chain complexes (I–IV)
were measured in cultured fibroblasts of eight cystinotic
patients and eight healthy controls. Mann–Whitney test
was used for statistical analysis.
Results: Median fibroblast cystine content of patients
with cystinosis was 9.3 compared to 0.4 in healthy controls
(P < 0.01). Total glutathione content did not differ between
cystinotic and control fibroblasts, while oxidized glutathi-
one was significantly higher in the patients (median 0.9
versus 0.23 nmol/mg protein, P < 0.05). Median ATP con-
tent was lower in cystinotic fibroblasts compared to the
controls (37.3 versus 51.5 nmol/mg protein, P < 0.05). No
difference in the activity of Na-K ATPase and mitochondrial
respiratory chain complexes was detected.
Conclusion: ATP depletion found in cystinotic fibro-
blasts did not result in decreased activity of Na-K ATPase.
The elevation of oxidized gluthatione points to increased
oxidative stress, which can be responsible for cell damage in
cystinosis.
P-130
Skeletal muscle gene expression profiling in
mitochondrial disorders
M. Crimi*, A. Bordoni, G. Menozzi, L. Riva, S. Galbiati, R.
Del Bo, U. Pozzoli, N. Bresolin, G. Comi
Dipartimento di Scienze Neurologiche, Universita` degli Studi
di Milano, Via Francesco Sforza 35, 20122 Milano, Italy
marcreamy@tiscali.it
Extremely variable clinic and genetic features charac-
terize Mitochondrial Disorders (MD). Pathogenic mito-
EUROMIT 672chondrial genome defects are large-scale rearrangements
and single point mutations. Clinical manifestations be-
come evident when a threshold percentage of DNA
molecules are mutated. The severity of the clinical phe-
notypes can be directly related to the heteroplasmic
mutant load; however, other factors may contribute to
the wide range of phenotypes associated with the same
mutation. These complex genotype–phenotype relations
must be governed by nucleo-mitochondrial interactions,
but the precise nature of this genomic ‘‘cross-talk’’ is
unknown. Using Affymetrix microarrays (HG-U133A),
we studied the gene expression profile of muscle biopsies
obtained from four patients carrying the ‘‘common’’
macrodeletion and eight A3243G (four PEO and four
MELAS phenotypes) compared with three age-matched
healthy individuals. We found several differentially
expressed genes: 33 were markedly up-regulated in mac-
rodeleted and four decreased; 57 genes were dysregulated
in A3243G-related disorders (53 down-regulated in PEO
and four up-regulated in MELAS). Eleven genes were
similarly differentially expressed in MD muscle tissues
when compared to healthy muscle samples. An increased
expression of genes mainly related to the metabolism of
the amino groups (most of them implicated in the Urea-
cycle), as well as of several genes involved in the genetic
information processing, contributed to this differential
profile. Moreover, few genes were similarly decreased
in MD patients versus the control group. Real-time PCR
demonstrated excellent reproducibility of the microarray-
based findings. The observed expression patterns may
reflect specific changes of nuclear genes and contribute
to the definition of a molecular signature for the MD.
P-131
Analysis of the ANT1 gene in progressive external
ophthalmoplegia with multiple mtDNA deletions:
identification of a novel mutation
M. Deschauer*,1, G. Hudson2, R. Taylor2, T. Mu¨ller1, P.
Chinnery2, S. Zierz1
1University of Halle-Wittenberg, Department of Neurology,
Ernst-Grube-Str. 40, 06097 Halle, Germany (Germany)
2Mitochondrial Research Group, School of Neurology, Neu-
robiology and Psychiatry, University of Newcastle upon
Tyne, NE2 4HH Newcastle upon Tyne, United Kingdom
marcus.deschauer@medizin.uni-halle.de
Progressive external ophthalmoplegia (PEO) associated
with multiple deletions of mitochondrial DNA (mtDNA)
can be caused by adenine nucleotide translocator 1 (ANT1)
mutations. Up to now, only four mutations have been
identified in the ANT1 gene in only a handful of PEO
patients. We screened 29 index patients with PEO (16
sporadic and 13 familial cases) with multiple mtDNA
deletions for ANT1 mutations. In one German family weidentified a novel heterozygous C-to-A transversion at
nucleotide 269. The mutation converted a highly conserved
alanine at codon 90 to aspartic acid (A90D) and was
identified in three siblings: two brothers presented with
PEO and limb muscle involvement and the sister suffered
from ptosis and schizoaffective disorder. Microsatellite
analysis was suggestive of autosomal dominant inheritance
from the mother who did not carry the mutation in blood
indicating germline mosaicism. In 28 patients no mutation
was found in the ANT1 gene. This study expands the
heterogeneity of ANT1 mutations and confirms that multi-
systemic involvement seems to be not very frequent in PEO
patients with ANT1 mutations apart from psychiatric symp-
toms. Furthermore, it underlines that ANT1 mutations are
very rare in patients with PEO and multiple mtDNA
deletions.
P-132
The 7472insC deafness-associated mitochondrial DNA
mutation impairs 5V and 3V processing of pre-tRNA
Ser(UCN)
M. Toompuu*, L. Levinger, A. Nadal, J. Gomez, H. Jacobs
Institute of Medical Technology, University of Tampere,
FinnMedi I Biokatu 6, FIN-33014 Tampere, Finland
marina.toompuu@uta.fi
The 7472insC mitochondrial DNA mutation, which
templates the insertion of an extra G within the T-arm of
tRNA Ser(UCN), is associated mainly with sensorineural
deafness. In cultured cybrid cells containing 100% mutant
mtDNA, it causes a 65% decrease in the steady-state level of
tRNA Ser(UCN), which we showed previously was due to a
posttranscriptional reduction in its rate of synthesis. In an
attempt to define the precise pathogenic molecular mecha-
nism of the 7472insC mutation, we have now analysed its
effects on both 5Vand 3Vprocessing of pre-tRNA Ser(UCN)
in vivo and in vitro.
The analysis of tRNA Ser(UCN) isolated from cybrid
cells revealed a high frequency of misprocessing of tRNA
carrying the mutation. Over 11% of molecules showed
evidence of misprocessing, and many molecules that were
5Vmisprocessed were also 3Vmisprocessed. Such species
were almost undetectable ( < 1%) in control cells. In vitro
assays using HeLa cell RNase P and mitochondrial tRNA
3Vprocessing endonuclease revealed that the efficiency of
both 5V and 3V processing was impaired by the mutation.
The effect on 3V processing of the mutant substrate was
dependent on whether it retained a 5V leader. Furthermore,
we observed 5V misprocessing in vitro of artificially 3V
misprocessed substrates. We conclude that the mutation
impairs tRNA Ser(UCN) synthesis by affecting several
RNA processing steps, representing a novel pathological
mechanism.
EUROMIT 6 73P-133
Proteomic techniques applied on skeletal muscle and
fibroblasts in the patients with oxphos deficiencies
R. Van Coster*, J. Smet, B. de Paepe, W. Lissens, S. Seneca,
L. De Meirleir, B. Devreese
Pediatric Neurology and Metabolism, University Hospital
Ghent, De Pintelaan 185, B-9000 Ghent, Belgium
joel.smet@ugent.be
Finding the underlying molecular defect in the patients
with deficient activity in one of the OXPHOS complexes is
not an easy task. Complementation studies can be used to
decide whether mutation analysis should be performed in
mtDNA or in nuDNA. These studies, however, can be
laborious. A diagnostic strategy was developed based on
the study of the abundance of the complexes and their
subunits for prediction of the location of the primary defect.
Immunohistochemical and immunocytochemical analysis
was performed in skeletal muscle and cultured skin fibro-
blasts using specific antibodies against OXPHOS subunits. In
isolated mitochondria, OXPHOS complexes were separated
by blue native polyacrylamide gel electrophoresis (BN-
PAGE) and estimation of the abundance of each complex
was performed using immunoblotting techniques. Two-di-
mensional electrophoresis (BN-PAGE/SDS-PAGE) was ap-
plied for separation of the subunits. Spots on the 2D gels were
identified by immunostaining and mass spectrometric se-
quence analysis. mtDNA mutations affect the intramitochon-
drial protein synthesis. These mutations result in a reduced
immunoreactivity in BN-PAGE gels for at least two com-
plexes (I and IV mostly), and in a mosaic pattern on
immunostaining of tissues and cells (using antibodies
against complexes I and IV). Mutations in the nuclearly
located assembly genes like SURF-1, BCS1L and ATP12
and in the nuclear genes coding for structural proteins were
associated with a reduced immunoreactivity of only one
complex, which was generalized. The combination of these
proteomic techniques can diminish the number of relevant
genetic tests and facilitate the identification of the under-
lying gene defect.
P-134
Is the mtDNA mutation A8348G pathogenic in patient
with hypertrophic cardiomyopathy?
M. Tesarova*, D. Fornuskova, L. Stiburek, L. Cerna, H.
Hansikova, M. Elleder, J. Zeman
Department Paediatrics and Center for Integrated
Genomics, Faculty of Medicine, Charles University, Ke
Karlovu 2, 2-12900 Prague, Czech Republic
marketa.tesarova@seznam.cz
The association of hypertrophic cardiomyopathy and
heteroplasmic mtDNA mutation A8348G in TWC loop oftRNALys has been described only once (Terasaki et al.,
2001). We present second three-generational family with
mtDNA mutation A8348G. The proband with exercise
intolerance and progressive hypertrophic cardiomyopathy
died at the age of 22 years due to heart failure with
ventricular dilatation. Results: The heart biopsy revealed
irregular decrease of COX and NADH diphorase activities
with increased SDH activity. In isolated muscle mitochon-
dria from muscle biopsy, spectrophotometric analyses
revealed decreased activity of complex I (40% of controls),
complex I + III (30% of controls), and complex IV (20% of
controls) and 2D-PAGE has shown decreased amount of
low-weight subunits of complex IV. On the contrary, no
substantial alterations were found in muscle and skin
biopsy using histochemistry and ELMI. At autopsy, excen-
tric heart hypertrophy (980 g, controls < 300 g) was found
with increased amount of mitochondria in some cardio-
cytes. Distribution of mitochondria in the liver and kidney
followed by immunohistochemistry revealed only moderate
variation of their number. The brain was edematous, of
normal weight and without overt macroscopic abnormali-
ties. Western blot analysis of 2D-PAGE revealed abnormal
pattern of COX assembly in heart. Conclusions: We
speculate that mtDNA mutation A8348G may hinder
protein synthesis in mitochondria, which may affect as-
sembly/stability and activity of complex IV in the heart.
Because the other seven family members with mtDNA
mutation A8348G are asymptotic, another molecular back-
ground for severe heart impairment in our patient cannot
be excluded. Supported by IGA NR/8065-3 and GAE`R
303/03/D132.
P-135
The mitochondrial prohibitin complex is essential
for embryonic viability, germline function and
mitochondrial morphology in Caenorhabditis elegans
M. Artal Sanz*, W. Tsang, E. Willems, L. Grivell, B.
Lemire, H. van der Spek, L. Nijtmans
Molecular Biology, University of Amsterdam, SILS, Krui-
slaan 318, 1095 JK Amsterdam, The Netherlands
artal@science.uva.nl
Prohibitins in eukaryotes consist of two subunits (PHB1
and PHB2) that together form a high molecular weight
complex in the mitochondrial inner membrane. The evolu-
tionary conservation and the ubiquitous expression in mam-
malian tissues of the prohibitin complex suggest an
important function among eukaryotes. The PHB complex
has been shown to play a role in the stabilization of newly
synthesized subunits of mitochondrial respiratory enzymes
in the yeast Saccharomyces cerevisiae. We have used
Caenorhabditis elegans as model system to study the role
of the PHB complex during development of a multicellular
organism. We demonstrate that prohibitins in C. elegans
EUROMIT 674form a high molecular weight complex in the mitochondrial
inner membrane similar to that of yeast and humans. By
using RNA-mediated gene inactivation, we show that PHB
proteins are essential during embryonic development and
are required for somatic and germline differentiation in the
larval gonad. We further demonstrate that a deficiency in
PHB proteins results in altered mitochondrial biogenesis in
body wall muscle cells. We report a strong loss of function
phenotype for prohibitin gene inactivation in a multicellular
organism and show for the first time that prohibitins serve
an essential role in mitochondrial function during organis-
mal development.
P-136
The mitochondrial RNA polymerase is directly
responsible for promoter recognition in mammalian cells
M. Gaspari*, M. Falkenberg, N.-G. Larsson, C. Gustafsson
Medical Nutrition and Biosciences, Karolinska Institutet,
Novum, KUS-Huddinge, SE-141 86 Stockholm, Sweden
martina.gaspari@mednut.ki.se
Characterisation of the basic mammalian mitochondrial
DNA (mtDNA) transcription machinery is of fundamental
biological interest and may also provide novel pathways
for therapeutic intervention in the large group of human
diseases associated with mitochondrial dysfunction. We
have previously identified two novel transcription factors,
transcription factors B1 (TFB1M) and B2 (TFB2M), and
demonstrated that they can each support promoter-specific
mtDNA transcription in a pure recombinant in vitro system
containing mitochondrial RNA polymerase (POLRMT)
and mitochondrial transcription factor A (TFAM, previous-
ly mtTFA). We have now investigated how the mitochon-
drial transcription machinery recognizes promoters and
initiates RNA synthesis. Site-specific mutagenesis of the
mitochondrial light-strand promoter allows us to define
essential elements required for transcription. We further-
more demonstrate that recombinant in vitro transcription
systems reconstituted from mouse and human cells only
can recognize the species-specific and not the heterologous
light-strand promoter. By swapping transcription factors
between the mouse and human transcription machineries,
we demonstrate that the observed promoter specificity is
governed by the mitochondrial RNA polymerase and the
mitochondrial transcription factor A. In contrast, transcrip-
tion factor B does not influence promoter recognition at all.
The RNA polymerse specifically recognizes sequence
elements localized between nt  1 and  14 relative to
the transcription start site, much similar to what has
previously been described for the homologous RNA poly-
merase encoded by bacteriophage T7. Our studies lead us
to propose a new model on how mitochondrial promoters
are recognized and transcription initiated in the mammalian
mitochondrion.P-137
Spatial dynamics of human mitochondrial nucleoids
during mitosis and apoptosis
N. Ashley*, D. Vaux, J. Poulton
Women’s Centre Level 3, Mitochondrial DNA Group, Nuf-
field, Department of Obstetrics and Gynaecology, John
Radcliffe Hospital, OX3 9DU Oxford, United Kingdom
neilashley57@yahoo.co.uk
Here we describe a simple and effective method for the
in situ visualisation of human mitochondrial DNA
(mtDNA) using the DNA specific dye picogreen. By this
method mtDNA is visualised as punctate, brightly fluores-
cent structures distributed throughout the mitochondrial
reticulum in a variety of cell types. The staining is superior
to other DNA dyes such as DAPI and ethidium bromide
and can be viewed using a basic eppifluorescent micro-
scope equipped with standard filters. The method is also
well suited to confocal microscopy and the superior
fluorescence and localisation allows mtDNA nucleoids to
be visualised and tracked over periods of several hours.
We have applied this approach to studying nucleoid
dynamics during normal mitochondrial fission and fusion
and in cells undergoing mitosis and apoptosis revealing
novel distribution dynamics. The method can also be used
in conjunction with immunocytochemistry which has
allowed us to study how human mtDNA interacts with
the cytoskeletal components actin and vimentin and with
mitochondrial transcription factor A.
P-138
Investigation of association between mitochondrial
backgrounds of Leber’s Hereditary Optic Neuropathy
and Multiple Sclerosis in Iranian patients
M. Houshmand*, F. Babrzadeh, M. Vakilian, M. Teimori,
M.-H. Sanati
Medical Genetic, National Research Centre for Genetic
Engineering and Biotechnology, 19#Abbass Shafie Alley,
Ghods Str, 14155-6343, 14155 Tehran, Iran
massoudh@nrcgeb.ac.ir
The hypothesis that mitochondrial DNA (mtDNA) may
be implicated in susceptibility to Multiple Sclerosis (MS) is
supported by an increasing number of reports. We studied
the mitochondrial possible point mutations background for
both diseases. In 56 Iranian MS patients we could not find
any primary Leber’s Hereditary Optic Neuropathy (LHON)
point mutations. We also investigated the same mitochon-
drial haplogroup (J, K) in Iranian patients.
We studied 70 MS patients and 149 healthy controls for
Haplogroup J and K with PCR RFLP method. Our result
showed that 14 out of 70 are positive (20%) in MS group
EUROMIT 6 75and 14/149 (9.4%) in control group for J (P < 0.05); and 9/
70 (13%) in MS group and 5 out of 70 (7%) in control group
are positive for Haplogroup K (P= 0.4). Association be-
tween haplogroup J and Optic Neuritis was shown (signif-
icant at P < 0.005).
Our haplogroup investigation (J, M, BM and N) in
LHON patients normal control group (149 controls for
haplogroup J. and 246 controls for haplogroups M, BM
and N, from different regions of Iran) showed relation
between LHON and the haplogroups J, M and N. However,
the results showed a slight relatedness between haplogroup
BM and LHON.
Conclusion:
(1) LHON and MS had not the same haplogroups
background as well as point mutations.
(2) This study showed that haplogroups J may be a risk
factor for MS diseases special for MS patient with
Optic neuritis but genetic susceptibility factors for these
disorders vary between different populations.
(3) There is a slight relatedness between haplogroup BM
and LHON.
P-139
Progressive muscle atrophy with selective loss of muscle
fibers in a patient with mtDNA TK2 deficiency
M. Vila`*, A. Limongelli, A. Castellote, E. Garcı´a-Arumı´, J.
Lloreta, A. Meseguer, M. Zeviani, M. Roig
CIBBIM (ECOGEN), Hospital Vall d’Hebron, Pg. Vall
d’Hebron, 119-129, 08035 Barcelona, Spain
maya@hg.vhebron.es
Mutations in thymidine kinase 2 (TK2) gene cause a
myopathic form of the mitochondrial DNA depletion syn-
drome (MDS). Although clinical manifestations in these
patients vary, most of them die during infancy and long-term
survival is unusual.
Here, we report the morphological and molecular find-
ings, as well as a 12-year clinical follow-up in a patient with
the myopathic form of MDS in whom pathogenic mutations
were identified in the TK2 gene.
Morphological studies were performed in muscle biop-
sies that were obtained at ages 2, 5, and 12. Quadriceps
muscle biopsy performed at age 2 depicted an extensive
muscle fiber necrosis and phagocytosis, moderate fibrosis
and numerous scattered fibers with diffuse increased oxida-
tive activity and neutral lipid accumulation. At age 5, biopsy
showed that the OXPHOS system was mildly affected but
completely normal at age 12. At this age, biopsy showed a
fairly well structured muscle integrated almost exclusively
by type I fibers. Other findings include minimal lipid
vacuoles and the presence of few, scattered COX negative
ragged red fibers. mtDNA depletion worsened over the time
(from 75% at age 5 to 90% at age 12). TK2 activity infibroblasts was significantly reduced (7.8% of controls) and
molecular analysis revealed the presence of two allelic
heterozygous mutations in the TK2 gene (T108M in exon
5 and R192K in exon 8).
We propose that mtDNA-depleted fibers undergo selec-
tive segmental necrosis and, with time, they progressively
vanish leading to muscle atrophy and weakness.
P-140
Hunting for a gene responsible for coenzyme Q10
deficiency
C. Quinzii*, A. Kattah, A. Naini, O. Musmeci, C. Lamperti,
S. DiMauro, M. Hirano
Neurology, Columbia University, 630 west 168th street,
10032 New York, NY, USA
cmq2101@columbia.edu
Coenzyme Q10 (CoQ10) is a component of the electron
transport chain. It also plays a role as antioxidant and
membrane stabilizer.
Primary CoQ10 deficiency is an apparently autosomal
recessive disorder with heterogeneous clinical presentations:
(1) a rare myopathic form, dominated by exercise intoler-
ance, recurrent myoglobinuria and central nervous system
dysfunction; (2) an infantile-onset encephalomyopathy with
ataxia and renal disease; (3) Leigh syndrome.
In 2001, we described a syndrome with cerebellar ataxia
and severe deficiency of CoQ10 in skeletal muscle. Known
genetic causes of cerebellar ataxia had been excluded; we
suggested that this was a new form of primary CoQ10
deficiency. To identify the genetic cause of this disease we
studied a family affected and we mapped the locus to chr.
9p13. We analyzed 10 genes as potential candidates and in
three index patients of the family we found a nonsense
homozygous mutation in a gene encoding a protein pre-
dicted to be targeted to mitochondria. We posit that a form
of CoQ10 deficiency may be caused by mutations in this
gene leading to mitochondrial respiratory chain impair-
ments. In addition, low levels of CoQ10 may lead to
oxidative stress.
P-141
Cell culture models for mitochondrial
neurogastrointestinal encephalomyopathy
C. Lagier-Tourenne*, W. Walker, M. Davidson, M. Hirano
Department of Neurology, Columbia University, College of
Physicians and Surgeons, 630 West 168th Street P and S 4-
443, NY 10032, New York, USA
lagier@igbmc.u-strasbg.fr
Mitochondrial neurogastrointestinal encephalomyopathy
(MNGIE) is an autosomal recessive disorder caused by
EUROMIT 676loss-of-function mutations in the gene encoding thymi-
dine phosphorylase (TP). Muscle biopsies of patients
have revealed morphological and biochemical abnormal-
ities of mitochondria as well as multiple deletions,
depletion and point mutations of mitochondrial DNA
(mtDNA).
Normally, TP breaks down thymidine to thymine and
ribose. In MNGIE patients, TP activity is very low or absent
resulting in elevated levels of plasma thymidine. To explain
how TP gene mutations cause mtDNA defects, we have
hypothesized that elevated levels of thymidine cause mito-
chondrial nucleotide pool imbalances, resulting in abnor-
malities of mtDNA.
We are attempting to generate in vitro mtDNA abnor-
malities by exposing cultured TP-deficient and control cells
to varying concentrations of thymidine. We transformed
control and patient fibroblasts with SV40 and treated these
immortalized cells with ethidium bromide to deplete
mtDNA completely. These rho0 cells will be repopulated
with wild-type mtDNA by fusion with normal cytoplasts
generating cybrids with nuclei from either patients or
healthy controls.
We will assess whether the cells accumulate higher
heteroplasmic levels of mtDNA mutations over time, lead-
ing to significant mitochondrial respiratory chain defect, as
assessed by histochemical stains and measuring biochemical
activities for COX and SDH. We will screen mtDNA for
point mutations by RFLP and for depletion and multiple
deletions by Southern blot.
If the accumulation of mtDNA abnormalities in MNGIE
fibroblasts is due to elevated thymidine levels in the
culture medium, this result will encourage us to attempt
therapies to eliminate circulating thymidine in MNGIE
patients.
P-142
Hypertrichosis and SURF1 mutations
E. Ostergaard*, I. Bradinova, S. Holst Ravn, M. Schwartz,
F. Wibrand
Department of Medical Genetics, John F. Kennedy Institute,
Gl. Landevej 7, 2600 Glostrup, Denmark
els@kennedy.dk
We present two patients with generalised hypertrichosis
and Leigh syndrome with COX defects due to mutations in
SURF1.
Hypertrichosis may be seen in association with a number
of diseases. The basic abnormality is often a conversion of
vellus hair to terminal hair, a process similar to the normal
response of the axillae and groin hairs to the increased
androgen production in adolescence. The other mechanism
of hypertrichosis is a change of the hair-growth cycle,
caused by, e.g. increased thyroid hormone, growth hormone
or androgens.Hypertrichosis has previously been reported in three
patients with mutations in SURF1. In a few patients with
MELAS syndrome, hypertrichosis has been reported as
well, but the mechanism behind the hypertrichosis in
respiratory chain disorders is not known and most patients
do not have hypertrichosis.
The two patients, a boy and a girl, both had noncongen-
ital hypertrichosis. The girl, who is 3 years old, had highly
elevated testosterone levels in blood: 4.96 mmol/l (ref.
1.1F 0.7).
The elevated testosterone level is likely the cause of the
hypertrichosis, and may be caused by either an unknown
effect of the SURF1 mutations on hormone metabolism, or
by the bad condition of the patient, something that may be
seen also in, e.g. anorexia nervosa.
In conclusion, hypertrichosis may be a frequent finding
in patients with SURF1 mutations and in some cases
probably caused by increased androgen levels.
P-143
Mitochondrial DNA sequence variation in patients with
CADASIL
J. Annunen-Rasila
Department of Neurology, University of Oulu, Aapistie 7,
90014 Oulu, Finland
mannunen@paju.oulu.fi
Mutations in Notch3 gene cause cerebral autosomal
dominant arteriopathy with subcortical infarcts and leu-
coencephalopathy (CADASIL) that is clinically character-
ized by recurrent ischemic strokes, migraine with aura,
psychiatric symptoms, cognitive decline and dementia. We
recently described a patient with CADASIL caused by
R133C mutation in Notch3 and with concomitant myop-
athy caused by a novel 5650G>A mutation in the
tRNAAla gene in mitochondrial DNA (mtDNA). We
assume that the co-occurrence of the two mutations is
not coincidental and that mutations in the Notch3 gene
may predispose mtDNA to mutations. We examined the
nucleotide variation in mtDNA coding region sequences of
87 individuals with CADASIL caused by mutations in the
Notch3 gene. The patients were from 21 nuclear families.
Conformation sensitive gel electrophoresis and direct se-
quencing were used to detect mutations and polymor-
phisms. Novel sequence variants were verified by
restriction fragment analysis or allele-specific PCR.
MtDNA sequence variation among the CADASIL patients
was compared to that among 192 healthy Finns. We found
a total of 197 mtDNA coding region sequence variants
among patients with CADASIL. The variants included 10
novel synonymous, six novel nonsynonymous, two novel
tRNA and two novel rRNA mutations. The variation was
larger than expected. Our results suggest that mtDNA
sequence variation is increased in patients with CADASIL
EUROMIT 6 77and point to the possibility of a relationship between
Notch3 and mtDNA.
P-144
Leigh Syndrome French Canadian Cytochrome Oxidase
deficiency due to an inherited mutation in the LRPPRC
gene produces a defect in translation of COX subunits
B. Robinson*, G. Mitchell, C. Morin, F. Xu
Metabolism, Research Institute, Hospital for Sick Children,
555 University Ave., M5G1X8 Toronto, Ontario, Canada
bhr@sickkids.ca
Leigh Syndrome French Canadian (LSFC) is a variant of
cytochrome oxidase (COX) deficiency caused by mutations
in the LRPPRC gene. It is an unusual form of COX
deficiency with almost normal expression of COX in heart,
skeletal muscle and kidney but with distinct deficiency in
brain liver and skin fibroblasts. In patients with the common
(A354V) founder mutation, the amount of LRPPRC protein
found in both fibroblast and liver mitochondria was consis-
tently reduced to < 25% of control levels. Immunofluores-
cence showed that LRPPRC had a mitochondrial
distribution in normal cells but was more diffusely distrib-
uted in the fibroblasts of mutant cells. A titre of LRPPRC
was also found in nuclear fractions. Northern blots showed
that the LRPPRC protein was expressed in skeletal
muscle>heart>placenta>kidney>liver>lung = brain, opposite
to the severity of the enzymatic cytochrome oxidase defect.
35S-Methionine labeling of mitochondrial translation prod-
ucts showed that the translations of COX I and COX III
were specifically affected. This was also seen in Northern
blots where LSFC cells had lower titres of COX I and COX
III transcripts relative to those of ND1 and actin. These
results suggest that LRPPRC has a role in the stability of the
mRNA for COX I and COX III.
P-145
Apoptosis in muscle with mitochondrial DNA deletion
G. Fayet*, K. Aure´, P. Frachon, F. Malka, A. Lombe`s
Inst. de Myologie-CHU Pitie´-Salpeˆtrie`re, INSERM 582, AP/
HP, 47, bd de l’hopital, 75651 Paris, France
a.lombes@myologie.chups.jussieu.fr
Mitochondrial DNA (mtDNA) deletions were the first
mtDNA alterations identified as the cause of mitochondrial
diseases. They have been associated with three clinical
presentations: two severe multisystemic diseases with early
onset (Pearson and Kearns Shy Sayre (KSS) syndromes)
and a milder adult disease with only muscle involvement
(Chronic Progressive External Ophthalmoplegia, CPEO).
However, many adult cases present with a multisystemic
disease but an evolution much less severe than typical KSS(CPEO+). Molecular mechanisms underlying the difference
of severity encompass tissue distribution, proportion, and
location of mtDNA deletion as well as the mechanisms
associated with the defect of the respiratory chain activities
such as apoptosis and overproduction of reactive oxygen
species (ROS). We have analysed the muscle biopsy of 16
patients with mtDNA deletion and diverse clinical presen-
tation. Serial sections were investigated for the presence of
defect of respiratory chain activity (COX histochemistry),
mitochondrial proliferation (SDH histochemistry), apoptosis
(caspase 3, Bax, TUNEL) and overproduction of ROS
(SOD). The study of more than 2000 muscle fibres showed
that apoptosis and ROS production are associated with the
respiratory chain defect and mitochondrial proliferation.
To correlate these parameters with their genetic cause,
the borders of the deletions were identified and the amounts
of deleted and wild-type mtDNA were evaluated using real
time PCR. The proportion of muscle fibres with diverse
alterations was correlated with the amount of both deleted
and wild-type mtDNA molecules in the muscle fragment.
This same correlation will be performed at the level of
individual muscle fibres.
P-146
Bioenergetic consequences of homoplasmic LHON
mutations
W. Kunz*, S. Vielhaber, A. Kudin, D. Varlamov, T. Kudina
Department of Epileptology, University of Bonn, Sigmund-
Freud-Str. 25, D-53105 Bonn, Germany
wolfram.kunz@ukb.uni-bonn.de
In the present report we investigated the bioenergetic
consequences of 3 different homoplasmic LHON (Leber’s
hereditary optic neuropathy) mutations affecting the mito-
chondrial-encoded subunits of NADH:CoQ oxidoreductase
ND2 (C4640A), ND4 (G11778A) and ND6 (T14484C) for
human skeletal muscle and brain (for the ND2 mutation
only). All mutations caused in patients and non-affected
carriers of the mutation an almost identical decrease of
citrate synthase-normalized activities of complex I being
most severe for the ND6, less severe for ND4 and close to
the detection limit for the ND2 mutation. This enzyme
activity change was observed to be responsible for de-
creased respiration rates with NAD-dependent substrates
detected in saponin-permeabilized muscle fibers, isolated
skeletal muscle mitochondria and digitonin-treated para-
hippocampal homogenates (for the ND2 mutation). Titra-
tions of the activity of NADH:CoQ oxidoreductase with the
complex I inhibitors amytal, rotenone and piericidin A
revealed with all mutations no difference to controls, indi-
cating no alteration of kinetic properties of the CoQ reduc-
tion site by any of the investigated mutations. Since all
mutations led to a considerable increase of amytal sensitiv-
ity of mitochondrial respiration, our data are compatible
EUROMIT 678with the concept that the investigated mutations lead to a
decreased quantity of the active NADH:CoQ oxidoreduc-
tase enzyme complex. This hypothesis was tested to be valid
applying quantitative immunohistochemistry with antibod-
ies against the nuclear-encoded 15-kDa subunit.
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A family with pyruvate dehydrogenase complex
deficiency due to a novel C>T substitution at nucleotide
position 407 in exon 4 of the X-linked E1alpha gene
M. Tulinius*, N. Darin, E. Holme, E. Holmberg, J.-E.
Eriksson, W. Lissens, L. De Meirleir
Department of Child Neurology, The Queen Silvia Child-
ren’s Hospital, SU/O¨stra, S-416 85 Go¨teborg, Sweden
mar.tulinius@vgregion.se
The pyruvate dehydrogenase complex (PDHc) is a mul-
tienzyme complex which converts pyruvate to acetyl CoA. A
deficiency of the PDHc leads to lactic acidemia. The major
cause of PDHc deficiency is a defect in the E1alpha compo-
nent of the complex. The gene is localised to Xp22.1. The
aim of this study is to describe the molecular genetic
findings, clinical and laboratory features in a family with
PDHc deficiency and a novel mutation in the E1alpha gene.
Onset of disease in the proband and his older brother was at
17 and 8 months, respectively. Both had a severe episode of
muscle weakness and lactic acidosis. The mother had milder
symptoms. Respiratory rates and enzyme activities were
measured in isolated muscle mitochondria and showed a
generally decreased activity with a decrease of pyruvate
oxidation that was considerably more pronounced than that
of glutamate. All patients had low lactate/pyruvate ratios
consistent with PDH deficiency, which was confirmed by
thrombocyte PDH measurements. Sequencing of the 11
exons of the PDH E1alpha gene was performed. The proband
and his brother were found to be hemizygous for a 407C>T
change in exon 4 of the gene. Their mother was found to be a
carrier of the mutation. Due to the X-linked inheritance
pattern combined with the overall results of clinical inves-
tigations, molecular genetic findings and the corresponding
functional deficiency of the gene product, we believe that the
A136V substitution in the PDHE1alpha gene is the mutation
leading to PDHc deficiency in this family.
P-148
Mitosim—a tool for simulation of mitochondrial
population dynamics
M. Hammer*, A. deGrey
Department of Electronics and Telecommunication, NTNU,
O.S. Bragstads pl 2B, N-7491 Trondheim, Norway
Mikael.Hammer@tele.ntnu.noWe describe a software tool, mitosim, for simulation of
mitochondrial population dynamics. Mitosim makes it pos-
sible to model division and mutations in mitochondrial
DNA; destruction, division and fusion of mitochondria;
and death and division of cells. The parameters controlling
the simulations can be set in a separate parameter file and
parameters are also state-dependent.
Mitosim is intended as a tool for the simulation of
accumulation of mutations in mitochondrial DNA in
various kinds of cell cultures, e.g. mitotically active
cells cultivated in vitro with periodic passaging and
postmitotic somatic cells in vivo. The tool can also be
employed as a tool for trying out different hypotheses
concerning the mechanisms of mitochondrial fusion and
replication.
P-149
Splicing error in E1alpha pyruvate dehydrogenase
(PDHA1) mRNA caused by a novel intronic mutation:
implication of the SR protein SC35
M. Mine´*, M. Gabut, C. Marsac, M. Brivet, J. Soret,
J. Tazi
Hoˆpital Biceˆtre, Biochimie I, 149 rue de Se`vres, 75015
Kremlin Biceˆtre, France
m1manu@yahoo.com, marsac@necker.fr
A boy with delayed development, lactic acidosis, dis-
played a decreased PDH activity in fibroblasts and lym-
phocytes, and protein analysis demonstrated a decrease of
the E1a and E1b subunits of the PDH complex. Recently,
an intronic point mutation was identified in his E1a PDH
gene (PDHA1). In addition to the normal spliced mRNA,
patient samples contained significant levels of an aberrant-
ly spliced mRNA: this mRNA involved a switch to the use
of a cryptic 5’ donor splice site (intron 7 position 45), with
retention of the corresponding intronic sequence. The
DNA analysis found no mutation in the coding regions
but revealed a hemizygous G-to-A substitution at position
26 of intron 7, between the normal exon 7 donor splice
site and the cryptic donor splice site. Splicing experiments
in COS-7 and HeLa cells demonstrated that this point
mutation at intron 7 was responsible for the aberrant
splicing. This mutation is unusual in that it generated a
consensus binding motif for the splicing factor SC35, one
of the best characterized SR proteins. In vitro splicing and
UV cross-linking experiments demonstrated that the muta-
tion generated a splicing enhancer motif specially recog-
nized by SC35. Consistently, reducing SC35 protein levels
in patient’s fibroblasts, using small interfering RNAs,
resulted in the almost complete disappearance of the
aberrantly spliced E1a PDH mRNA. We here not only
define a new mutation with its mechanism in human
pathology, but our findings also illustrated more generally
EUROMIT 6 79that the SR proteins could be new promising targets for
therapeutic agents.
P-150
The neuropathology of mitochondrial DNA disorders
J. Betts*, E. Jaros, R. Perry, A. Schaefer, M. Barron, D.
Cottrell, G. Borthwick, R. Lightowlers, D. Turnbull
Department of Neurology, University of Newcastle-upon-
Tyne, Framington Place, NE2 4HH Newcastle-upon-Tyne,
United Kingdom
joannebetts@ncl.ac.uk
Diseases associated with mitochondrial DNA (mtDNA)
mutations are increasingly recognised as an important cause
of neurological disability. The involvement of the central
nervous system (CNS) is prominent, progressive and may be
the most disabling feature for patients. The neurological
features include optic atrophy, deafness, seizures, dementia,
ataxia, extrapyramidal features and stroke-like episodes.
These features are extremely variable even between patients
with the same mutation, and our understanding of the
correlation between mtDNA defects and specific neurologi-
cal features is at a rudimentary stage.
We have had the opportunity to correlate the clinical,
neuroradiological and neuropathological features of several
patients with mtDNA disease. In addition, we have evaluated
enzyme activity in frozen brain sections to correlate biochem-
ical changes with the level of individual mtDNAmutations in
single neurons.
Our data shows that:
 There is a remarkable difference in the number of
cytochrome c oxidase (COX)-deficient neurons in differ-
ent regions of the brain.
 Pathological features, including neuronal loss, may be
prominent in some CNS regions but this does not directly
correlate with the percentage of surviving COX-deficient
cells. This suggests either that loss of COX-deficient
neurons has already occurred, or that COX deficiencies in
other cell types contribute to the neuron loss.
 In single neurons, COX deficiency is associated with the
highest level of mutated mtDNA.
 The ‘‘threshold’’ level, the level of mutation required to
before a neuron becomes COX deficient, varies and in
part may depend on the CNS region examined.
P-151
Mitochondrial DNA mutations in human colonic crypt
stem cells—implications for function
L. Greaves*, M. Barron, R. Taylor, D. Turnbull
Neurology, University of Newcastle Upon Tyne, Medical
School, NE2 4HH Newcastle upon Tyne, United Kingdom
l.c.greaves@ncl.ac.ukColonic stem cells are pluripotent and give rise to all
cell lineages within the crypt epithelium. These cells are
not totally defined but it is generally accepted that a stem
cell ‘niche’ consisting of several stem cells exists at the
base of the colonic crypt. Recent studies have shown not
only a very high incidence of mitochondrial DNA muta-
tions in human colons, but also the presence of extensive
respiratory chain deficiency within crypts. The high inci-
dence of cytochrome c oxidase-deficient crypts raises
important questions not only regarding the possible influ-
ence of the respiratory chain deficiency on stem cell and
colonic crypt function, but also to their possible influence
in the development of colorectal cancers. Here we present
new data showing:
1. the true incidence of respiratory chain deficiency in
normal human colonic epithelium as determined by both
histochemical and immunohistochemical techniques;
2. immunohistochemical data indicating that the presence
of respiratory chain deficiency may influence several
aspects of colonic stem cell and epithelial cell
function (cell proliferation, apoptosis and the APC
pathway);
3. extensive sequencing studies of the mitochondrial
genome which indicate that the respiratory chain
deficiency may influence colonic crypt division
creating clusters of crypts derived from the same stem
cell.
We believe these observations are relevant to other
human stem cell populations.
P-152
Rapid mutation screening of the mitochondrial genome
S. Keers*, K. Craig, P. Chinnery
Neurology, University of Newcastle upon Tyne, Medical
School, NE2 4HH Newcastle upon Tyne, United Kingdom
s.m.keers@ncl.ac.uk
Although complete sequencing of the mitochondrial
genome (mtDNA) is well established in the research and
diagnostic setting, it still remains relatively expensive,
the analysis time-consuming, and there are concerns
about missing low levels of mtDNA heteroplasmy
( < 30%). Denaturing high performance liquid chromatog-
raphy (DHPLC) can be used to screen PCR-generated
DNA fragments for mutations by the formation of
heteroduplexes. We used the Transgenomic MitoScreen
Assay Kit to screen the entire genome in 19 PCR
fragments. These fragments were then digested and
analysed on the Transgenomic WAVE at different melt
temperatures. A total of 10 patients were included in the
study with well-characterised mutations at different levels
of heteroplasmy. The DHPLC method identified the
EUROMIT 680mutations within specific fragments for all of these
individuals.
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An adenine phosphoribosyltransferase-like protein is
down-regulated in a patient with OXPHOS deficiency
D. Molina*, J.-M. Nuoffer, S. Gallati, A. Schaller
Department of Human Genetics and Institute of Clinical
Chemistry, University Children’s Hospital, Inselspital, 3010
Bern, Switzerland
daniel.molina@dkf2.unibe.ch
To investigate the molecular consequences of OXPHOS
deficiencies in patients suffering from mitochondriopathies,
we compared patient’s proteomes to healthy individuals’.
The mitochondrial proteome originated from primary cul-
tured fibroblast cell lines. In one patient, a nuclear-encoded
gene mutation of unknown origin was suspected since
enzyme complex activity measurements proved dysfunction
of succinate dehydrogenase (complex II) and ATPase (com-
plex V) in skeletal muscle and liver, but no mutation in the
mtDNA was found. The patient’s proteome revealed a
significant diminished expression of an unknown protein
having 41.6% identity to the human adenine phosphoribo-
syltransferase (APRT) protein. So far, we found human liver
and leiomyosarcoma EST’s matching the APRT-like se-
quence. The enzymatic function of the APRT itself takes
place in the well-known salvage pathway restoring the
nucleotide pool in the cytoplasm. AMP is generated from
adenine and phosphoribosyl pyrophosphate (PRPP) and is
used as a substrate for the ADP synthesis. ADP is subse-
quently imported into the mitochondria and used as a
substrate for the OXPHOS system. To date, it still remains
unclear whether there is a specific APRT-related mitochon-
drial protein producing AMP already in the mitochondria
itself. Therefore, the APRT-like protein could be either
down-regulated due to a lower requirement of ADP precur-
sor in OXPHOS deficiencies or due to a gene mutation.
P-154
Marked mtDNA mutational load in isolated blood
CD34+ cells from healthy subjects
M. Sciacco*, R. Del Bo, S. Corti, C. Donadoni, S. Ghezzi,
F. Locatelli, S. Salani, M. Crimi, N. Bresolin, G. Comi
Dipartimento di Scienze Neurologiche, Universita` di
Milano, Via Francesco Sforza 35, 20122, Milan, Italy
Roberto.delbo@unimi.it
The accumulation of somatic alterations affecting the
mitochondrial DNA (mtDNA) has been observed in aging
and in pathological conditions. Recently, high levels of
mtDNA sequence heterogeneity have been reported inCD34+ cells from adult bone marrow, and, also, mtDNA
mutations have been described in colonic crypt stem cells,
associated with a significant biochemical defect in their
progeny. In the present study, we investigated the possibility
that mtDNA mutations might accumulate also in isolated
blood CD34+ cells. Peripheral blood was collected from five
healthy subjects (range 23–79 years) and mononucleated
fraction recovered through a density gradient. CD34+ cells
were obtained by positive selection with magnetic cell
separation and with fluorescence-activated cell sorter. The
D-loop and the coding region spanning nucleotides 3200–
3700 were amplified and analysed.
The cloning-sequencing strategy allowed to demonstrate
that mtDNA mutated molecules (16.7–90%) and high mu-
tational burdens (0.34 kb–4.8 kb) are present in all
samples. CD34+ cells had always similar or increased fre-
quencies of mutations, compared to those observed in whole
blood-derived samples. All CD34+ cells showed a random
distribution of the mutation pattern within the regions ana-
lysed; no recurrent nucleotides or short subregions showed
increased mutational frequencies; both regions were charac-
terised by the presence of individually rare point mutations.
Our data suggest that the accumulation of somatic mtDNA
mutations occurs on a frequent basis in CD34+ peripheral
blood mononucleated cells. As previously observed, it may
be assumed that the presence of a relatively high mtDNA
mutation load does not select the CD34+ bone marrow sub-
population from the circulating blood mononucleated cells.
P-155
Mutation analysis of the D-Loop and the 12S and 16S
rRNA genes in prostate cancer
M. Gomez-Zaera*, J. Abril, L. Gonzalez, M. Nadal,
V. Nunes
Centre de Genetica Medica i Molecular, Institut de Recerca
Oncologica, Hospitalet de Llobregat, Gran Via, s/n. Km. 2,
7, 08907 Barcelona, Spain
mgomez@iro.es
Prostate cancer (PC) is the most commonly diagnosed
cancer among men in Western countries. It has been
suggested that mtDNA mutations could provide a very
useful tool for the early detection of cancer. This is partic-
ularly interesting in the case of PC for which there is no
effective diagnostic marker as yet.
We studied the presence of mtDNA mutations in 26
samples of prostatic tissue: 11 pairs (normal-tumour) from
individuals with prostate cancer, three benign prostate
hyperplasias, and one young control. For all samples, 4
kilobases of mtDNAwere amplified and sequenced in eight
different reactions. This region encompassed the D-loop, as
well as the 12S and 16S ribosomal RNA genes.
A total of 55 sequence variants were identified, and
distributed as follows: 45 in the D-loop (four not listed neither
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databases); five in the 12S rRNA gene (one unlisted); and
five in the 16S rRNA gene. Changes were detected in normal,
tumour and hyperplastic prostates. The normal samples and
their counterparts exhibited the same set of sequence variants.
None of the mutations identified thus far seems to be specific
for carcinogenic growth. These are the first results from a
much more extensive study currently in progress that
includes the analysis of a larger number of samples and the
sequencing of the whole mtDNA molecule.
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Is a novel nucleotide change in ND3 pathogenic?
A. Pagnamenta*, P. Clayton, S. Rahman
Biochemistry, Endocrinology and Metabolism Unit, Institute
of Child Health, 30 Guilford Street, WC1N 1EH London,
United Kingdom
a.pagnamenta@ich.ucl.ac.uk
Transmitochondrial cybrid studies had previously been
carried out on a cell line from a patient presenting with
cardiomyopathy and complex I and IV deficiency. A wild-
type nucleus (from A549 cells) did not correct the COX
activity and so the mutation was assumed to be mitochon-
drial. Sequencing of the entire mitochondrial genome
revealed a novel change (A10306G) in the ND3 gene. This
results in an asparagine to serine substitution at amino acid
position 83, which appears to be only moderately conserved
across a selection of mammals and other organisms. The
change was also found in the unaffected mother at lower
mutant loads but was not present in 746 controls. An assay
was designed using last-cycle fluorescent PCR-RFLP to
determine the degree of heteroplasmy in each of the 12
transmitochondrial cybrid cell lines. Because the percentage
of A10306G in the cybrid cell lines was found to vary
considerably, we attempted to use these cybrid cell lines to
find functional evidence of pathogenicity. However, high
enzyme activities did not correlate with a decrease in the
mutant load, so it is thought that this change is simply a
heteroplasmic polymorphism. The real pathogenic change in
this patient has not been discovered. In cases where the
mutant load in transmitochondrial cybrids does vary widely,
the authors suggest that these can be used as a means of
obtaining functional evidence for (or against) pathogenicity.
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Towards stable allotopic expression of the human
mitochondrial ATPase 6 (subunit a) gene
M. Bokori-Brown
Dunn Human Nutrition Unit, MRC, Hills Road, CB2 2XY
Cambridge, United Kingdom
mbb@mrc-dunn.cam.ac.ukOne of the mutations of mitochondrial DNA (mtDNA)
was localised to the MTATP6 gene that encodes subunit 6 of
ATP synthase (ATP6). The mutation, a thymine to guanine
transversion at nucleotide position 8993 of human mtDNA
(T8993G), converts a highly conserved leucine to an argi-
nine at amino acid position 156. The mutation impairs ATP
synthesis. Disease manifests when T8993G accounts for
80–90% of all mtDNA molecules, in the form of maternally
inherited neurogenic muscle weakness, ataxia and retinitis
pigmentosa (NARP).
The approach we have adopted to complement the ATP
synthesis deficiency associated with the T8993G mutation
is termed allotopic expression and has been established in
yeast. It entails introduction of a wild-type MTATP6 (nA6)
into the nucleus. The nA6 gene has been fused with
selected mitochondrial targeting sequences (MTS) joined
at the 5V -end to ensure the protein product is imported by
mitochondria.
A neuronal cell line carrying the T8993G mutation has
been established to provide an improved cell model. In
preliminary transfection experiments with the nA6 gene,
cell survival is greater for cells carrying the T8993G
mutation than control cells, yet all the cells tested failed
to maintain expression of nA6. As the protein is highly
hydrophobic and mitochondrial import is inefficient, longer
MTS are being tested. Alternative expression systems and
co-expression of molecular chaperones are also under
investigation. These modifications aim to limit the toxic
effects of nA6 expression and provide mitochondria with
sufficient copies of functional ATP synthase to reverse the
ATP synthesis deficiency.
P-158
The role of mitochondrial ND1 gene mutations in the
aetiology of MELAS
D. Kirby*, R. McFarland, Akira Ohtake, C. Dunning
Mitochondrial Research, Murdoch Childrens Research
Institute, Flemington Road, Parkville, 3052 Melbourne,
Victoria, Australia
denise.kirby@mcri.edu.au
Mitochondrial encephalopathy, lactic acidosis and
stroke-like episodes (MELAS) is one of many clinical
presentations associated with complex I deficiency.
MELAS is genetically heterogeneous, with about 80% of
patients harbouring the 3243A>G mutation in MTTL1.
Other mutations in MTTL1, other transfer RNA genes and
MTND complex I structural subunit genes, most notably
MTND5, have also been reported in patients with a
MELAS phenotype. We report three unrelated children
with MELAS who expressed a specific deficiency of
complex I activity in skeletal muscle and cultured fibro-
blasts, and lacked the 3243A>G mutation. Each harboured
a different novel mutation in the MTND1 subunit gene of
EUROMIT 682complex I: 3696G>A (G131S), 3946G>A (E214K) and
3949T>C (Y215H). All affect highly conserved residues
that are predicted to be in hydrophilic loops that face the
matrix. Complex I activity was not restored on fusion of
patient cells with a rho zero cell line, confirming patho-
genicity. BN-PAGE showed markedly reduced levels of
fully assembled complex I, suggesting these mutations
affect complex I assembly or turnover, and confirming a
crucial role for ND1 in complex I assembly. MTND1
mutations have been associated predominantly with Leber
Hereditary Optic Neuropathy, but only the 3460G>A
mutation has unambiguous evidence for pathogenicity.
With three new pathogenic mutations, our findings sug-
gest MTND1 may be a hotspot for mutations causing
MELAS.
P-159
Mitochondrial DNA mutations distinctively alter nuclear
gene expression
R. Jahangir*, P. Svensson, G. Janssen1, K. Szuhai, J.
Antonie Maassen, A. Raap
MCB, LUMC, Wassenaarseweg 72, 2333 AL Leiden, The
Netherlands
R.S.Jahangir_Tafrechi@lumc.nl
The pathobiochemical pathways determining the wide
variability in phenotypic expression of mitochondrial
DNA (mtDNA) mutations are not well understood.
Most pathogenic mtDNA mutations induce a general
defect in mitochondrial respiration and affect ATP
synthesis. Yet phenotypic expression of the different
mtDNA mutations shows large variations that are diffi-
cult to reconcile with ATP depletion as sole pathogenic
factor, implying that additional factors contribute to the
phenotype. Here we use DNA microarrays to identify
the changes in nuclear gene expression resulting from
the presence of the A3243G diabetogenic mutation and
from a depletion of mtDNA (r0 cells). We find that
cells respond to these states of mitochondrial dysfunc-
tion with both general and mutation-specific changes in
nuclear gene expression. This observation indicates that
cells can sense the nature of mtDNA dysfunction. As a
common response in A3243G and r0 cells, the mRNA
levels of genes involved in ubiquitin-mediated protein
degradation and in ribosomal protein synthesis are
down-regulated, while mRNA levels for extracellular
matrix genes are up-regulated. In contrast, a number
of other genes show divergence in expression in r0
cells compared to cells with the A3243G mutation,
such as genes involved in oxidative phosphorylation.
Our findings show that mitochondrial dysfunction by
different mutations affects nuclear gene expression in par-
tially distinct ways, suggesting that multiple pathways link
mitochondrial function to nuclear gene expression andcontribute to the development of the different phenotypes
in mitochondrial disease.
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Mutations of mtDNA in children with isolated complex I
deficiency
N. Esteitie*,1,2, R. Mehta¨la¨3, U. von Do¨beln2, R. Wibom2,
H. Nilsson2, K. Naess4, G. Malm4, K. Tea¨r-Fahnehjelm4, K.
Majamaa3, N.-G. Larsson5
1Department of Women and Childrens Health, Karolinska
University Hospital, SE-14186 Stockholm, Sweden
2Department of Laboratory Medicine, Karolinska Universi-
ty Hospital, SE-14186 Stockholm, Sweden
3Department of Neurology, University of Oulu, P.O. Box
5000, FIN 90014 Oulu, Finland
4Department of Clinical Sciences, Karolinska University
Hospital, SE-14186 Stockholm, Sweden
5Department of Medical Nutrition, Karolinska Institu-
tet, Karolinska University Hospital, SE-14186 Stockholm,
Sweden
alexander.christow@swipnet.se
Complex I (NADH dehydrogenase) of the mitochon-
drial respiratory chain consists of seven mtDNA-
encoded and f 39 nucleus-encoded subunits. Complex
I has several biochemical activities including NADH
oxidation, electron transport, proton pumping, coenzyme
Q reduction and formation of reactive oxygen species.
A variety of different clinical phenotypes are associated
with complex I deficiency, but the pathogenesis is not well
understood. We have diagnosed isolated complex I defi-
ciency in 11 children by measurement of the mitochondrial
ATP production rate (MAPR) and complex I enzyme
activity in isolated skeletal muscle mitochondria. We divid-
ed the patients into four clinical groups based on their
symptoms: (i) Leigh and Leigh-like syndrome (n = 3
patients); (ii) neonatal lactic acidosis, encephalomyopathy
and hypertrophic cardiomyopathy (n = 3); (iii) encephalo-
myopathy with hearing impairment, optic nerve atrophy and
cardiac involvement (n= 4; all siblings); (iv) hearing im-
pairment, cataract, muscle weakness and hypertrichosis
(n = 1). Five of the patients had elevated blood lactate,
which in all cases was accompanied by excretion of lactate
and Krebs cycle intermediates, in particular fumarate, in the
urine.
Conformation sensitive gel electrophoresis (CSGE)
was used to analyze 63 DNA fragments corresponding
to the coding region of mtDNA in 10 of the patients.
All fragments with aberrant migration were sequenced.
Fragments with mtDNA mutations corresponding to
known polymorphisms were not further investigated.
Previously unreported polymorphisms/mutations or
known pathogenic mutations were confirmed by sequenc-
ing in the reverse direction and by restriction fragment length
EUROMIT 6 83polymorphism analysis. Two patients with Leigh syndrome
(group I) had the 10191T!C mutation in the ND3 gene and
the 14487T!Cmutation in the ND6 gene, respectively. The
four patients of group III were siblings and they were all
homoplasmic for the 11778G!A mutation of the ND4
gene. The 11778G!A mutation causes Leber’s hereditary
optic neuropathy (LHON) and may therefore explain the
finding of optic atrophy in these patients. However, the
patients also had encephalopathy and hearing impairment,
which may represent a novel phenotype caused by the
11778G!A mutation. Alternately, the patients may also
have a nuclear mutation explaining part of their phenotype. In
conclusion, we demonstrate here that a variety of phenotypes
may be present in children with complex I deficiency; our
findings indicate that mutations of mtDNA may be common
in children with Leigh syndrome and complex I deficiency.
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Isolated Complex I deficiency results in increased
superoxide production: a single-cell study
S. Verkaart*, W. Koopman, H.-J. Visch, L. van den Heuvel,
J. Smeitink, P. Willems
NCMLS, University of Nijmegen, P.O.Box 9101, 6500 HB,
Nijmegen, The Netherlands
s.verkaart@ncmls.kun.nl
Human Isolated Complex I deficiency is the most
frequent encountered abnormality of the mitochondrial
oxidative phosphorylation system. Complex I (CI) is a
multi-subunit protein complex that dehydrogenates
NADH and shuttles electrons to ubiquinone. Recently,
the Nijmegen Centre for Mitochondrial Disorders of the
department of Pediatrics has identified mutations in
nuclear DNA, encoding several structural subunits of
CI in patients with an isolated CI deficiency. To date,
the mechanisms by which such mutations produce cell
injury are poorly understood. One hypothesis is that
mutations in CI subunits increase electron leakage which
subsequently can react with oxygen resulting in an
increased amount of damaging reactive oxygen species,
especially superoxide. To test this hypothesis, we used
the superoxide specific fluorescent probe dihydroethidium
to measure cellular superoxide production at single cell
level. Studies revealed that patient fibroblasts, in which a
CI deficiency was determined, displayed significantly
elevated superoxide production compared to controls.
Furthermore, superoxide production from these cells
inversely correlated with residual CI activity found by
enzymatic analysis. This indicates that in patients more
superoxide is produced by a smaller amount of active
(though mutated) CI, compared to greater CI amounts in
wild-type controls.
Further experiments will be conducted to gain more
insight in the cellular superoxide detoxification mechanismsin patient and control fibroblasts and to restore the observed
superoxide overproduction to control levels using a bacu-
lovirus-based complementation assay.
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The absence of apoptosis-inducing factor AIF induces
complex I deficiency
N. Vahsen*, C. Cande, J. Briere, P. Benit, P. Rustin,
G. Kroemer
Genetique Oncologique, Institut Gustave Roussy, 39, Rue
Camille Desmoulins, 94805 Villejuif, France
vahsen@igr.fr
Apoptosis inducing factor (AIF) is a mitochondrial
flavoprotein that, after apoptosis induction, translocates to
the nucleus where it participates in apoptotic chromatinol-
ysis. We show that mouse cells lacking AIF as a result of
homologous recombination exhibit a high lactate production
and an enhanced dependency on glycolytic ATP generation.
This is due to a severe reduction of the respiratory chain
complex I (CI) activity. We confirmed this CI deficiency in
human cells in which AIF is knocked down by small
interfering RNA. Although AIF does not co-migrate with
CI, AIF-deficient cells lack selected CI subunits, pointing to
a role of AIF in the biogenesis and/or maintenance of this
polyprotein complex.
Harlequin mice, described by Klein et al. (Nature 2002),
with reduced AIF expression due to a retroviral insertion
into the AIF gene also manifest a reduced oxidative phos-
phorylation (OXPHOS) in the retina and in the brain, mostly
CI, correlating with neuronal defects. Harlequin mice could
therefore serve as an animal model for complex I deficiency.
Altogether, these data point to a role of AIF in the
OXPHOS and emphasize the dual role of AIF in life and
death.
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Mmm1p spans both the outer and inner mitochondrial
membranes and contains distinct domains for targeting
and foci formation
N. Kondo-Okamoto*, J. Shaw, K. Okamoto
Department of Biology, University of Utah, 257 South 1400
East, 84112 Salt Lake City, UT, USA
nokamoto@biology.utah.edu
Maintenance of mitochondrial morphology is important
for optimal function of the organelle. In Saccharomyces
cerevisiae, the integral membrane protein Mmm1p is
required for formation of tubular mitochondrial morpholo-
gy and mitochondrial DNA (mtDNA) retention. Mmm1p
forms discrete foci on the mitochondrial surface that are
adjacent to mtDNA nucleoids in the matrix, raising the
EUROMIT 684possibility that this protein plays a direct role in anchoring
mtDNA nucleoids. Mmm1p consists of a long N-terminal
extension followed by a putative transmembrane segment
and a large C-terminal domain. Although previous studies
suggested that Mmm1p is inserted into the outer mem-
brane with its C-terminus in the cytoplasm, the location of
the N-terminus and the function of each domain remained
unclear.
In this study, we examined the topology and function of
different Mmm1p domains. We found that Mmm1p spans
both the outer and inner mitochondrial membranes, with its
C-terminus in the cytoplasm and its N-terminus in the
matrix. Although this topology would allow the Mmm1p
N-terminal extension to interact with mtDNA nucleoids,
deletion of this region did not affect mitochondrial morphol-
ogy or mtDNA retention. Moreover, the mtDNA loss phe-
notype of mmm1 null cells was rescued by expression of the
Neurospora crassaMmm1p homolog, which naturally lacks
an N-terminal extension. These observations indicate that
Mmm1p is not directly linked to mtDNA nucleoids. Addi-
tional studies showed that the transmembrane segment and
C-terminal domain are essential for Mmm1p foci formation
and mitochondrial targeting, respectively. Our data suggest
that the double membrane-spanning topology of Mmm1p is
crucial for maintenance of mitochondrial morphology.
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Development of subdural effusions: pyruvate
dehydrogenase complex (PDHc) deficiency can be
mistaken for shaken baby syndrome
O. Grafakou*, A. Xaidara, P. Nikolaidou, M. Raisaki, A.
Giannopoulos, R. Rodenbourg, B. van den Heuvel, J.
Smeitink, A. Evangeliou
Neurometabolic Unit, Pediatric Department, Heraklion
University Hospital, Paradisou 16, 151 25 Heraklion,
Greece
Grafakou@hol.gr
A 3-month-old male infant was admitted in the pediatric
department due to status epilepticus. Prior history was unre-
markable with the exception of a UTI episode. A neonatal
death was reported in the mother’s family history. Physical
examination revealed increased head circumference, retro-
gnathia, dysmorphic ears, axial hypotonia and increased
tendon reflexes. Fundoscopy demonstrated early signs of
optic atrophy. Initial laboratory investigation was unreveal-
ing. The MRI scan revealed a relative increase of extracere-
bral CSF spaces and generosity of the perimesencephalic
cisterns. During the next 20 days, head circumference in-
creased 10 cm. The subsequent MRI scan revealed subdural
effusions (hygromas) and leukodystrophy. As the combina-
tion of macrocephaly, leukodystrophy, mild dysmorphias,
and seizures is indicative of a mitochondrial disease, meta-
bolic investigations were performed showing only ethyl-malonic aciduria. A muscle biopsy was then performed
revealing isolated PDHc deficiency (19 mU/U CS, normal
range: 28–89 mU/U CS) with normal activities of E1 and E3
PDHc subunits.
The patient underwent surgical treatment of the hy-
gromas and was placed under anticonvulsant therapy and
ketogenic diet. A 15-month follow-up reveals severe
psychomotor retardation, deviant developmental curve,
brittle hair, axial hypotonia, limb spasticity and recurrent
infections.
Spontaneous subdural effusions have been predomi-
nantly described in shaken baby syndrome, as a result of
tear at the bridging veins during shaking of the infant:
this was indeed the initial suspicion in this case. In the
metabolic field, they are associated with glutaric aciduria
type I. To our knowledge, this is the first described
PDHc deficiency case associated with acquired subdural
effusions.
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Gene expression profiling of thyroid mitochondria rich
tumours reveals a coordinated up-regulation of genes
involved in oxidative metabolism
O. Baris*, F. Savagner, V. Nasser, B. Loriod, S. Granjeaud,
S. Guyetant, B. Franc, P. Rodien, V. Rohmer, F. Bertucci, D.
Birnbaum, Y. Malthie`ry, R. Houlgatte, P. Reynier
INSERM E0018, CHU Angers, 4 rue Larrey, 49033 Angers,
France
olivier.baris@med.univ-angers.fr
Oncocytomas are a particular class of follicular thyroid
neoplasms associated with a high cellular richness in
functional mitochondria. In order to explore the mecha-
nisms triggering this mitochondrial accumulation, we
performed a gene expression profiling study of thyroid
oncocytic tumours.
The mRNA from 29 thyroid oncocytomas and 58 sam-
ples including normal thyroid, thyroid papillary carcinomas,
other thyroid pathologies, non thyroidal mitochondrial rich
tumours and human thyroid cell lines were analysed using
Nylon microarrays containing the PCR products for 6720
cDNA clones and radioactive labelling of the samples.
Analysis of the data set produced was performed using
supervised and unsupervised hierachical clustering.
These two approaches revealed two gene clusters specif-
ically overexpressed in thyroid oncocytomas and 163 genes
distinctly regulated between oncocytoma and normal thy-
roid. Differential expression for five genes (APOD, BCL-2,
COX, CTSB and MAP2) was confirmed at the protein level
using immunohistochemistry on 15 oncocytoma-normal
thyroid couples. The two oncocytic specific clusters were
rich in genes coding for mitochondrial proteins from both
mitochondrial and nuclear genomes. The increase in mito-
chondrial biogenesis was confirmed by the overexpression
EUROMIT 6 85of genes involved in this process, such as NRF-1 or NOS3.
Several genes involved in oxidative metabolic pathways
(glycolysis, tricarboxylic acid cycle and oxidative phosphor-
ylation) were up-regulated. Interestingly, the lactate dehy-
drogenase gene, involved in anaerobic metabolism, was
down-regulated in oncocytomas.
Our gene expression profiling of thyroid oncocytoma
revealed a coordinated overexpression of oxidative metab-
olism genes in these tumours. Our results suggest that,
unlike a majority of solid tumours, thyroid oncocytoma
produce energy through an aerobic pathway.
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Molecular mechanisms and biochemical consequences of
9205delTA mutation in ATP6 gene
P. Jesina*, M. Tesarova, D. Fornuskova, A. Vojtiskova, P.
Pecina, H. Hansikova, V. Kaplanova, J. Zeman, J. Houstek
Department of Bioenergetics, Inst. of Physiol. AS CR,
Videnska 1083, 14220 Prague-4, Czech Republic
paveljesina@seznam.cz
We have investigated a new case of mtDNA mutation,
2-bp-deletion TA at position 9205, in ATP6 gene that was
present at increasing load in a three-generation family
(blood-grandmother 16%, mother 82%, patient 98%). In
the affected boy with severe encephalopathy, a homoplas-
mic 9205delTA mutation was found also in fibroblasts and
skeletal muscle. Patient fibroblasts showed normal auro-
vertin-sensitive ATPase hydrolytic activity, 70% decrease
of ATP synthesis and 85% decrease of cytochrome c
oxidase (COX) activity. ADP-stimulated respiration and
ADP-induced decrease of mitochondrial membrane poten-
tial (state 4) were 50% reduced. Subunit a content was 10-
fold decreased compared to other ATPase subunits and
[35S]methionine labelling showed pronounced decrease in
subunit a biosynthesis. The content of COX subunits 1, 4
and 6c was 30–60% decreased. NB and QT/RT/PCR
analysis further demonstrated that the primary ATP6-
COX3 transcript is cleaved to ATP6 and COX3 mRNAs
two- to threefold less efficiently. Structural studies by
Blue-Native and 2D-electrophoresis revealed altered pat-
tern of COX assembly and instability of the ATPase
complex, which dissociated into subcomplexes. The results
indicate that 9205delTA mutation, which affects ATP6
gene STOP codon and the cleavage site between ATP6
and COX3 RNAs, prevents the synthesis of ATPase
subunit a and causes the formation of incomplete ATPase
complexes that are capable of ATP hydrolysis but not ATP
synthesis. Mutation also affects COX biogenesis that is
present in decreased amount. Interestingly, unchanged
RNA processing and only some accumulation of F1-
intermediate were found in the only other known case of
9205delTA with much milder clinical presentation.P-167
Mitochondrial ATPase 6 gene mutation in two brothers
with Leigh syndrome
P. Kowalski*, D. Piekutowska-Abramczuk, E. Popowska,
H. Mierzewska, M. Pronicki, E. Karczmarewicz, M. Kra-
jewska-Walasek, E. Pronicka
Department of Medical Genetics, The Children’s Memorial
Health Institute, Al. Dzieci Polskich 20, 04-730 Warsaw,
Poland
pkowalski@wp.pl
Leigh syndrome (LS) is a progressive neurodegenerative
disorder with variety in inheritance mode consisting of
autosomal recessive, autosomal dominant, X-linked or ma-
ternal trait. Leigh syndrome results from several defects of
mitochondrial oxidative phosphorylation including pyruvate
dehydrogenase complex, NADH-ubiquinone oxidoreduc-
tase, cytochrome c oxidase and ATP synthase.
We present two brothers with severe clinical symptoms
of Leigh syndrome. The first boy was hypotonic from the
neonatal period and showed failure to thrive, dissociated
eyes movements and developmental delay. At the age of 5
months he rapidly deteriorated during intercurrent infection
and died. Autopsy revealed gray and white matter spongi-
form degeneration with small vessel proliferation. The
second boy was slightly hypotonic but during first three
months his development seemed to be normal. At age of 4
months after intercurrent infection, failure to thrive, bizarre
movements of eye globes and progressive weakness began
to develop. He died at the age of 6 months. Biochemical
analysis revealed elevated lactate in serum and cerebrospi-
nal fluid. Muscle biopsy showed only mild lipid accumu-
lation. Brain CT revealed bilateral hypodensities in basal
ganglia.
Genetic study was performed on DNA isolated from dry
blood spots. Mitochondrial DNA and nuclear SURF1 gene
were examined to look for pathogenic mutations. PCR-SSCP
analysis excluded presence of any SURF1 mutations. Direct
sequencing of mtDNA showed presence of homoplasmic T-
to-G transversion at nucleotide position 8993 in the MTATP6
gene. The mutation resulted in change of a highly conserved
hydrophobic leucine-156 to a hydrophilic arginine in subunit
6 (ATPase 6) of mitochondrial ATP synthase.
Supported by EC-QLG1-CT-2002-90358.
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MitoScreena¨ Assay Kit, a novel approach for rapid
mutation screening of the entire mitochondrial genome
using multiplex DHPLC
M.Noyer-Weidner*, H. Lamb, L. Jures, S.Morrow, P. Krause
Transgenomic Ltd., Albrechtstr. 22, 10117 Berlin, Germany
mnoyer-weidner@transgenomic.com
EUROMIT 686Mutations of the mitochondrial genome are the cause of
various disorders. Many of them involve multiple organ
systems and present prominent neurological and/or myo-
pathic features. Development of diabetes type II is also
frequently observed. Mitochondrial DNA mutations have
further been associated with cancer and aging.
Denaturing High Performance Liquid Chromatography
(DHPLC) in combination with the WAVER System enables
automated mutation detection via heteroduplex analysis. This
technique is capable of providing high efficiencies when
scanning for unknown mutations. A further advantage is
the ability to detect small proportions of a mutant allele in a
wild-type population. This high level of sensitivity, which is
particularly relevant in revealing heteroplasmic mtDNA
mutations, has explicitly been documented in the context of
mtDNA mutation discovery(1).
We will show the development of a novel assay kit
facilitating the rapid, reliable and highly sensitive discovery
of mtDNA mutations using the WAVER System. Human
total DNA is used as template for amplification of the
mitochondrial genome using 19 primer sets. The resulting
overlapping fragments range in size from 300 to 1500 bp.
Four of these fragments can be used for conventional DHPLC
analysis. The remaining 15 fragments undergo a subsequent
restriction digestion step to produce a collection of fragments
that can be analyzed by multiplex DHPLC.
Results presented address the following aspects: purity of
primers for best PCR results, PCR protocol using a proof
reading polymerase (OptimaseR polymerase), restriction
conditions, influence of DNA template concentration.
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Complex I deficiency a central mechanism for energetic
depression at mitochondrial disorders, aging, sepsis,
cancerogenesis and intoxications
F. Gellerich*, Y. Chen, Z. Gizatullina, E. Seppet, S. Trum-
beckaite, M. Deschauer, M. Wussling, J. Holtz, T. Kuhnt, T.
Pelz, J. Dunst, S. Zierz
Neurologische Klinik der Martin-Luther-Universita¨t Halle
Wittenberg, Muskellabor, Ernst-Grube-Str. 40, D-06097
Halle, Sachsen-Anhalt, Germany
frank.gellerich@medizin.uni-halle.de
Due to the complexity of energy metabolism the relations
between mutation load, enzyme activity and functional def-
icits are not linear and often uncertain. The aim of the present
investigation was to detect complex I (CI) caused dysfunction
at different pathological states and to estimate the flux control
coefficients (Co) of CI in intact myoblasts at acute inhibition
by haloperidol.
Scaling the pyruvate-dependent respiration on the succi-
nate respiration measured in the same sample (SRPR), we
obtained a parameter which is sensitive to CI-changes but
independent of the amount of mitochondria. SRPRwas foundto be 120F 18% in normal human muscle and 123F 5% in
human atrium but reduced in muscle from patients with
mitochondrial cytopathies (CPEO 79F 21%, MELAS
100F%), in atrium of patients with fibrillation 100F 2%,
and in several tumors (21–64%). Similar changes we
detected in aged FISHER rats and in endothelial smooth
muscle cells after incubation with TNFa and endotoxin. All
these changes correlated with reduced activities of complex I
and I + III.
As a model for a defined decrease of complex I in living
cells we investigated the effect of haloperidol on intact
myoblasts. Haloperidol (50 mM) caused a 50% inhibition
of CI, increased Co of CI in intact cells from 0.13 to 0.46
and caused energetic depression as detected by impaired
Ca2 + signalling.
The large variety of hereditary and acute CI-related
impairments indicates that complex I is one central target
at mitochondrial diseases.
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In situ genotyping mitochondrial DNA suggests physical
clustering of pathogenic alleles as a factor influencing
segregation of mitochondrial point mutations in mitotic
cells
T. Raap*, M. Nilsson, K. Shuhai, G. Janssen, H. Vrolijk, T.
Maassen
Molecular Cell Biology, Leiden University Medical Center,
Wassenaarseweg 72, 2333 AL Leiden, The Netherlands
a.k.raap@lumc.nl
The mode of mitochondrial genome segregation in mitosis
is currently obscure, but of fundamental importance for
understanding the mechanism by which pathogenic muta-
tions are purged from the population, and how they may
become enriched in tissues of affected individuals. We have
applied an in situ genotyping approach to visualize and
quantify the distribution of pathogenic mtDNA variants
within and among cells from a heteroplasmic cybrid cell line.
By using padlock probes and fluorescence microscopy, we
show that the mutant variant can be readily distinguished
from the normal variant. We observed a high variability in
heteroplasmy level among cells, indicating a rapid bidirec-
tional drift from the initial heteroplasmy level of the founding
cell. Also intracellular clustering of the respective variants
was observed, which may underlie mechanisms of rapid drift.
P-171
Another patient with the T14487C mutation in mtND6:
severe movement disorder and Leigh-like syndrome
P. Freisinger*, R. Horva´th, C. Scharfe, K. Gerbitz, K.
Gempel, M. Jaksch
Metabolic Disease Center, Technical University, Ko¨lner
Platz 1, 80804 Muenchen, Germany
freisinger@lrz.tum.de
EUROMIT 6 87Very recently, a new mtND6 mutation, T14487C, was
described in four patients presenting with ataxia, dystonic
movements, severe spasticity and optic atrophy in two of
them. These symptoms were associated with Leigh-like
lesions on MRI. Here we describe another patient carrying
the same mutation. The leading symptoms of our patient
are dystonia, dysarthria, tremor and ataxia, which are
associated with spasticity and optic atrophy; however,
the mental functions are nearly normal. On muscle biopsy
no typical ragged red fibers were noted, however, sub-
sarcolemmal accumulation of enlarged mitochondria was
present. Biochemical measurement of respiratory chain
enzymes showed decreased activity of complex I. Se-
quencing of mtDNA identified a T14487C mutation in
ND6 with a high rate of heteroplasmy both in skeletal
muscle and leukocytes. This mutation was not detectable
in leukocytes of the mother. Our case confirms that
T14487C causes a Leigh-like syndrome, where the most
prominent features are dystonia and ataxia. Optic atrophy
is also present reminding of LHON plus dystonia symp-
tomatology caused by other mutations of the same ND6
gene. These findings suggest that mtND6 and particularly
the T14487C mutation should be studied in patients with
maternally inherited or spontaneous Leigh-like syndrome
and dystonia.
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Stimulation of mitochondrial activity induces
transformation and a defective myogenic phenotype
in human dermal fibroblasts
S. Grandemange
UMR 866, DCC, INRA, 2, place viala Bat 22, 34060
Montpellier, France
grandema@ensam.inra.fr
Mitochondrial dysfunctions are frequently reported in
tumor tissues, but their involvement in tumorigenesis
remains unclear. In this study, we have investigated the
influence of a mitochondrial stimulation induced by over-
expression of triiodothyronine (T3) receptors on human
dermal fibroblasts.
Cells were stably transfected with an expression vector
encoding nuclear (c-ErbAa1) and mitochondrial (p43) T3
receptors. Two clones (MT1 and MT2) were selected. We
found that only p43 was synthesized and specifically
addressed to mitochondria, leading to an increase in
organelle activity. In contrast to control cells, these clones
displayed strong morphological changes, fused into mul-
tinucleated structures and expressed muscle specific genes
(Myf 5, b-myosin, connectin, AchRa). Moreover, MT1
and MT2 cells displayed all features of transformation: (i)
serum or anchorage-independent growth; (ii) loss of
contact inhibition; (iii) tumorigenicity in vivo. This trans-
formed phenotype was associated to a rise in c-Jun andc-Fos expression, and a strong inhibition of the expres-
sion of tumour suppressor genes sensitive to methylation
(p53, p21, Rb). Lastly, DNA methyltransferase activity
and ROS production were increased in correlation to
mitochondrial activity.
Inhibition of mitochondrial activity resulted in a partial
restoration of the normal phenotype, with the loss of ability
to fuse, a strong decrease in muscle-specific gene expres-
sion, and an inhibition of the transformed phenotype.
However, expression of tumour suppressor genes was not
restored.
In conclusion, stimulation of mitochondrial activity in
human dermal fibroblasts induces cell transformation
through events involving ROS production and stimulation
of DNA methylation.
P-173
Application of the yeast Yarrowia lipolytica as a model to
analyse human pathogenic mutations
S. Kerscher*, A. Garofano, L. Grgic, U. Brandt
Biochemie I, Uniklinik Frankfurt, Theodor-Stern-Kai 7,
60590 Frankfurt, Germany
kerscher@zbc.kgu.de
We have used the obligate aerobic yeast Yarrowia
lipolytica to reconstruct and analyse human pathogenic
mutations in nuclear-coded subunits of mitochondrial
complex I. Homozygosity for an exon 2 skipping muta-
tion in the NDUFV2 (24 kDa) gene had been found to
cause hypertrophic cardiomyopathy and encephalomyop-
athy. Although the mitochondrial targeting sequence was
partially deleted, mitochondrial import was not complete-
ly abolished. After reconstruction in Y. lipolytica, isolated
mutant enzyme was indistinguishable from parental com-
plex I with regard to activity, inhibitor sensitivity and
EPR signature. Size and isoelectric point were altered,
indicating that the residual targeting sequence was
retained on the mature 24 kDa protein. Homozygosity
for substitution V122M in NDUFS7 (PSST) and hetero-
zygosity for substitutions P79L and R102H in NDUFS8
(TYKY) had been found to cause Leigh syndrome. After
reconstruction in Y. lipolytica, mitochondrial membranes
from all three mutant strains exhibited similar complex I
defects, with Vmax being reduced by about 50%. In
addition, changes in the KM for n-decyl-ubiquinone and
in the I50 values for hydrophobic complex I inhibitors
were observed. Mutations in the NDUFS2 (49-kDa
subunit) gene had been found to cause cardiomyopathy
and encephalomyopathy. After reconstruction in Y. lip-
olytica, mitochondrial membranes from mutants R228Q
and S413P showed no differences to wild type with
regard to KM, Vmax, and temperature stability, whereas no
assembly of complex I was found in mutant P229Q.
These results reveal that functionally critical regions in
EUROMIT 688many cases are conserved between mammalian and
fungal complex I.
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Two novel mutations in the mitochondrially encoded
ATPase 6 gene
A.-R. Moslemi
Pathology, Gothenburg University, SS/Gula Straket 8, S-413
45 Go¨teborg, Sweden
ali-reza.moslemi@pathology.gu.se
Human ATP synthase, complex V, contains a catalytic
domain (F1) and a proton channel domain (F0). The F0
domain comprises nine subunits including the mitochondrial
DNA (mtDNA) encoded ATPase 6 and 8. Pathogenic
mutations in ATPase 6 leading to partial complex V defi-
ciency have been described in several neurological diseases,
e.g. Leigh syndrome (LS). Here we have analysed the
ATPase 6 and 8 genes in two children with LS. Biochemical
analysis showed a clear reduction of ATPase activity in
muscle mitochondria of both patients. Mutational analysis
of ATPase 6 and 8 revealed a maternal inherited hetero-
plasmic T!C substitution (T9185C) in the ATPase 6 gene
of patient 1, resulting in a substitution of a leucine to proline
(L220P). The proportion of the mutation in the patient’s
blood and muscle was >96%. It was 85% in a blood sample
of his asymptomatic mother. Patient 2 exhibited a novel and
nearly homoplasmic T9191C missense mutation in the
ATPase 6 gene, which changed a highly conserved leucine
to proline (L222P) of the polypeptide. The functional
consequences of the T9185C mutation have been previously
shown in E. coli to cause reduction of ATP synthesis. The
novel T9191C mutation in patient 2 may have similar
functional consequences as the T9185C, since both the
mutations are located in the same region of the polypeptide
and result in the same type of amino acid substitution
(L! P). Our findings expand the spectrum of mutations
causing LS and furthermore emphasize the role of ATPase 6
gene mutations in pathogenesis of LS.
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Measurement of ATP synthesis in fibroblasts from
patients with mitochondrial disorders
F. Wibrand*, E. Ostergaard
Department of Medical Genetics, John F Kennedy Institute,
Gl. Landevej 7, 2600 Glostrup, Denmark
flw@kennedy.dk
Decreased ATP synthesis in fibroblasts is considered one
of several diagnostic criteria for respiratory chain (RC)
disorders. To investigate the diagnostic value of this func-
tional assay, we have measured ATP synthesis rates infibroblasts from patients with suspected or proven RC
deficiency or pyruvate dehydrogenase (PDH) E1-alpha
deficiency. The rates of ATP synthesis were determined in
digitonin-permeabilized cells using pyruvate +malate, glu-
tamate +malate and succinate as substrates. Fibroblasts from
patients with isolated cytochrome c oxidase deficiency had
significantly lower ATP synthesis rates with all substrates
compared to the controls. PDH-deficient fibroblasts had
decreased ATP synthesis rates with pyruvate +malate when
expressed relative to the rates with glutamate +malate or
succinate. Fibroblasts from patients with other isolated or
combined RC deficiencies showed more variable results;
some had low ATP synthesis rates and others had normal
rates. In a few cases, decreased ATP synthesis rates in
fibroblasts were found in patients with normal RC enzyme
activities. Our data confirm the usefulness of the ATP
production assay as a supplementary diagnostic tool for
mitochondrial disorders.
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Heart transplantation in a patient harboring the mtDNA
3271T>C mutation
L. Vilarinho*, C. Pereira, C. Nogueira, M. Pinon, E.
Martins, M. Maciel, E. Lea˜o-Teles
Clinical Biology, Medical Genetics Institute, Praca Pedro
Nunes, 88, 4099-028 Porto, Portugal
laura.vilarinho@igm.min-saude.pt
Dysfunction of mitochondria can affect any organ sys-
tem, though tissues such as mucle, heart, and brain are more
susceptible to oxidative phosphorylation (OXPHOS) defects
because of their high-energy requirement.
We identified the 3271T>C mtDNA mutation (‘‘MELAS
mutation’’) in the explanted heart from a 15-year-old Por-
tuguese girl presenting with dyspnea and marked asthenia
after mild exercise in the past months. She had had
echocardiographic features of dilated cardiomyopathy with
severe dysfunction of left ventricle which were confirmed
upon an endomyocardiac biopsy. The central nervous sys-
tem was not affected. After cardiac transplantation, she
presented generalized tonic-clonic seizures with respiratory
arrest. The patient was on a comatous state with frequent
episodes of status epilepticus.
Morphological studies and biochemical analyses of
OXPHOS activities in skeletal muscle biopsy were normal.
Seven months after transplantation, a brain MRI revealed
alterations compatible with a mitochondrial disease.
mtDNA analysis in a paraffin-embedded heart fragment
showed the heteroplasmic 3271T>C mutation. Molecular
studies in blood from five maternal relatives and in muscle
from the patient showed different levels of the mutation.
Conclusion: This case reinforces the notion that dilated
cardiomyopathy can be the presenting and predominant
clinical expression of the mtDNA 3271T>C mutation.
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Directly repeated motifs occur more often than expected
in mtDNA
L. Pereira*, A. Goios, C. Nogueira, C. Pereira, L. Vilarinho,
A. Amorim
Population Genetics, IPATIMUP, R. Dr. Roberto Frias s/n,
4200-465 Porto, Portugal
lpereira@ipatimup.pt
Rearrangements on the human mtDNA molecules are to
blame for a great variety of pathological states that result from
the dysfunction of the respiratory chain and the failure to
retrieve cellular energy. They are either deletions, duplica-
tions or inversions of parts of the molecule within a pair of
breakpoints that frequently appear as short, directly repeated
(DR) sequences of up to 13 bp. Probable mechanisms for the
rearrangements are illegitimate recombination and replica-
tion slippage.
We surveyed the CRS mtDNA molecule in search for
DR, using the DknSet program. An astonishing value of
158255 DR from 5 bp onwards was obtained, with relative
proportions of: 5 bp—71.570%; 6 bp—21.135%; 7 bp—
5.900%; 8 bp—1.695%; 9 bp—0.500%; 10 bp—0.156%;
11 bp—0.031 bp; 12 bp—0.010%; 13 bp—0.003%; 14
bp—0.001%; and 15 bp—0.001%.
We then generated three assays of random sequences
with the same size and base composition as the CRS. The
mean DR distribution of the random assays was significant-
ly different from the distribution of the CRS (P= 0.0011;
S.E. = 0.00106), the random sequence harbouring systemat-
ically a lower number of DRs (average 143171). In contrast,
comparing the human and the chimpanzee mtDNA sequen-
ces, the DR distributions were not significantly different
(P= 0.57502; S.E. = 0.04510).
Therefore, Homo and Pan sequences carry a significantly
higher number of DRs than expected by chance. Further-
more, since all DR motifs, irrespectively of their length,
appear to be evenly overrepresented, the excess cannot be
attributed to any kind of codon based bias. It is thus more
tempting to hypothesise that higher order molecular strin-
gencies relevant to mtDNA spatial structure do shape
sequence features of the molecule.
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Reconstitution of the mammalian mitochondrial DNA
replisome in vitro
M. Falkenberg-Gustafsson*, J. Korhonen, X. Pham,
M. Pellegrini
Medical Nutrition, Karolinska Institutet, Novum, KUS-Hud-
dinge, SE-141 86 Stockholm, Sweden
maria.falkenberg-gustafsson@mednut.ki.se
We here reconstitute the mammalian mitochondrial
DNA (mtDNA) replisome in vitro. The mtDNA poly-merase (POL?) cannot use double-stranded DNA
(dsDNA) as template for DNA synthesis. Similarly, the
TWINKLE DNA helicase is unable to unwind longer
stretches of dsDNA. In combination, POL? and TWIN-
KLE form a processive replication machinery, which can
use dsDNA as template to synthesize single stranded
DNA molecules of about 2 kb. The addition of the
mitochondrial single-stranded DNA binding protein stim-
ulates the reaction further, generating DNA products of
about 16 kb, the size of the mammalian mtDNA mole-
cule. The observed DNA synthesis rate is 180 base pairs
per minute, corresponding closely to the previously
calculated value of 270 base pairs per minute for in
vivo DNA replication. Our findings provide the first
biochemical evidence that TWINKLE is the helicase at
the mitochondrial DNA replication fork. Furthermore,
mutations in TWINKLE and POL? cause autosomal
dominant progressive external ophthalmoplegia (adPEO),
a disorder associated with deletions in mitochondrial
DNA. The functional interactions between TWINKLE
and POL? thus explain why mutations in these two
proteins cause an identical syndrome.
P-179
Shifting mitochondrial DNA heteroplasmy by
mitochondrially targeted restriction endonucleases
M. Bayona*, B. Blits, B. Battersby, A. Shoubridge,
T. Moraes
Neurology, University of Miami, 1095 Nw 14th Terrace,
33136 Miami, FL, USA
pbayona@miamiproject.med.miami.edu
In a heteroplasmic environment, the wild-type
mtDNA fraction has a strong protective effect, and
cellular defects are only observed in the presence of
very high percentages of mutated mtDNA. We have
developed a system to decrease specific mtDNA haplo-
types by expressing mitochondrially targeted restriction
endonucleases in vivo. Such system has the potential to
reduce a mutated mtDNA fraction, if a restriction
endonuclease site is created by a pathogenic nucleotide
alteration. As a model system, we used hepatocytes from
heteroplasmic mice harboring mtDNA from both BALB
and NZB haplotypes. Among several nucleotide varia-
tions, these haplotypes differ by the absence of ApaLI
sites in the NZB mtDNA and the presence of a single
site in the BALB mtDNA. Transfection of mitochond-
rially targeted ApaLI in these cells resulted in a rapid
shift in heteroplasmy towards the NZB mtDNA. To
better understand the timing of heteroplasmy shift, we
placed the mitochondrially targeted ApaLI gene in a
vector system inducible by mifeprestone (RU486). We
have analyzed the kinetics of heteroplasmy shift. Heter-
oplasmic hepatocyte clones containing the inducible
EUROMIT 690construct treated with mifeprestone showed a complete
shift in heteroplasmy and became homoplasmic for the
NZB mtDNA in less than 24 h. We also detected a fast
recovery of mtDNA depletion caused by the induction
of the system. These results indicate that the hetero-
plasmy shift triggered by mitochondrially targeted re-
striction endonucleases is extremely fast and specific.
We are currently testing the system in a live animal,
using infection with AAV in different tissues of hetero-
plasmic mice.
P-180
Automatic analysis of variability in the mitochondrial
DNA from human cell lines: implications in functional
genomics
G. Perez*, C. Lopez, J. Enriquez, S. de Cordoba
Centro de Investigaciones Biologicas (CSIC), Avda. Ramiro
de Maeztu nj 9, 28040 Madrid, Spain
egallardo@cib.csic.es
Cell lines as experimental models in biology have
been used for a long time. Nowadays, is well known that
mitochondrial DNA (mtDNA) play an important role in
cancer, apoptosis, and neurodegenerative diseases. How-
ever, no detailed analysis of variability in the mtDNA of
human cell lines used in a routine way as experimental
models of these processes has been done.
In this study, the complete mitochondrial genome of
13 human cell lines related to cancer, apoptosis, and
neurodegenerative diseases has been analysed. For this
purpose, a relatively simple and quick approach for
automating the detection of sequence variants in human
mtDNA has been developed. This approach involves the
simultaneous generation and purification of 24 overlap-
ping PCR fragments of 800–1000 bp length in a
multifunctional robot followed by their automatic se-
quencing. The assembling of sequences and identification
of variations has been carried out using specialised
software.
Among the 13 cell lines sequenced 186 variations
from the Cambridge sequence reference were identified.
Five cell lines had no apparent functionally significant
mutations, i.e., all found sequence variations were previ-
ously described polymorphisms, whereas each of the
remaining eight cell lines harboured at least one new
variant of the coding sequence. Functional analysis of
these variations, currently in progress, suggests impaired
oxidative phosphorylation activity.
In summary, we report an automatic approach for
quickly detecting and generating mtDNA variability data.
In addition, we show that human cell lines present high
variability in their mtDNA which might represent a useful
tool in the functional genomic analysis of the mitochon-
drial genome.P-181
A frameshift mutation leading to an unstable mRNA
in a boy with dihydrolipoamide dehydrogenase (E3)
deficiency
M. Brivet*,1, M. Mine´1, J. Berthelot2, G. Simard3, A. Slama1
1Laboratoire de biochimie, AP-HP hoˆpital de Biceˆtre, 78,
rue du general leclerc, 94270 Kremlin Biceˆtre, France
2Service de ge´ne´tique, CHU d’Angers, France
3Laboratoire de biochimie, CHU d’Angers, France
michele.brivet@bct.ap-hop-paris.fr
Dihydrolipoamide dehydrogenase (E3) is a component of
the pyruvate dehydrogenase complex (PDHc), the alpha-
ketoglutarate dehydrogenase complex and the branched-
chain alpha-keto acid dehydrogenase complex. A boy from
non-consanguineous parents was diagnosed with E3 defi-
ciency. He presented at day 4 with hypotonia, metabolic
acidosis (pH 6.99, lactate 16.2 mM, elevated lactate/pyruvate
ratio), ketonuria, 2-oxoglutaric and 2-OH isovaleric aciduria.
Plasma branched-chain amino acid levels were normal. After
a transient improvement, a fatal metabolic decompensation
occurred at 3 months. Decreased activities of PDHc and E3
were found in fibroblasts (20% and 5% of controls, respec-
tively). Western blot analysis using a specific anti-E3 anti-
body displayed a barely detectable E3 subunit, comparing to
the immunoreactivity of control E3 and all the other PDHc
subunits. cDNA sequencing analysis revealed only a homo-
zygous transition, 1174 G>A (V392M) in exon 11. This
mutation was found heterozygous in exon 11 genomic DNA
and inherited from the father. An unstable mRNA species was
then suspected in the patient, corresponding to the other
allele. Sequencing of the 14 exons and exon–intron bound-
aries enabled us to find the second heterozygous mutation:
858_859insT (287fs290X) in exon 9, inherited from the
mother. As this mutation created a premature stop codon, a
mechanism of nonsense mRNA decay may be suggested to
explain the unstability of the corresponding mRNA.
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Cultured cell phenotypes of patients with Twinkle and
POLG mutations
M. Lampinen*, H. Tyynismaa, K. Ahlqvist, A. Suomalainen
Programme of Neurosciences, Biomedicum-Helsinki, Haart-
maninkatu 8, 63, 00290 Helsinki, Finland
milla.lampinen@hus.fi
Defects of the new mitochondrial DNA helicase Twinkle
and polymerase gamma (PEO-proteins) cause autosomal
recessive or dominant progressive external ophthalmoplegia
(PEO) associated with various muscle and nervous system
symptoms, such as polyneuropathy, depression, ataxia and
parkinsonism. Our aim was to determine the functional
consequences of PEO-protein defects in cultured human
primary fibroblasts and myoblasts, as well as in retroviral-
EUROMIT 6 91transduced cell lines expressing mutant and wild-type
PEO-proteins.
We studied the levels of the PEO-proteins and their
RNAs in native state in control and patient lines, carrying
a 39-bp duplication-mutation of Twinkle, as well as domi-
nant POLG lines with Y955C and R953C mutations. We
also followed the expression of Twinkle, POLG, POLG2
and other mitochondrial proteins in induced oxidative stress
by quantitative PCR. We also studied the viability of the
cells in induced oxidative stress and when exposed to DNA
alkylating agents. We studied the DNA-repair system of the
mitochondria in the patient cells, as well as the consequen-
ces of the expression of the mutant proteins.
We present here functional data supporting the role of
Twinkle as a replication helicase, as well as data describing
the cellular phenotype of mutant Twinkle and polymerase
gamma.
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The Harlequin mouse: a faithful mouse model for Hu-
man complex I deficiency
P. Be´nit*,1, N. Vahsen2, J. Brie`re1, P. Rustin1, G. Kroemer2
1INSERM U393, Hoˆpital Necker-Enfants Malades, 149 Rue
de Sevres, 75743 Paris, France
2CNRS-UMR8125, Institut Gustave Roussy, 94805 Villejuif,
France
benit@necker.fr
Upon a variety of either physiological or adverse con-
ditions, mitochondria release intermembrane space proteins
prone to trigger cellular apoptosis. Besides being pro-apo-
ptotic effectors, these proteins may hold additional and yet
apparently unrelated function, e.g. electron transfer for cyto-
chrome c. In an attempt to characterize such a potential
function for AIF (Apoptosis Inducing Factor) protein, we
discover that a variety of conditions where AIF expression is
either absent or strongly reduced lead to a severe complex I
deficiency and abnormal subunit composition of this latter
complex (Vahsen et al., submitted for publication). Two years
ago, Klein and colleagues [Nature 419 (2002) 367] showed
that the Harlequinmouse has reduced AIF expression due to a
proviral insertion in the AIF gene. The insertion resulted in an
80% decreased AIF protein and a simultaneous oxidative
stress. AIF-depleted Harlequin mice develop progressive
neurological involvement with optic neuropathy and retinal
degeneration. We therefore studied respiratory chain activity
in the Harlequin mouse, and found profound complex I
deficiency in affected tissues. Complex I activity was partic-
ularly decreased in the retina, in agreement with the retinal
degeneration observed in this mouse. The function of AIF in
the biogenesis/maintenance of complex I is still to be clari-
fied. However, the progressive neurological deterioration,
with optic involvement, and the late onset cardiomyopathy
are strongly reminiscent of the clinical symptoms associatedwith complex I deficiency in human. This makes Harlequin
mouse model the first faithful model for complex I deficiency
which will be used to test for therapeutic compounds.
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Screening for mutations in DGUOK in patients with
mitochondrial DNA depletion
P. Briones*, A. Navarro-Sastre, A. Playan, E. Lopez-Gal-
lardo, J. Montoya, L. Yanes, M. Ruiz-Pons, J. Campistol,
M. Pineda, M. Vilaseca, A. Ribes
Institut de Bioquı´mica Clı´nica-CDB, Corporacio´ Sanita`ria
y CSIC, Ed. Helios III-c/mejı´a Lequerica s/n, 08028 Barce-
lona, Spain
pbriones@clinic.ub.es
Mitochondrial DNA depletion syndrome (MDS) are a
group disorders characterised by a reduction in the mtDNA
copy number. The myopathic form of MDS has been asso-
ciated to mutations in the thymidine kinase 2 gene (TK2), and
the hepathocerebral form to deoxyguanosine kinase
(DGUOK).
As most of our patients presented the hepathocerebral
form, we started with the study of DGUOK. We selected 26
patients with the clinical and biochemical characteristics of
hepatocerebral MDS. In 18/26, mtDNA depletion was dem-
onstrated in one or more tissues by Southern blot. DGUOK
was studied in genomic DNA by PCR and sequencing.
We have found mutations in three families. Patient 1 was
homozygous for 763dupGATT, a mutation previously
reported by Salviati et al. (2002). In addition, we have
identified a new mutation which is present in homozygous
form in four patients of two unrelated families. The new
mutation (c677 A>G) changes histidine 226 to arginine
(H226R). It is present in heterozygous form in the parents,
but was absent in 100 control alleles. Histidine 226 is highly
conserved between species and between different deoxynu-
cleotide kinases; and its substitution for arginine would
provoke a change in the hydrophobicity leading to incorrect
conformation of the protein.
Our results have important consequences for the affected
families, who may now apply for prenatal diagnosis in future
pregnancies. Nevertheless, only a part of our patients pre-
sented mutations in DGUOK. Therefore, it is necessary to
further investigate other genes and mechanisms that may be
implicated in the disease.
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Mitochondrial saponin permeabilisation prior to
measurement of complex I activity
R. Wibom*, U. von Do¨beln
Department of Laboratory Medicine, Centre for Inherited
Metabolic Diseases, Karolinska University Hospital (Hud-
dinge), S-141 86 Stockholm, Sweden
rolf.wibom@hs.se
EUROMIT 692In measurements of complex I and complex I + III
activities, it is a challenge to sufficiently permeabilise the
mitochondrial inner membrane to give NADH full access to
its binding site at the matrix side of complex I without
disrupting the integrity of the respiratory chain complexes.
Common published values for complex I and complex I + III
activities in isolated mitochondria range from 0.1 to 0.5
mmol/min/g protein (35 C). These values are apparently low
when compared to oxymetric measurements of coupled
oxidation of NADH-linked substrates or uncoupled oxida-
tion of NADH, indicating turnover rates in the respiratory
chain that are nearly one magnitude higher. A possible
reason for the discrepancy is lack of an adequate sample
preparation method prior to the measurements of the single
enzyme complex activities. Saponin, a detergent extracted
from Quillaja bark, was found to effectively permeabilise
mitochondria. Unlike other detergents, the integrity of the
respiratory chain enzymes appears to be maintained after the
saponin treatment. We developed a quick and straightfor-
ward preparation procedure resulting in complex I and
complex I + III activities that are well in level with the
turnover rates derived from oxymetric measurements. The
procedure has been used for a while in our laboratory, and
has been approved to detect patients with mitochondrial
disorders and to deliver reliable results in several inves-
tigations of mitochondrial function. In conclusion, the
improved preparation procedure leads to a considerable
reduction of the sample size needed for the analysis, and
probably also to a higher accuracy and precision in the
measurements.
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Mitochondrial DNA depletion in asymptomatic
HIV-infected patients receiving didanosine plus
stavudine-based antiretroviral regimen seems to be
compensate by up-regulatory mechanisms
S. Lopez*, G. Garrabou, M. Rodrı´guez de la Concepcio´n1,
E. Martı´nez2, E. Pedrol3, M. Giralt1, F. Cardellach, J.
Gatell2, F. Vilarroya1, J. Casademont, O`. Miro´
Mitochondrial Research Laboratory, Muscle Research Unit,
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BAPS, Villarroel 170, 08036 Barcelona, Spain
1Department of Biochemistry and Molecular Biology, Uni-
versity of Barcelona, Spain
2Department of Infectious Diseases. Hospital Clı´nic, IDI-
BAPS, Barcelona, Spain
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Hospital-Asil de Granollers, Granollers, Catalonia, Spain
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Objective: The use of nucleoside analogues is uniform-
ly associated with mitochondrial DNA (mtDNA) deple-
tion, but diverse studies in asymptomatic patients have
reported functional indemnity of mitochondria. We deter-mined whether homeostatic mechanisms are able to com-
pensate this mtDNA depletion in patients receiving
stavudine plus didanosine (d4T + ddI), an antiretroviral
association with great in vitro and in vivo capacity to
decrease mtDNA.
Design: A prospective, cross-sectional study with cases
and controls.
Methods: We included 28 symptom-free HIV-infected
individuals: 17 on first-line antiretroviral regimen consisting
of d4T + ddI for at least 6 months (case group) and 11 naı¨ve
subjects (control group). In peripheral blood mononuclear
cells we assessed: (1) the quantity of mitochondria by citrate
synthase activity, (2) the content of mtDNA by quantitative
real-time PCR, (3) COX-II expression (subunit II of cyto-
chrome c oxidase (COX), encoded by mtDNA) by Western
blot, and (4) COX activity by spectrophotometry.
Results: The quantity of mitochondria and the mtDNA
content of cases (d4T + ddI) were decreased when compared
to controls, whether calculated by cells or by mitochondria.
The expressions of COX-II and COX activities were similar
in cases and controls. The expression of COX-II was found
to be constant and independent of the mtDNA content, but
was closely related to COX activity.
Conclusions: Decreased mitochondrial mass and mtDNA
content are associated with ddI + d4T treatment, but the
expression of COX-II and COX activity remains unaltered.
These data suggest that, at least during the initial phases of
treatment, up-regulatory transcriptional or posttranscription-
al mechanisms compensate mtDNA depletion caused by
ddI + d4T.
P-187
Novel mt-tRNA mutations present in two patients with
sensorineural hearing loss
T. Nogueira*, C. Nogueira, C. Pereira, L. Vilarinho,
F. Santorelli
Unidade de Biologia Clı´nica, Instituto de Gene´tica Me´dica,
Praca Pedro Nunes, 88, 4050-466 Porto, Portugal
teresa.nogueira@igm.min.saude.pt
In a study of 70 Portuguese patients with sensorineural
hearing loss (SNHL), we identified two novel mtDNA
mutations.
Case 1: A 12-year-old boy harbors a new 5558A>G
mutation in the tRNATrp. The mutation affects the
highly conserved nucleotide A49 at the bottom of the
T psi C stem. This mutation is strongly suspected of
being pathogenic as it probably destabilizes the tRNA
secondary structure, compromising either the tRNA af-
finity for its cognate aminoacyl-tRNA synthetase or its
placement at the A-site of the ribosome, during transla-
tional decoding. MtDNA haplotyping indicates that this
patient belongs to the U haplotype, typical of the Iberian
population.
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mutation in the tRNAAla gene affecting the conserved A41
nucleotide in the anticodon stem. This mutation is also
potentially pathogenic in that it might destabilize the anti-
codon arm, and affect the tRNAAla folding, via the loss of
the interactions with both the D-arm and the variable arm.
Interestingly, this patient also harbors the 10044A>G mu-
tation in the tRNAGly, which is rarely observed ( < 0.5%) in
the normal population.
Both novel mutations were not found in 100 ethnically
matched controls.
On the whole, our study suggests that seeking genetic
alterations in SNHL patients may add to the variegate array
of changes in the mitochondrial genome.
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Replication intermediates of human mtDNA in cell lines
J. Poulton
Nuffield, Department of Obstetrics and Gynaecology, Uni-
versity of Oxford, John Radcliffe Hospital, Headington,
OX3 9DU Oxford, United Kingdom
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We have studied mtDNA synthesis in intact cells
using saponin permeabilisation followed by pulse label-
ing with 32P-dTTP [Nucleic Acids Res. 29(2) (2001)
E1], restriction digestion and size separation on one-
dimensional agarose gels. After Southern blotting the
newly synthesized mtDNA in each band can be quanti-
tated using a phosphorimager. Corresponding unlabelled
DNA in the same band can be quantitated after probing
with a mtDNA probe.
We detected transient mitochondrial DNA (mtDNA)
forms in pulse-labeled mtDNA samples, which were not
readily detectable in unlabelled cells. Analysis of these
forms using restriction enzyme and S1 digestion suggests
that these species represent paused replication intermediates.
These results have implications for the mechanism(s) of
human mtDNA replication [J. Biol. Chem. 278(51)
(2003)50961; Trends Biochem. Sci. 28(7) (2003) 357].
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Mitochondrial oxidative capacity in the atrophied rat
skeletal muscle: effect of acetyl-L-carnitine
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The impact of acetyl-L-carnitine (ALCAR) administra-
tion on the expression profile of atrophying rat soleus
muscle as induced by 14 days of hindlimb suspension
was investigated. ALCAR was provided ad libitum to a
group of control and hindlimb suspended animals (n = 7)
and ALCAR-untreated control and suspended groups were
housed under the same condition. ALCAR effects were
monitored through a microarray approach using commer-
cially available ATLASTM Rat 1.2 cDNA filters. The
statistical method to detect differentially expressed genes
relied on L1 regression on all possible permutations of
scatter plots of raw values combined with the conservative
Bonferroni method to correct the type I error. Statistical
significance was assessed at P < 0.05.
No difference in soleus weight normalized to body mass
was noted between ALCAR-treated and untreated groups.
Both hindlimb suspended groups underwent a drop in the
soleus muscle ( 21%) compared to the respective control
groups. ALCAR was very effective on fatty acids transport
and oxidative metabolism. The decrease in mitochondrial
muscle carnitine palmitoyltransferase I isoform with the
unloading was prevented with ALCAR dietary. As far as
the oxidative phosphorylation metabolism, both nuclear
(COX IV, Vb, VIII-H) and mitochondrial (COX I) cyto-
chrome oxidase subunits were up-regulated with nutritional
intervention. The results indicate that nutraceuticals admin-
istration to unloaded atrophied rat muscle is able to modu-
late the expression of genes involved in mitochondrial
oxidative capacity, improving the fatty acid import as well
as the cytochrome oxidase subunits. These findings could
suggest a potential role of ALCAR in the therapeutical
treatment of muscle disuse conditions as bed rest, immobi-
lization or aging itself.
P-190
Entire mtDNA sequence analysis in Russian LHON
family
N. Povalko*, E. Zakharova, Y. Akita, J. Nishioka, Y. Koga
Pediatrics, Kurume University, 67 Asahi-machi, 830-0011
Kurume, Japan
npovalko@med.kurume-u.ac.jp
EUROMIT 694Introduction: Leber’s Hereditary Optic Neuropathy
(LHON) is a mitochondrial genetic disease that preferen-
tially causes blindness in young adult males. It is charac-
terized by acute or subacute loss of central vision due to
focal degeneration of the retinal ganglion cell layer and
optic nerve. More than 30 mutations of mitochondrial
DNA have been associated with LHON patients but only
three ‘‘primary’’ mutations may contribute in a major way
to the development of blindness: G3460A, G11778A,
T14484C. Other ‘‘secondary’’ mutation may contribute in
LHON by increasing the probability of expressing the
phenotype.
Patients and methods: We analyzed mtDNA of two
patients—mother and son which have the primary mutation
T14484C. DNA was purified from blood by standard
methods. Entire mtDNA was sequenced after long-range
PCR followed by automated sequencer (Beckman-Coulter
CEQ8000). After we have sequence information, we eval-
uated by PCR-RFLP analysis.
Results: We found following secondary mutations
T4216C, G13708A, and G15812A of mtDNA in both
mother and son. However, we found additional second-
ary mutation G15257A of mtDNA in mother. Majority
of nonpathogenic polymorphism have seen in both
patients.
Conclusion: According to our sequencing date, we may
suggest that mtDNA is not always transmitted completely in
disease state.
P-191
Mitochondrial DNA mutations in ragged red fibers of
healthy individuals of different age
P. Cantatore*, A. Cormio, F. Milella, J. Vecchiet, G. Felzani,
M. Gadaleta
Department of Biochemistry and Molecular Biology, Uni-
versity of Bari, Via Orabona 4, 70125 Bari, Italy
p.cantatore@biologia.uniba.it
In order to get insights on the mechanisms of forma-
tion of ragged red fibers in human skeletal muscle during
aging, we analyzed the mitochondrial genotype of single
skeletal muscle fibers of 15 healthy individuals having an
age comprised between 45 and 92 years. The sequencing
of the D-loop region showed many sequence changes with
respect to the Cambridge Reference Sequence, in both
RRF and normal fibers. These changes were more abun-
dant in RRF and their number increased between 50–60
and 60–70 years and then remained approximately con-
stant. Each subject contained one or more changes asso-
ciated to RRF in positions of D-loop region that either do
not change or that change very rarely. In general, the
same type of RRF-associated change was not found in
more than one individual; exceptions were changes in
positions 189, 295, 374 and 514, detected in 20–50% ofanalyzed subjects. In particular, the A189G age-associated
mutation was found only in old individuals and preva-
lently in RRF. Sequencing of other two mtDNA regions
showed no relevant changes in the 16S/ND1 region and
two RRF-associated original mutations, G5847A and
A5884C, in two very conserved positions of tRNATyr.
These results indicate that each subject has its own pattern
of RRF-associated sequence changes in both coding and
non-coding region of human mtDNA. Mutations in the
coding region might impair mitochondrial function,
whereas changes in the D-loop might affect mtDNA
replication rate and might produce large-scale deletions
due to strand slippage during mtDNA replication of
mutated molecules.
P-192
Presence of complex V subcomplexes in the patients with
oxphos defects
R. Van Coster*, J. Smet, B. de Paepe, W. Lissens, S. Seneca,
L. De Meirleir
Pediatric Neurology and Metabolism 1K6, University Hos-
pital Ghent, De Pintelaan 185, 9000 Ghent, Belgium
rudy.vancoster@ugent.be
The oxidative phosphorylation (OXPHOS) generates
ATP through passage of electrons along the four com-
plexes of the respiratory chain (I–IV) in the mitochondrial
inner membrane. ATP synthase (complex V) is a multi-
subunit enzyme consisting of a catalytic portion (F1), a
membrane portion (F0) and two stalks linking F1 and F0.
Using Blue Native Polyacrylamide Gel Electrophoresis and
subsequent catalytic staining for ATPase, only one band
corresponding to complex V was detected in most of the
patients. In nine patients, however, in addition to the
normal band, complex V subcomplexes with lower molec-
ular weight were detected. This phenomenon was seen in
skeletal muscle (two patients), liver (three patients) and in
cultured skin fibroblasts (four patients). A severe, com-
bined deficiency of OXPHOS complexes (I, III, IV and V)
together with normal activity of complex II was seen in
two patients, and a less severe, combined deficiency (I and
IV) in four patients. Two of the latter patients were carriers
of a MERRF point mutation. In three patients no other
defects of OXPHOS complexes were found. The exact
cause of incomplete complex V synthesis, or decreased
stability, is not known. One likely hypothesis is a defective
intramitochondrial protein synthesis. The associated find-
ing of a combined OXPHOS complex deficiency in several
patients is in favor of this hypothesis. Remarkably, two of
these patients carried a MERRF mutation. Other possible
explanations are a mutation in a complex V subunit,
especially in subunit 6 or increased intramitochondrial
oxidative stress.
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Action of carnitine in treatment of patients with glutaric
aciduria type 1
H. Scholte*, L. Hussaarts-Odijk
Biochemie I, Erasmus Universiteit, Dr. Molewaterplein 40,
1738, 3000 DR Rotterdam, The Netherlands
h.scholte@erasmusmc.nl
Glutaric aciduria type I is caused by the deficiency of
glutaryl-CoA dehydrogenase in the mitochondria. In the
past, most children with glutaric aciduria type 1 suffered
from a sudden severe neurological disease and died before
the age of 10 years. Since the introduction of carnitine and
the limitation in the dietary intake of lysine and tryptophane
in treatment of the children, they develop normally, provid-
ed the treatment is instituted before the encephalopathy
occurs. The pathogenesis of this disease is still not fully
understood. There are several hypotheses explaining the
brain disease in the condition.
We studied the possibility that glutaryl-CoA could act
as an inhibitor of 2-ketoglutarate dehydrogenase of the
Krebs cycle, and that this inhibition is abolished by
carnitine. This hypothesis was supported by the finding
that 25 mM glutaryl-CoA inhibited 2-ketoglutarate dehy-
drogenase (from 100% to 54%) in homogenate from
cultured fibroblasts from a patient with glutaryl-CoA
dehydrogenase deficiency, and not in control fibroblasts
(100% to 93%). The inhibition in the patient cells was
abolished by L-carnitine (54% to 89%).
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Cells lacking mitochondrial DNA as a model to study the
interaction between the respiratory chain and cellular
proliferation
R. Wiesner*, M. Schauen, D. Spitkovsky, J. Fischer
Institute of Vegetative Physiology, University of Ko¨ln, Rob-
ert-Kochstr. 39, 50226 Cologne, Germany
Rudolf.Wiesner@uni-koeln.de
We have used HeLa rho0 cells to analyze how the
absence of a functional respiratory chain slows down
proliferation. ATP content and energy charge were the same
in wt and rho0 cells, ruling out these parameters as impor-
tant causes for the proliferative defect of rho0 cells. Flow
cytometric analysis revealed that the distribution of cells in
different stages of the cell cycle was not different in wt and
rho0 cells, implying that a deceleration of all stages was
responsible for the growth defect of rho0 cells. Cell cycle
progression is under control of cell cycle-dependent kinases
in association with specific cyclins, some of which were
analyzed by Western blotting. Expression of cyclin E andcyclin A, which control initiation and progression of S-
phase, and cyclin B, which controls G2/M, were not
different in both cell lines, consistent with similar cell cycle
profiles. However, we found global decreases in the expres-
sion of kinase inhibitors (p18, p19, p21CIP1/WAF, p27),
which control D-type specific kinase activity as well as
down-regulation of cyclin D3 protein expression. In sum-
mary, our data suggest that respiratory chain activity influ-
ences cellular proliferation by as yet unknown mechanisms
other than general energy supply.
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Respiratory complex III is required to maintain complex
I in mammalian mitochondria
J. Enriquez*, R. Acin-Perez, M. Bayona-Bafaluy, P. Fer-
nandez-Silva, R. Moreno-Loshuertos, A. Perez-Martos, C.
Bruno, C. Moraes
Biochemistry and Molecular Biology, Zaragoza University,
Miguel Servet, 177, 50013 Zaragoza, Spain
enriquez@unizar.es
A puzzling observation in patients with oxidative
phosphorylation (OXPHOS) deficiencies is the presence
of combined enzyme complex defects associated with a
genetic alteration in only one protein-coding gene. In
particular, mutations in the mtDNA encoded cytochrome
b gene are associated either with combined complex
I + III deficiency or with only complex III deficiency.
We have reproduced the combined complex I + III defect
in mouse and human cultured cell models harboring
cytochrome b mutations. In both, complex III assembly
is impeded and causes a severe reduction in the amount
of complex I, not observed when complex III activity was
pharmacologically inhibited. Metabolic labeling in mouse
cells revealed that complex I was assembled, although its
stability was severely hampered. Conversely, complex III
stability was not influenced by the absence of complex I.
This structure dependence among complexes I and III was
confirmed in a muscle biopsy of a patient harboring a
nonsense cytochrome b mutation.
P-196
Mitochondrial DNA adaptative mutations affect sperm
motility and latitude distribution
M. Lopez-Perez*, F. Montiel-Sosa, E. Ruiz-Pesini, J. Enrı´-
quez, A. Marcuello, C. Dı´ez-Sa´nchez, J. Montoya, D.
Wallace
Biochemistry, Molecular and Cell Biology, University of
Zaragoza, Miguel Servet 177, 50013 Zaragoza, Spain
lopezper@unizar.es
EUROMIT 696We have proposed that as humans migrated out of
Africa into temperate Eurasia, new mutations were se-
lected in the mitochondrial DNA (mtDNA) that shifted
the energy balance (coupling efficiency) of oxidative
phosphorylation (OXPHOS) from primarily ATP produc-
tion to increased heat production. To test this hypothesis,
we have analysed the mtDNAs of the ancient and
diverse European haplogroup U for mutations that could
increase heat and decreased ATP production. Three such
lineages were identified harbouring four different cyto-
chrome b (cytb) mutations. To determine if these cytb
mutations caused reduced ATP production, we examined
the motility rate of sperm from each U sub-lineage and
found that lineages with founding cytb mutations had
reduced sperm motility. To determine if these same
lineages had increased heat production, we examined
the north–south European distribution of the U sub-
lineages and found those with cytb mutations were
enriched in the more northern European latitudes. Thus,
haplogroup U sub-lineages with founding cytb mutation
have the features expected for cold-adaptive uncoupling
mutations.
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Familial mitochondrial myopathy and diabetes mellitus
due to a rare mtDNA mutation (tRNAGlu 14.709T>C):
clinical presentation and therapeutical effects
E. Wilichowski*, S. Bo¨ttcher, A. Ohlenbusch, A. van
Riesen, F. Hanefeld
Paediatrie II, Universitaets-Kinderklinik, Robert-Koch-
Strasse 40, D-37075 Go¨ttingen, Germany
EWilich@med.uni-goettingen.de
Background: Pure mitochondrial myopathies (MM) are
frequent in adult but rare in childhood patients, and present
with muscle weakness, hypotonia, exercise intolerance and
external ophthalmoplegia. ‘‘Ragged red fibers‘‘ (RRF) and
combined complex I + IV deficiencies are the morphological
and biochemical hallmarks in muscle biopsies. Awide range
of mitochondrial (mt)DNA mutations have been described
which usually involve tRNA genes of the mitochondrial
genome (mtDNA).
We here describe a family in whom the mother and
her daughter present with typical clinical signs of MM
and in which the disease segregates with a rare mt-tRNA
mutation.
Goals of this study: To describe the clinical, morpholog-
ical, biochemical and genetic presentation of MM in a
family and the effectiveness of various therapeutical
attempts.
Case report and results: The 15-year-old girl showed
hypotonia and delayed motor milestones since early
infancy and developed exercise intolerance with crampiand diabetes mellitus during the following years. The
43-year-old mother complains about increasingly exer-
cise intolerance and muscle crampi since some years. In
both, numerous RRF and a combined complex I + IV
deficiency were found on muscle biopsy. Sequencing of
all mt-tRNA genes in muscle DNA revealed a hetero-
plasmic T-to-C transition at position 14.709 in the
tRNAGlu gene with higher levels in the daughter than
in the mother. A therapeutical trial with riboflavine and
creatine monohydrate was of great benefit in the daugh-
ter—as indicated by bicycle ergometry—but not in the
mother.
Conclusion: We describe a family with the rare mt-
tRNAGlu mutation 14.709T>C. This maternal inherited
mutation manifests as a pure MM, which can successfully
be influenced by cofactors of the energy metabolism, and as
diabetes mellitus.
P-198
Homozygous POLG mutation in a young patient
presenting with SANDO phenotype
V. Paquis-Flucklinger*, M. Naı¨mi1, C. Richelme2,
C. Butori3, M. Monfort4
Faculte´ de Me´decine, FRE 2720 CNRS/UNSA, Av de
Valombrose, 06107 Nice cedex 2, France
1Service de Ge´ne´tique Me´dicale, CHU Nice, France
2Service de Pe´diatrie, CHU Nice, France
3Service d’Anatomo-Pathologie, CHU Nice, France
4Service d’Explorations Fonctionnelles, CHU Timone, Mar-
seille, France
paquis@unice.fr
POLG mutations in PEO families compatible with
recessive inheritance have been previously reported.
Here, we describe a 15-year-old boy who first presented
with frequent falls secondary to a cerebellar ataxia. The
family history is not contributory and he has a healthy
younger sister. The other clinical features of ophthalmo-
plegia and dysarthria led to the clinical diagnosis of
sensory ataxic neuropathy, dysarthria and ophthalmopa-
resis (SANDO). Histopathological examination revealed
typical mitochondrial myopathy features with 30% of
ragged fibers. Biochemical analysis showed decreased
activities in complexes I, III and IV. Multiple mtDNA
deletions were found in muscle. We identified an L304R
homozygous POLG mutation in exon 4. This mutation
has been previously described in a Belgian SANDO
family, carrying compound heterozygous POLG muta-
tions. Onset age was 8 years in our patient, 16–25
years in Belgian patients who had a milder phenotype.
This observation demonstrates that homozygous POLG
mutations can be responsible for ArPEO patients with
SANDO phenotype.
EUROMIT 6 97P-199
Exertional dyspnea in mitochondrial myopathy:
a consequence of severely impaired muscle oxidative
phosphorylation
R. Haller
Neurology, Institute for Exercise and Environmental Medi-
cine, 7232 Greenville Avenue, 75220 Dallas, TX, USA
Ronald.Haller@UTSouthwestern.edu
Exertional dyspnea (ED), mimicking severe cardiopul-
monary disease, may be the dominant symptom of mito-
chondrial myopathy (MM). We investigated this symptom
by comparing responses to peak cycle exercise (ventilation,
VE; oxygen uptake, VO2; carbon dioxide production,
VCO2; ventilatory equivalent for O2, VE/VO2; respiratory
exchange ration, VCO2/VO2; cardiac output, Q; and a-v
O2difference—calculated from the Fick equation, VO2=
Q a-v O2difference) in six patients with prominent ED
(EDMM), compared to 30 patients in whom dyspnea was
less prominent (MM) and 30 healthy subjects (HS). Resting
values were similar in all subjects. Peak VO2 in exercise in
EDMM (10.2 + 2.6 ml/kg/min) and MM (17.7 + 8 ml/kg/
min) were lower than controls (32.3 + 7.0 ml/kg/min), due to
a low peak a-vO2diff (EDMM=4.1 + 1.1, MM=8.8 + 3.4
ml/dl, controls = 15.22 + 2.1 ml/dl). Peak VE in EDMM
(69 + 26 l/min) and MM (58 + 24 l/min) were lower than
in HS (103 + 32 l/min) and peak VE/VO2 was dramatically
higher in EDMM (101 + 20) compared to MM (58 + 16) and
HS (41 + 7). Similarly peak RER was higher in EDMM
(1.66 + 0.4) than MM (1.18 + 0.01) or HS (1.14 + 0.06). In
both patient groups, peak VE/VO2 showed a close inverse
relationship (r2 = 0.73) to the level of impaired oxidative
phosphorylation, as reflected in peak a-vO2diff. We con-
clude that prominent ED in MM is associated with markedly
exaggerated ventilation and carbon dioxide production in
relation to O2 utilization. The degree of hyperventilation
correlates inversely with the level of muscle oxidative
defect, consistent with the hypothesis that exertional dys-
pnea is a direct consequence of the severity of impaired
oxidative phosphorylation in mitochondrial myopathy.
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Point mutations of mtDNA associated with acute
leukemia developing from myelodysplastic syndromes
B. Linnartz1, R. Anglmayer1, S. Zanssen*,2
1Department of Biochemistry, University Hospital Aachen,
Pauwelsstr. 3, 52074 Aachen, Germany
2Columbia University, Department of Neurology, 630 West
168th Street, 10032 New York, NY, USA
sz2106@columbia.eduMyelodysplastic syndromes (MDS) are clonal mye-
loid disorders characterized by ineffective hematopoiesis
resulting in refractory cytopenias. Transformation result-
ing in acute myeloblastic leukemia is the final stage in
the multistep process of MDS evolution. The MDS
subtype sideroblastic anemia has been shown to be
associated with mutations of mtDNA. To search for
alterations of the mitochondrial genome in other sub-
types of MDS and leukemia, we used high-resolution
techniques like SSCP and fluorescent sequencing for
investigation of the whole mitochondrial genome of 10
patients with MDS. New point mutations, fulfilling the
criteria for pathogenetically relevant mtDNA alterations
in tRNATyr, tRNAHis, 16S rRNA, and ATP synthase
subunit 6, were detected. Our work shows that muta-
tions of the mitochondrial genome exist not only in
sideroblastic anemia but also in other subtypes of
MDS. MDS and the developing acute myeloid leuke-
mia are connected by an increasing mutation load of
mtDNA. Several point mutations of mtDNA in the
bone marrow of one patient, including secondary point
mutations for Leber’s hereditary optic neuropathy
(LHON), occur in one bone marrow and may syner-
gically affect bone marrow stem cells by an apoptotic
pathway.
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In utero exposure to anti-HIV drugs causes
mitochondrial damage and mtDNA depletion in
umbilical cord tissue from human infants and
fetal Erythrocebus Patas monkeys
R. Divi*, S. Leonard, M. Kuo, K. Nagashima, M. St. Claire,
N. Wade, V. Walker, M. Poirier
CDI/LCCTP, National Cancer Institute, 37 Convent Dr,
Bldg.37, Rm 4032B, 20892-0001 Bethesda, MD, USA
NCI-Frederick, SAIC, Frederick, MD; Bioqual Inc., Rock-
ville, MD; Albany Medical Center, Albany, NY; LRRI,
Albequerque, NM
divir@exchange.nih.gov
Nucleoside reverse transcriptase inhibitors (NRTIs),
when given to HIV-1-infected pregnant women, effective-
ly reduce the risk of mother-to-child HIV transmission.
Mitochondrial dysfunction, a toxic consequence of NRTI
exposure in adults, has been reported in a few HIV-1-
uninfected children born to women receiving AZT and/or
3TC during pregnancy. However, most exposed children
do not present with clinical symptoms. To identify
potential molecular mitochondrial damage in the fetus,
we evaluated mitochondrial integrity in umbilical cords
from HIV-1-uninfected infants born to HIV-1-infected
women receiving Combivir (AZT + 3TC) during pregnan-
cy, and in fetal Erythrocebus Patas monkeys born to HIV-
1-uninfected dams given 3TC, AZT + 3TC, AZT+ ddI or
EUROMIT 6983TC + d4T during gestation. Umbilical cords from off-
spring of HIV-1-uninfected mothers and Patas dams were
used as controls. Mitochondrial morphology was analyzed
by electron microscopy, and mtDNA was measured by
hybrid capture chemiluminescence assay. Severe mito-
chondrial ultrastructural pathology, characterized by cris-
tae dissolution and membrane disruption, correlated
(r = 0.939) with significant mtDNA depletion (27–78%)
in umbilical cords from exposed human infants and fetal
monkeys. In the monkey model, the degree of morpho-
logical damage due to NRTI exposure ranked as follows:
3TC + d4T>AZT+ ddI>AZT+ 3TC>3TC. Despite the fact
that the infants were born to HIV-1-infected mothers and
the fetal monkeys were born to HIV-1-uninfected dams,
strikingly similar mitochondrial damage was observed in
the exposed offspring. This indicates that NRTI treatment
alone, irrespective of HIV-1 status, can cause mitochon-
drial toxicity.
P-202
Assessment of oxidative stress in transmitochondrial cell
lines
R. Gonzalo*, T. Vives-Bauza, E. Garcia-Arumi, A. Andreu
CIBBIM, Hospital General Vall Hebron, Pg Vall Hebron
119-129, 08035 Barcelona, Spain
rgonzalo@vhebron.net
The oxidative phosphorylation (OXPHOS) system is
the major production source of reactive oxygen species
(ROS) in cells. It is thought that oxidative stress could
play an important role modulating the cell phenotype
produced by mtDNA mutations. The aim of the study
was to assess the status of free radical production and
damage in cybrid cell lines harbouring different mtDNA
point mutations. These included the A8344G mutation in
tRNALys (MERRF line), the A3243G mutation in
tRNALeu(UUR) (MELAS line), and the G6930A muta-
tion in COX-I (COX line). Biochemical studies to assess
the levels of free radical damage and antioxidant defen-
ces included: hydrogen peroxide production, superoxide
dismutase (SOD), catalase and glutathione peroxidase
activities. Western blot analysis of SOD and catalase
proteins was performed to evaluate a putative increase in
protein levels. Lipid peroxidation was assessed by mea-
suring the malondialdehyde levels.
Hydrogen peroxide production and antioxidant enzyme
activities were increased in MERRF and MELAS cell lines,
but no increase was observed in COX cell line. Western blot
analysis suggested a different pattern for SOD and catalase
proteins (increase in SOD and maintenance in catalase
levels). Any of these cell lines showed changes in lipid
peroxidation levels.These results suggest that the impairment in the
activity of the OXPHOS system (such as in MELAS
and MERRF cells) leads to an increase in ROS pro-
duction. This increase results in an up-regulation of the
antioxidant system. Oxidative stress status will be more
important in some mutations than in others, and prob-
ably would modulate the phenotype of some mtDNA
mutations.
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Maternal inheritance in cyclic vomiting syndrome
R. Boles*, K. Adams
Pediatrics/Genetics, Childrens Hospital Los Angeles, 4650
Sunset, 90027 Los Angeles, CA, USA
rboles@chla.usc.edu
Background: Cyclic vomiting syndrome (CVS), char-
acterized by severe discrete episodes of nausea, vomiting
and lethargy, is a fairly common and disabling pediatric
condition that is associated with dysautonomia. Our
group recently published that maternal inheritance is
present in most children with CVS and additional
neuromuscular disease manifestations.
Methods: To determine if CVS in general demon-
strates maternal inheritance, a structured clinical inter-
view was administered to both parents of 80 unrelated
individuals with CVS ascertained randomly from the
database of the Cyclic Vomiting Syndrome Association.
HV1 and HV2 were cyclosequenced in patients and in
95 controls.
Results: Subjects and their matrilineal relatives
suffer at a far higher incidence from depression,
hypothyroidism, and several dysautonomic-related con-
ditions including migraine, irritable bowel and chronic
fatigue. There was a strong bias for maternal inher-
itance of disease, including in mothers vs. fathers
(relative risk 5.5; P= 3 10 9) and in maternal versus
paternal grandmothers (relative risk 4.0; P= 210 6).
Maternal inheritance is suggested in 53% of the
families, with no difference between subjects with
and without neuromuscular disease. Single nucleotide
polymorphisms were threefold (P < 0.01) more frequent
in CVS than in control subjects in an evolutionarily
highly conserved 150-bp region of HV1 encompassing
TAS.
Conclusions: Our data strongly suggest that mtDNA
sequences predispose towards the development of dis-
ease in our CVS subjects and their matrilineal rela-
tives, and that CVS is but one potential clinical
presentation. Our findings have important applications
in the treatment and counseling of individuals with
CVS.
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Modifiers of mitochondrial disease phenotype in
Drosophila
R. Manjiry
Molecular Biology, IMT, Biokatu 6, P.O. Box 607, 33520
Tampere, Finland
llshma@uta.fi
Human mitochondrial disease manifests with a wide
range of clinical phenotypes of varying severity. We have
manipulated the Drosophila gene technical knockout (tko),
encoding mitoribosomal protein S12, in order to create an
animal model to study some of these disorders.
A point mutation in this Drosophila gene (tko) produces
distinct developmental phenotypes of relevance to mito-
chondrial disease. The developmental and pathophysiolog-
ical abnormalities associated with the tko mutant, L85H, are
being studied using the GAL4 conditional expression sys-
tem. The wild-type tko gene has been engineered in to a P-
element construct that places it under the control of the
GAL4 UAS. Three UAS-tko+ lines have been selected for
detailed phenotypic characterization. Selective expression of
the wild-type allele indicates critical times and cell types in
development, in which mitochondrial protein synthesis
deficiency leads to specific phenotypic outcomes.
Currently, I am employing in situ hybridisation and real
time PCR to localise and quantify the specific tko mRNA
sequences in the three UAS-tko+ lines both with and
without induction by exogenously supplied Gal4p. The
three genes affected due to the transgene’s placement in
the genome will also be studied.
The third instar larvae stage is the major growth period
during larval development and we have previously shown
that restoration of mitochondrial translational capacity at
this stage is sufficient to overcome almost half of the tko25t
developmental delay.
In the adult fly, the bang-sensitive phenotype is essen-
tially the result of a neural deficit of mitochondrial bioen-
ergy, suggesting the involvement of the nervous system in
mitochondrial translation disorders.
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Spontaneous recovery of a childhood-onset
mitochondrial myopathy caused by a stop mutation
in the mitochondrial cytochrome c oxidase III gene
R. Horvath*, H. Lochmu¨ller, M. Hoeltzenbein, J. Mu¨ller-
Ho¨cker, B. Schoser, D. Pongratz, P. Freisinger, M. Jaksch
Metabolic Disease Center Munich-Schwabing, Academic
Hospital Schwabing, Koelner Platz 1, 80804 Muenchen,
Germany
horvath@lmb.uni-muenchen.deRecently, we reported on a patient suffering from mito-
chondrial myopathy with ragged red fibers (RRF), lactic
acidosis, exercise intolerance and delayed growth with a
heteroplasmic G9379A nonsense mutation (W58X) in the
mtDNA encoded COIII subunit gene.
An actual follow-up examination of the patient showed
remarkable clinical and electrophysiological improvement.
On a second muscle biopsy, signs of histological and
immunohistological improvement of the mitochondrial
myopathy were found, which was associated with a
significant decrease (from 93% to 50%) of the mutational
load of G9379A in skeletal muscle confirming a sponta-
neous regression of the disease. Myoblasts of the patient
did not carry the mutation, therefore, we suggest that the
fusion of wild-type mtDNA containing myoblasts into
existing muscle fibers might positively influence the
mutational rate in our patient’s muscle.
Our results demonstrate the variable course of diseases
caused by mtDNA mutations. We suggest that this possible
positive outcome should be considered in counselling
patients with mtDNA-mediated disorders.
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Protein import pathways to the mitochondrial inner
membrane
R. Rainey*, C. Koehler
Chemistry and Biochemistry, University of California, 607
Charles E. Young Drive East, 90095 Los Angeles, CA, USA
rrainey@chem.ucla.edu
In the general protein import pathway of mitochondrial
proteins imported from the cytosol, the Tim17p/Tim23p
complex of the inner membrane with a matrix-located
ATP-driven import motor consisting of Tim44p, mhsp70,
and mGrpE mediates import into the matrix. However,
mitochondria have a separate TIM machinery for import-
ing polytopic inner membrane proteins including the
multispanning metabolite carriers. This system consists
of at least two distinct complexes: a 70-kDa complex of
Tim9p and Tim10p in the intermembrane space and a
300-kDa inner membrane complex with Tim12p, Tim18p
Tim22p, Tim54p, and a fraction of Tim9p and Tim10p.
The Tim9p/Tim10p complex guides the carrier proteins
across the intermembrane space and the 300-kDa inner
membrane complex mediates insertion of the carriers into
the inner membrane. Tim9p, Tim10, and Tim12p along
with Tim8p and Tim13p form the small Tim family that
share an identity of 25% and have conserved cysteine
residues. The mitochondrion thus has developed an elab-
orate import system for guiding the hydrophobic inner
membrane proteins across the intermembrane space and
mediating insertion into the inner membrane.
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Organization of mtDNA heteroplasmy examined by in
situ hybridization
R. Gilkerson*, M. Davidson, E. Schon
Department of Neurology, Columbia University, 630 W.
168th St., 10032 New York, NY, USA
rg2156@columbia.edu
The existence of multiple forms of mitochondrial DNA
(mtDNA) within individual tissues and cells has been shown
to be an important determinant of respiratory phenotype and
clinical presentation. Both point mutations and deletions of
mtDNA are frequently found to exist alongside wild-type
(WT) mtDNAs in tissue and cell samples from mitochondrial
disease patients. Standard Southern blot analysis of mito-
chondrial genotype in cultured human cells can efficiently
determine themtDNA species present, but thismethod cannot
distinguish between intercellular heteroplasmy (i.e. a mixture
of completely WT and completely mutant cells) and intracel-
lular heteroplasmy, in whichWTandmutant mtDNAs coexist
within the same cell. We show that two-color fluorescence in
situ hybridization (FISH) can distinguish between these two
models of heteroplasmic organization and allows sequence-
specific determination of mtDNA content and distribution in
a cell culture system. Further studies of mtDNA heteroplasmy
will benefit from detailed information on the organization of
mtDNA genotypes within cultured cell populations.
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Mitochondrial biogenesis is under the control of two
different genetic systems: the nuclear and the mitochondrial
genome (mtDNA). To investigate the genetic mechanisms
controlling the cross talk between nucleus and mitochondria,
we studied the transcriptome of two human cell lines,
143B.206 and A549, which had been entirely depleted of
mtDNA (ro cells), and compared it with the corresponding r+
parental cells. Affymetrix Microchips U133A, containing
23000 annotated genes, were probed in triplicate with cRNAs
extracted from ro and parental cells. A list of 191 differen-
tially expressed genes, common to both cell lines, was
obtained by analyzing the hybridization profiles with dedi-
cated softwares (Mas 5 and Gene Spring). Real-time quanti-
tative reverse transcription PCR (qRT-PCR) is in progress to
validate the microarray results.Only 16 out of the 191 differentially expressed genes
are known to encode proteins targeted to mitochondria.
However, softwares scoring the likelihood of protein
sequences to be targeted to mitochondria (MitoProt, Pre-
dotar, TargetP) gave high values for 13 functionally un-
known additional proteins, which will be further analyzed
by using standard in organulum import assays. Other
differentially expressed proteins belong to different meta-
bolic pathways, including purine/pyrimidine biosynthesis,
cell cycle, and, notably, response to oxidative stress and
apoptosis.
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Many deficiencies in complex I, the first and largest
enzyme complex in the oxidative phosphorylation chain,
cannot be explained by means of genetic screening. Since
in these cases no mutation is found in any of the genes
encoding its 46 subunits, the problem may, analogous to
complexes III and IV, be in assembly. Although not much
is known about complex I assembly, intensified research in
the area has recently led to the first models in humans. Two
putative assembly factors are found in the fungus Neuros-
pora crassa of which the homologue of one, CIA30, is
found in humans. CIA30 is thought to be a chaperone in
assembly through the association of the small and large
membrane arm assembly intermediates of complex I. Fur-
ther investigation of its function in human complex I
assembly may aid the molecular characterisation of the
assembly pathway and thus of many of the unexplained
complex I deficiencies.
In this study we have developed an inducible expression
system for assembly factor CIA30. Using this system, we
show that CIA30 is targeted to the mitochondrion. By
using an antibody in combination with two-dimensional
blue native/SDS electrophoresis we demonstrate that
CIA30 occurs in high molecular weight subcomplexes.
The exact composition of these subcomplexes is still under
investigation. Interestingly, complex I deficient patients
show a significant change in the amount and relative
distribution of the CIA30 containing subcomplexes, con-
firming the important role of this protein in complex I
assembly.
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